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ABSTRACT 
To achieve fertilisation, human sperm have to navigate and interact with the female 
reproductive tract (FRT) on molecular and mechanical levels. The current knowledge of 
some aspects of both types of interactions are limited and they were examined in this 
research. 
Proteomic analysis of crude and depleted human follicular fluid (hFF) by three proteomic 
approaches identified 479 hFF-proteins of which 22% were novel. A table of hFF-proteins, 
compiled from twenty-four hFF proteomic studies, resulted in 1586 hFF proteins; a 
resource for folliculogenesis and discovery of hFF biomarkers. 
A comparative proteomic study of media-capacitated human sperm versus capacitated 
sperm in the presence of hFF revealed certain hFF proteins were acquired by sperm during 
capacitation.  Comparative metabolomics revealed some elevated metabolites in the sperm 
capacitation-media following 6-hour incubation compared to 1-hour swim-up, which may 
have relevance to sperm energy metabolism and potentially to sperm signalling 
mechanisms in the FRT causing remodelling for fertilisation and preparation for 
implantation.     
Sperm micro-particle image-velocimetry revealed an average fluid velocity around the 
motile sperm of ≤ 25- 45 µm/s and ≤ 20-35 µm/s in low and high viscosity media 
respectively. The averaged fluid vorticity manifested a trail of spatially confined mixing of 
the fluid surroundings motile sperm.  To the best of our knowledge, this work is the first to 
conduct a comparative proteomic analysis of human sperm versus sperm-hFF interaction 
and to perform metabolomics analysis of human sperm capacitation media at two time 
points. The novel perspective of mechanical aspects of sperm motility by studying fluid 
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velocity and vorticity around motile sperm adds a new approach to the study of sperm 
motility and chemotaxis.  
In conclusion, sperm-FRT interactions involve complex molecular and physical 
interactions and regulatory events. Further research of these interactions may enhance our 
understanding of potential applications for improved assisted reproductive techniques’ 
outcome and possible diagnostic approaches of infertility.     
  
III 
 
 
Dedications 
 
To the memory of my father, I miss you every second of my life 
To the memory of my brothers Mustafa and Abdullah, I hope you are in 
heaven 
To my devoted mother, I love you so much  
To my sister Abier, you taught me the love of books  
To all my sisters, Eman, Hana, Nada, Nisreen and Raja, I love you all so 
much  
To my brothers, Ahmed and Osama, I hope you all the best in your life 
 
 
 
 
 
 
 
  
IV 
 
Acknowledgments 
I would like to thank my lead supervisor Dr. Jackson Kirkman-Brown for his profound 
support and advice throughout my PhD. I am deeply grateful to his guidance and 
unconditional support. I would like to thank Dr. Linda Lefievre, my co-supervisor, for her 
great input and unlimited support throughout the years and hope her all the best.  I also 
would like to thank Dr. Sarah Conner for her valuable feedback and input and I really 
appreciate her kind support.  I am also grateful to Dr. Ashley Martin and Dr. Douglas 
Ward for running the mass spectrometry analyses of my proteomic data and their input for 
the experimental designs and proteomic approaches applied in this research.  
I am also deeply grateful to Dr. Hermes Gadelha (University of York) and Dr. David 
Smith for their kind collaboration and development of the MATLAB codes for my sperm 
micro-particle image velocimetry’s data analysis and their fruitful discussions and valuable 
feedback.  I am also extremely grateful to Dr. Warwick Dunn for running the mass 
spectrometry analysis of my metabolomics data, metabolomics data annotation and 
comparative analysis of the data and his valuable discussions and feedback.   
My immense gratitude goes to Dr. Lorraine Frew for the provision of research sperm 
donors throughout my PhD study and her kind cooperation and I would like to thank all 
the donors and patients at the Assisted Conception Unit, Birmingham Women’s Hospital 
who made this work possible. I am also highly grateful to Mrs Sarah Magson who 
facilitated my meetings with my supervisors and enabled smooth and organised PhD 
course and conferences’ attendance throughout my PhD study.     
I would like to extremely thank my colleague Benjamin Taiwo for his valuable discussions 
and feedback and I really appreciate his friendship. I am also grateful to his brother Dami, 
who I never met, for his kind support.  I also would like to thank the Libyan Ministry of 
V 
 
Higher Education for funding my PhD and the staff at the Libyan Cultural Attaché in 
London with special thanks to my supervisors Dr. Ali Al Faitori and Fowzi Alshawish for 
the precious administrative assistance. Finally I am very grateful to my family in Libya for 
their unconditional love and support and to my husband Ahmed for his great support and 
my children Mohamed and Suhaib who I hope will, one day, have their own PhD degree.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
VI 
 
TABLE OF CONTENTS 
Chapter 1: GENERAL INTRODUCTION ....................................................................... 1 
1.1 The Sperm cell ........................................................................................................ 2 
1.1.1 Spermatogenesis: ............................................................................................. 2 
1.1.2 Sperm cell structure: ........................................................................................ 4 
1.1.3 Sperm maturation in the Epididymis: .............................................................. 7 
1.1.4 Semen ............................................................................................................ 10 
1.2 The female reproductive tract (FRT): ................................................................... 13 
1.2.1 Menstrual cycle: ............................................................................................ 13 
1.2.2 Oogenesis: ..................................................................................................... 16 
1.2.3 Folliculogenesis: ............................................................................................ 17 
1.3 Sperm journey toward the oocyte: ........................................................................ 28 
1.3.1 Sperm transport through the vagina and cervix: ............................................... 28 
1.3.2 Sperm transport through the uterus and uterotubal junction: ............................ 29 
1.4 Regulation of sperm function ............................................................................... 33 
1.4.1 Sperm capacitation: ....................................................................................... 33 
The biphasic role of Ca
2+
 in capacitation: .................................................................... 35 
Tyrosine phosphorylation in sperm capacitation: ........................................................ 36 
The role of de-capacitation factors in regulation of capacitation: ................................ 38 
1.4.2 Post-translational modifications (PTM) of sperm proteins : ......................... 39 
1.4.3 Sperm motility ............................................................................................... 40 
1.4.4 Sperm guidance mechanisms in the FRT ...................................................... 42 
1.4.5 Acrosome reaction (AR):............................................................................... 44 
1.5 FF and sperm function and kinetics: ..................................................................... 48 
1.5.1 FF and sperm capacitation: ............................................................................ 49 
1.5.2 FF and sperm motility: .................................................................................. 49 
VII 
 
1.5.3 FF and sperm chemotaxis .............................................................................. 51 
1.5.4 FF and sperm acrosome reaction: .................................................................. 52 
1.5.5 FF and sperm quality: .................................................................................... 55 
1.6 Techniques: ........................................................................................................... 55 
1.7 Research aims: ...................................................................................................... 64 
Chapter 2: IDENTIFICATION OF NOVEL HUMAN FOLLICULAR FLUID 
PROTEINS BY PROTEOMIC TECHNIQUES ............................................................ 66 
2.0 Abstract ................................................................................................................. 67 
2.1 Introduction: .......................................................................................................... 68 
2.2 Objectives: ............................................................................................................ 72 
2.3 Materials and methodology: ................................................................................. 73 
2.3.1 Materials: ....................................................................................................... 73 
2.3.2 hFF collection: ............................................................................................... 74 
2.3.3 BCA assay for hFF protein concentration estimation: .................................. 75 
2.4 hFF preparations ................................................................................................... 75 
2.4.1 1st Approach: SPE/HPLC/MS ...................................................................... 75 
2.4.2 2
nd
 Approach :HAPs/SDS-PAGE/MS ........................................................... 78 
2.4.2.1 hFF (HAPs) depletion prior to SDS-PAGE: ..................................................... 78 
2.4.2.2 SDS -PAGE: ...................................................................................................... 78 
2.4.2.3 In-gel protein digestion and MS: ....................................................................... 79 
2.4.3  3rd Approach: HAPs/FC/SDS-PAGE/MS ................................................................ 81 
2.4.3.1 hFF (HAPs) depletion prior to SDS-PAGE: ........................................................ 81 
2.4.3.2 hFF concentration and filtration following depletion: ......................................... 81 
2.4.3.3 SDS-PAGE: ......................................................................................................... 82 
2.4.3.4 In-gel protein digestion: ....................................................................................... 82 
2.4.4 Mass spectrometry analysis: .......................................................................... 83 
VIII 
 
2.4.5 hFF proteins functional analysis: ................................................................... 84 
2.5 hFF compiled protein table from the literature: .................................................... 84 
2.5.1 Methodology for the hFF compiled protein data: ............................................... 84 
2.6 Results of hFF proteomics: ................................................................................... 89 
2.7 Discussion ............................................................................................................. 97 
Chapter 3: COMPARATIVE PROTEOMIC STUDY OF SPERM VERSUS SPERM 
AND HUMAN FOLLICULAR FLUID INTERACTIONS ......................................... 107 
3.0 Abstract: .............................................................................................................. 108 
3.1 Introduction: ........................................................................................................ 109 
3.1.1 Human sperm and hFF proteomics: .................................................................. 114 
3.2 Objectives ........................................................................................................... 117 
3.3 Methods: ............................................................................................................. 118 
3.3.1 Materials: ..................................................................................................... 118 
3.3.2 Sperm preparation: ...................................................................................... 119 
3.3.3 Follicular fluid collection: ........................................................................... 119 
3.4 Methodology: ...................................................................................................... 120 
3.4.1  Sperm + hFF total protein binding approach: .................................................. 120 
3.4.2 Sperm + hFF membrane-associated proteins approach: ................................... 121 
3.4.3 SDS -PAGE: ................................................................................................ 125 
3.4.4 In-gel protein digestion: .............................................................................. 126 
3.4.5 Mass spectrometry analysis: ........................................................................ 126 
3.4.6 Acrosome reaction assay ............................................................................. 127 
3.5 Results ................................................................................................................. 129 
3.5.1 Sperm + hFF total binding approach: .......................................................... 129 
3.5.2 Sperm + hFF membrane-associated proteins approach: .............................. 134 
3.5.3 Compiled results from both approaches: ..................................................... 139 
IX 
 
Novel sperm proteins: ................................................................................................ 141 
3.5.4 hFF proteins identified in sperm + hFF binding fraction: ........................... 142 
Functional classification of the hFF proteins bound to sperm: ...................................... 145 
3.5.5 Acrosome reaction results: .......................................................................... 147 
3.6 hFF proteins identified in sperm + hFF samples: ............................................... 149 
3.7 hFF and sperm acrosome reaction data:.............................................................. 155 
3.8 Discussion: .......................................................................................................... 155 
Chapter 4: SPERM METABOLOMICS ....................................................................... 164 
4.0 Abstract ............................................................................................................... 165 
4.1 Introduction: ........................................................................................................ 166 
4.1.1 Metabolomics in reproductive biology: ............................................................ 168 
4.1.2 Sperm metabolomics: ........................................................................................ 170 
4.2 Objectives: .......................................................................................................... 172 
4.3 Methods .............................................................................................................. 172 
4.3.1 Materials: ..................................................................................................... 172 
4.3.2 Sperm preparations: ..................................................................................... 174 
4.2.3 Metabolic profiling of samples: ............................................................................ 176 
Ultra-Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS): ........ 176 
Data pre-processing: ................................................................................................... 177 
Univariate and multivariate analysis: ......................................................................... 177 
4.3 Results: ..................................................................................................................... 178 
4.4 Discussion: ............................................................................................................... 194 
Chapter 5: SPERM MICRO-PARTICLE IMAGE VELOCIMETRY  (Sperm µPIV)
 ........................................................................................................................................... 203 
5.0 Abstract ............................................................................................................... 204 
5.1 Introduction: ........................................................................................................ 205 
X 
 
5.2 Objectives: .......................................................................................................... 212 
5.3 Methods: ............................................................................................................. 213 
5.3.1 Material ........................................................................................................ 213 
5.3.2 Methodology: .............................................................................................. 214 
5.3.3 PIV data analysis: ........................................................................................ 221 
5.4 Results: ................................................................................................................ 228 
5.4.1 Results in LVM: ................................................................................................ 228 
5.4.2 Results in HVM ................................................................................................. 239 
5.5 Discussion: ............................................................................................................... 242 
Future research and recommendations .......................................................................... 249 
Chapter 6 GENERAL DISCUSSION AND RECOMMENDATIONS ...................... 252 
General discussion ......................................................................................................... 253 
Future work: ................................................................................................................... 259 
APPENDICES .............................................................................................................. 264 
Appendix 1: Recipes and buffers ................................................................................... 265 
Appendix2:  (chapter 2) List of hFF proteins identified in the hFF proteomic study .... 266 
Appenidix 3 (chapter 2) Inclusion criteria for the hFF protein table ............................. 270 
Appendix 4 (chapter 3) List of proteins identified in sperm + hFF proteomic interactions
 ....................................................................................................................................... 273 
Appendix 5 (chapter 4) List of metabolites identified in sperm capacitation media ..... 289 
Appendix 6 (chapter 5) MATLAB codes for fluid vorticity .......................................... 296 
LIST OF REFERENCES ............................................................................................ 298 
 
  
XI 
 
LIST OF FIGURES 
Figure 1-1 Stages of spermatogenesis and illustration of sagittal view of the seminiferous 
tubule and epididymis (adapted from OpenStax College, Anatomy & Physiology book 
available at http://cnx.org/content/col11496/latest/ aslo available on public domains). ....... 3 
Figure 1-2 human sperm cell structure with two main components: head and tail. The tail 
is subdivided into four regions: conncting piece, mid piece, principal piece and end piece  
(adapted from https://www.boundless.com/ physiology/textbooks), figure is available on 
public domains. ...................................................................................................................... 4 
Figure 1-3  sperm head is composed of an acrosome and nucleus, the connecting piece 
contains the centriole while the midpiece mainly contains mitochondrial sheath (adapted 
from https://www.boundless.com/ physiology/ textbooks, also available on public 
domians) ................................................................................................................................ 5 
Figure 1-4 Diagram representing human sperm and ultrastructure of the flagellum. The 
flagellum is subdivided into four regions: conncting piece, mid piece, principal piece and 
end piece (from Gaffney et al, 2011, no permission is required from Annual Reviews). ..... 7 
Figure 1-5 The human female reproductive cycle showing changes in ovarian hormones 
and uterine lining (from https://www.britannica.com/science/menstrual-cycle) also 
available on public domains. ............................................................................................... 15 
Figure 1-6 Stages of follicular development and ovulation. A- Preantral stage of 
folliculogenesis, B- Antral stage of folliculogenesis, accumulation of hFF and ovulation 
(from Huang and Wells, 2010, with permission). ................................................................ 21 
Figure 1-7 Signalling pathways in human sperm capacitation. Two pathways are essential 
for sperm function. The first is the HCO
-3 
dependent activation of PKA by sAC/cAMP and 
the second involves the down-regulation of Ser/Thr phosphatases.  Human capacitation 
involve both early (1 minute)and late events (at least 6 h)  to achieve functional 
capacitation state, SFK stands for Src family kinase. Figure from  (Battistone et al., 2013) 
with permission. .................................................................................................................. 37 
Figure 1-8 Human sperm flagellar bending patterns in A- progressive motility and B- 
hyperactivated motility (figure from Suarez et al (2008a) with permission, adapted from 
Morales et al. (1988) . .......................................................................................................... 42 
XII 
 
Figure 1-9 Sperm guidance mechanisms in the mammalian FRT namely chemotaxis, 
thermotaxis, rheotaxis, ciliary beating and muscular contractions. Thermoatxis was 
described for rabbit (Bahat et al., 2005). ............................................................................. 44 
Figure 1-10 Acrosome reaction in human sperm (from 
http://humanphysiology2011.wikispaces.com/15.%20Reproductive%20Physiology), also 
available on public domain. ................................................................................................. 46 
Figure 1-11 Solid phase extraction by DSC18 spin columns, four main steps are 
performed to achieve sample peptide purification as shown in the figure: column 
conditioning, sample addition, washing to remove interferents (contaminants) and elution 
of the target sample peptides (figure from SPE, DSC18 manual). ...................................... 57 
Figure 1-12 The twelve high abundance proteins (HAPs) targeted by IgY-12 SCs in 
plasma which are similar to that in hFF and the pool of enriched medium and low 
abundance proteins obtained following depletion. The IgY-12 SCs are also shown (both 
figures from Beckman coulter IgY-12 manual at http://www.protocol online.org/) ........... 59 
Figure 1-13 The range of proteins molecular weights migration in NuPAGE Bis-Ris gels 
4-12% according to the buffer system utilised in running the gels. BSA: bovine serum 
albumin, MOPS: (3-(N-Morpholino) propanesulfonic acid), MES: 2-(N-morpholino) 
ethanesulfonic acid(figure from www.invitrogen.com) ...................................................... 62 
Figure 1-14 Basic components of mass spectrometry instruments, prepared samples are 
introduced into the ionisation source where molecules are charged into positive and 
negative charges and then analysed in the mass analyser according to their m/z ratio, the 
detector detects signals from the ionised molecules and deliver them to a computer system 
where the signals are interpreted to a mass spectrum. ......................................................... 63 
Figure 2-1 Summary of the 1
st
approach methodology, Solid Phase Extraction- Sodium 
Dodecyl Sulfate PolyAcrylamide Gel Electrophoresis/High Performance Liquid 
Chromatography/Mass Spectrometry (SPE SDS-PAGE/HPLC/MS). ................................ 77 
Figure 2-2  Summary of the 2
nd
 approach methodology, High Abundance Protein 
depletion/ Sodium Dodecyl Sulfate PolyAcrylamide Gel Electrophoresis/Mass 
Spectrometry (HAPs/SDS-PAGE/MS). .............................................................................. 81 
Figure 2-3  Summary of the 3
rd
 approach methodology, High Abundance Protein 
depletion/ Filtration concentration/Sodium Dodecyl Sulfate PolyAcrylamide Gel 
Electrophoresis/Mass Spectrometry (HAPs/FC/SDS-PAGE/MS). ..................................... 82 
XIII 
 
Figure 2-4 The number of hFF proteins identified in each of the 24 published studies 
included in the compiled hFF protein data. See table 2-1 for the detail of techniques 
utilised in each study. .......................................................................................................... 88 
Figure 2-5 Biological processes involved in the whole hFF proteome according to 
PANTHER classification system. Cellular process and metabolic process were among the 
highest categories. ............................................................................................................... 89 
Figure 2-6 Venn diagram of the results of the three approaches compiled together with the 
nuber of proteins identified in each approach. .................................................................... 90 
Figure 2-7 Venn diagram comparing number of protein detected in crude and HAPs 
depleted hFF in this study .................................................................................................... 91 
Figure 2-8  Venn diagram of the number of hFF protein identified in this study compared 
with the number of hFF proteins from the published studies. ............................................. 92 
Figure 2-9  hFF protein classification according to molecular functions ........................... 93 
Figure 2-10  hFF protein classification according to biological process ............................ 94 
Figure 2-11  hFF protein classification according to cellular components ........................ 95 
Figure 3-1 Diagrammatic representation of the roles of glycodelins in reproduction (from 
Yeung et al, 2009, with permission). Glycodelin S (GdS) in seminal plasma works as a de-
capacitation factor which retains the ejaculated sperm in non-capacitated condition by 
inhibiting albumin-induced cholesterol efflux (Yeung et al., 2006; Uchida et al, 2013). 
Following semen deposition in the FRT, cervical mucus removes the GdS from the sperm 
surface and permits capacitation by enhancing cholesterol efflux (Yeung et al., 2006). 
GdA, found in endometrial fluid (Li et al, 1993) and GdF (from hFF) bind to sperm and 
GdF suppresses early onset AR induced by P4 (progesterone)  and inhibits sperm zona 
binding while GdC, from the cumulus cells, stimulates sperm-zona (ZP) binding (Chiu et 
al., 2003a, Chiu et al., 2007, Yeung et al., 2006, Yeung et al., 2009, Chiu et al., 2005, Chiu 
et al., 2003b). ..................................................................................................................... 113 
Figure 3-2  The sequential steps in different human sperm proteomic approaches starting 
with sperm purification using swim-up or Percoll gradient centrifugation to the final 
analysis of peptides using mass spectrometry (from Amaral et al, 2014a, with permission).
 ........................................................................................................................................... 116 
Figure 3-3 Summary of the methodology of the sperm + hFF total binding approach, 
sperm cells were prepared by Percoll gradient centrifugation (Percoll GC), two sets of 
XIV 
 
samples prepared with and without hFF, both samples were incubated and washed prior to 
SDS-PAGE using only the pellet parts. SDS-PAGE/MS was then performed ................. 121 
Figure 3-4  NaCl concentration curve for membrane-associated approach. NaCl molarity 
and Tris-base pH in these experiments were as follow: A- 750 mM NaCl/Tris-base pH 7.5, 
750 mM NaCl/Tris-base pH 10.6 and 1M NaCl/Tris-base  pH 7.5 (samples were prepared 
from the same ejaculate from one donor). B- 1 M NaCl/Tris-base pH 10.6, and C- 2 M 
NaCl/Tris-base pH 7.5, 2 M NaCl/Tris-base pH 10.6 (the two gels in B and C were 
prepared from two ejaculates from the same donor) . ....................................................... 124 
Figure 3-5 Summary of the methodology of sperm + hFF membrane-associated protein, 
sperm cells were prepared by Percoll gradient centrifugation (Percoll GC), two sets of 
samples prepared with and without hFF, both samples were incubated and washed and the 
pellet part was further incubated in 2M NaCl prior to SDS-PAGE using only the 
supernatant parts. SDS-PAGE/MS was then performed ................................................... 125 
Figure 3-6  SDS-PAGE of samples in both approaches (A- Total binding approach and B- 
membrane-associated approach). Sperm and sperm + hFF samples were run along with a 
prestained standard in a precast 10% gel, gels were stained with Coomassie Brilliant blue.
 ........................................................................................................................................... 126 
Figure 3-7 Summary of the data analysis of the of sperm + hFF samples in the total 
binding approach. Protein data were compared with sperm data from Amaral et al, 2014a 
to recognise novel sperm proteins. Data were also compared with hFF compiled data from 
the literature to identify hFF acquired by sperm. .............................................................. 131 
Figure 3-8  Venn diagram for the results of sperm + hFF samples in the total binding 
approach. 22 hFF proteins were identified in the sperm + hFF samples in this approach 132 
Figure 3-9  Summary of the data analysis of sperm control samples in the total binding 
approach.  Protein data were compared with sperm data from Amaral et al, 2014a to 
recognise novel sperm proteins. ........................................................................................ 133 
Figure 3-10  Venn diagram of the results of sperm control protein data analysis in the total 
binding approach, 53 novel sperm proteins were identified in this approach ................... 134 
Figure 3-11 Summary of the data analysis of sperm + hFF samples in the membrane-
associated approach. Protein data were compared with sperm data from Amaral et al, 
2014a to recognise novel sperm proteins. Data were also compared with hFF compiled 
data from the literature to identify hFF acquired by sperm. .............................................. 136 
XV 
 
Figure 3-12  Venn diagram of the results of the sperm +hFF membrane-associated 
approach. Five hFF proteins identified in the sperm + hFF samples, 8 novel sperm proteins 
and 3 unknown source proteins. ........................................................................................ 137 
Figure 3-13 Summary of the data analysis of sperm control samples in the membrane-
associated approach. Protein data were compared with sperm data from Amaral et al, 
2014a to recognise novel sperm proteins, 13 proteins were novel sperm proteins. .......... 138 
Figure 3-14 Venn diagram of the protein results of sperm control samples in the 
membrane-associated approach, 13 novel sperm proteins were identified. ...................... 139 
Figure 3-15 Summary of the data analysis of the compiled results from both approaches.  
The total number of proteins identified in this study was 1530 proteins, Keratin proteins 
(four) were excluded from the final list. ............................................................................ 140 
Figure 3-16  Data compiled from both approaches, total binding and membrane-associated 
(both sperm control and sperm + hFF samples). hFF compiled proteins data were obtained 
from chapter two. The total number of proteins identified in this study was 1530 proteins, 
11 proteins were unknown source proteins (either novel sperm or novel hFF) not shown in 
this Venn diagram. Four other proteins were keratins and excluded from the final list. .. 141 
Figure 3-17 Molecular functions of the hFF proteins bound to sperm using PANTHER 
classification system, binding and catalysis were among the the highest categories 
followed by the enzyme regulation and receptor activity.................................................. 145 
Figure 3-18  Functional analysis for protein class of the hFF proteins acquired by sperm 
using PANTHER classification system. ............................................................................ 147 
Figure 3-19  Acrosome reaction assay data (n = 6) plotted as mean ± SEM. Sperm cells 
were treated with ionomycin (positive control), DMSO (negative control), progesterone 
and hFF.  * indicates a significant difference between control and treatments (* = P ≤ 0.05, 
** = P ≤0.01, *** = P ≤ 0.0001). ...................................................................................... 149 
Figure 4-1 Summary of the methodology of sperm sample preparations for metabolomics 
analysis. Three sets of samples were prepared: Control media (no sperm), TP1: 1 hour 
swim-up and TP7: 6 hours capacitation following 1 hour swim-up.................................. 175 
Figure 4-2 Metabolites  with the median concentration highest in the TP1 samples (one 
hour swim-up) compared to the TP7 samples (7 h-hour capacitation) and media (control).
 ........................................................................................................................................... 182 
XVI 
 
Figure 4-3 Metabolites with the median concentration is highest in the  TP1 samples (one 
hour swim-up) compared to the TP7 samples (7 h hour capacitation) and media (control)
 ........................................................................................................................................... 183 
Figure 4-4  Metabolites with the  median concentration is highest in the TP1 samples (one 
hour swim-up) compared to the TP7 samples (7 h-hour capacitation) and media (control)
 ........................................................................................................................................... 184 
Figure 4-5 Metabolites with the  median concentration is highest in the TP1 (one hour 
swim-up) compared to the TP7 samples (7 h-hour capacitation) and media (control) ..... 185 
Figure 4-6 Metabolites with the  median concentration is highest in the TP1 samples (one 
hour swim-up) compared to the TP7 samples (7 h-hour capacitation) and media (control)
 ........................................................................................................................................... 186 
Figure 4-7 Metabolites with the  median concentration is highest in the TP7 (7-hour 
capacitation) samples compared to the TP1 (one hour swim-up) samples and control media
 ........................................................................................................................................... 187 
Figure 4-8 Metabolites with the  median concentration is highest in the TP7 (7-hour 
capacitation) samples compared to the TP1 (one-hour swim-up) samples and control media
 ........................................................................................................................................... 188 
Figure 4-9 Metabolites with the  median concentration is highest in the TP7 (7-hour 
capacitation) samples compared to the TP1 (one-hour swim-up) samples and control media
 ........................................................................................................................................... 189 
Figure 4-10 Metabolites with the  median concentration is highest in the TP7 (7-hour 
capacitation) samples compared to the TP1 (one-hour swim-up) samples and control media
 ........................................................................................................................................... 190 
Figure 4-11 Metabolites with the  median concentration is highest in the TP7 (7-hour 
capacitation) samples compared to the TP1 (one-hour swim-up) samples and control media
 ........................................................................................................................................... 191 
Figure 4-12 Metabolites with the  median concentration is highest in the TP7 (7-hour 
capacitation) samples compared to the TP1 (one-hour swim-up) samples and control media
 ........................................................................................................................................... 192 
Figure 4-13 Metabolites with the  median concentration is highest in the TP7 (7-hour 
capacitation) samples compared to the TP1 (one-hour swim-up) samples and control media
 ........................................................................................................................................... 193 
XVII 
 
Figure 5-1 Selection of interrogation regions for PIV analysis; two interrogation areas are 
selected and cross correlation coefficient is calculated to determine vector displacement 
per image analysed. ........................................................................................................... 209 
Figure 5-2 Image of sperm cells ≤ 2-10  in low viscosity media (LVM), PS beads’ 
diameter is 0.5µm) viewed in a 10 micron chamber under 40 × magnification lens. ....... 216 
Figure 5-3  10 μm vertical depth chamber used in this study; A, B, C, D are the loading 
zones with loading capacity of 1-2 µl................................................................................ 217 
Figure 5-4  Clumps formation following the addition of the methylcellulose powder to the 
PS beads preparation to obtain high viscosity media of 1 % methylcellulose + PS beads, 
this preparation was not utilised in the study. ................................................................... 219 
Figure 5-5 Improved HVM preparations with minimum clumps formation following the 
addition of PS beads solution to the  2% MC (methylcellulose) to achieve final 
concentration of 1% MC containing PS beads .................................................................. 220 
Figure 5-6  PIV analysis workflow for fluid velocity and vorticity analysis. Recorded 
sperm movies were sequenced into images and the quality of the retrieved images was 
enhanced using pre and post-processing tools available in MATLAB built-in function .. 222 
Figure 5-7  Sperm in LVM, original image before and after pre-processing filters enabled. 
CLAHE (Contrast limited adaptive histogram equalisation) enables equalisation of light 
intensities on the different regions of the image. The intensity high-pass filter allows the 
removal of background noise while the intensity capping filter enables selection of  a 
threshold to adjust the image brightness. .......................................................................... 223 
Figure 5-8  Sperm in HVM (high viscosity media), original image before and after pre-
processing filters enabled (the function of the filters are illustrated in figure 5-7 in LVM)
 ........................................................................................................................................... 224 
Figure 5-9  A- Selection of region of interest (ROI) from the full field of view in the 
original movie and B-  the analysis of the velocity magnitude based on the selected ROI. 
Sperm position is indicated on the velocity plot by illustration taken from the matching 
frame in the original movie. .............................................................................................. 225 
Figure 5-10  Fast Fourier Transform (FFT) with three passes and interrogation areas 
selected, pass 1 at 64 × 64 pixels, pass 2 at 32× 32 pixels and pass 3 at 16× 16 pixels (each 
pass with 50 % overlap between the neighbouring interrogation areas). The image was 
taken from sperm in HVM movie 2. ................................................................................. 226 
XVIII 
 
Figure 5-11 An example of a scatter plot to select velocity limit and exclude any outliers 
which may affect the average value in the data analysis (velocity magnitude is shown in 
pixel/frame, prior to calibration). ...................................................................................... 227 
Figure 5-12  Fluid velocity around motile sperm coded in yellow colour shows a 
maximum velocity magnitude 4.5 × 10
-5 
m/s (45 µm/s). Minimum velocity was 5× 10
-6 
m/s 
(5 µm/s) in areas distant from the motile sperm coded in blue colour. The range of fluid 
velocity near a motile sperm in this movie was 30-45 µm/s. Sperm position is indicated on 
the velocity plot by illustration taken from the matching frames in the original movies. 
Data taken from LV8: low viscosity 8th movie with ≤ 2-10 motile sperm in the field of 
view. .................................................................................................................................. 229 
Figure 5-13 Fluid velocity magnitude around single motile sperm in LVM at different 
frame points. Sperm position is indicated on the velocity plot by illustration taken from the 
matching frames in the original movie. Fluid velocity magnitude near motile sperm 
(yellow coded areas) in this movie ranged from 2.5 × 10 
-5 
m/s – 4 × 10 -5 m/s (25-40µm/s)  
. .......................................................................................................................................... 230 
Figure 5-14 Control area with no sperm in the field of view in LVM, the maximum 
velocity magnitude coded in yellow was 4 × 10 
-6 
m/s (4 µm/s) and the minimum was 0.5 
10 
-6 
m/s (0.5 µm/s) ............................................................................................................ 231 
Figure 5-15  The time-averaged fluid vorticity near motile sperm manifested as sperm 
trails along the sperm swimming paths. Trail LV1 is for a single sperm analysed in a full 
field of view, trail LV2 is for a single sperm analysed in a ROI, trails LV3 and LV4 for 
two sperm analysed in ROI and trails LV5 and LV6 are for ≤ 2-10 sperm in the full field of 
view, colour codes represent fluid vorticity around motile sperm measured in inverse 
seconds S
-1 
. ....................................................................................................................... 233 
Figure 5-16 The same time-averaged fluid vorticity near motile sperm in figure 5-15 to 
show how adjusting the colormap bar in each data set will enhance the visualisation of  the 
averaged vorticity trails analysed. ..................................................................................... 234 
Figure 5-17 Time-averaged fluid vorticity for a single sperm adhered to the surface of the 
chamber’s wall.  LV7: averaged vorticity trail manifested as a circumscribed area around 
the adhered sperm in LVM with single sperm in the field of view. LV8: averaged fluid 
vorticity around ≤ 2-10 sperm in the field of view with one sperm adhered to the 
chamber’s inner wall. The adhered sperm showed a circumscribed area for the averaged 
XIX 
 
fluid vorticity similar to the one observed in LV7 while the freely motile sperm showed 
trails. .................................................................................................................................. 235 
Figure 5-18  Averaged fluid vorticity for control area with no sperm in the field of view in 
LVM, , no trail was manifested. ........................................................................................ 235 
Figure 5-19  Sperm-motility path of a single sperm  A- Image 1, the first image in the 
original movie with sperm position highlighted in red, B- Image 1727, the last image in the 
image sequence with sperm position highlighted in red. C- The averaged fluid vorticity 
analysis over the whole frame range of image sequence; a fluid vorticity trail can be 
visualised along the sperm motility path (images were taken from movie LV1 in LVM).
 ........................................................................................................................................... 236 
Figure 5-20 Fluid velocity magnitude around motile sperm coded in yellow colour shows 
a maximum velocity magnitude of 2.5 × 10
-5 
m/s (25 µm/s). Minimum velocity magnitude 
was < 5 × 10
-6 
m/s (5 µm/s) in areas distant from sperm, coded in blue colour. The range 
of fluid velocity near a motile sperm in this movie was 15-25 µm/s.  Sperm position is 
indicated on the velocity plot by illustration taken from the matching frames in the original 
movies. Data taken from HV4 movie with ≤ 2-10 sperm in the field of view. ................. 239 
Figure 5-21 Sperm velocity magnitude in HVM in the range of 20-30 µm/s in this movie. 
Sperm position is indicated on the velocity plot by illustration taken from the matching 
frames in the original movies, data  taken from movie HV2, ROI.................................... 240 
Figure 5-22 Averaged-fluid vorticity around motile sperm analysed in HVM;  trails HV1, 
HV3 and HV4 analysed with ≤ 2-10 sperm in the field of view while HV2 was analysed 
with a single sperm in the field of view............................................................................. 241 
 
  
XX 
 
 
LIST OF TABLES 
Table ‎1-1 Summary of Follicular fluid contents: ................................................................ 26 
Table ‎1-2 A comparison of certain HAPs contents in hFF with blood serum (adapted from 
Johnson, 1973, Edwards, 1974) ........................................................................................... 27 
Table ‎2-1  List of proteomic studies of  hFF protein since 1996 to date, abbreviations are 
included in the list of abbreviations ..................................................................................... 69 
Table ‎2-2 Materials for hFF proteomic  .............................................................................. 73 
Table ‎2-3 hFF biomarkers described in the literature ....................................................... 105 
Table ‎3-1 Materials for sperm + hFF proteomic interactions ........................................... 118 
Table ‎3-2 Materials for acrosome reaction assay ............................................................. 127 
Table ‎3-3 hFF proteins detected in sperm + hFF samples compiled from both approaches
 ........................................................................................................................................... 143 
Table ‎3-4 % stimulation of AR ......................................................................................... 148 
Table ‎3-5 Methods of sperm purification for proteomic analysis in the literature, data 
taken from Amaral et al, 2014a, total number of studies 29 ............................................. 163 
Table ‎4-1 Materials for sperm metabolomics  .................................................................. 172 
Table ‎4-2 Components of suplemented Earls Balanced Salt Solution (sEBSS) ............... 173 
Table ‎4-3 Detail of number of metabolites and their classes in sperm metabolomics ..... 181 
Table ‎5-1 Materials for sperm µPIV ................................................................................. 213 
 
  
XXI 
 
LIST OF ABBREVIATIONS 
µPIV: micro-particle image velocimetry 
cP  centipoise 
1cP 1cP = 0.001Pa.s 
2D-PAGE: 2 dimensional Polyacrylamide Gel Electrophoresis 
ART Assisted Reproductive Techniques 
BSA  Bovine serum albumin 
CASA  computer assisted semen analysis 
COC cumulus oocyte complex 
DTT Dithiothreitol 
EDTA  Ethylene diaminetetra acetic acid 
ESI electro spray ionization 
ESI-QTOF electrospray ionization-quadrupole time of flight mass spectrometry 
FC fold change 
FDR False discovery rate 
FF follicular fluid 
fps Frame per second 
FRT Female reproductive tract 
GC–MS gas chromatography–mass spectrometry  
GCs granulosa cells 
HAPs High Abundance Proteins 
hFF Human follicular fluid 
HMD       Human Metabolome Database  
HPLC  high performance liquid chromatography 
HVM High viscosity media  
i TRAQ Isobaric tags for relative and absolute quantitation 
IEF  Iso Electric Focusing 
LAPs  Low abundance proteins 
LPC  lysophosphatidylcholine 
LVM  low viscosity media 
XXII 
 
MALDI-TOF  Matrix-assisted laser desorption/ ionization-Time of Flight  
MC methylcellulose 
MS Mass spectrometry 
NMR nuclear magnetic resonance  
Pa.s Pascal.second 
PS beads  Polystyrene beads 
PBS Phosphate buffered solution 
ROI Region of interest 
rnd proteins random sequence proteins 
SCX Strong cation exchange chromatography 
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
sEBSS supplemented Earle’s balance salt solution 
SELDI-TOF Surface-enhanced laser desorption/ionization- Time of Flight  
SP seminal plasma 
SPE Solid phase extraction 
TP1 1-hour swim-up samples (sperm capacitation media at time point at1h) 
TP7 7-hour samples (sperm capacitation media at time point after 7-hour 
capacitation) 
UPLC–MS Ultra-performance liquid chromatography–mass spectrometry  
  
 
 
1 
 
 
 
 
 
Chapter 1  
GENERAL INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
  
2 
 
1.1 The Sperm cell 
1.1.1 Spermatogenesis:  
Spermatogenesis is a distinct biological process by which undifferentiated spermatogonia 
develop, over a period of several weeks, into mature sperm cells with a haploid number of 
chromosomes (Hermo et al., 2010).  This process occurs in the testis within the 
seminiferous epithelium, which is composed of Sertoli cells and several germ cells types.  
Spermatogenesis begins at puberty and continues throughout adult life with approximately 
200 million sperm per ejaculate in human. Four consecutive stages are involved in 
spermatogenesis with the whole cycle taking around 64-74 days to finally produce mature 
sperm (figure 1-1) (Heller and Clermont, 1963, Heller and Clermont, 1964). The first 
phase of spermatogenesis involves spermatogonial proliferation through several mitotic 
divisions resulting in two diploid cells (spermatogonia and primary spermatocytes).  The 
primary spermatocyte undergoes the second phase of cellular division through two rounds 
of meiosis; from primary spermatocyte to two secondary spermatocytes, then to four 
haploid round spermatids.  The third phase of spermatogenesis is the spermiogenesis in 
which the spherical spermatids transform by differentiation of a head and tail structure and 
reduction of cytoplasm to produce the mature spermatozoa, which is followed by the final 
stage of spermatogenesis (spermiation), marked by the sperm release into the tubule lumen 
(McLachlan et al., 2002, Amann, 2008).  These stages are interdependent; nevertheless, 
each stage has distinctive regulatory microenvironment contributed by the secretions of the 
neighbouring Sertoli cells, Leydig cells and the surrounding vascular network in endocrine 
and paracrine patterns (Amann, 2008). Testosterone, growth factors and neuroendocrine 
compounds secreted by Sertoli and Leydig cells determine the intrinsic regulatory 
mechanism of spermatogenesis (Middendorff et al., 1997) while follicle stimulating 
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hormone (FSH) secreted by the anterior pituitary gland and gonadotropin releasing 
hormone (GnRH) secreted by the hypothalamus determine the extrinsic regulation of 
spermatogenesis (Holstein et al., 2003).  FSH stimulates Sertoli cells whereas GnRH 
induces luteinizing hormone (LH) release from the hypophysis which in turn stimulates 
Leydig cells to secrete testosterone (Holstein et al., 2003). Additionally, feedback 
mechanisms are manifested by inhibin secreted via Sertoli cells and testosterone levels 
released from Leydig cells to regulate the hypophysis-GnRH secretory activity (Holstein et 
al., 2003). 
 
 
Figure 1-1 Stages of spermatogenesis and illustration of sagittal view of the seminiferous 
tubule and epididymis (adapted from OpenStax College, Anatomy & Physiology book 
available at http://cnx.org/content/col11496/latest/ also available on public domains). 
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1.1.2 Sperm cell structure: 
Mature sperm are compact, highly differentiated and compartmentalised cells with a 
haploid number of chromosomes.  All mammalian sperm share a common structure of a 
head and tail (flagellum) (Peter and Gaurishankar, 2006) (figure 1-2).  The sperm head is 
approximately 4-5µm long and is composed of a membrane-enclosed nucleus and 
acrosome (Mortimer, 1997); the nucleus is highly condensed due to the partial replacement 
of histones with protamines during spermatogenesis (Wouters-Tyrou et al., 1998). This 
nuclear hyper-condensation is important for sperm head hydrodynamic shape and 
compactness which enables sperm motility and oocyte penetration (Brewer et al., 2002).  
Nonetheless, this highly packed DNA within the sperm nucleus means sperm are not 
capable of transcription and translation (Luconi et al., 2004). This inability to synthesise 
new proteins results in sperm reliance on post-translational modifications of already 
existing proteins to achieve functional competence and fertilisation (Naz and Rajesh, 
2004).  These modifications are evident within the epididymis (see section 1.1.3) and 
during capacitation (section 1.4.1). 
 
 
 
Figure 1-2 human sperm cell structure with two main components: head and tail. The tail 
is subdivided into four regions: conncting piece, mid piece, principal piece and end piece  
(adapted from https://www.boundless.com/ physiology/textbooks), figure is available on 
public domains. 
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The sperm acrosome is a secretory vesicle packed with a complex combination of lytic 
enzymes, including hyaluronidase and acrosin which are released upon acrosome 
exocytosis (Yanagimachi, 1994b). The acrosomal cap is formed from the Golgi apparatue 
during early spermiogenesis and covers the anterior two thirds of the sperm nucleus 
(Yoshinaga and Toshimori, 2003), figure 1-3.  
 
 
 
Figure 1-3  sperm head is composed of an acrosome and nucleus, the connecting piece 
contains the centriole while the midpiece mainly contains mitochondrial sheath (adapted 
from https://www.boundless.com/ physiology/ textbooks, also available on public 
domians)  
 
6 
 
Acrosome abnormalities, such as acrosome hypoplasia in which the acrosome is small and 
detached and chromatin condensation is diminished, are associated with male infertility 
(Chemes and Alvarez Sedo, 2012).  Total globozoospermia, where the semen contains 
only round-headed sperm with absent or malformed acrosomes is a further example of 
acrosomal deficiency resulting in male infertility (Dam et al., 2007).  Increased levels of 
DNA damage and perturbed chromatin compaction have also been observed in the 
globozoospermic sperm (Dam et al., 2007).    
The sperm tail (flagellum) is generally divided into four regions (figure 1-4); the 
connecting piece, which links the tail with head region; the mid-piece, which links the 
connecting piece with the annulus which marks the end of the mid-piece and the beginning 
of the principal piece and finally the end piece (Mortimer, 1997, Fawcett, 1975).  Each of 
the four regions has some unique characteristics, for example, the midpiece exclusively 
contains the mitochondria essential for adenosine triphosphate (ATP) production required 
for sperm flagellar motility while the principal piece exclusively contains the fibrous 
sheath (FS) (Turner, 2006).   
The ultrastructure of the sperm tail is critical for its function (Turner, 2006).  The axoneme 
is the motor part and is arranged in 9 + 2 microtubule doublets extending throughout the 
length of the four tail regions and it has inner and outer dynein arms which extend from 
each of the outer nine doublets (Turner, 2006). These dynein arms are believed to be 
responsible for the generation of the propulsive force of the sperm flagellum (Fawcett, 
1975, Clermont et al., 1990, Turner, 2006).  In the mid-piece, the presence of nine outer 
dense fibres (ODFs) surrounding each of the nine outer axonemal microtubules enclosed in 
a mitochondrial sheath is characteristic of this region (Turner, 2006). The principal piece 
has seven ODFs as two of the nine ODFs are replaced by two longitudinal columns of FS 
7 
 
in this region and both ODFs and FS taper and terminate at the end of the principal piece 
(Turner, 2006).  The end piece has only the axoneme surrounded by plasma membrane and 
marks terminal section of the sperm flagellum (Turner, 2006).  
 
 
Figure 1-4 Diagram representing human sperm and ultrastructure of the flagellum. The 
flagellum is subdivided into four regions: conncting piece, mid piece, principal piece and 
end piece (from Gaffney et al, 2011, no permission is required from Annual Reviews).   
 
1.1.3 Sperm maturation in the Epididymis: 
From the testis to the deferent duct, sperm cells are exposed to a distinct environment 
created by very restrictive exchange that is isolated from the rest of the body by a blood-
testis barrier (Dacheux and Dacheux, 2014).  Both Sertoli cells within the testis and 
epididymal epithelium play major roles in the formation of this unique milieu which sperm 
are exposed to prior to ejaculation (Dacheux and Dacheux, 2014).  However, testicular 
sperm are unable to fertilise oocytes (Cornwall, 2009) and as they transit through the 
epididymis, sperm acquire progressive motility and the ability to capacitate in a series of 
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sequential events termed maturation which culminates with the sperm’s capability for 
fertilisation (Cooper, 1995, Cooper, 2007).  The epididymis is a long convoluted tubule, 
several metres in length, which is divided into distinct segments that each have a unique 
microenvironment (Cornwall and von Horsten, 2007).  These epididymal segments 
(namely caput, corpus and cauda) synthesise and secrete proteins in a segment-defined 
manner (Cornwall, 2009). The transit time of sperm through the epididymis varies from a 
few days to three weeks with an average of 11 days in humans  (Cooper, 2007).  
The maturing sperm acquire some epididymal proteins which are vital for functional 
modulation (Cooper, 1995). Simultaneously, the epididymal milieu’s composition also 
undergoes consecutive changes throughout the epididymis length in parallel to the sperm 
maturation process (Dacheux and Dacheux, 2014).  Extensive research has been devoted to 
understand the interplay between both sperm maturation within the epididymis and the 
changes in epididymal environment composition and the role of these changes in sperm 
fertilisation in several species (reviewed in Dacheux and Dacheux (2014)).   
During their transit through the epididymis, sperm are exposed to changes in the 
composition of the epididymal fluid caused by water reabsorption, leading to increased 
sperm concentration paralleled to remarkable changes in the epididymal fluid ionic 
composition (Da Silva et al., 2006). Furthermore, there are resultant increases in the 
luminal fluid’s protein concentration which reaches an average of 20-30 mg/ml in the 
distal parts of the epididymis (Fouchécourt et al., 2000, Belleannée et al., 2011, Dacheux 
et al., 2012).  Modifications of epididymal protein and ionic compositions have been 
linked to sperm maturation events such as cytoplasmic droplet migration, initiation of 
flagellar beating and ability to bind to the zona pellucida in several mammalian species 
(Dacheux and Dacheux, 2014).  The roles of epididymal proteins in the modification of the 
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sperm surface and their contribution to sperm survival and function have been 
demonstrated in several studies (reviewed in Dacheux and Dacheux (2014)).  Sperm 
acquire low molecular weight compounds from epididymal secretions during the 
maturation process (Cooper, 2007). The sperm interaction with epididymal proteins is 
critically important as the sperm are unable to actively synthesise new proteins as 
discussed earlier (Cornwall, 2009). However, the exact biochemical and molecular 
changes which  are involved in the sperm maturation within the epididymis remain elusive 
(Cornwall, 2009).  
Several studies have aimed to identify the epididymal proteins’ composition and to 
understand the specific roles of the identified proteins in the sperm maturation process 
(Turner et al., 1979, Brooks, 1981, Dacheux and Dacheux, 2014).  Despite considerable 
progress in proteomics technology in recent years, the complete epididymal protein profile 
is still proving technically challenging (Dacheux and Dacheux, 2014).  This is attributed to 
the immense variation in protein concentrations seen in epididymal fluid which exceeds 12 
orders of magnitude in comparison with the 4-6 orders of magnitude detectable by the 
most sensitive mass spectrometers (Dacheux and Dacheux, 2014).  Currently, hundreds of 
the epididymal proteins have been identified (Dacheux and Dacheux, 2014).  Albumin, 
clusterin, lactoferrin, α1-antitrypsin, extracellular matrix protein, transferrin, actin binding 
protein, prostaglandin D2 synthase (PTGDS) and Niemann-Pick disease type C2 (NPC2) 
protein represent approximately 77% of the total human epididymal proteins (for the full 
list of the identified human epididymal proteins and their proportions see (Dacheux et al., 
2006).  However, the molecular functions of these proteins in sperm maturation is still not 
fully characterised (Cornwall, 2009). One of the important epididymal, non-sperm 
expressed proteins acquired by sperm during their epididymal transit is the cysteine-rich 
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secretory protein 1 (CRISP1) (Cohen et al., 2000).  CRISP1 has been shown to work as a 
decapacitation factor to maintain sperm in a quiescent state within the epididymis 
(Koppers et al., 2011). 
1.1.4 Semen  
In humans, ejaculated semen comprises of sperm and seminal plasma (SP). The SP is a 
complex fluid mixture which determines the chemical properties of the ejaculate and is 
crucial for sperm survival (Juyena and Stelletta, 2012).  Seminal plasma is a mixture of 
constituents secreted by a number of glands (Owen and Katz, 2005). First are the 
secretions of the Cowpers (bulbourethral) and Littre glands which contribute  about 5% of 
the  ejaculate while the prostate forms the second part which is around 15-30% of the 
ejaculated semen (Owen and Katz, 2005).  The seminal vesicle contributes the bulk of the 
semen while the ampulla and epididymis contribute small amounts (Owen and Katz, 
2005).  Notably, these constituents are not entirely mixed and therefore, the first part of the 
ejaculated semen is not completely homogenous  (Owen and Katz, 2005).  Within the 
ejaculate, sperm form only around 1-5% of the total semen volume (Mortimer, 1994).  The 
roles of SP have been studied extensively in different species (Juyena and Stelletta, 2012). 
Some components within SP have been shown to contribute to fundamental events in 
sperm function, to provide optimum nutrition and to prevent premature capacitation 
through capacitation inhibitors (Desnoyers and Manjunath, 1992, Villemure et al., 2003, 
Juyena and Stelletta, 2012).  For example, prostasomes, which are sub-micron, membrane-
bound secretory granules secreted by the prostate epithelium and form a fraction of the 
seminal fluid (Burden et al., 2006, Ronquist and Brody, 1985), have been shown to 
undergo fusion with sperm resulting in direct transfer of the prostasomes’ proteins to the 
sperm (Ronquist and Nilsson, 2004).  The newly acquired prostasomes’ proteins contribute 
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to sperm Ca
2+
 signalling mechanisms (Park et al., 2011) and are important for sperm 
survival and motility in the female reproductive tract (FRT) (Ronquist and Nilsson, 
2004).  Prostasomes and their functions in sperm are extensively reviewed in (Ronquist, 
2012) and for a review of seminal plasma properties see Owen and Katz (2005) and Juyena 
and Stelletta (2012). 
The response of the FRT to semen exposure and its effect on the success of natural fertility 
and ART has been the core of numerous studies in several species.  Immunological, 
inflammatory and molecular changes have been observed following the deposition of 
semen into the FRT (Muller et al., 2006) in several species.  Both sperm (Pandya and 
Cohen, 1985, Thompson et al., 1992) and seminal fluid (Sharkey et al., 2007) have been 
suggested to elicit signalling response in human FRT, mainly in the form of leucocytic 
infiltration of the vagina and cervix.   Exposure of the FRT to semen has also been shown 
to provoke an inflammatory response manifested by a remarkable infiltration of 
macrophages, T cells and dendritic cells and increased cytokines release (Schuberth et al., 
2008);  in pig (O’Leary et al., 2006),  in sow (Rodriguez-Martinez et al., 2010) in mouse 
(Robertson et al., 1996) and in humans (Sharkey et al., 2007).   
It has also been suggested that prior contact of the FRT to semen may enhance endometrial 
receptivity and improve pre-implantation embryo development (Katila, 2012, Tremellen et 
al., 2000). This is attributed to enhanced immune tolerance of the FRT prompted by the 
previous exposure to seminal fluid which represents the paternal alloantigens (Robertson et 
al., 2009, Katila, 2012).  Furthermore, greater risk of failed implantation, spontaneous 
miscarriage and pre-eclampsia have been linked to lack of prior exposure to semen in 
women in their first pregnancy or who conceived via IVF or in those using barrier method 
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of contraception such as condoms (Klonoff-Cohen et al., 1989, Robillard et al., 1994, 
Bellinge et al., 1986, Tremellen et al., 2000).  
In mouse, transforming growth factor-b (TGF-B) from seminal fluid has been identified as 
a significant component to maintain maternal tolerance to pregnancy and implantation 
(Robertson et al., 2006a, Robertson et al., 2009) through regulation of endometrial 
epithelium and stimulation of certain pro-inflammatory cytokines such as Granulocyte-
macrophage colony-stimulating factor (GM‐CSF) (Tremellen et al., 1998).  Similarly, 
TGF-B from human seminal fluid has been suggested to play a role in cervical immune 
response to infection (Sharkey et al., 2012).   
The evidence supporting significant role of seminal fluid in improving pregnancy rate in 
several other species is still elusive (Hansen, 2011). For instance, there was no impact of 
seminal vesicle surgical excision on fertility rates in boars (Davies et al., 1975) and no 
difference was observed in pregnancy rates in pigs (Flowers and Alhusen, 1992) and mare 
(Newcombe and Cuervo-Arango, 2011) whether the pregnancy followed natural mating or 
was induced by artificial insemination in which only a fraction of the seminal fluid is 
introduced to the FRT (Hansen, 2011).  In contrast, removal of the seminal vesicle resulted 
in decreased implantation rate and poor embryo development in mice (Robertson, 2014, 
Robertson et al., 1996). Obesity, abnormal metabolic parameters and decreased glucose 
tolerance were also manifested in the male mice offspring in another study which 
highlighted the implications of FRT exposure to seminal fluid on the offspring health 
(Robertson et al., 2006b). 
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1.2 The female reproductive tract (FRT): 
1.2.1 Menstrual cycle: 
From the onset of menarche, the female reproductive tract (FRT) undergoes hormonal and 
developmental changes and the menstrual cycle commences to provide female gametes for 
fertilisation. Menstruation occurs in response to coordinated interactions between 
hypothalamic, anterior pituitary and ovarian hormones (Johnson and Everitt, 2000). The 
gonadotropins secretion by the anterior pituitary manifests a pulsatile pattern with pulse 
frequency and amplitude fluctuating according to the phase of menstrual cycle with LH 
reaching a maximum prior to onset of ovulation (figure 1-5).  The median duration of 
menstrual cycle is 28 days divided into two phases: follicular or proliferative phase and 
luteal or secretory phase. The follicular phase starts from the first day of menstrual 
bleeding until the onset of ovulation (days 1-14) and is dominated by the hormone 
oestrogen. During this phase, follicle stimulating hormone (FSH) is secreted by the 
anterior pituitary leading to the development of ovarian follicles and LH receptors 
formation on the surface of follicular granulosa cells (Johnson and Everitt, 2000).  The 
growing follicles produce large amounts of oestrogen which results in thinning of cervical 
mucus, proliferation and increased vascularisation of uterine endometrium and increased 
FSH receptors on the granulosa cells (GCs) (Johnson and Everitt, 2000).  Oestrogen also 
provides feedback regulation to the hypothalamic-pituitary axis which regulates the 
secretions of gonadotropin-releasing hormone (GnRH) from the hypothalamus and the LH 
and FSH by the anterior pituitary (Johnson and Everitt, 2000).  The sharp rise in oestrogen 
secretion around day 10-14 causes positive feedback to the hypothalamic-pituitary axis 
which results in the onset of LH surge, around mid-cycle, followed 36 hours later by 
ovulation (Johnson and Everitt, 2000).  Exposure to 200 pg/ml of oestrogen for 
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approximately 50 hours has been shown to induce hypothalamic secretion of GnRH with 
subsequent increase of LH and FSH from the anterior pituitary gland (Young and Jaffe, 
1976). 
The resultant LH surge triggers resumption of meiosis in the oocyte and the expulsion of 
the first polar body 10-12 hours following the peak of the LH surge (Johnson and Everitt, 
2000).   The mechanisms by which the LH surge induces the release of the oocyte from the 
mature follicle is not fully clear and is suggested to involve LH-induced rise in the 
follicular contents of collagenase, plasminogen activator and prostaglandins (LeMaire et 
al., 1973).  These factors are suggested to contribute to the increased fluid pressure within 
the follicle (Diaz-Infante Jr et al., 1974, Koos and Clark, 1982) and digestion of the 
follicular wall and rupture of the follicle releasing the cumulus oocyte complex (COC) 
(Beers et al., 1975, Downs and Longo, 1983).  The next phase of the menstrual cycle is the 
luteal phase (day 14-28) which marks the formation of corpus luteum from the follicular 
remains that contributes predominantly to the secretion of progesterone.  If oocyte 
fertilisation does not occur, the corpus luteum degenerates leaving scar tissue known as 
corpus albicans and resulting in progesterone withdrawal and onset of menstrual bleeding. 
The decline in progesterone level relieves negative feedback on the anterior pituitary 
inducing secretion of FSH and a new cycle commences.    
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Figure 1-5 The human female reproductive cycle showing changes in ovarian hormones 
and uterine lining (from https://www.britannica.com/science/menstrual-cycle) also 
available on public domains. 
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1.2.2 Oogenesis: 
The general accepted concept regarding the reserve of primary oocytes is that females have 
a finite number of follicles/oocytes which is established before birth and declines with 
female age until the permanent cessation of menstruation at menopause (Rodrigues et al., 
2008).  However, some recent studies have opposed this concept and suggested the 
presence of de novo synthesis of oocytes similar to the spermatogenesis that operates in 
human adult testis (Zou et al., 2009, White et al., 2012).  The presence of postnatally 
functional stem cells at different stages of development in the mammalian ovaries 
including in humans has raised the question of formation of oogonia during adulthood 
(Virant-Klun, 2015).  A recent review has critically presented the supporting and the 
contradicting views of postnatal oogenesis in humans (Virant-Klun, 2015).  
Oogenesis is an episodic process which commences in the ovaries during the fetal period 
of life followed by a stage of arrest which continues until puberty (Johnson and Everitt, 
2000).   
The primordial germ cells (PGCs), with high rates of mitosis, divide into oogonia 
(premeiotic germ cells) which reach approximately 6 million cells at 20 weeks of gestation 
after which the rate of mitosis diminish progressively parallel to an increased rate of 
atresia which continues throughout the rest of the female life (Oktem and Oktay, 2008).  
Oogonia divide in a number of mitotic cycles to progress to the early stage of meiosis I 
forming diploid primary oocytes (Oktem and Oktay, 2008; Virant-Klun, 2015).  At this 
stage, the primary oocytes become arrested at the prophase I of the first meiosis (diplotene 
stage) and their nucleus is known as the germinal vesicle (GV). The GV oocytes become 
enclosed within the primordial follicle (see section 1.2.3).  This stage of arrested meiosis is 
vital for the oocyte development and storage (Voronina and Wessel, 2003).  All the 
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primary oocytes are formed by the end of the fetal period and only ~1 million are available 
at birth (Oktem & Oktay, 2008).  The synthesis of mRNA and rRNA by the primary 
oocytes continues despite being in meiotic arrest and this process is crucial for the 
generation of proteins required for oocyte maturation and development following 
fertilisation (Johnson and Everitt, 2000).  
Due to continuing atresia, by puberty, only 3000-4000 primary oocytes are still available 
and recruitment of around 15-20 takes place during each menstrual cycle with one 
secondary oocyte being released at ovulation (Oktem and Oktay, 2008). During maturation 
and prior to ovulation, the primary oocytes resume meiosis and complete meiosis I and 
undergo an asymmetric division into two daughter cells: a secondary oocyte with haploid 
number of chromosomes and first polar body (Johnson and Everitt, 2000). The secondary 
oocytes proceed to the second meiotic division and undergo a second arrest at the 
metaphase II until the time of fertilisation when the completion of meiosis is activated 
(Oktem and Oktay, 2008).  
1.2.3 Folliculogenesis:  
The ovarian follicles are the functional units of the ovary and they undergo growth and 
development to achieve the ovulatory stage of a mature oocyte in a highly complex 
process termed folliculogenesis (Oktem and Oktay, 2008).  Folliculogenesis involves an 
array of events which include proliferation and morphological changes of GCs, 
steroidogenesis, gonadotrophin receptor expression, oocyte maturation and ends with 
ovulation (Oktem and Oktay, 2008).   
The earliest stage of follicular development commences at week 7 of embryo development 
in humans and involves the formation of primordial follicles which are dormant follicles; 
each contains a primary oocyte encapsulated in a layer of squamous pre-GCs and a basal 
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membrane (Oktem and Oktay, 2008).  The residence of the primary oocyte in the quiescent 
state within the primordial follicle may extend for decades maintained by a complex 
inhibitory signalling array of events (reviewed in McLaughlin and McIver (2009)). The 
primordial follicles represent the ovarian reserve and they undergo transition into primary 
follicles which are recruited into a pool of growing follicles during each menstrual cycle 
(Oktem and Oktay, 2008).  The recruitment of primordial to primary follicles commences 
at puberty and continues until menopause (Oktem and Oktay, 2008).  During the transition 
from primordial to primary follicles, several morphological changes occur including 
increase in the oocyte diameter and its encapsulation in zona pellucida (ZP) (Rankin et al., 
1996).  The pre-antral stage of follicle is characterised by proliferation of GCs into a multi-
layered structure surrounding the enlarging oocyte along with the formation of basal 
lamina and theca interna cell layer from the condensed stroma cells (Rankin, et al., 1996) 
with a follicle diameter reaching 40-120 μm ((Knight and Glister, 2006, Oktem and Oktay, 
2008).  
Factors contributing to trigger the transition from the quiescent primordial to the growing 
primary follicles are not fully characterised (Oktem and Oktay, 2008). The lack of FSH 
receptors on the primordial follicles suggested that the transition process is gonadotropin-
independent (Oktay et al., 1997, Oktem and Oktay, 2008).  Locally produced members of 
the transforming growth factor-beta family (TGF-β), bone morphogenetic proteins BMP4 
and BMP7 from stromal and theca cells (Nilsson and Skinner, 2003, Lee et al., 2001) have 
been shown along with growth differentiation factor 9 (GDF9) (Vitt et al., 2000) and 
FIGalpha (Soyal et al., 2000) to be crucial factors for the formation of primary follicle. 
Factors contributing to the transition of primordial to primary follicle are reviewed in 
Oktem and Urman (2010).  The regulation of primordial follicle quiescence/activation 
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involves interactions with somatic cells and oocytes (Kim, 2012). Several factors such as 
antimullerian hormone (AMH), Foxo3a and Foxl2 are involved in maintaining primordial 
follicle quiescence and survival and prevention of premature activation and depletion of 
primordial follicles reserve (reviewed by Kim (2012)).  
In the antral stage of follicle development, the secondary follicle is formed over a 
prolonged period of several months and is characterised by extensive proliferation of the 
GCs forming numerous layers surrounding the oocyte. GCs undergo differentiation into 
two distinct cell types: mural GCs which form the follicle wall and responsible for 
steroidogenesis; and cumulus cell mass surrounding the oocyte (Chian et al., 2004, Huang 
and Wells, 2010).  The size of the oocyte and its surrounding follicle increases 
progressively along with increased vascularisation and formation of fluid-filled space with 
follicular fluid (FF) accumulation.  At this stage, the GCs become responsive to FSH 
which is along with members of the (TGF-β) family, GDF9, BMP15, BMP6 and activin 
promote granulosa cell proliferation and positive regulation of follicle growth (Oktem and 
Urman, 2010).   Bidirectional signalling communications between the oocyte and its 
surrounding GCs and between the granulosa and theca cells in the presence of growth 
factors are some of the suggested critical events involved in triggering follicle growth and 
development (Oktay et al., 2000, Eppig, 2001, Skinner, 2005).  
The regulation of follicle growth and development and the mechanisms involved in the 
cyclic recruitment of follicles and selection of a dominant (tertiary) follicle is a complex 
multifactorial process (Oktem and Umran, 2010).  This process involves a complex array 
of events in which both local (paracrine) and endocrine factors are involved (Oktem and 
Urman, 2010).  Both LH and FSH play principal roles in the endocrine modulation of 
follicle development with more prominent role of high FSH (and oestradiol) in the 
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formation of the dominant follicle (Danforth, 1995, Salha et al., 1998).  One of the 
suggested mechanisms implicated in the dominant follicle selection is the differentially 
expressed FSH sensitivity in the growing cohort of follicles which is regulated by 
members of the TGF-β family, activin, inhibin and anti-mullerian hormone (AMH) 
(Oktem and Oktay, 2008). While the majority of follicles undergo atresia, the selected 
dominant follicle undergoes further development and expansion with increased human 
follicular fluid (hFF) accumulation (Johnson, 2007).  It has also been observed that low 
concentrations of follicular FSH and oestradiol are associated with follicle atresia (Salha et 
al., 1998).   Local factors within the ovarian follicle such as growth factors, steroids, 
cytokines and inhibin/activin are also suggested to be involved in the modulation of 
follicle growth and atresia via modification of FSH and LH response during 
folliculogenesis (Erickson and Danforth, 1995).  
At ovulation, the cumulus-oocyte complex (COC) is released along with hFF (figure 1-6) 
(Johnson, 2007). In some studies ovulation is described as an inflammatory process as the 
majority of hFF proteins detected are acute phase proteins which belong to the 
complement cascade category (Angelucci et al., 2006). However, ovulation is also 
described in other studies as a hormone-induced injury as many of hFF proteins belong to 
angiogenesis and blood coagulation categories (Jarkovska et al., 2010) and tissue 
restoration (Murdoch et al., 2010). 
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Figure 1-6 Stages of follicular development and ovulation. A- Preantral stage of 
folliculogenesis, B- Antral stage of folliculogenesis, accumulation of hFF and ovulation 
(from Huang and Wells, 2010, with permission).  
 
 
The oocyte, zona pellucida and cumulus cells: 
The oocyte is the female gamete which is involved in fertilisation and is considered one of 
the largest cells in the body (Johnson and Everitt, 2000).  In humans, the diameter of the 
oocyte prior to ovulation is around 100 µm (Mehlmann, 2005).  At ovulation, the 
secondary oocyte is surrounded by zona pellucida (ZP) and cumulus mass forming the 
COC) which is released into the peritoneal cavity and transferred to the ampullary region 
of the oviduct where fertilisation by sperm may take place.  
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All mammalian oocytes are encapsulates in the ZP which is a 7-20µm thick matrix of 
highly glycosylated proteins formed during oogenesis (Talbot, 1985).   
In humans, ZP is composed of four glycoproteins ZP1, ZP2, ZP3 and ZP4 (Lefievre et al., 
2004).  The roles of the ZP glycoproteins have been studied extensively in murine species 
which only possess three ZP proteins, unlike humans (Lefievre et al., 2004).  In mouse, 
ZP1 has been shown to provide structural integrity to the ZP matrix (Wassarman, 1999, 
Wassarman, 1988), ZP2 and ZP3 are both sperm receptors with ZP3 being the primary 
sperm ligand and inducer of AR (Bleil and Wassarman, 1983) while ZP2 is the secondary 
sperm ligand which binds to AR-sperm and contributes to polyspermy prevention (Bleil 
and Wassarman, 1980). In human, ZP2 has been shown as the sperm-oocyte binding 
ligand and the site for gamete recognition and prevention of polyspermy (Baibakov et al., 
2012).  
 Several functions have been attributed to ZP including species-specific binding of sperm, 
prevention of polyspermy (Yanagimachi, 1994) and protection of the embryo prior to 
implantation as it has been shown to surround embryos until shortly before implantation 
(Wasserman, 2008; Florman et al, 2006). ZP is also considered as the principal 
physiological inducer of AR following sperm-ZP binding (Kopf and Gerton, 1991) 
although, as will be discussed later, other more recent studies indicate the onset of AR 
prior to the encounter of both gametes (reviewed in Gervasi and Visconti (2016)). 
The cumulus oophorous is approximately 700 μm in size and comprises two layers of 
cells; the cumulus cell mass which is the outer layer rich in hyaluronic acid and the corona 
radiata cells which form the inner layer adjacent to and penetrating through the ZP to 
contact the oocyte.  The cumulus cells contribute significantly to the development of 
competent oocytes via bi-directional communication established by gap junctions (Huang 
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and Wells, 2010).  Both of these cell layers contribute to steroid hormones and protein 
secretions of the COC (Laufer et al., 1984, Osman et al., 1989, Tesarik et al., 1988) which 
are rich in progesterone and other chemotactic substances (De Jonge, 2005). Progesterone 
is secreted in the concentration of 5–10µM by the oocyte and the cumulus mass during 
ovulation (Osman et al, 1989) and the level of progesterone in the pre-ovulatory hFF is 
approximately 22 µM (Anderson, 1991). Progesterone is highly available at the vicinity of 
the ovulated egg and may be encountered by sperm prior to fertilisation (Florman et al, 
2008).   
 In addition to their secretory functions, Ca
2+ 
signal propagation through their gap 
junctions with the oocyte is another important feature of the corona radiata cells (Motta et 
al., 1994, Mattioli and Barboni, 2000). Phagocytosis has been also suggested as a selective 
mechanism operated by the cumulus and corona cells to remove excessive and abnormal 
sperm cells from the site of fertilisation (Nottola et al., 1998).   
Human follicular fluid (hFF): 
Human follicular fluid (hFF) is a straw coloured, slightly viscous fluid (Edwards, 1974) 
with an average volume of 2.7 ml in mature follicles (Simonetti et al., 1985).  hFF within 
the follicle is separated from the circulation by blood-follicle barrier which is determined 
by cellular and physiological properties (Edwards, 1974). The generally accepted theory 
about hFF formation suggests that secretions from granulosa cells along with diffused 
substances from blood-follicle barrier are the principal source of the hFF contents 
(Fortune, 1994, Spitzer et al, 1996, Anahory et al, 2002, Jarkovska et al, 2010).  The 
blood-follicle barrier is suggested to work as a selective molecular sieve only permeable to 
substances of molecular weight up to 500 kDa (Cran et al., 1976).  The high permeability 
of the basement membrane of the GCs in growing follicles enables the transmission of 
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molecules between the follicular cells without active transport being involved (Edwards, 
1974).  
Some of the suggested physical functions of hFF are to facilitate the escape of the oocyte 
from the follicle and to provide a medium for oocyte transport and protection during 
ovulation (Edwards, 1974).  At ovulation, the movement of the fimbria near the ovary 
where the oocyte is released creates an environment for the ciliary beat to gently sweep the 
oocyte into the ampulla (Edwards, 1974).  Although not clearly elucidated, hFF is 
suggested to modulate the oviductal environment to enable oocyte transport to the ampulla 
(Edwards, 1974).  Some of the suggested mechanisms include hFF enhancement of tubal 
fimbria contractility via its prostaglandin content (Sterin-Speziale et al., 1978) and 
increases in ciliary beat frequency in the oviduct (Lyons et al., 2006). Both mechanisms 
are suggested to assist oocyte pick-up and facilitate gametes transport through the oviduct 
contributing an increased chances of pregnancy (Lyons et al, 2006). 
Despite the significance of the formation of follicular antrum and synthesis of FF in 
mammalian reproduction, only few studies have considered this mechanism and elaborated 
on its implications (Clarke et al., 2006). One of the few proposed theories which explains 
the mechanism of FF accumulation states that large molecular weight molecules contained 
within the follicules are osmotically active and thereby create an osmotic gradient which 
attracts fluid from the highly vascular stroma to accumulate and form an antrum (Clarke et 
al., 2006).   
Most studies considered the assessment of follicular expansion by ultrasound as a 
satisfactory tool to evaluate follicular maturity when conducting in vivo studies, while 
relying on granulosa cells proliferation when carrying out in vitro research (Rodgers and 
Irving-Rodgers, 2010).  Interestingly, the rate of follicular antrum expansion and not the 
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thickness of granulosa cells is the sign for the maturation of a dominant follicle for 
ovulation (Clarke et al., 2006). Nonetheless, Rodgers and Irving-Rodgers (2010) 
demonstrated that not only should the expansion of the antrum be considered but also 
follicular growth which incorporates several aspects; oocyte growth, follicular cell 
proliferation and antral enlargement and all should be considered when evaluating follicle 
maturity. The size of the mature Graafian follicle seem to vary widely among species, 
ranging from few millimetres in mouse to up to 5cm in horse (Edwards, 1974).  The rate of 
FF accumulation and the size of resultant follicles seem to also be correlated to the species 
type (Rodgers and Irving-Rodgers, 2010). Smaller amount of fluid accumulates within the 
follicles of smaller animals such as rats and mice, while larger species have larger follicles 
with greater amount of FF within their antrum (Rodgers and Irving-Rodgers, 2010). The 
protein and steroid hormone contents of FF have also been shown to differ according to the 
stage of follicular development (Edwards, 1974). The biochemical composition of FF has 
been related to the developmental potential of oocyte in several studies (Hartshorne, 1989, 
Nayudu et al., 1989, Salha et al., 1998).  FF composition is highly complicated and table 
1-1 summarises the contents of FF. 
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Table 1-1 Summary of Follicular fluid contents: 
FF main components 
groups 
Examples  References 
1. Hormones:  
1.1 Steroid hormones 
 
 
Progesterone, Oestrogens  (17beta-estradiol ) 
and androgen (testosterone) 
 
Uehara  et al., 1985 
Tesarik   and Mendoza, 1997 
 
1.2 Gonadotrophins : 
 
 
FSH, LH,  human chorionic gonadotropin 
(hCG) 
Suchanek   et al., 1988, 
Ellsworth  et al., 1984 , Cha   
et al., 1986 
1.3 Growth hormone  
 
Tarlatzis  et al., 1993 
1.4 Corticoids  Cortisol, cortisone Keay   et al., 2002 
 
1.5 prolactin   Lindner  et al., 1988 
2-growth factors of the 
Transforming Growth 
Factor-beta (TGF-beta) 
superfamily 
Inhibin and Activin  
Anti-mullerian hormone, Bone morphogenetic 
protein-15 
Lau   et al., 1999, Ebner   et 
al., 2006, Wu   et al., 2007 
3-Other growth factors 
and interleukins 
Insulin-like growth factors (IGF), 
Amphiregulin  
Wang   et al., 2006, Inoue   et 
al., 2009, Bili  et al., 1998 
4-Reactive Oxygen 
Species (ROS) and 
antioxidant factors 
 
enzymes: superoxide dismutase (SOD) and 
selenium-dependent glutathione peroxidase 
(SeGPx) 
Vascular Endothelial Growth Factor (VEGF), 
vitamin C, E 
Sabatini   et al., 1999, Attaran  
et al., 2000, Lee  et al., 2000, 
Oyawoye  et al., 2003, 
Monteleone  et al., 2008, 
Prieto  et al., 2012 
5-Proteins, peptides and 
amino acids 
Albumin, fibronectin, clusterin  Nandedkar   et al., 1992 
Schweigert  et al., 2006 
Sinclair   et al., 2008 
6-Sugars  Hyaluronan, Myo-inositol, Glucose, fructose, 
Lactic acid, Protein bound hexose and fucose.  
Józwik   et al., 2007, Saito  et 
al., 2000, Anifandis   et al., 
2010, Chiu et al., 2002 
7-Lipids Cholesterol, Triglycerides, Non esterified fatty 
acids (NEFA), vitamin D 
Chang  et al., 1976, Sinclair et 
al., 2008, Anifandis et al., 
2010 
8-anti-apoptotic factors  Tumor Necrosis Factor (TNF), soluble FAS 
(sFas) and its ligand sFas-L  
Lee et al., 2000, Malamitsi -
Puchner et al., 2004 
9-Prostanoids   Prostaglandin F2alpha, PGE2 Jeremy  et al., 1987 
10-Ions  sodium, potassium, chloride, magnesium  
 
Knudsen   et al., 1979 
Nandi   et al., 2007,  
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hFF protein contents versus plasma proteins:  
Remarkable similarity has been observed between hFF and blood plasma/serum proteins 
(Anderson et al, 1976). The increased follicular permeability during maturation especially 
in the pre-ovulatory follicle allows more proteins from the serum to cross the blood-
follicular barrier (Gerard et al., 2002, Gosden et al., 1988, Bianchi et al., 2013).  Some 
studies have run comparative proteomic analysis of paired hFF and blood serum samples 
from the same patients to differentiate proteins which are specific to the follicle from 
common non-specific proteins from the blood (Schweigert et al., 2006; Angelucci et al., 
2006; Jarkovska et al., 2010). The protein concentration in hFF ranges from 35 to 52 
mg/ml (Ambekar et al, 2013). Table 1-2 shows a comparison of certain High Abundance 
Proteins (HAPs) in hFF with blood serum (adapted from Johnson (1973 ) in Edwards 
(1974). 
Table 1-2 A comparison of certain HAPs contents in hFF with blood serum (adapted from 
Johnson, 1973, Edwards, 1974) 
Protein name hFF (mg%)  Human serum (mg%)  
Albumin 2560 4400 
Alpha1 glycoproteins 45 90 
IgG 580 1300 
Beta1-A globulin 45 100 
Transferrin 149 320 
Haptoglobin 65 160 
IgA 75 210 
IgM 17 140 
Alpha 2-macroglobulin 28 240 
28 
 
1.3 Sperm journey toward the oocyte:  
Exposure of sperm to the FRT different environments is critical for sperm to acquire the 
necessary equipment to accomplish their journey in the FRT and to achieve its principal 
goal to fertilise oocyte. In the FRT, sperm travel a relatively long journey and encounter 
several anatomical and biochemical obstacles to arrive at the fertilisation site (Druart, 
2012).  This section highlights the stages of the sperm journey in the FRT. 
1.3.1 Sperm transport through the vagina and cervix:  
Following their deposition in the vagina, human sperm escape this acidic and immuno-
hostile environment by swimming directly toward the cervix (Sobrero and Macleod, 1962).  
In other species the the site of semen deposition varies due to anatomical differences, for 
instance, while straight deposition of the ejaculate into the uterine cavity occurs in pigs 
(Hunter, 1981, Roberts, 1986), rodents deposit sperm into the vagina from which sperm 
immediately pass through the cervix to the uterine cavity (Zamboni, 1972, Bedford and 
Yanagimachi, 1992).  
In humans, cervical mucus is described as a physiological selective barrier which prevents 
the passage of sperm with abnormal morphology and poor motility into the uterine cavity 
(Hanson and Overstreet, 1981, Barros et al., 1984, Katz et al., 1997, Suarez and Pacey, 
2006).  Additionally, the priming influence of the cervical mucus on sperm capacitation is 
well recognised in the literature (Lambert et al., 1985, Overstreet and VandeVoort, 1989 ).  
The high viscosity of the cervical mucus may serve as a guide to allow sperm to swim in a 
straight path during their journey toward the uterus (Katz et al., 1978, Suarez and Pacey, 
2006). The viscosity of the cervical mucus varies with the stage of menstrual cycle; thin 
watery mucus formation is induced by oestrogen while thick hostile mucus is formed in 
response to high progesterone (Wolf et al., 1978). Furthermore, cervical mucus facilitates 
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the elimination of seminal components which maintain sperm plasma membrane stability 
and thus initiates sperm capacitation (De Jonge, 2005).  An immune response has been 
recognised in the cervical mucus in the form of immunoglobulins A, G and leukocytes 
especially neutrophils which aim to protect the cervix from microbial invasion without 
damaging the sperm (Suarez and Pacey, 2006). However, the presence of antibodies in the 
cervical secretion which identify antigens on the sperm surface (anti-sperm antibodies) 
may cause infertility (reviewed in Suarez and Pacey, 2006). 
1.3.2 Sperm transport through the uterus and uterotubal junction:  
The viscosity of uterine fluid is lower than that of cervical mucus (Eytan and Elad, 1999). 
Uterine contractions have been suggested to enable sperm transport to the oviduct in 
domestic animals with less contribution from sperm motility (Troedsson et al., 2001, 
Katila, 2001).  Dead and immotile sperm have been recovered from some mammalian 
oviducts (Overstreet and Tom, 1982, Katila, 2001) which may indicate that mechanisms 
other than sperm motility may contribute to sperm transport in the FRT (Suarez and Pacey, 
2006).  SP may also enhance uterine contractions (Katila, 2001) containing oxytocin 
(Watson et al., 1999), prostaglandins (Harper, 1988, Katila, 2001) and oestrogen; the later 
stimulates prostaglandin F-2α production which enhances uterine contractions (Claus, 
1990, Suarez and Pacey, 2006) and contributes to sperm transport. SP is also involved in 
the protection against the defensive uterine environment (Troedsson, 2001, Katila, 2001) 
by inhibition of complement cascade and suppression of uterine polymorphonuclear 
leukocyte (PMN) chemotaxis (Rozeboom et al., 1999). Nonetheless, the uterine 
inflammatory response and phagocytosis in response to sperm deposition has been 
described as a physiological process aiming to eliminate the damaged and excessive sperm 
from the uterine cavity in mares (Troedsson et al., 2001, Troedsson et al., 2005).   
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Only a few thousands of sperm migrate through the uterotubal junctions (UTJ) to reach the 
oviduct where a combination of thermotaxis and chemotaxis may guide sperm to reach the 
oocyte (Eisenbach and Tur-Kaspa, 1999, Bahat et al., 2003).  In the UTJ, passage of sperm 
may be hindered by anatomical and physiological challenges such as the narrowness and 
tortuosity of the UTJ which may also contain thick mucus (Suarez and Pacey, 2006). 
Further elimination of some seminal plasma components from the surface of sperm takes 
place during sperm passage through the UTJ (Polge, 1978, Einarsson et al., 1980, Hunter, 
2008).  Furthermore, not only normal morphology and motility are required for sperm to 
successfully pass through the UTJ but also possession of normal genes (Suarez and Pacey, 
2006) which encode: fertilin β or Adam2 (Cho et al., 1998) calmegin (Ikawa et al., 1997, 
Ikawa et al., 2001) and testis-specific angiotensin converting enzyme (ACE) (Krege et al., 
1995, Hagaman et al., 1998). These observations were obtained following 
experimentations on null mutant mice for the genes encoding these proteins (fertilin β, 
calmegin and ACE) as sperm from these mice were unable to cross the UTJ and also 
incapable of ZP-binding (Suarez and Pacey, 2006).  More recently, further sperm factors 
have been identified to be essential for sperm passage through UTJ (Druart, 2012) which 
include: Adam1a or fertilin alpha (Nishimura et al., 2004), Adam3 or cyritestin 
(Yamaguchi et al., 2009), PGAP1 (Post-GPI Attachment to proteins 1) (Ueda et al., 2007), 
Calreticulin3 or calsperin (Ikawa et al., 2011) and PDILT (Tokuhiro et al., 2012). 
Therefore, evidence has been established for the significance of certain sperm surface 
proteins for successful passage through the UTJ (Suarez and Pacey, 2006, Druart, 2012).  
1.3.3 Sperm transport along the oviduct  
Despite the fact that the ejaculate may contain millions of sperm, only hundreds to 
thousands actually arrive at the oviduct of which only one sperm may succeed in fertilising 
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the oocyte (Motta  et al., 1995, De Jonge, 2005, Suarez and Pacey, 2006).  The influences 
of oviductal epithelium and fluid on sperm have been investigated in several species 
(Scott, 2000, Reeve et al., 2005).   In humans, both the oviductal fluid and epithelium 
lining have been areas of interest in reproductive research particularly their influence on 
sperm fertilising capacity (Hunter, 2008; Zumoffen et al., 2010).  However, due to ethical 
and practical challenges, the limited number of studies on human tubal fluid have been 
conducted with conditioned media prepared from cells and tissue explants of the human 
oviductal epithelium (Lippes et al., 1972, Zumoffen et al., 2010). 
The mammalian oviduct functions as a sperm reservoir in animals (Suarez et al., 1991a, 
Lefebvre et al., 1995, Suarez, 1998, Reeve et al., 2005) and in the maintenance of motility, 
viability and fertilising capability of sperm (Smith and Yanagimachi, 1990, Pollard et al., 
1991, Smith and Nothnick, 1997, Reeve et al., 2005). The oviductal environment has been 
described as an indispensable site for sperm modulation prior to fertilisation (Holt et al., 
2006).  Oviductal secretions are suggested to influence the rate of sperm capacitation and 
acrosome reaction (Zumoffen et al., 2010) and to ensure synchronisation of sperm 
capacitation with the onset of ovulation (Reeve et al., 2005).  Broadening the sperm 
capacitation window to prolong sperm survival is suggested to be one of the mechanisms 
by which oviductal fluid retain sperm fertilising capacity (Cohen-Dayag et al., 1995, 
Eisenbach, 1999a, Holt et al., 2006, Rodriguez-Martinez, 2007, Hunter, 2008, Zumoffen et 
al., 2010, Hunter and Rodriguez-Martinez, 2004). Oviductal fluid has been suggested to 
increase sperm plasma membrane stability and therefore contribute to the reduction of 
sperm capacitation and AR (Morales et al., 1996, Zumoffen et al., 2010).  
Assessment of tyrosine phosphorylation revealed diminished levels of tyrosine 
phosphorylation for sperm incubated in medium conditioned with oviductal secretions 
32 
 
(Zumoffen et al., 2010).  Inhibition of the cAMP/PKA pathway and/or enhancement of 
dephosphorylation processes are suggested as mechanisms involved in the reduced sperm 
tyrosine phosphorylation observed in this study (Zumoffen, 2010).  Yao et al. (1999) 
indicated that sperm AR induced by Ca
2+
 ionophore was suppressed in sperm incubated 
with media conditioned by oviductal cells.   Selection of the most competent sperm which 
may arrive at the fertilisation site also presumably occurs within the oviductal environment 
(Cohen-Dayag et al., 1995, Zumoffen et al., 2010).   
Sperm oviductal epithelium binding and the existence of a sperm reservoir in human are 
still controversial and has been described as non-essential for successful achievement of 
fertilisation in mammals (Hunter, 2008).  This was shown when direct insemination into 
the ampullary region of the oviduct resulted in fertilisation and live birth (Yaniz et al., 
2002, Hunter, 1998, Hunter, 2008).  In contrast, some studies on the effect of 
endometriosis on the sperm-endosalpingeal epithelial interaction suggested that infertility 
in patients with endometriosis could be due to the damaged sperm-oviductal interaction 
(Reeve et al., 2005).  The mechanism of sperm release from the oviductal reservoir in 
mammals is suggested to be facilitated by several mechanisms (Reeve et al., 2005).  For 
example, hyperactivated sperm motility (Demott and Suarez, 1992, Pacey et al., 1995) 
thermo-tactic (Bahat et al., 2003) and chemotactic (Eisenbach, 1999b) factors within the 
ipsilateral oviduct and the diminished sperm-epithelium bonds as sperm undergo 
capacitation (Lefebvre and Suarez, 1996, Fazeli et al., 1999).  Thus, some studies 
suggested that a normally functioning sperm plasma membrane which responds efficiently 
to the several molecular signalling in the surrounding environment is critical for sperm 
release from the oviductal reservoir in mammals (De Jonge, 2005).   
33 
 
1.4 Regulation of sperm function 
1.4.1 Sperm capacitation: 
Sperm have been shown to acquire fertilising capacity only following their deposition in 
the FRT (Chang, 1951, Austin, 1951).  In the FRT, sperm undergo sequential, highly 
complex physiological and biochemical modifications and membrane remodelling, 
collectively termed capacitation, which equip sperm with their fertilising capability (de 
Lamirande et al., 1997, Visconti et al., 2011). Capacitation involves acquisition of 
hyperactivated motility through capacitation induced-signalling in the tail region (Eddy et 
al., 2003) while preparing sperm for acrosome reaction (AR) through capacitation induced-
signalling in the head region (Mayorga et al., 2007).   Additionally, it has been shown that 
only capacitated sperm may undergo a chemotactic response to a progesterone gradient in 
vitro (Uñates et al., 2014).    In the FRT, capacitation is believed to mainly occur in the 
oviduct through sperm interaction with components from oviductal, FF and cumulus 
secretions (Quintero et al., 2005, Suarez, 2008b).   The contribution of such components in 
the modulation of sperm capacitation and preparation for fertilisation has been explored in 
several studies (Martinez-Leon et al., 2015, Harrison and Miller, 2000, Quintero et al., 
2005).  
The molecular aspects of capacitation are not yet fully elucidated and whether the different 
signalling events are interdependent or coordinated is not known (Gervasi and Visconti, 
2016).  Nevertheless, the linear pathway description of molecular signalling in capacitation 
is disputed and more independent, compartmentalised and multi-factorial mechanisms are 
suggested (Gervasi and Visconti, 2016).  Several studies have revealed a series of changes 
during sperm capacitation involving cholesterol efflux from the plasma membrane (Davis, 
1982), loss of membrane stability (Wolf et al., 1986), an increase in pH (Fraser, 1995) and 
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alteration in ion concentration mainly of calcium (Ca
2+
) (Fraser and McDermott, 1992) and 
bicarbonate (HCO3
-
 ) (Leclerc et al., 1996).  Other two important aspects of sperm 
capacitation are activation of the cyclic adenosine monophosphate/protein kinase A 
(cAMP/ PKA) pathway (Harrison, 2004) and increased tyrosine phosphorylation (Leclerc 
et al., 1997, Visconti et al., 1995a).   
The crucial roles of some of the above mentioned factors, namely HCO3
-
, Ca
2+
 and 
albumin have been challenged in some studies which suggested cell vitality, intracellular 
pH and high availability of ATP are sufficient for sperm to undergo capacitation and 
tyrosine phosphorylation (Baker et al., 2004, Aitken et al., 1998b, Ecroyd et al., 2004, 
Aitken and Nixon, 2013).    
A sequence of changes in sperm membrane lipid composition takes place during 
capacitation (McNutt and Killian, 1991).  Loss of cholesterol from the sperm surface is 
described as the initial stage of capacitation as cholesterol is considered a potent de-
capacitation factor which maintains sperm plasma membrane stability in the epididymis 
prior to ejaculation (Davis et al., 1979, Davis and Bilayer, 1980, Aitken and Nixon, 2013).   
Cholesterol transfer from the sperm membrane is enhanced by the presence of albumin and 
high density lipoproteins (HDLs) which act as acceptor molecules for cholesterol (Aitken 
and Nixon, 2013).  Cholesterol peroxidation and oxysterol formation induced by oxidative 
stress have also been shown to play a significant role in facilitating cholesterol efflux and 
increased membrane fluidity during capacitation (Brouwers et al., 2011).  Additionally, an 
ATP-binding cassette (ABC A17), a member of cholesterol transport family, has been 
suggested to promote the transport of cholesterol to albumin (Morales et al., 2012).  Both 
oviductal and follicular fluids are rich sources of albumin and HDLs which have been 
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shown to have greater affinity to binding cholesterol than serum albumin (Gangwar and 
Atreja, 2015).  
In addition to albumin, HCO3
-
 has been indicated as an important ion in sperm capacitation 
involved in lipid peroxidation, formation of reactive oxygen species (ROS) by the sperm 
(Ecroyd et al., 2003, Leclerc et al., 1996, Boerke et al., 2013) and enhancement of albumin 
affinity for cholesterol (Flesch et al., 2001).  The presence of high levels of HCO3
- 
also 
results in the stimulation of sperm-specific pH-dependent soluble adenylyl cyclase (sAC) 
(Gangwar and Atreja, 2015).  Activation of sAC increases levels of cAMP which is 
involved in the activation of cAMP-dependent PKAs and in tyrosine phosphorylation 
which are events critical for capacitation (Flesch et al., 2001, Harrison and Miller, 2000, 
Gadella and Harrison, 2002).   HCO3
-
 is also involved in PKA-dependent alterations in the 
sperm plasma membrane lipid architecture through cholesterol redistribution and 
phospholipid scrambling via activation of a phospholipid scramblase enzyme which 
further enhances albumin-mediated cholesterol efflux and subsequent capacitation (Flesch 
et al., 2001, Gadella and Harrison, 2002).  
The biphasic role of Ca
2+
 in capacitation:  
Another vital ion involved in capacitation is Ca
2+
 (Ruknudin and Silver, 1990) which has 
been shown to have both stimulatory and inhibitory effects on enzymatic pathways linked 
to tyrosine phosphorylation and capacitation (Navarrete et al., 2015).  Controversial results 
have been obtained in independent studies regarding the effects of Ca
2+ 
in the regulation of 
tyrosine phosphorylation (Baker et al., 2004).  An increase in Ca
2+ 
concentration has been 
shown to enhance tyrosine phosphorylation through positively modulating sAC activity  
(Jaiswal and Conti, 2003) which activate cAMP/PKA pathway (Hess et al., 2005).  
Conversely, Ca
2+ 
interaction with calmodulin (CaM), a Ca
2+
 modulating protein, results in 
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activation of Ca
2+ 
/CaM-dependent enzymes, for instance phosphodiesterase 1 (PDE1), 
which negatively regulate cAMP-dependent pathways and supress tyrosine 
phosphorylation (Navarrete et al., 2015). Figure 1-7 summarises the signalling pathways 
during capacitation.  
Tyrosine phosphorylation in sperm capacitation: 
An increase in tyrosine phosphorylation has been observed during sperm capacitation in all 
species studied to date (Aitken and Nixon, 2013) and is considered a marker of sperm 
capacitation (Visconti et al., 1995a, Ficarro et al., 2003).  Tyrosine phosphorylation is an 
important post-translational modification event, which is particularly relevant to the 
transcriptionally and translationally inactive sperm cells, and is involved in the regulation 
of capacitation, hyperactivation and acrosome exocytosis (Jagan Mohanarao and Atreja, 
2011).  Characterisation of proteins involved in tyrosine phosphorylation is believed to be 
critical in unravelling molecular principles of signal transduction during capacitation (Naz 
and Rajesh, 2004).  Some phosphoproteins have been revealed as targets for tyrosine 
phosphorylation during human sperm capacitation including a number of A kinase 
anchoring proteins  (AKAP3, AKAP4, AKAP82) (Mandal et al., 1999, Vizel et al., 2015, 
Carrera et al., 1996) and the Ca
2+
-binding and tyrosine phosphorylation-regulated protein 
(CABYR) (Naaby-Hansen et al., 2002). 
cAMP, a key second messenger in many biological systems, has a distinctive signalling 
pathway in sperm cells through the activation of PKA which is involved in the regulation 
of tyrosine phosphorylation in several species (Naz and Rajesh, 2004). The 
compartmentalisation of PKA in sperm cells enables the activation of specific functions 
via binding to the relevant AKAPs subunits (Naz and Rajesh, 2004).  PKA activation is 
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important in sperm capacitation and its associated hyperactivated motility (Baker et al., 
2009).  
 
 
Figure 1-7 Signalling pathways in human sperm capacitation. Two pathways are essential 
for sperm function. The first is the HCO
-3 
dependent activation of PKA by sAC/cAMP and 
the second involves the down-regulation of Ser/Thr phosphatases.  Human capacitation 
involve both early (1 minute) and late events (at least 6 h) to achieve functional 
capacitation state, SFK stands for Src family kinase. Figure from  (Battistone et al., 2013) 
with permission. 
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The mechanism of regulation of tyrosine phosphorylation in sperm during capacitation via 
cAMP/PKA pathway occurs via a unique cascade of signal transduction events (White and 
Aitken, 1989, Aitken et al., 1998a).  Increased or decreased levels of intracellular cAMP 
production have been shown to have equivalent effects on the levels of tyrosine 
phosphorylation of the cell (Visconti et al., 1995b, Rivlin et al., 2004, Baker et al., 2004, 
Baker et al., 2006).  Factors such as ROS, Ca
2+
 levels and HCO3
-
  have been shown to 
regulate the cAMP-dependent tyrosine phosphorylation events in sperm via stimulation of 
sAC (Aitken et al., 1995, Baker et al., 2004, Visconti et al., 1995b).   The mechanism of 
regulation of cAMP-mediated activation of PKA is complicated and involves both direct 
and indirect pathways (Baker et al., 2006, Aitken and Nixon, 2013). Direct activation of 
protein kinases, increased availability of cAMP and inhibition of tyrosine phosphatases 
action along with pH buffering are some of the suggested mechanisms involved  (Leclerc 
et al., 1996, Baker et al., 2006, Aitken et al., 1998b). For recent reviews of sperm 
capacitation, see Gervasi and Visconti (2016) and Aitken and Nixon (2013).  
The role of de-capacitation factors in regulation of capacitation: 
Although not fully elucidated, the mechanism of in vivo capacitation regulation is 
suggested to involve acquisition and/or loss of certain ligands, some of which become 
absorbed on or integrated into the sperm surface in a receptor-mediated mechanism 
(Breitbart and Etkovitz, 2011, Aitken and Nixon, 2013).  Several de-capacitation factors, 
which sperm acquire from the epididymal secretions and seminal fluid, have been shown 
to regulate capacitation in its early stages (Aitken and Nixon, 2013).  For example, 
glycodelin S from seminal plasma retains the ejaculated sperm in un-capacitated state 
(Yeung et al., 2006) while cholesterol associated with the sperm membrane (Davis and 
Bilayer, 1980) and phosphatidylethanolamine binding protein 1 (Nixon et al., 2006) have 
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been suggested to prolong sperm survival via prevention of premature capacitation and 
subsequent sperm apoptosis (Fraser, 1998, Gibbons et al., 2005).  Dissociation of such de-
capacitation factors from sperm membrane may initiate the onset of capacitation (Aitken 
and Nixon, 2013).    
 
1.4.2 Post-translational modifications (PTM) of sperm proteins : 
Post-translational modifications (PTM) is defined as any variations between the original 
polypeptide sequence produced following translation and the final structure of a fully 
functional protein (Samanta et al., 2016) which may also result in alteration of protein 
mass and characteristics (Baker, 2016). Currently, a list of 307 types of PTM has been 
generated in the database of UniProt (http://www.uniprot.org/docs/ptmlist) (Baker, 2016). 
Several types of PTM, such as phosphorylation, glycosylation, nitrosylation, 
ubiquitination, acetylation and methylation, have been detected in sperm following 
epididymal maturation and capacitation and have been linked to sperm acquisition of 
functional competence (Baker, 2016, Cornwall, 2009). Phosphorylation is one of the most 
significant PTM occurring in sperm (Baker, 2016) with tyrosine phosphorylation of 
several proteins during capacitation as a prominent example. During epididymal transit, 
one of the most important proteins which undergo phosphorylation is IZUMO 1, the 
sperm- oocyte fusion receptor (Inoue et al., 2005), which has manifested seven 
phosphorylation sites in mature sperm (Baker et al., 2012).  Glycosylation is another 
significant example of PTM in sperm with various glycoproteins being identified as 
sperm-associated epididymal proteins such as CD59 and fertilin (Baker, 2016). 
Glycosylation of sperm proteins is also suggested as a possible mechanism by which 
sperm escape the immune recognition and damage by the FRT (Clark et al., 1997; Baker, 
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2016). S.nitrosylation has also been shown as an important PTM in sperm with 240 
proteins being identified to undergo nitrosylation (Lefievre et al., 2007).  Sperm cells rely 
considerably on PTM of existing proteins and proteins acquisition and/or loss to achieve 
maturation in the epididymis and functional competence in the FRT (Baker, 2016).   
1.4.3 Sperm motility  
Two distinct categories of sperm motility are described in the literature as crucial for 
fertilisation; the progressive active motility in the fresh ejaculate and the hyperactivated 
motility mainly in the ampulla (site of fertilisation) (figure 1-8) (Suarez et al., 1991b, 
Suarez and Ho, 2003) .  Both types are essential in mammalian fertility for the sperm to 
migrate toward the oocyte, disconnect from the oviductal epithelium and to penetrate the 
ZP (Suarez, 2008b). As described previously, testicular sperm are immotile and only 
acquire motility after the transit period in the epididymis where sperm undergo maturation 
steps (section1.1.3).  
The unique structure of the sperm flagellum and the modulations sperm undergo during 
capacitation enable sperm to display both motility patterns according to the surrounding 
environment and signalling pathways (Turner, 2006).  Progressive motility with low 
amplitude and symmetrical flagellar waves drives the sperm in more or less a straight line 
(Turner, 2006; Suarez, 2008) and is suggested to enable sperm to navigate the FRT 
(Turner, 2006).  The second type of motility, hyperactivation, is mainly observed at the 
site of fertilisation (ampulla) and is considered as an event accompanying capacitation 
with major tyrosine phosphorylation of sperm tail proteins as an important feature (Suarez 
et al, 2008; Baker et al, 2006).  Hyperactivation is described as a pattern of sperm motility 
in which sperm cells exhibit high amplitude of lateral head displacement associated with 
low linearity and whiplash flagellar motion (de Lamirande et al., 1997, Kulin et al., 1994, 
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Yanagimachi, 1970, Suarez and Ho, 2003).  The significance of sperm hyperactivation is 
linked to sperm release from oviductal epithelium in animals and sperm ability to penetrate 
ZP via the propulsive forces of sperm tail (Suarez and Ho, 2003, Suarez, 2008b, Visconti 
et al., 2011).  In human, hyperactivation is suggested to enable sperm motility through the 
viscous oviductal fluid and to penetrate ZP and cumulus matrix surrounding the oocyte 
(Pacey et al., 1995, Suarez, 2008a). Physiological inducers of in vivo hyperactivation are 
not fully elucidated, however, several in vitro studies have shown that hyperactivation can 
be triggered by hFF (Yao et al, 2000), progesterone (Sueldo et al., 1993) and cumulus cells 
surrounding the oocyte (Fetterolf et al., 1994).   
Regulation of sperm motility and hyperactivation involves a number of signalling 
pathways (Yanagimachi, 1994b, Suarez and Ho, 2003, Turner, 2006).  The regulation of 
sperm motility is highly complex as Ca
2+
 signalling, cAMP/PKA signalling pathway and 
tyrosine phosphorylation of flagellar proteins are some of the suggested mechanisms (Ho 
and Suarez, 2001, Darszon et al., 2006).  In brief, activation of cAMP production via sAC 
in the presence of Ca
2+
 and HCO3
-
  will result in activation of PKA (Chen et al., 2000, Xie 
et al., 2006, Marquez and Suarez, 2008).  PKA activation will initiate a signalling pathway 
to enhance tyrosine phosphorylation of flagellar proteins associated with hyperactivation 
(Si and Okuno, 1999, Suarez, 2008a).  
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Figure 1-8 Human sperm flagellar bending patterns in A- progressive motility and B- 
hyperactivated motility (figure from Suarez et al (2008a) with permission, adapted from 
Morales et al. (1988) . 
 
1.4.4 Sperm guidance mechanisms in the FRT  
Several factors have been suggested to guide sperm in their lengthy journey toward the 
oocyte (figure 1-9); chemotaxis (Spehr et al., 2003, Eisenbach, 2004) and thermotaxis 
(Bahat et al., 2003) have been suggested to provide guidance in the immediate vicinity of 
the oocyte.  Rheotaxis has been suggested to guide sperm on longer distance scales (Miki 
and Clapham, 2013).  
The concept of chemotaxis in mammalian sperm and its correlation to fertilisation is 
relatively novel and only proposed approximately twenty years ago (Villanueva-Diaz et 
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al., 1990, Ralt et al., 1991, Eisenbach and Tur-Kaspa, 1999, Eisenbach and Giojalas, 
2006).  Sperm chemotaxis can be defined as the change of the direction exhibited by 
motile sperm exposed to a chemical gradient, such as human follicular fluid (hFF) (Ralt et 
al., 1994, Fabro et al., 2002). The directional swimming of the sperm in the FRT toward 
the ipsilateral site where the oocyte resides in the oviduct is attributed partially to the 
chemo-attractant effect of hFF and mainly progesterone (Serrano et al., 2001).  
Chemotaxis has been suggested as a selective measure for high competence sperm to 
approach the COC at the appropriate time and in the proper condition (only capacitated 
sperm) (Ralt et al., 1991).   Some studies suggested that only good quality and capacitated 
sperm manifest a chemotactic response to hFF (Tacconis et al., 2001, Fabro et al., 2002).  
The chemotactic response of sperm to hFF was only observed in normozoospermic 
samples while poor sperm samples with oligoasthenozoospermia or 
asthenoteratozoospermia failed to manifest chemotactic responses to FF even following 
prolonged incubation for more than 6 hours with neither chemotactic response nor 
hyperactivation observed (Tacconis et al., 2001).   
The ability of sperm to orient their motility to a temperature gradient is termed thermotaxis 
and is suggested to direct sperm toward the ampulla of the ovulating oviduct where the 
temperature is 2°C greater than in the isthmus as described for rabbit (Bahat et al., 2003).  
Rheotaxis is another phenomenon which has been observed in some marine species and is 
defined as the orientation response of motile cells and microorganisms to the alterations in 
a gradient of fluid flow (Kantsler et al., 2014, Miki and Clapham, 2013). Rheotaxis has 
been reported for sperm long time ago as indicated by Miki and Clapham (2013) and was 
described as positive rheotaxis for cells which have the tendency to direct their motility 
against the fluid flow (Miki and Clapham, 2013).     
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Figure 1-9 Sperm guidance mechanisms in the mammalian FRT namely chemotaxis, 
thermotaxis, rheotaxis, ciliary beating and muscular contractions. Thermoatxis was 
described for rabbit (Bahat et al., 2005).  
 
 
1.4.5 Acrosome reaction (AR): 
The process of AR involves the fusion of the outer acrosomal membrane at various points 
with the overlying plasma membrane (figure 1-10) (Harper et al., 2008).  This membrane 
fusion results in the dispersal of the acrosomal contents and exposure of sites on the inner 
acrosomal membrane that are required for gamete fusion (Patrat et al., 2000, Harper et al., 
2008).  AR is an indispensable pre-requisite for fertilisation and is considered as an 
essential modification step to provide sperm with competence for oocyte fusion and 
interaction (Florman et al., 2008). 
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Sperm capacitation is an essential pre-requisite to enable AR as similar signalling 
transduction mechanisms activated during capacitation are required to initiate AR (de 
Lamirande et al., 1997, Saling and Storey, 1979). Therefore, some studies use the ability of 
sperm to undergo AR as a marker of the occurrence of capacitation (Baldi et al., 2000, 
Leclerc et al., 1996).  While the biochemical and physiological changes occurring during 
capacitation are reversible (Bedu-Addo et al., 2005), AR is an irreversible process and 
therefore the onset of AR has to be coordinated spatially and temporally to coincide with 
the presence of oocytes (Florman et al., 2008). 
Although not fully elucidated, factors contributing to in vivo AR induction are suggested to 
involve receptor-mediated mechanism (Daniel et al., 2010, Florman et al., 2008).   ZP2 
have been shown to mediate sperm-ZP binding and human sperm-oocyte recognition 
(Baibakov et al., 2012).  AR has been also triggered in vitro by sperm exposure to the 
oviductal fluid and/or FF both containing progesterone and nitric oxide and described as 
priming factors for AR (Serrano and Garcia-Suarez, 2001, Machado-Oliveira et al., 2008).  
Sperm traversing through the cumulus cell layer or incubated with COC have also been 
shown to undergo AR (Tesarik et al., 1988, Carrell et al., 1993, De Jonge et al., 1988).  
The principal AR priming factor introduced by these conditions is suggested to be the 
steroid hormone progesterone (Tesarik et al., 1988, Carrell et al., 1993, De Jonge et al., 
1988).  Progesterone has been shown to trigger AR through the release of calcium influx 
by the direct activation of the cation channel CatSper (Lishko et al., 2011, Strunker et al., 
2011). 
Various other components of the FRT secretions have also been shown to induce AR in 
vitro such as prostaglandins (Joyce et al., 1987), atrial natriuretic peptide (ANP) (Rotem et 
al., 1998) and EGF (Lax et al., 1994, Daniel et al., 2010).  Although not yet confirmed, 
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some studies suggested that such ligands may also have a role in in vivo AR induced either 
by interaction with other FRT ligands or ZP via synergistic actions (Roldan et al., 1994, 
Daniel et al., 2010). 
 
 
 
Figure 1-10 Stages of acrosome reaction in human sperm; fusion of the outer acrosomal 
membrane with the plasma membrane and dispersal of acrosomal contents (from 
http://humanphysiology2011.wikispaces.com/15.%20Reproductive%20Physiology), also 
available on public domains. 
 
 
Similar to capacitation, AR timing and place within the FRT are important for sperm to 
achieve fertilisation of the oocyte (Florman et al., 2008). Sperm undergoing premature 
onset of AR have been shown to be incapable of passing through the cumulus oophorous 
surrounding the oocyte (Cummins and Yanagimachi, 1986). This premature or 
spontaneous AR has been suggested in some studies as a selection mechanism by which 
FRT eliminate sperm with abnormal morphology prior to fertilisation (Breitbart and 
Etkovitz, 2011).  
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AR is considered as a key for fertilisation (Florman, et al., 2008) and this is attributed 
partially to the actions of the lytic enzymes released which, along with hyperactivated 
sperm motility, are suggested to facilitate sperm penetration through the zona layer 
(Talbot, 1985). Another suggested mechanism for AR role in fertilisation is the change of 
the sperm’s apical head shape from blunt to tapered following AR which further enables 
sperm penetration through physical thrust (Bedford, 1998).        
Some recent studies have debated whether only acrosome-intact sperm are capable of 
binding to the ZP (Gervasi and Visconti, 2016) as acrosome-reacted sperm have been 
shown to fertilise ZP-enclosed oocytes (Inoue et al., 2011).  Another study applied real-
time tracking of fluorescent protein (142 EGFP, a mutant of Green Fluorescent Protein) 
developed by Nakanishi et al (1999)  to track the sperm acrosome region revealed that 
mouse sperm that had lost their acrosome in advance of arriving at the ZP were still able to 
fertilise the oocyte (Jin et al., 2011).  These observations and others suggest that AR may 
commence before the sperm encounter the ZP layer of the oocyte (Gervasi and Visconti, 
2016).  Two more recent studies have also shown that sperm in the isthmus region of the 
oviduct are still acrosome-intact while those in the ampullary region are acrosome-reacted 
(La Spina et al., 2016, Muro et al., 2016).  These results have suggested that acrosome-
reacted and not acrosome-intact sperm are required for sperm-ZP interaction (Inoue et al. 
2011) and that sperm-ZP binding is not essential for fertilisation (Okabe, 2013; Gervasi 
and Visconti, 2016).      
Further work is required to resolve these contradictory results linking AR and sperm-ZP 
binding and whether an intact acrosome is indispensable for sperm-ZP binding as shown in 
numerous previous studies (Gervasi and Visconti, 2016). One suggested explanation could 
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be the discrepancy between sperm-ZP binding used in in vitro assays and the equivalent in 
vivo events necessary for fertilisation (Gervasi and Visconti, 2016).   
Regardless of the timing of AR, sperm-oocyte fusion has been shown to only occur 
between acrosome-reacted sperm and oocyte as the AR is necessary for exposure of sperm 
receptors on the inner acrosomal membrane that are required for gamete fusion (Patrat et 
al., 2000, Harper et al., 2008, Gervasi and Visconti, 2016).  Izumo1 is a sperm-specific 
protein located on the anterior acrosome, which has been shown by gene deletion in mice 
to be an indispensable protein for gamete fusion (Sutovsky, 2009, Inoue et al., 2005).  
Izumo 1 has been shown to interact with Juno, from the oocyte and this interaction 
facilitates gamete fusion (Okabe, 2013, Bianchi et al., 2014).  The re-localisation of 
Izumo1 during AR is dependent on the presence of testis-specific kinase (TSSK6) with 
Tssk6-null mice demonstrating failed sperm-oocyte fusion (Sosnik et al., 2009). The 
translocation of Izumo1 within the sperm head during AR and proper final location of this 
protein are both suggested crucial for successful gamete fusion (Gervasi and Visconti, 
2016, Sosnik et al., 2009, Miranda et al., 2009).  
1.5 FF and sperm function and kinetics: 
 FF has been shown to play an important role in the process of fertilisation by provision of 
a favourable environment for sperm capacitation, hyperactivation, chemotaxis and 
acrosome reaction (Hong et al., 1993).  Progesterone, a major steroid hormone in hFF, is 
suggested to be the main component involved in these aspects of sperm function (Uhler et 
al, 1992, Eisenbach and Giojalas, 2006, Roldan et al, 1994). The micro-molar levels of 
progesterone have been shown to induce AR (Osman et al., 1989). Other studies 
investigated the effects of progesterone when the exposure is presented in a gradient; the 
sperm responses were mainly observed in hyperactivation and chemotaxis (Harper and 
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Publicover, 2005, Harper et al., 2004, Teves et al., 2006).  This section highlights the 
effects of FF on sperm regulation with emphasis on the role of hFF proteins. FF is used to 
refer to follicular fluid from any species while hFF is specific for human follicular fluid.    
1.5.1 FF and sperm capacitation: 
Since capacitation is a critical prerequisite for fertilisation (Yanagimachi, 1994a); 
appropriate timing of capacitation to coincide with ovulation is also essential (Hunter and 
Rodriguez-Martinez, 2004).  Sperm capacitation has been described to occur in a rapid 
response to hFF exposure which is relevant for sperm-FF contact in vivo within the oviduct 
which occurs prior to the onset of fertilisation (Yao et al., 2000).  The rate of sperm 
capacitation on exposure to hFF has been shown as dose dependent (Yao et al., 2000).  
Different hFF concentrations (for example 10%, 20%, 50% and 75%) have demonstrated a 
range of sperm capacitation with no response at 1% hFF and the highest response at 75% 
(Yao et al., 2000). In bovine FF, Therien et al. (2005) purified and investigated two 
glycosaminoglycans, the first was heparan sulphate which was demonstrated to have high 
potency to induce bovine sperm capacitation. The second was chondroitin sulphate B 
which has similar binding capacity to heparan sulphate but less affinity to induce 
capacitation (Therien et al., 2005). 
1.5.2 FF and sperm motility: 
Several studies have demonstrated that FF induces progressive sperm motility in in vitro 
studies in both animal and human sperm (Calvo et al., 1989, Falcone et al., 1991, Getpook 
and Wirotkarun, 2007, Revelli et al., 1992).  FF has also been shown to stimulate sperm 
hyperactivation (Mbizvo et al., 1990, Kulin et al., 1994) and this stimulatory effect has 
been attributed to the steroid hormones in hFF, mainly progesterone (Uhler et al., 1992, 
Kulin et al., 1994).  The addition of activated charcoal to hFF media, which eliminate the 
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hFF steroid constituents, has been shown to inactivate the hFF ability to induce sperm 
hyperactivation and support the concept that progesterone is the main hyperactivation 
inducer in hFF (Calogero et al., 2000, Jaiswal et al., 1999). 
The effects of FF on sperm kinetics in the previously published data were contradictory 
with earlier studies indicated inhibitory effects (Mortimer and Camenzind, 1989) whereas 
more recent ones showed stimulatory effects of FF on sperm motility parameters (Yao et 
al., 1999, Hong et al., 1993, Getpook and Wirotkarun, 2007).  Nonetheless, these 
inconsistent observations in the previous literature may have resulted from several factors 
such as varied levels of FF concentrations and whether the sperm were capacitated or not 
(Yao e al., 1999).  
 The effect of different concentrations of FF and duration of action (of up to 48 hours) on 
sperm motility was also investigated by numerous studies (Kulin et al., 1994, Fabbri et al., 
1998, Mendoza and Tesarik, 1990, Getpook and Wirotkarun, 2007).  Most of these studies 
indicated the ability of FF to enhance sperm motility at various concentrations (20, 30, 50, 
80 and 100%) and to preserve this action for prolonged periods of time of up to 12 hours 
(Mendoza and Tesarik, 1990, Chao et al., 1991, Fabbri et al., 1998, Getpook and 
Wirotkarun, 2007).  However, the best suggested hFF concentration is 20-50% and period 
of incubation of a maximum of 12 hours after which sperm motility starts to decline 
(Getpook and Wirtkarun, 2007).  Further to these conditions of incubation, Kulin et al., 
(1994) suggested that FF can only exert this stimulatory effect on sperm motility following 
a pre-incubation period in capacitating media (Kulin et al., 1994). However, vast majority 
of other studies has demonstrated that no requirement for sperm pre-incubation in order to 
be stimulated by FF (Getpook and Wirtkarun, 2007). The activating influence of FF on 
sperm motility was suggested to diminish following FF heating to 100°C for a period of 30 
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minutes (Chao et al., 1991).  A heat unstable substance in the hFF was, therefore, 
suggested as one of the important sperm motility’s stimulator in hFF (Chao et al., 1991). 
The chemical structure of the proposed substance was described as highly similar to 
apolipoprotein H with an identical sequence of the N- terminal amino acid (Chao et al., 
1991).   
In addition to studying the effects of hFF on normozoospermic freshly collected semen 
samples, some studies have considered the effect of hFF on post thawed cryopreserved and 
oligozoospermic semen samples (Briton-Jones et al., 2001). Since sperm cryopreservation 
is shown to reduce sperm motility and to affect fertilising capacity (Briton-Jones et al., 
2001), optimisation of assisted reproduction results following thawing demands the design 
of appropriate incubation media to improve post-thaw sperm motility (Briton-Jones et al., 
2001).  Aiming to enhance motility in cryopreserved oligozoospermic sperm , Briton-Jones 
et al. (2001) incubated the thawed sperm from good and poor quality semen samples in FF 
and compared the result with the incubation in media containing platelet activating factor 
(PAF) and another with human tubal fluid (Briton-Jones et al., 2001). This study 
demonstrated that, while hFF led to an increase in progressively motile sperm in 
normozoospermic samples, no such a stimulatory influence was detected in 
oligozoospermic cryopreserved sperm (Briton-Jones et al., 2001).  Nonetheless, further 
studies on the effect of hFF on post-thawed cryopreserved sperm with multiple 
concentrations of hFF and for variable durations may show more promising outcomes in 
enhancing sperm motility following cryopreservation (Briton-Jones et al., 2001).    
1.5.3 FF and sperm chemotaxis  
FF has been demonstrated to attract sperm  in in vitro study media in humans (Tacconis et 
al., 2001, Ralt et al., 1994), murine species (Giojalas and Rovasio, 1998, Oliveira et al., 
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1999), rabbit (Fabro et al., 2002) and pig (Serrano et al., 2001).  This chemotactic activity 
of FF has been mainly linked to progesterone (Villanueva-Diaz et al., 1995) and/or ANP 
(Anderson et al., 1995). However, few studies have suggested that the chemotactic effect 
of progesterone is only observed when progesterone is bound to a certain protein in FF 
(Cohen-Dayag et al., 1995, Ralt et al., 1994, Serrano et al., 2001). Some studies suggested 
that progesterone is not the only chemo-attractant agent in FF and proposed the presence 
of other active chemo-attractant components in hFF (Jaiswal et al., 1999).  This study 
indicated that progesterone action on sperm is predominantly manifested as 
hyperactivation which results in sperm accumulation and trapping and not genuine 
chemotaxis (Jaiswal et al., 1999).  This study applied strict criteria to define chemotaxis by 
the alteration in sperm direction of swimming toward the origin of the chemo-attractant 
described as directed turning behaviour of the sperm (Jaiswal et al., 1999).  The authors 
also examined the effect of hFF in the presence of progesterone and following its removal 
by the treatment of hFF by dextran coated charcoal (Jaiswal et al., 1999).  This study 
showed that similar chemotactic figures represented by sperm trajectory toward the hFF 
were obtained prior and following charcoal addition to the hFF which suggested that 
progesterone is not the only major chemo-attractant in hFF (Jaiswal et al., 1999).  Some 
other studies suggested a non-hydrophobic low molecular weight protein of approximately 
8.6 kDa which is homologous to apolipoprotein B2 to be responsible for this chemotactic 
effect of hFF (Ralt et al., 1994, cohen-Dayag et al., 1995, Serrano et al., 2001).   
1.5.4 FF and sperm acrosome reaction:  
FF has been shown to act as a biological promoter of AR in IVF media and was recognised 
as a potent AR mediator in several studies (Suarez et al., 1986, Calvo et al., 1989, Revelli 
et al., 1992, Tesarik, 1985, Morales et al., 1992, Siegel et al., 1990).  The duration 
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following which FF induces sperm AR and the rate of induction varied in the literature 
(Siegel et al., 1990, Yao et al., 2000).  AR following 1-6 hours of sperm incubation with 
FF has been observed (Gearon et al., 1994, Yao et al., 2000).   The rate of AR induction 
also ranged from 5% to up to 45% in some studies (Mortimer and Camenzind, 1989, 
Suarez et al., 1986, Siegel et al., 1990). This diversity of FF influence on AR may be 
attributed to the variations among different laboratories in sperm preparation, period of 
incubation in FF and the procedures applied to detect sperm AR (Siegel et al., 1990).  
Comparison of peritoneal and follicular fluids effects on sperm AR in human revealed that 
hFF has higher AR inducing capacity due to its considerably greater concentrations of both 
steroid hormones and proteins compared to peritoneal fluid (Munuce et al., 2006).  Most 
studies indicated that steroid hormone progesterone is the principal component in hFF 
which induces AR (Morales et al., 1992, Saaranen et al., 1993).  However, there has been a 
developing body of evidence to indicate the presence of other contents in the hFF 
participating in the induction of sperm AR (Fabbri et al.. 1998, Morales et al.. 1992). For 
example; proteins and peptides may play a part in the induction of sperm AR (Fabbri et al.. 
1998, Morales et al.. 1992).  Morales et al. (1992) showed that hFF samples treated with 
charcoal and dextran to reduce their progesterone contents by 1000 time could only restore 
88% of their original detected ability to induce AR when progesterone was re-added to the 
media (Morales et al., 1992).  It has also been demonstrated that albumin is highly 
abundant in hFF with approximately 70-80% of the overall protein contents (Munuce et 
al., 2004) and suggested that albumin may act as a cholesterol sink to facilitate cholesterol 
efflux and enhance membrane fluidity and thereby contribute in sperm capacitation 
followed by AR (De Jonge, 2005, de Lamirande et al., 1997). 
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Burrello et al (2004)  indicated that AR is hFF dose dependent and thay examined the role 
of gamma aminobutyric acid (GABA) receptors in inducing AR by sperm incubation in 
hFF at different concentrations. Nonetheless, the authors stated that GABA receptors 
binding may not be the only mechanism by which hFF stimulates AR in humans as GABA 
receptors antagonists could not totally inhibit the AR induced by hFF (Burrello et al., 
2004).  Their study did not also identify which components in the hFF may interact with 
the GABA receptors to induce AR.   
Another study suggested that sperm AR triggered by hFF is a multicomponent effect and 
progesterone alone is insufficient to induce AR (Fehl et al., 1995).  Some observations in 
this study suggested the requirement for progesterone to be bound to another component to 
be able to induce sperm AR (Fehl et al., 1995).  The observed low rate of AR in sperm 
incubated in hFF which had proteins eliminated by the addition of non-specific protease 
enzyme (Fehl et al., 1995).  Further to this work, some studies have shown that the 
substance which expected to be bound to progesterone has a molecular weight in the range 
of 37-53 kDa (Fehl et al., 1995) while other authors indicated a range of 45-50 kDa (Siiteri 
et al., 1988, Suarez et al., 1986, Miska et al., 1994).  Therefore, evidence indicating the 
requirement for certain proteins in the FF for the progesterone to possess its AR 
stimulating capacity requires further investigations (Fehl et al., 1995). Additionally, the 
effect of corticosteroid-binding globulin (CBG) antibodies on the hFF ability to stimulate 
sperm AR was examined and revealed diminished rate of sperm AR (Miska et al., 1994).  
CBG-Progesterone complex was suggested to be the AR triggering substance in hFF 
(Miska et al., 1994).   hFF treated with proteases enzymes was shown to be biologically 
inactive even following addition of progesterone which may demonstrate the importance 
of the progesterone-binding protein (Calogero et al., 2000). 
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1.5.5 FF and sperm quality: 
The observed stimulatory effects of FF on sperm motility was suggested to be linked to 
improved sperm quality following incubation in FF (Bahmanpour et al., 2012). The 
presence of antioxidant factors in FF such as superoxide dismutase and glutathione 
peroxidase have been suggested to inhibit ROS formation and minimize sperm DNA 
damage (Bahmanpour et al., 2012).  Improvement of sperm functionality and reduction of 
DNA damage following sperm incubation in FF have been suggested to enhance 
fertilisation and improve pregnancy rate in ART (Fabro et al., 2002, Bahmanpour et al., 
2012).  A study examining the influence of hFF on the chromatin content of sperm in in 
vitro culture media suggested that hFF can be used as incubation media to enhance sperm 
quality and reduce DNA damage (Bahmanpour et al., 2012).  The study indicated that 
prolonged incubation period in hFF of up to 180 minutes enhanced more histones to be 
replaced with protamines and decreased abnormal chromatin in the incubated sperm cells 
(Bahmanpour et al., 2012). However, these results were not statistically significant and 
further validation of these observations in future studies is recommended (Bahmanpour et 
al., 2012). 
1.6 Techniques: 
Several techniques have been utilised in the current research work and this section 
highlights the basic principles of these techniques.  Further details are provided in the 
relevant chapters.  
1.6.1 Solid Phase Extraction (SPE ):  
Solid phase extraction (SPE) is a valuable technique for proteins fractionation and peptides 
purification, which allows retention and elution of analytes from complex samples, 
56 
 
elimination of interfering compounds, and sample concentration (Martínez-Maqueda et al., 
2013). SPE is a rapid and selective sample preparation technique which enhances peptides 
detection for the mass spectrometry analysis (Martínez-Maqueda et al., 2013). Numerous 
commercial sorbents (for example: C18, C8, C2, and ion exchange bonded materials, 
among others) are available to enhance the flexibility of SPE according to the range of 
physico-chemical properties of the analytes of interest (Martínez-Maqueda et al., 2013).  
Sample preparation has a significant effect on protein identification and peptide separation 
and their subsequent analysis.  In this work, hFF will be prepared using SPE by Discovery 
Carbon 18% spin columns (DSC18 SCs) from Suppleco (chapter 2, section 2.4.1). DSC18 
SCs are polymerically bonded trifunctional C18 silica sorbent that have high binding 
capacity due to their great carbon loading (18% C) (Martínez-Maqueda et al., 2013). In the 
SPE technique, the DSC18 spin columns extract protein elements from their liquid 
condition into a resin or sorbent (a stationary phase) which allows the extraction of wide 
ranges of analytes from the sample with great sample recovery (Martínez-Maqueda et al., 
2013).  The high binding capacity of the column enables maximum amount of the analytes 
to be retained from the sample and minimises sample loss (Martínez-Maqueda et al., 
2013).  The carbon loading uniformity of the DSC18 SCs ensure high reproducibility of 
the obtained results and enables effective and quick extraction, isolation and purification of 
peptides from  biological samples (Martínez-Maqueda et al., 2013).   
According to the manufacturer’s instructions, the DSC18 SC is first conditioned and 
equilibrated to activate the sorbent and permit maximum interaction and retention of the 
target sample, which is then loaded to the column. The column is then washed using a 
strong solvent to remove any contaminants which are not bound to the sorbent.   Finally, 
the DSC18 SC is eluted to release the purified target sample analytes (the purified hFF 
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peptides in this research) from the sorbent, figure 1-11, for further analysis by high 
performance liquid chromatography mass spectrometry (HPLC-MS), see also chapter 2, 
section 2.4.1 for further detail.  
 
 
Figure 1-11 Solid phase extraction by DSC18 spin columns, four main steps are 
performed to achieve sample peptides purification as shown in the figure: column 
conditioning, sample addition, washing to remove interferents (contaminants) and elution 
of the target sample peptides (figure from DSC18 manual, also available on public 
domains).  
  
 
1.6.2 High Abundance Proteins Depletion (HAPs depletion):  
In follicular fluid, high abundance proteins such as albumin and immunoglobulins occupy 
approximately 85-90% of the total protein constituents in humans (Angelucci et al., 2006; 
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Hanrieder et al., 2008; Bayasula et al., 2013) and in the follicular fluid of other species 
such as porcine and equine (Fahiminiya et al., 2011a).  The presence of HAPs may hinder 
the detection of low abundance proteins (LAPs) which are defined as being in the 
concentration range of < 100 ng/ml (Millioni et al., 2011).  LAPs are considered more 
follicle-specific as they may be produced locally within the follicle itself and may be 
valuable for understanding follicle growth and development (Jarkovska et al., 2010).  
Several types of depletion formats are available such as columns, cartridges, micro-
columns or spin columns based on ion exchange, affinity ligands, antibodies or 
combination of all of these techniques, provided by companies such as Agilent, GenWay, 
Biotech, BioRad, Sigma–Aldrich and Amersham Biosciences (reviewed in Ahmed 
(2009)).  
 
In this research, hFF will be prepared by HAPs depletion using immunoglobulin yolk spin 
columns (IgY-12 SCs) (chapter 2, section 2.4.2) to overcome the high complexity of hFF 
protein composition and to enhance low and medium abundance proteins identification 
(Jarkovska et al., 2010, Ambekar et al., 2013).  The IgY-12 SCs are designed on the basis 
of avian antibody-antigen interactions; the column contains 12 avian polyclonal 
immunoglobulin yolk (IgY) antibodies against 12 of the most high abundance proteins in a 
biological sample covalently coupled to microbeads to pack the column (Ahmed, 2009).  
The HAPs, which are targeted for depletion by the IgY-12 SCs according to 
manufacturers’ specifications, are: albumin, immunoglobulin G (IgG), IgM, IgA, 
transferrin, fibrinogen, alpha2-macroglobulin, alpha1-antitrypsin, haptoglobin, alpha1-
acidic glycoprotein and apolipoproteins A-I and A-II, figure 1-12. 
59 
 
HAPs depletion by IgY-12 SCs involves a selective immune-depletion which provides 
very specific binding and clean capture compared to mammalian antibodies to provide an 
enriched pool of LAPs (Corrigan et al, 2011, Qian et al, 2008).   
 
 
 
Figure 1-12 The twelve high abundance proteins (HAPs) targeted by IgY-12 SCs in 
plasma which are similar to that in hFF and the pool of enriched medium and low 
abundance proteins obtained following depletion. The IgY-12 SCs are also shown (both 
figures from Beckman coulter IgY-12 manual at http://www.protocol online.org/ also 
available on public domains). 
 
 
The IgY-12 SCs kit contains two 1.2 ml IgY-12 spin columns and three buffers (dilution 
buffer, stripping buffer and neutralisation buffer) to prepare the column (see appendix 1 
for buffers’ recipes). The IgY-12 SCs can be regenerated for reusability by eluting and 
stripping off the bound proteins in 1× stripping buffer and immediately neutralising the 
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column in the 1 × neutralisation buffer and then re-suspending the columns’ beads in the 
dilution buffer to store the column at 2-8°C for future use.  For full details of the IgY SCs 
regeneration procedure see Beckman Coulter, proteomelab IgY-12 SCs manual at 
http://www.protocol online.org. The reusability of the IgY-12 SCs following their 
regeneration makes their application cost effective and relatively inexpensive.  Another 
technique utilised in this research to enhance the protein yield was filtration and 
concentration of the depleted hFF samples which is highlighted in chapter 2, section 
2.4.3.2. 
1.6.3 One dimensional Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE): 
Pre-separation of proteins by one- or two-dimensional gel electrophoresis (1D SDS-PAGE 
and 2D SDS-PAGE) are the workhorse in the majority of proteomic studies (Shevchenko 
et al., 2007).  SDS-PAGE is a powerful most widely used electrophoretic method for the 
analysis of complex proteins mixtures that separates proteins according to their molecular 
weights (Berkelman and Stenstedt, 1998).  Proteins identification using gel electrophoresis 
provides significant advantages compared to gel-free techniques such as the in depth 
analysis of a wide dynamic range of proteins in a safe to handle matrix (Shevchenko et al, 
2007).     
The principle of the technique is that charged molecules migrate through the gel matrix 
upon application of a constant electric field (Wright et al, 2012). The presence of SDS, an 
ionic denaturing detergent, in both the prepared protein samples and the running buffer 
masks the charge of the sample proteins and results in a constant net negative charge per 
unit mass leading to proteins migration governed by molecular weights (Wright et al, 
2012).  Additionally, SDS, assisted by heat, enables partial unfolding of the protein 
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molecules, disruption of hydrogen bonds and blocks hydrophobic interaction (Wright et al, 
2012).  Additionally, a reducing agent such as dithiothreitol (DTT) is added to enhance the 
cleavage of the proteins’ disulphide bonds and unfold any tertiary or quaternary protein 
structures (Wright et al, 2012).  
A pre-stained protein standard of known proteins masses (known as molecular weight 
marker or protein ladder) is run in the same gel alongside the protein samples to allow 
determination of the mass of the sample proteins, figure 1-13. Protein samples are loaded 
into the gel wells and the proteins start to migrate through the gel matrix once the electric 
current is applied creating lanes or bands of proteins (Wright et al, 2012).  Protein bands 
differ in their migration patterns according to the SDS-PAGE buffer system utilised, 
figure 1-13.  Each buffer system has a slightly different pH which affects the charge of  a 
protein and its binding capacity for SDS and therefore their migration (Wright et al, 2012). 
The gels are then stained, to visualise the separated proteins, using dyes such as Coomassie 
Brilliant blue, zinc imidazol, and silver nitrate (Wright et al, 2012). 
The pore size of the acrylamide matrix works as a sieve, allowing larger proteins to 
migrate slower while smaller proteins propagate much faster. Low-percentage gels are 
used to resolve large proteins, and high-percentage gels are used to resolve small proteins 
(Wright et al., 2012) (see chapter 3, section 3.1.1 for further detail of SDS-PAGE 
application in proteomics studies).  In this research work, 10% NuPAGE gel with MOPs 
buffer system will be utilized.  This selection is based on our preliminary data obtained 
following the experimentations on hFF proteins and sperm + hFF protein interactions 
which showed clear protein bands using this selection. For convenience, reproducibility 
and high quality, a  precast NuPAGE gel will be utilised in this research work.  
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Figure 1-13 The range of proteins molecular weights migration in NuPAGE Bis-Ris gels 
4-12% according to the buffer system utilised in running the gels. BSA: bovine serum 
albumin, MOPS: (3-(N-Morpholino) propanesulfonic acid), MES: 2-(N-morpholino) 
ethanesulfonic acid(figure from www.invitrogen.com, available on public domains). 
 
 
1.6.4 Mass spectrometry:  
Mass spectrometry (MS) is the analytical technique of choice for proteins identification 
and quantitation in proteomic studies, which offers accuracy, sensitivity and flexibility in 
biological research (Ho et al, 2003). MS instruments are generally composed of the 
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following main components: i- an ionisation source into which the molecules of interest 
are introduced to acquire positive or negative charges, ii- mass analyser which allows the 
travel of the ionised molecules according to their mass/charge (m/z) ratio, iii- detector 
which detects the generated signals from the ionised molecules and delivers them to the 
forth component of MS iv- a computer system which displays the signals as a mass 
spectrum according to the m/z ratio recorded (Ho et al, 2003), figure 1-14.   
 
 
 
Figure 1-14 Basic components of mass spectrometry instruments; prepared samples are 
introduced into the ionisation source where molecules are charged into positive and 
negative charges and then analysed in the mass analyser according to their m/z ratio, the 
detector detects signals from the ionised molecules and delivers them to the computer 
system where the signals are interpreted to a mass spectrum.    
 
 
Several types of MS are available, for example Electro Spray Ionisation – Time of Flight 
MS (ESI -TOF MS), Matrix-assisted laser desorption/ ionization-Time of Flight (MALDI-
TOF MS) among others, based on different technical principles. Coupled with high 
performance liquid chromatograph (HPLC) for molecular fractionation prior to MS 
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analysis, HPLC-MS has become a very powerful technique capable of analysing at femto-
mole quantities in micro-litre sample volumes of a complex biological sample (Ho et al., 
2003).  
In this research work, ESI -TOF MS will be utilised for proteomic analysis (chapter 2, 
section 2.4.4 and chapter 3, sections 3.1.1 and 3.4.5) and Ultra-Performance Liquid 
Chromatography-Mass Spectrometry (UPLC-MS) for metabolomics analysis (chapter 4, 
section 4.3.3).  
1.6.5 Micro-Particle Image Velocimetry (µPIV): 
The principles of the technique of micro-particle image velocimetry (µPIV) are 
highlighted in detail in chapter 5, sections 5.1.1 and  5.3.3.   
 
 
1.7 Research aims:  
To achieve fertilisation, human sperm have to navigate and interact with the female 
reproductive tract (FRT) on molecular and mechanical levels. This research intends to 
investigate some molecular and mechanical aspects of sperm interactions with the FRT 
secretions, mainly follicular fluid and high viscosity fluids such as cervical mucus 
(represented in this study by 1% methylcellulose).  Limited knowledge is available about 
the role of hFF proteins in sperm regulation and whether sperm acquire any hFF proteins. 
The study of the human sperm metabolome under in vitro conditions is a novel approach in 
this research, which may enable characterisation of the sperm metabolic substrates for 
better understanding of sperm energy metabolism. The lack of knowledge regarding the 
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effects of sperm on their surrounding fluids in terms of mixing and perturbation were the 
main motivations for the sperm micro-particle image velocimetry study in this work.  
 The aims of the current research work are: 
 To identify proteins present in the human follicular fluid, which is one of the fluid 
milieu sperm are exposed to just prior to fertilisation. A combination of proteomic 
techniques will be utilised along with compiling the human follicular fluid protein 
data from the existent literature. 
 To examine if sperm may acquire any hFF proteins and the possible roles of the 
acquired hFF proteins, utilising proteomic approaches.  
 To investigate and identify sperm metabolites released and/or consumed during 
capacitation, which is another aspect of molecular interaction of sperm with the 
FRT, using metabolomics techniques.   
 To examine some physical aspects of sperm motility represented by the effect of 
motile sperm on their surrounding fluid’s instantaneous velocity and vorticity in 
low and high viscosity media using a µ-particle image velocimetry technique. 
Finally, a global discussion and conclusions are included with suggestions for future 
research. Appendices are also included which contain buffers and recipes, list of hFF 
proteins identified, list of proteins identified in sperm and hFF proteomic interactions, list 
of metabolites identified in sperm metabolomics and codes for fluid vorticity analysis in 
MATLAB. 
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Chapter 2  
IDENTIFICATION OF NOVEL HUMAN FOLLICULAR 
FLUID PROTEINS BY PROTEOMIC TECHNIQUES 
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2.0  Abstract 
Human follicular fluid (hFF) is the in-vivo microenvironment for oocytes to develop and 
mature.  The composition of hFF is highly complicated with a high variety of steroid 
hormones and proteins. The knowledge of hFF protein constituents and their roles in 
folliculogenesis and reproductive biology is still limited. Aims: to perform an in-depth 
analysis of hFF proteins and to classify the identified proteins according to their biological 
functions and cellular localisation. Methods: a combination of proteomic techniques were 
utilised; solid phase extraction (SPE), proteins fractionation and peptide purification by 
DSC 18 spin columns followed by HPLC/MS was used as a first proteomic approach, 
High Abundance Proteins (HAPs) depletion followed by SDS-PAGE/MS as a second 
approach and HAPs depletion followed by filtration and concentration by Amicon Ultra 
centrifugal filter units and SDS-PAGE/MS as the third approach. Results: 212, 431 and 81 
proteins were detected by the first, second and third approaches respectively with 180 
proteins detected in both crude and depleted hFF samples. A total of 479 proteins were 
identified of which 103 (22%) were novel hFF proteins newly added to the repertoire and 
376 proteins confirm those previously detected hFF proteins. Classification of the 
identified hFF proteins according to their molecular function in this study indicated that 
catalytic activity was the most common category with 38% followed by binding function 
with 29%. This study will contribute to the knowledge of hFF protein composition by 
increasing the data of the repertoire present. The study also compiled available hFF protein 
data from 24 published studies into a hFF protein table.  The extensive hFF proteins table 
complied in this study comprising 1586 hFF proteins is an important resource for further 
research into folliculogenesis, discovery of biomarkers in hFF, study of fertilisation 
environment and potential improvements in assisted reproductive techniques (ART).  
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2.1 Introduction: 
Human follicular fluid (hFF) is the in vivo microenvironment in which oocytes develop 
and mature (Fortune, 1994).  During folliculogenesis, hFF is formed by secretions from the 
GCSs of the growing follicle and diffused exudate from the blood-follicle barrier (Fortune, 
1994, Edwards, 1974). The hFF composition is recognised as highly complex with a 
variety of chemical substances ranging from steroid hormones, inorganic salts, muco-
polysaccharides to a diversity of peptides and proteins (Spitzer et al, 1996) important for 
oocyte development and maturation (Emiliozzi et al., 1996, De Jonge, 2005).  hFF has 
been the core of several studies which aimed to evaluate the roles of hFF steroid 
hormones, particularly progesterone, in sperm regulation and fertilisation (De Jonge et al., 
1993, Harper et al., 2004, Revelli et al., 2009).  hFF also denotes a distinctive and an 
enriched pool of biologically significant markers in terms of proteins and peptides 
(Kolialexi et al., 2007). Although the high dynamic range of hFF proteins renders its 
proteomics’ study challenging (Bianchi et al., 2013), advances in proteomic approaches in 
hFF analysis have been evolving progressively and enabled identification of hundreds of 
hFF proteins up to date (Ambekar et al, 2014; Zamah et al, 2015). Table 2-1 lists the 
recent proteomic studies of hFF proteome and techniques utilised. 
Some of the hFF proteomic studies considered the levels of expression of certain hFF 
proteins as a biomarker in reproductive pathologies such as recurrent spontaneous 
miscarriage (Kim et al., 2006), endometriosis (Lo Turco et al., 2010, Lo Turco et al., 2013, 
Cunha-Filho et al., 2003) and polycystic ovarian syndrome (PCOS) (Moos et al., 2009, 
Ambekar et al., 2014).   
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Table 2-1  List of proteomic studies of  hFF protein since 1996 to date, abbreviations are 
included in the list of abbreviations 
Techniques utilised Number of proteins 
identified 
Reference 
iTRAQ labelling and strong cation-exchange 
chromatography + LC-MS/MS analysis 
770 (Ambekar et al., 2014) 
SDS-PAGE, OFF GEL and SCX-based separation 
followed by LC–MS/MS 
480 (Ambekar et al., 2013) 
2D-PAGE + MALDI MS 13 (Anahory et al., 2002) 
2D-PAGE + MALDI-TOF-MS 69 (Angelucci et al., 2006) 
LTQ Orbitrap + (LC-MS/MS). 503 (Bayasula et al., 2013) 
(excluded from the hFF  
table) 
2D-PAGE+IEF +MALDI-TOF/TOF MS 43  (Bianchi et al, 2013)  
2D-PAGE LC –tandem MS 11 (Estes et al., 2009)  
IEF, nano-LC MALDI TOF /TOF MS 69 (Hanrieder et al., 2008)  
IEF, MALDI TOF MS/MS 73 (Hanrieder et al., 2009) 
2D-PAGE + MALDI-TOF-TOF MS 6 (Hashemitabar et al., 
2014) 
2D-PAGE+ LC + MALDI MS 15 (Jarkovska et al., 2010) 
In solution digestion + Nano-LC-QTOF 73 (Kushnir et al., 2012) 
2D-PAGE + MALDI-TOF MS   +   nano-LC MS/MS    5 (Kim et al., 2006) 
2D-PAGE +MALDI MS 10 (Lee et al., 2005) 
Protein digestion + MALDI-TOF MS 18 (Liu et al., 2007)  
SELDI-TOF-MS + cation exchange protein chip 4 (Li et al., 2008) (excluded 
from the hFF  table) 
Multidimensional 
Protein Identification Technology (MudPIT) 
170  (Lo Turco et al., 2010) 
2D-PAGE + ESI-QTOF MS 21 (Lo Turco et al., 2013) 
Immunoprecipitation + SULPHATESELDI- TOF-MS-
based ProteinChip System 
4 (Schweigert et al., 2006) 
Multiplexed protein array and iTRAQ  30 (Severino et al., 2013) 
2D-PAGE MALDI-TOF MS 37 (Sim and Lee, 2008)  
2D-PAGE 7 (Spitzer et al., 1996) 
pre-fractionation of proteolytic peptides and nanoflow 
reversed-phase LC-MS/MS 
246 (Twigt et al., 2012) 
MALDI-TOF MS 11 (Wu et al., 2015)  
In solution protein digestion + Q-TOF MS 535 (Regiani et al., 2015)  
HPLC-MS 742 (Zamah et al., 2015) 
Total hFF proteins 1586  proteins  
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Identification of potential biomarkers for oocyte quality, pregnancy outcome and IVF 
success in hFF has also been considered in several studies (Michael et al., 1993, Kolialexi 
et al., 2007, Michael and Papageorghiou, 2008, Kushnir et al., 2012).  For example, the 
level of 11 β- hydroxyl steroid dehydrogenase in hFF has been recommended as a feasible 
predictor of IVF success with lower levels of 11 βHSD  increasing the chances of 
successful IVF (Michael et al., 1993).  Additionally, levels of sex hormone binding 
globulin (SHBG), corticosteroid binding globulins (CBG) (Andersen, 1990) and some 
cytokines such as IL8 and IL18  (Sarapik et al., 2012) in hFF have been recommended as 
predictors of IVF success.  hFF has also been investigated as a source for proteins 
supplementation in IVF to replace the previously commonly used fetal cord serum and 
maternal serum (Chi et al., 1998).  Furthermore, hFF has been shown as a valuable source 
of proteins in in vitro maturation media of immature oocytes (Cha et al., 1991, Jee et al., 
2008) and for supplementation of embryo culture media to enhance embryo cleavage 
during IVF (Davoodi et al., 2005, Hemmings et al., 1994).  It has also been shown that 
hFF stimulates several sperm functions (Getpook and Wirotkarun, 2007, Yao et al., 2000, 
Mbizvo et al., 1990, Ralt et al., 1994) (section 1.5, chapter 1).  The possible beneficial 
effects of hFF on implantation prior to intracytoplasmic sperm injection (ICSI) have been 
investigated by flushing the uterine cavity with hFF prior to embryo transfer to enhance 
implantation, however, no significant improvement in implantation rates was detected in 
this study (Hashish et al., 2014).  Protein profiling of hFF has also been suggested as a 
fundamental approach for understanding ovarian folliculogenesis and as an indicator of 
follicular developmental stage (Liu et al., 2007, Spitzer et al., 1996, Bianchi et al., 2013). 
For example, the biochemical profile of FF has been shown to vary between large and 
small follicles in the same species which suggests links between the FF composition, 
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follicle size and the stage of oocyte maturation (Thomas et al., 2000, Revelli et al., 2009).  
In animals, some studies were performed to determine the relationship between protein 
concentration, FF volume and follicle size and some of their results were conflicting 
(Nandi et al., 2007).  Studies on bovine FF (Andersen et al., 1976, Brantmeier et al., 1987) 
and ovine FF (Nandi et al., 2007) indicated similar or increased total protein concentration 
in small and large follicles.  In human, comparison of hFF protein contents from mature 
and immature follicles revealed remarkable differences in the pattern and amount of 
proteins of these follicles and was suggested as a potential tool to identify the stage of 
follicular maturation (Spitzer et al., 1996).  
Metabolic changes in hFF chemical constituents have also been observed in obese patients 
seeking fertility treatment with dramatic elevation in C-reactive protein concentration in 
their hFF samples (Robker et al., 2009).  hFF from patients with advanced maternal age 
and diminished ovarian reserve also showed alteration in the metabolic profile of hFF 
which was attributed to changes in follicular cell activity (mainly GCs) (Pacella et al., 
2012). Pacella et al (2015)  indicated that changes in the carbohydrate and hormonal 
contents of hFF were statistically significant while those in ions and proteins were not. 
These studies applied metabolomics techniques which are novel approach aims to analyse 
the total molecular metabolites in a biological fluid (Revelli et al, 2009, Pacella et al, 
2012).   
The various applications of hff protein contents, as shown in the above mentioned studies, 
provide impetus for extensive hFF proteomic analysis and exploration (Hanrieder et al., 
2008). The high complexity of the different processes involved in oocyte maturation 
(Picton et al., 1998) may also indicate the necessity for the whole hFF proteome profile to 
predict the oocyte quality for ART instead of relying on single biomarkers (Twigt et al, 
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2012). The lack of the complete hFF protein profile and the currently limited 
understanding of the diverse range of functions of its proteins contents render further 
research into hFF proteins indispensable (Kushnir et al., 2012).  This chapter presents hFF 
proteomic study using a combination of proteomic techniques and also introduces a hFF 
protein table compiled from 24 hFF proteomic studies. A table with the potential hFF 
biomarkers in several applications has also been constructed in this study.   
 
 
2.2 Objectives:  
 To identify novel hFF proteins and to compile the existing hFF protein data from 
the literature in hFF protein table. 
 To describe the functional classifications of the identified hFF proteins and any 
potential implications in reproduction. 
 To use the hFF protein identified in this study and the compiled hFF protein table 
in the comparison and data analysis of the sperm + hFF proteomic interaction 
which is introduced in chapter 3 of this thesis. 
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2.3 Materials and methodology: 
2.3.1 Materials: 
Table 2-2 Materials  
Product name  Company  Product code  
96 Well flat bottom plate Corning Incorporated, New York, USA 3595 
Acetonitrile Millipore, Watford, UK. UN1648 
Amicon Ultra 0.5ml-30K centrifugal 
filters units   
Millipore, Watford, UK. UFC503096 
Ammonium bicarbonate Sigma, Dorset, UK 09830-1KG 
Bicinchoninic Acid protein assay kit Sigma, Dorset, UK. B9643 
Bovine serum albumin Millipore, Watford, UK. 82-002-4 
Dithiothreitol (DTT) Melford Laboratories , Suffolk, UK MB1015 
DSC18 spin columns Sigma, Dorset, UK 52602-U 
Ethylene diamine tetra-acetic acid 
(EDTA) 
Sigma, Dorset, UK E5134EDTA 
Formic acid Sigma(Fluka analytical), Dorset, UK 14265-50ML 
IgY-12 spin column kit  Beckman Coulter, High Wycombe, UK A24618 
Iodoacetamide BioRad laboratory, Hertfordshire, UK 1632109 
NuPAGE Novex (10% Bis-Tris gel)  Invitrogen, Paisley, UK NP0302Box 
Sodium deoxycholate Sigma, Dorset, UK 30970 
Sodium dodecyl sulphate (SDS) Sigma, Dorset, UK L6026-250G 
Tris (hydroxymethyl) amino-
methane 
Sigma, Dorset, UK 252859 
Trypsin (sequencing grade, 
modified, porcine) 
Promega, Southampton, UK V511A 
Trypsin Resuspension Buffer Promega, Southampton, UK V542A 
Urea Sigma, Dorset, UK U5378-5KG 
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2.3.2 hFF collection: 
Follicular fluid was obtained under Local Research Ethical Approval from South 
Birmingham 2003/239. Follicular fluid was obtained from women undergoing fertility 
treatment (IVF or ICSI) at the Assisted Conception Unit (HFEA Centre: 0119), 
Birmingham Women’s Hospital following informed consent in agreement with the HFEA 
(Human Fertilization and Embryology Authority) Code of Practice (Ethical approval 
number 2003/239) (Frettsome, 2011).  Patients received hormonal treatment to stimulate 
multiple follicles development prior to oocytes retrieval; briefly, down regulation of 
patient’s cycle was achieved using Buserelin acetate (a GnRH agonist) (Sanofi-Aventis, 
France) followed by long protocol stimulation using urinary follicle stimulating hormone 
(FSH) (Frettsome, 2011). The follicles were aspirated under trans-vaginal ultrasound 
guided puncture to collect COCs and follicular fluid. A flushing media containing 
heparinised Hartman’s solution was used in some cases to aspirate the follicle (Frettsome, 
2011). Only clear hFF with no blood or flushing media contamination and with follicle 
size ranging from 16-18 mm and containing an oocyte were included in the study. 
Centrifugation of the collected hFF was carried out at 3500g, for 30 minutes at room 
temperature to eliminate any cellular debris (Frettsome, 2011).  hFF from three donors 
were pooled together and then divided into small aliquots of 50μl which kept in the freezer 
at -80°C until use.  
Donor codes: 119ECF11, 119ECF25 (patient with male factor infertility( and 119ECF04 
(patient with unexplained infertility), all three female donors were healthy and had 
successful cycles and positive pregnancy outcomes.  
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2.3.3 BCA assay for hFF protein concentration estimation:  
The concentration of the total proteins in the pooled sample of hFF was estimated by the 
BCA (Bicinchoninic acid assay).  Briefly, 200 μl of the working solution (bicinchoninic 
acid and copper (II) sulphate, 50:1 respectively) was added to 25μl diluted hFF samples 
(diluted at a concentration range of 1:5, 1:10, 1:20). Similarly, 200 μl of the working 
solution was added to a bovine serum albumin (BSA) standard (ranging from 0 μg/ml to 
1000 μg/ml).  All the preparations were added to a flat bottomed 96 well plate and left to 
incubate for 30 minutes at 37°C. The optical density values were measured in a plate 
spectrophotometer at 540 nm wavelength. The protein concentration was determined by 
comparison to BSA standard curve that was constructed in parallel.    
2.4 hFF preparations  
Three proteomic approaches were used and the details of each approach are shown in the 
sections below as follows:   
2.4.1 1st Approach: Solid Phase Extraction/High Performance Liquid 
Chromatography/Mass Spectrometry (SPE/HPLC/MS): 
For abbreviation, this approach is referred to as SPE/HPLC/MS.  In this approach, hFF 
was prepared using Discovery DSC18 column from Suppleco ( see section 1.6.1 for further 
detail of the technique principles).  
hFF was prepared prior to loading into the DSC18 columns as follow:  
30 μl of hFF were added to 470 μl of 50mM ammonium bicarbonate.  500 μl of 2% sodium 
deoxycholate prepared in 10mM DTT/100mM ammonium bicarbonate was added to the 
hFF preparation (to end up with 1% sodium deoxycholate/5mM DTT/50mM ammonium 
bicarbonate) and incubated for 60 minutes at 65°C. The sample was left to cool down 
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before adding  20 μl of 1M iodoacetamide/50mM ammonium bicarbonate to the prepared 
hFF sample and left in the dark at room temperature for 20 minutes.  Then, 150 μl of 
trypsin on ice was added to the sample and left overnight on a shaker at 37°C.  Next, 125 
μl of 100% formic acid was added to the 1250 μl  prepared hFF sample to achieve a final 
concentration of 10% formic acid.  The preparation was left for 5-7 minutes and then 
centrifuged at 2000g for 15 minutes.  Only the supernatant fluid (without disturbing the 
pellet which was discarded) was collected to be loaded into the equilibrated DSC 18 
columns.  
The DSC 18 column was prepared prior to loading the hFF sample as follow: the DSC 18 
column was conditioned by adding 1ml of 1% formic acid in acetonitrile and allowed to 
dribble slowly under the column under gravity into a Falcon tube and discarded (all the 
next additions were left in a similar way, under gravity effect).  The column was then 
equilibrated by adding 1ml of 1% formic acid in high purity water and left to dribble and 
the flow through was discarded. 
Then, the prepared hFF sample was loaded into the DSC 18 column and left to dribble and 
collected into a Falcon tube. When the dribbling was completed, 1ml of 1% formic acid 
was added to wash the DSC18 column, to remove any contaminants, and left to dribble 
into the same Falcon tube.  Another 1ml of a mixture of 75% of 1% formic acid in 
acetonitrile and 25% of 1% formic acid in distilled water was added to elute the DSC 18 
column and release the target analyte of hFF and the dribbling fluid was collected in a 
clean Falcon tube to be analysed.  The collected hFF sample was divided into two parts (50 
μl and 950 μl); both were dried completely under vacuum in the Speedvac. The 50μl 
sample was used to confirm presence of peptides by MS while the second part of 950μl 
was kept for further analysis. When the presence of peptides in the 50μl sample was 
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confirmed, further processing of the 950μl was pursued as follows: 110μl of mixed HPLC 
solvent A was added to the dried 950μl sample, vortexed and sonicated for 10 minutes. 
The sample was then centrifuged at 2000g for 5 minutes and the supernatant was collected 
before immediately transferring the sample into the HPLC machine. The yield from the 
HPLC was collected every 3 minutes into clean 0.65 µl Eppendorf tubes. The collected 
samples were dried completely in Speedvac at 45°C for around 120 minutes and finally 
they were re-suspended in 20μl of 1% formic acid and kept frozen until further analysis by 
the MS.  Figure 2-1 summarises the methodology for the SPE/HPLC/MS approach.  
 
 
Figure 2-1 Summary of the 1
st
approach methodology, Solid Phase Extraction/High 
Performance Liquid Chromatography/Mass Spectrometry (SPE /HPLC/MS). 
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2.4.2 2nd Approach : High Abundance Proteins (HAPs) depletion/Sodium Dodecyl 
Sulphate Polyacrylamide Gel Electrophoresis/Mass Spectrometry  
For abbreviation, this approach is referred to as HAPs/SDS-PAGE/MS. 
2.4.2.1 hFF (HAPs) depletion prior to SDS-PAGE: 
In this approach hFF sample was first depleted from the 12 most highly abundant proteins 
using IgY-12 spin columns (IgY-12 SCs) (see section 1.6.2 for further detail). The 
procedure of HAPs depletion was performed according to the manufacturer’s instructions.  
Briefly, the IgY-12 SCs were centrifuged at 2000g for 30 seconds to obtain dried beads.  
65μl of hFF was diluted in 1× Dilution buffer (provided with the IgY-12 SCs kit) to a final 
volume of 1300 μl.  The diluted hFF sample was divided into two tubes, 650 μl each and 
each was added to one of the IgY-12 SCs and mixed on an end to end rotator for 15 
minutes to assure complete blending of the IgY-12 SCs’ beads with the hFF samples.  The 
two IgY-12 SCs were then centrifuged for 30 seconds at 2000g and the flow-through hFF 
samples were collected.  The hFF samples were then prepared for running the SDS-PAGE 
as shown below. The IgY-12 SCs can be regenerated for reusability by eluting and 
stripping off the bound proteins (see section 1.6.2, chapter 1). 
2.4.2.2 SDS -PAGE: 
The same SDS-PAGE protocol was used in the preparation of both the depleted hFF 
samples (section 2.4.2) and the depleted and filtered/concentrated hFF samples (section 
2.4.3).  Briefly,  samples were divided into 20 μl aliquots and 5μl of 5 × SDS-PAGE 
sample buffer (0.05% (w/v) bromophenol blue, 0.25 M DTT, 50% (v/v) glycerol, 5% 
(w/v) SDS and 0.225 M Tris-Cl, pH 6.8) was added to each of the aliquots, heated at 
100°C for 5 minutes and centrifuged at 500g for another 5 minutes immediately before 
loading the samples into SDS-PAGE gel along with 5 μl a pre-stained protein standard. 
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Proteins were resolved by electrophoresis on a precast 10% NuPAGE Bis-Tris gel for 60 
minutes at 200 V voltages in MOPS buffer (1 × MOPS prepared by diluting 25 ml of 20 × 
MOPS in high purity water up to a total volume of 500 ml). The gels were stained 
overnight with Coomassie Brilliant Blue stain on a shaker at room temperature. Each 
whole protein lane was then carefully cut into approximately 23 pieces 1mm each 
according to the stained protein bands. Positive pressure hood, sterile scalpels and clean 
(dust free) Eppendorf tubes were used throughout the experiments to minimise keratin 
contamination of the gels. The sliced protein bands were further treated according to 
standard in-gel protein digestion protocol for MS analysis as follows: 
2.4.2.3 In-gel protein digestion and MS: 
In- gel protein digestion protocol of Coomassie Brilliant Blue stained gels (Shevchenko et 
al., 2007) was applied, with minor modifications, to digest proteins in the gels and prepare 
them for MS analysis as follows: (all the in-gel protein digestion steps were carried out 
inside a positive pressure hood as mentioned earlier and all chemical preparations were 
freshly made on the day of the experiment). 
De-staining : On a clean glass plate and inside a positive pressure hood the whole 
Coomassie stained gel lanes were sliced by a sterile scalpel. Each lane was sliced into 
around 23 small pieces (around 1mm each) which preferably coincide with the stained 
protein bands in the gel. 500μl of 50% Acetonitrile/50mM Ammonium bicarbonate was 
added to each of the Eppendorf tubes containing one gel slice and left to incubate for 20-
45 minutes with vigorous shaking on a shaker at room temperature. Then the supernatant 
was aspirated by a suction machine and discarded.  
Reduction and alkylation: 250μl of 50mM DTT in 10% Acetonitrile/50mM Ammonium 
bicarbonate was added to the Eppendorf tubes containing the gel slices and incubated for 
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60 minutes at 54°C.  The supernatant fluid was aspirated by suction machine and 250μl of 
100mM Iodoacetamide in 10% Acetonitrile/50mM Ammonium bicarbonate was added to 
each tube and incubated in the dark at room temperature for 30 minutes. The supernatant 
fluid was then discarded and 500μl of 10% Acetonitrile/50mM ammonium bicarbonate 
was added and the tubes were left on a rotator for 15-30 minutes. The tubes were dried in 
the Speedvac for 120 minutes or until the gel pieces were completely dry.  
In-gel protein digestion: sequencing grade modified trypsin was prepared according to 
the manufacturer’s specifications and 20-40μl of the prepared trypsin was added to the 
dried gel pieces and left overnight at 37°C on a shaker. All trypsin additions were carried 
out quickly on ice.  
Protein extraction: On the following day, 150μl 1% formic acid in 50% acetonitrile was 
added to each of the tubes containing gel slices and incubated for 60 minutes on a shaker. 
Then the supernatant fluid was transferred to new Eppendorf tubes and the pipette tips 
were left inside the new tubes (to minimise peptide loss). Next, 150μl 1% formic acid in 
distilled water was added to each gel slice in the original tubes and left for 60 minutes on a 
shaker and the supernatant fluid from each tube was then transferred into the same new 
tubes again. This step was performed twice   and the collected supernatant fluids were then 
dried completely in the Speedvac for 120-180 minutes.  Finally, 20μl of 1% formic acid 
was added to each tube and the samples were ready for MS analysis (kept frozen at -20°C 
until the MS analysis was performed). Figure 2-2 summarises the methodology for the 
HAPs/SDS-PAGE/MS approach. 
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Figure 2-2  Summary of the 2
nd
 approach methodology, High Abundance Protein 
depletion/ Sodium Dodecyl Sulfate PolyAcrylamide Gel Electrophoresis/Mass 
Spectrometry (HAPs/SDS-PAGE/MS).  
 
2.4.3 3rd Approach: High Abundance Proteins (HAPs) depletion/ filtration and 
concentration/SDS-PAGE/MS (HAPs/FC/SDS-PAGE/MS) 
For abbreviation, this approach is referred to as HAPs/FC/SDS-PAGE/MS. 
2.4.3.1 hFF (HAPs) depletion prior to SDS-PAGE:   
    See section 2.4.2.1   
2.4.3.2 hFF concentration and filtration following the HAPs depletion: 
To further enhance the yield of hFF proteins detection, a step of filtration and 
concentration by Amicon Ultra 0.5ml centrifugal filter units (with pore size 30 kDa 
molecular weight cut off) was introduced following the depletion technique in this 
approach.  According to the manufacturer’s specifications, these centrifugal filter units 
have a concentration factor of 15-20 times.  The depleted hFF sample was processed 
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further to obtain depleted concentrated hFF sample as follows: 300μl of the depleted hFF 
sample was loaded into  each Amicon Ultra 0.5ml centrifugal filter unit following addition 
of 8M urea and 1% SDS to the depleted hFF sample. The filter units were then centrifuged 
for 15minutes and the fluid in the filter device of the centrifugal units was retrieved for 
running on SDS-PAGE. Figure 2-3 summarises the methodology for the HAPs/FC/SDS-
PAGE/MS approach. 
2.4.3.3 SDS-PAGE: 
See section 2.4.2.2  
2.4.3.4 In-gel digestion: 
See section 2.4.2.3  
 
Figure 2-3  Summary of the methodology in the 3
rd
 approach, High Abundance Proteins 
depletion/ Filtration concentration/Sodium Dodecyl Sulfate PolyAcrylamide Gel 
Electrophoresis/Mass Spectrometry (HAPs/FC/SDS-PAGE/MS). 
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2.4.4 Mass spectrometry analysis: 
This work was completed by Dr. Ashley Martin and Dr Douglas Ward, University of 
Birmingham. Briefly, the obtained tryptic peptides from the individual protein bands from 
the three hFF proteomic approaches were subjected to an on-line, direct infusion into an 
Electro Spray Ionisation interface – Time of Flight MS (ESI -TOF MS) that has MS/MS 
capability. The peptides were sprayed into a MicroTof II MS via a nano ESI interface 
following separation on a Dionex Ultimate 3000 HPLC system.  The HPLC column was 
an Acclaim C18 Pep Map (25 cm long, 75 µm internal diameter, 3µm particle size) 
(Frettsome, 2011).   An online nanospray source fitted with a metal needle with a 10 µm 
tip connected the HPLC column to a Bruker ETD Amazon mass spectrometer (Frettsome, 
2011). The drying gas set to 6.5 l/min at 180°C and 1600 V was applied to the end plate 
(Frettsome, 2011).  
An MS survey scan from 350 to 1600 m/z was accomplished and the selection of the five 
most abundant ions in each MS spectrum was performed (Frettsome, 2011). An exclusion 
list was applied following each two cycles of fragmentation. The data search was 
performed by the Mascot search engine (version 3.0) and applying 10 ppm (part per 
million) mass accuracy rate for both the parent and fragment ions.  The search was 
performed by using SwissProt sequence of database for human. Trypsin as a protease, 0.5 
Da for minimum mass accuracy for the parent and fragment ions and 
carbaminomethylation of cysteines as a fixed modification were selected. Protein 
identifications were filtered using both a 1% false discovery rate (FDR) (99% probability) 
and a requirement of a minimum 2 or more peptides using Proteinscape 2.1 software 
(Frettsome, 2011).   
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2.4.5 hFF proteins functional analysis:  
The identified hFF proteins in this study were classified according to molecular functions, 
biological processes and cellular localisation. The functional classification was achieved 
using PANTHER (Protein ANalysis THrough Evolutionary Relationship) Classification 
System Version 10 at http://www.pantherdb.org/(accessed in July 2015).  PANTHER is 
part of the Gene Ontology Reference Genome Project and is a comprehensive free online 
knowledgebase of protein pathways which was designed to classify proteins in order to 
facilitate high-throughput analysis (Mi et al., 2013, Thomas et al., 2006).  The following 
terms are used in the PANTHER classification system: molecular function which is the 
function of a protein at a biochemical level e.g. a protein kinase; biological process: the 
function of a protein in the context of a larger network of proteins that interact to achieve a 
process at the level of the cell or organism, e.g.metabolic process. 
2.5  hFF compiled protein table from the literature: 
 2.5.1 Methodology for the hFF compiled protein data: 
Following an extensive literature search in Medline via the PubMed search platform using 
the following search terms: (“human follicular fluid” OR (“Follicular fluid”[All Fields] 
AND “proteins”[All Fields]]) OR “human follicular fluid proteomics”[All Fields] OR 
(“follicular fluid proteins ”[All Fields] AND “identification”[All Fields]) OR “follicle 
”[All Fields]) AND (“fluid”[Subheading] OR (“biological”[All Fields] AND 
“markers”[All Fields]) OR “biological markers”[All Fields] OR “biomarker”[All Fields]) 
and by selecting (Human) for species.  Studies retrieved from the PubMed search were 
assessed for eligibility using the title and abstract or where necessary the full text.  
Twenty-six studies were available online from 1996 up to July 2015 on hFF proteomic 
85 
 
studies published in English. A list of the techniques applied in each of the 26 identified 
studies and the number of proteins identified per study are illustrated in table 2-1 and 
figure 2-4.  All studies included in the analysis were on human follicular fluid.  Twenty-
four studies were included in the hFF ptotein table while two studies were excluded (one 
study only the abstract was available in English and the article and protein data were only 
available in Chinese (Li et al, 2008 ). The second study (Bayasula et al, 2013) was 
excluded since most of the FF proteins described in the hFF protein list were of none homo 
sapien origin, including yeast and mouse proteins. None of the studies were excluded on 
the basis of the proteomic techniques used which is unlike a compiled study of human 
sperm proteome (Amaral, et al, 2014a) in which the authors excluded studies using 
MALDI-TOF/ MS as the technique is described as outdated.  Nonetheless, inclusion of 
potentially false positive hFF proteins was minimised by applying the following selection 
criteria for protein identification in the included published studies according to: 
identification of at least two peptides per protein and a false discovery rate (FDR) < 5% or 
an FDR < 1%.  In studies when the hFF protein data retrieved by SDS-PAGE, only protein 
data from direct amino acid sequencing of proteins were included. The inclusion criteria 
for each of the studies included are highlighted in appendix 3.  
All the proteins identified in the included 24 hFF studies were loaded into UniProt 
knowledge base (the Universal Protein Resource, http://www.uniprot.org/uploadlists) 
which is one of the major databases for protein information containing an exhaustive and 
accurate annotation for proteins along with their sequences.   All proteins were annotated 
using Swiss-Prot accession number even when the original data was in other forms of 
protein ID (for example: GI accession number or in some cases ENSEMBL proteins). This 
was performed to achieve homogeneity of the data in terms of protein names and accession 
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numbers and also to avoid proteins redundancy.  For example, in three studies (Kushnir et 
al, 2012; Ambekar et al, 2013, Ambekar et al, 2014) which used GI numbers for protein 
data annotation, two or more GI numbers have only one UniProt accession number. Thus a 
study referring to 770 proteins identification (Ambekar et al., 2014), actually had 404 
proteins when the protein data was loaded into UniProt knowledge base (UniProtKB) and 
annotated using UniProt accession numbers.  Some of the listed proteins in the study by 
Ambekar et al (2014) and Regiani et al (2015) were either fragments or deleted proteins 
and their GI numbers have been merged into a single UniProt accession number.  
 
2.5.2 Results and discussions of the compiled hFF protein data from the literature: 
By compiling the protein data from the available articles, a list of 1586 proteins was 
generated along with the references to the studies identified them. This table only contains 
proteins with UniProt accession numbers; any proteins with accession number that has 
been merged into another protein’s accession number or proteins with deleted or obsolete 
accession numbers were not included in the compiled hFF protein table.  Obsolete or 
deleted proteins are considered as redundant proteins.  In proteomic, a redundant protein is 
defined as the one in which all or nearly all protein sequences are highly similar or 
identical to an existing protein from the same species (as defined in UniProt knowledge 
base, www.uniprot.org). The UniProtKB further reduces proteins redundancy by merging 
all proteins sequences which are encoded by the same gene into a single UniProt entry 
record and are shown as merged proteins in the UniProt database.  In this compiled study, 
some proteins were found to be merged into their corresponding proteins following their 
annotation with a UniProt accession number.  
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In the compiled hFF protein data from the literature,  around one third of the proteins were 
reported more than once, which may indicate the high biological variation in the proteins 
identified by the different proteomic techniques in terms of protein depletion, fractionation 
and analysis.  This also shows the importance of compiling  hFF proteins to include up to 
date hFF proteins reported in the literature.  This work may provide a resource for further 
hFF proteomic research. This observation is similar to the work done in plasma proteome 
where combining data for the Plasma Proteome’s Reference Database from different 
plasma proteomic studies which applied different sample preparation techniques resulted 
in the identification of considerably diverse sets of proteins (Farrah et al., 2011). The total 
number of hFF proteins identified also varied from previous publications. Ambekar et al, 
2013 reported that 789 hFF proteins are found in hFF proteomic data while  Zamah et al 
(2015) indicated that hFF contains 982 proteins up to the date of their publication.  In this 
work, 1586 hFF proteins were compiled out of 24 published studies from 1996 to 2015.   
The list of compiled hFF proteins was searched in PANTHER classification system 
http://pantherdb.org/ to describe the biological processes involved for  hFF protiens, figure 
2-5. 
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Figure 2-4 The number of hFF proteins identified in each of the 24 published studies 
included in the compiled hFF protein data. See table 2-1 for the detail of techniques 
utilised in each study. 
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Figure 2-5 Biological processes involved in the compiled hFF proteins according to 
PANTHER classification system. Cellular process and metabolic process were among the 
highest categories. 
 
2.6  Results of hFF proteomics: 
The hFF proteins identified in the three approaches (n = 3) were compared and compiled 
in one table for the total number of distinct hFF proteins detected in this study. The 
original data obtained was 346, 660 and 102 proteins from the 1st, 2nd and 3rd approaches 
respectively. Random sequence proteins (rnd proteins) were deleted from the data at 1% 
FDR.  A total of 479 hFF proteins were included in the final analysis; 212 proteins from 
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the 1st approach (SPE/HPLC/MS), 431 proteins from the 2nd approach (HAPs/SDS-
PAGE/MS)  and 81 proteins from the 3rd approach (HAPs/FC/SDS-PAGE/MS). The 1
st
 
approach using a crude non-depleted hFF sample enabled the detection of 32 proteins 
which were not detected in the other two approaches following HAPs depletion.  
Alternatively, 267 proteins out of the total 479 were only identified following the HAPs 
depletion in the 2
nd
 and 3
rd
 approaches (154 and 17 proteins respectively with 4 proteins 
detected in both).  180 proteins were identified in both crude and depleted hFF samples in 
this study.  Venn diagrams figure 2-6 and 2-7 illustrate the number of proteins detected in 
each approach and numbers of proteins in the crude and depleted hFF samples 
respectively. 
 
 
Figure 2-6 Venn diagram of the results of the three approaches compiled together with the 
number of proteins identified in each approach. Some proteins were only detected the 
crude or the HAPs depleted hFF. 
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Figure 2-7 Venn diagram comparing number of proteins detected in the crude and HAPs 
depleted hFF in this study, 180 proteins were detected in both samples while 32 proteins 
were only detected only in the crude hFF and 267 proteins only detected in the HAPs 
depleted hFF sample.  
   
 
The list of the compiled proteins detected in this study was loaded into UniProt knowledge 
base (http://www.uniprot.org/uploadlists/) to retrieve UniProt accession numbers for each 
protein. The annotation of the identified proteins with UniProt accession numbers enabled 
the comparison of our data with the data in the literature(an exhaustive hFF protein table 
from 24 hFF proteomic published studies was compiled in this work, section 2.5.1). 
When the hFF protein data was compared with the hFF data compiled from the literature, 
103 (approximately 22%) out of the total detected proteins were novel hFF proteins while 
92 
 
376 proteins (approximately 78%) have been previously reported in the hFF proteomic 
literature (figure 2-8).  
Previous detection of each of the hFF proteins in this study was verified by comparison of 
UniProt accession numbers of the identified hFF proteins with the list of the compiled hFF 
proteins from the published studies. The list of the hFF proteins detected in this study are 
included in appendix 2.  
 
 
Figure 2-8  Venn diagram showing the number of hFF proteins identified in this study 
compared with the number of hFF proteins from the hFF proteomic literature, 103 novel 
hFF proteins were detected in our study. 
 
 
Functional analysis of hFF proteins identified  
Based on the PANTHER Classification System, 38 %  of the identified hFF proteins in this 
study belong to the enzyme catalytic function and 29 % belong to the binding category 
followed by 24 % with receptor activity. Other hFF functional categories included enzyme 
regulation, transport activity, structural and antioxidant activities (figure 2-9). However, 
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74 proteins out of the 479 proteins loaded into PANTHER Classification System were not 
mapped into any specific function (unknown function).  
Figure 2-9  hFF protein classification according to molecular functions in PANTHER 
classification system; catalysis and binding were among the highest categories identified in 
this study followed by receptor activity and enzyme regulation.  
 
 
In terms of protein classification by biological process, the majority of the hFF proteins 
were shown to belong to the metabolic process category (75%) followed by cellular 
process and bioloigical regulation (figure 2-10).  Response to stimulus, developmental 
process and immune system were the next categories of hFF proteins. Most proteins were 
involved in more than two types of biological processes.    
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Figure 2-10  hFF protein classification according to biological process in PANTHER 
classification system; metabolic processes and cellular processes were among the highest 
categories followed by biological regulation 
 
 
On the basis of cellular localisation, the majority of the identified hFF proteins in this 
study were extracellular proteins followed by cell part (figure 2-11). The next localisations 
of the identified hFF proteins were in organelles, extracelluar matrix and macromolucular 
complex (which is defined in PANTHER Classification System as a stable assembly of 
two or more constituents (or macromolecules), for example, proteins, nucleic acids, 
carbohydrates or lipids to function together). 
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Figure 2-11  hFF protein classification according to cellular localisation in PANTHER 
classification system, extracellular region and cell part were among the highest categories 
followed by organelle and extracellular matrix  
 
 
Novel hFF proteins: 
One hundred and three  novel hFF proteins have been detected in the current study.  Some 
of the novel hFF proteins identified in this study are members of protein families with the 
other members being identified in previous hFF proteomic studies. For example, three 
types of annexins have been detected in the hFF in this study, one of them was annexin 
A1,a novel hFF protein. In the literature, annexins A2, A5, A6 (Zamah, et al, 2015), 
annexin A4 (Angelucci et al, 2006) and annexin A10 (Ambekar et al, 2014) have been 
detected in the hFF.  Annexins are protein family with different biological functions 
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(Takagi et al., 2002).  Annexin A1 is a calcium-dependent phospholipid binding protein 
which is involved in several cellular functions mainly anti-inflammatory response and 
apoptotic functions (Flower and Rothwell, 1994). Annexin A1 has been shown to be 
expressed in syncytiotrophoblast of the placenta (Sun et al., 1996) and to be elevated in 
plasma of women with pre-eclampsia  (Perucci et al., 2015).  Further functions of this 
protein in hFF may require further research.  
Four enzymes which belong to the protein disulphide isomerases (PDI) family have been 
detected in this study which includes PDIA1, PDIA3, PDIA4 and PDIA6 members.  
PDIA1 (Zamah, et al, 2015) and PDIA3 (Angelucci et al, 2006; Zamah et al, 2015) have 
already been identified in hFF while PDIA4 and PDIA6 were detected for the first time in 
this study.   This makes 4 members of the PDIs family identified in hFF. PDIs enzymes are 
involved in the catalysis of thiol/disulphide reactions (Wilkinson and Gilbert, 2004) and 
participate in several cellular functions (Turano et al., 2002). 
Up to date 15 SERPINs (SERpin Peptidase INhibitors) have been identified in hFF 
(Ambekar et al., 2013, Bayasula et al., 2013, Kushnir et al., 2012) namely SERPIN A1, 
A3, A4, A5, A6, A7, A8, A10, C1, D1, E1, E2, F1, F2, G1.  Two more SERPINs have 
been identified in this study namely SERPIN B5 and B6 (serpin peptidase inhibitor clade 
B, member 5 and member 6) making 17 SERPINs in hFF. The functions of SERPINs 
range from coagulation, fibrinolysis and cellular differentiation and they have been 
suggested to be vital for ovarian follicle maturity and ovulation (Ambekar et al., 2013). 
Interestingly, some of the published studies have listed keratins as components of hFF 
proteome (Ambekar et al, 2013), however, in the current study they were considered as a 
potential contamination from hair and dust and were only included in the final analysis 
when they were found in the hFF protein data from the literature.  
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There are clearly many other proteins some of which may have key roles in fertility; 
however, it is out of the scope of this work to include all of them.  The functional analysis 
of the hFF protein data may highlight the general function of the identified hFF proteins 
and their localisation. 
2.7  Discussion  
This study identified a total of 479 distinct proteins adding 103 novel proteins to the hFF 
repertoire and confirming 376 proteins of the previously reported hFF proteins in the 
literature (figure 2-8).  hFF protein profiling was achieved by a combination of proteomics 
approaches in an attempt to overcome the challenges of the high dynamic range of hFF 
proteins (Bianchi et al, 2013) which is defined as the variation in the abundance between 
the high abundance detectable proteins and the lowest abundance detectable proteins in a 
biological samples (Brewis and Gadella, 2010). In  proteomic studies, it is a well 
documented challenge to detect the lower abundance proteins, which generally have high 
biological functional relevance (Brewis and Gadella, 2010).  
Discussion of the methodolgical choices, strengths and limitations: 
The application of a combination of proteomic techniques to study hFF is highly valuable 
to enable the detection of large number of variety of proteins (Twigt et al, 2012) and also 
to overcome the limitation of one technique by the advantages of the others.   
In the first approach, a technique of protein fractionation and peptide purification using 
SPE of crude hFF samples by DSC 18 spin columns was used.  One of the advantages of 
the use of crude hFF in this approach was to have an overall view of the hFF with a 
minimum sample manipulation and to maintain the physiological and biochemical nature 
of the hFF (Bianchi et al, 2013).  SPE has the advantages of being a rapid and selective 
sample preparation technique which enhances peptides detection for the MS analysis 
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(Martínez-Maqueda et al., 2013). Protein fractionation of highly complex biological 
samples is suggested as a vital procedure to reduce sample complexity prior to subsequent 
proteomic analysis (Josic and Clifton, 2007). One of the reasons to apply the SPE 
technique in this study was to tackle the challenge of high complexity of the hFF protein 
composition.  Coupled with HPLC/MS, the SPE using DSC18 SC enabled the detection of 
212 proteins in a crude none depleted sample of hFF of which 30 proteins were novel hFF 
proteins.  
Although advantageous, the use of crude none depleted hFF may create challenges in the 
detection of Lower Abundance Proteins (LAPs) (Fahiminiya et al., 2011a).  Research into 
hFF proteomics is mostly interested in the identification of candidate biomarkers which are 
generally LAPs rather than the HAPs which are considered as common non-specific 
proteins (Fahiminiya et al., 2011), (see also section 1.6.2 for further detail).   
 
Since HAPs are usually described as housekeeping proteins (Gorg et al., 2004) and their 
presence may mask the detection of LAPs on SDS-PAGE (Fahiminiya et al., 2011a), the 
second and third approaches in this study applied HAPs depletion of the hFF prior to SDS-
PAGE/MS.  The technique of HAPs depletion has been recommended for hFF proteomics 
mainly to overcome the high complexity of hFF protein composition (Jarkovska et al., 
2010, Ambekar et al., 2013).  Some studies have applied the technique of HAPs depletion 
successfully on human FF (Jarkovska et al., 2010, Ambekar et al., 2013, Zamah et al., 
2015) and animals such as mare FF (Fahiminiya et al., 2011b) to enhance low and medium 
abundance proteins identification. In this study, a total of 447 proteins were detected 
following HAPs depletion of hFF samples in two sets of experiments (2
nd
 and 3
rd
 
approaches).  267 hFF proteins out of the total proteins identified were only detected in the 
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depleted hFF samples and were not detected in the crude hFF sample prepared by the SPE 
approach.  The 2
nd
 and 3
rd
 approaches with HAPs depletion enabled the detection of 107 
novel hFF proteins (of which 15 proteins were also detected in the crude hFF sample). 
However, similar to other techniques, HAPs depletion strategy has some drawbacks.  
Although the HAPs depletion technique is designed to target 12 of the mostly abundant 
proteins in a biological sample (the targeted 12 HAPs are listed in section 1.6.2), the 
depletion process could be non-specific (Zhou et al., 2004).  For instance, some studies 
indicated that the process of proteins elimination during HAPs depletion carries the risk of 
loss of potential candidate proteins which were bound to the depleted proteins and also 
eliminated none specifically during the HAPs depletion (Jacobs et al., 2005, Bayasula et 
al,, 2013). This would be supported by our observations where SPE technique using the 
crude none depleted hFF has detected a series of proteins (32 proteins) not identified in the 
HAPs depleted samples. The most likely cause being that these proteins were also 
depleted, non-specifically, during sample treatment. This is described in the literature as 
the sponge phenomenon (Zhou et al., 2004) in which albumin and other HAPs may bind 
other fragments of LAPs and lead to some LAPs loss during the depletion process. 
However, the IgY-12 SCs used in this study, have been shown as selective and a robust 
technique for biological fluids analysis (Corrigan et al., 2011, Qian et al., 2008). The high 
specificity of the column is attributed to the avian nature of the polyclonal IgY antibodies 
of the column which provides very specific binding and clean capture compared to 
mammalian antibodies (Corrigan et al, 2011, Qian et al, 2008).  It has also been observed 
that only very few non-specific proteins loss occur following the use of the IgY-12 SCs 
(Carrigan et al, 2011).  
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In the current study, out of the 12 HAPs targeted by the IgY-12 SCs five were removed 
completely (not detected following depletion), while seven proteins were still detectable 
following the depletion cycle.  For example, albumin, apolipoprotein AI and II were still 
detected in the depleted hFF samples in this study although they were targeted by the 
depletion column. This observation is similar to work by others, for example (Jarkovska et 
al, 2010, Ambekar et al, 2013).  In some studies which applied the HAPs depletion on 
hFF, application of more than one depletion cycle was performed to ensure complete 
depletion of HAPs (Ambekar et al., 2013).  Only one depletion cycle was performed in the 
current study in both the 2
nd
 and 3
rd
 approaches. However, further enhancement of the 
depletion technique was achieved in the third approach by the application of Amicon Ultra 
centrifugal filter units for concentrating the depleted hFF samples and to increase LAPs 
detection.  The use of the  centrifugal filter units enabled the concentration of hFF sample 
by approximately 15-20 times (that of the previously depleted hFF) to run on SDS-PAGE.  
81 proteins were detected following the use of the third approach of which 13 proteins 
were only detected in the depleted concentrated hFF and 4 of them were novel hFF 
proteins. However, a recognised issue with the use of the filtration/concentration technique 
is the risk of increased sample loss due to increased samples manipulation (Jacobs et al., 
2005). This was prominent when only 81 proteins were detected in the HAPs 
depleted/concentrated sample compared to 431 in the depleted sample without 
concentration/filtration.  
In this study, 180 proteins were identified in both depleted and none depleted hFF samples.  
However, 32 proteins out of the total 479 were only detected in the crude none depleted hff 
sample  which may indicate that some of these proteins were removed, non-specifically, by 
the depletion technique as highlighted earlier.  Additionally, the role of certain proteins can 
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be overlooked when considering only the depleted hFF samples, for example albumin, 
which is one of the HAPs,  has been shown to play a role in oocyte protection against 
oxidative damage (Otsuki et al., 2012).  Conversely, 267 proteins out of the total 479 hFF 
detected in this study were only detected in the depleted hFF samples following HAPs 
depletion which may also indicate the advantages of the application of HAPs depletion in 
hFF proteomic studies along with other techniques for enhanced coverage of the protein 
range in hFF.   
 
Both depleted and depleted concentrated hFF samples from the 2
nd
 and 3
rd
 approaches 
were run on SDS-PAGE for proteins separation. SDS-PAGE along with MS are 
considered the workhorse in proteomic studies particularly in investigating highly 
complicated body fluids such as hFF (Gorg et al., 2004, Bianchi et al., 2013).  The 
application of MS in hFF proteomic studies has resulted in enormous advancements in the 
detection of proteins in hFF and their potential importance for reproduction (Hanrieder et 
al, 2008). Specific peptide peak patterns detected by MALDI-TOF MS have been 
described as potential biomarkers for follicular development and maturity (Liu et al., 
2007).   
The application of SDS-PAGE in hFF proteomic analysis was described for the first time 
by the pioneering work of Spitzer et al (1996). Advances in proteomic approaches of hFF 
analysis have been evolving progressively since then and some disadvantages have been 
linked to the use of SDS-PAGE (Baker et al, 2007).  For example, although the gel lanes 
are sliced into approximately 1mm pieces, yet each slice may contain up to 40 proteins 
leading potentially to difficulty in identifying all the proteins present (Baker et al., 2007).  
Another issue is the risk of contamination with keratin from dust and hair. In this study, 
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contamination was minimised by following certain precautions such as preparation of the 
samples in positive pressure hoods, use of gloves, clean tubes and high purity chemicals to 
avoid possible contamination of the gels while running hFF samples.   
 
Discussion of functional hFF proteins analysis: 
The functional classification of the hFF proteins differed from one study to another in the 
literature according to the range of proteins identified in the study data. For example, some 
studies have described acute phase proteins as the major category in hFF proteins and 
defined ovulation as an inflammatory process (Anahory et al., 2002; Lee et al., 2005; 
Angelucci et al., 2006; Hanrieder et al., 2008).  In contrast, other later studies manifested 
that other functions such as complement cascade, blood coagulation and angiogenesis are 
also involved in hFF protein functions (Jarkovska et al, 2010; Bianchi et al, 2013) adding 
another definition to ovulation as a hormone-induced injury (Murdoch et al., 2010) 
because of the involved coagulation and tissue restoration.   In the current study, majority 
of hFF protein were metabolic proteins with catalytic enzyme activity, binding proteins 
followed by receptor activity are the major categories.  
With regards to cellular localisation analysis of hFF in this study, the majority of the 
identified hFF proteins were extracellular followed by proteins from cell parts. These 
findings are similar to the classification results obtained by Ambekar et al (2013 ) of hFF 
proteins using HPRD (Human Protein Reference Database).  The presence of proteins 
from the cell part and organelle specific proteins (intracellular proteins) has been 
suggested as a result of cellular apoptosis and epithelial shedding during follicular growth 
(Ambekar et al., 2013, Markstrom et al., 2002).  
 
103 
 
Limitations of the study around number of samples analysed:  
In addition to the above discussed limitations, such as non-specific loss of LAPs using 
HAPs depletion, there were some limitations in this study in terms of number of pooled 
hFF samples.  The hFF proteomic analysis in this study was performed on a pooled hFF 
sample from three healthy donors with positive pregnancy outcomes and comparable 
follicle maturity (follicle diameter 16-18 mm) only seeking fertility treatment for male 
factor infertility and unexplained infertility.  Most proteomic studies utilise pooled samples 
of hFF from at least two or more donors to increase hFF protein coverage (Twigt et al, 
2012).  In this study, the hFF sample was pooled from three donors which again may result 
in limited analysis of biological variations. Since hFF may be considered as a by-product 
of IVF (Bianchi et al, 2013), future studies may consider pooling hFF samples from larger 
numbers of patient, or analysing many samples individually to ensure enriched proteomic 
analysis of biological variation (Ambekar et al, 2014).     
In the current study, hFF was obtained following controlled ovarian stimulation. A study 
which examined the variation in hFF protein profile from 6 women with natural cycles 
versus 6 women undergoing ovarian stimulation suggested increased immune and 
inflammatory response with eight proteins being differentially expressed in the ovarian 
stimulation group (Wu et al, 2015).  However, the authors indicated that the results of their 
study are preliminary and large-scale studies are required to reveal any differences in the 
protein profile from women with natural cycle versus patients with induced cycles (Wu et 
al, 2015).             
hFF biomarker detection and reproductive biology applications: 
It is beyond the scope of this work to list all the potential biomarkers in the hFF proteins 
detected up to date, however, this section highlights some of the important aspects of hFF 
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protein applications in reproduction. One of the advantages of the application of hFF as a 
source of biomarkers is its easy collection in a non-invasive way as it is described as a by-
product during the IVF procedure (Bianchi et al., 2013). The criteria of an ideal biomarker 
are non-invasive collection (Liu et al., 2007, Kovac et al., 2013), sensitivity, specificity 
and identification of disorders at an initial stage when diagnosis and appropriate 
management are more advantageous for patients (Kovac et al., 2013, Liu et al., 2007).   
Biomarkers for diagnosis and prognosis of ovarian hyperstimulation syndrome especially 
in its severe form have been suggested in hFF (Moos et al., 2009, Jarkovska et al., 2011).  
As a result of the growing trend toward single embryo transfer, the identification of the 
highest quality oocyte for selection in ART has become highly critical (Bianchi et al., 
2013).  Some correlation between hFF contents of several substances and oocyte maturity 
and folliculogenseis have been indicated in the literature (Kawano et al., 2004, Ocal et al., 
2004, Lee et al., 2005, Wu et al., 2007).  Nonetheless, the role of several proteins in the 
characterization of follicle growth and oocyte quality is still elusive (Revelli etal., 2009).  
Table 2-3 lists some of the hFF biomarkers described in the literature and compiled in this 
study. For a review of the suggested FF biomarkers for oocyte quality see Revelli et al. 
(2009).   
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Table 2-3 hFF biomarkers described in the literature 
Applications  Potential hFF biomarkers  References 
PCOS and pre-eclampsia Apo lipoprotein A IV (Kim et al., 2013) 
 
oocyte maturity and 
folliculogenseis 
Macrophage inflammatory protein-
3alpha, inhibins A and B, follistatin, 
activin,  transforming growth factor 
beta family and bone morphogenetic 
protein 15 (BMP15) 
(Kawano, 2004, Ocal, 2004, 
Lee, 2005, Wu, 2007) 
 
 
 
IVF success 
 
 
Haptoglobin alpha, apolipoprotein 
H, dihydrolipoyl dehydrogenase, 
lyzozyme C, fibrinogen alpha-chain, 
and immunoglobulin heavy chain V-
III (region BRO), antithrombin, 
vitamin D–binding protein, and 
complement C3 
11 β- hydroxyl steroid 
dehydrogenase 
 
 
(Estes, et al, 2009) 
 
 
 
 
(Michael et al., 1993) 
 
Recurrent spontaneous 
miscarriage  
Fibrinogen γ (Kim et al., 2006) 
 
Predictor of IVF outcome  
Sex hormone binding globulin 
(SHBG), corticosteroid binding 
globulins (CBG) 
Cytokines such as IL8 and IL18   
(Andersen, 1990) 
 
 
(Sarapik et al., 2012) 
 
Despite the above mentioned advantages of hFF as a source of biomarkers for oocyte 
quality and other reproductive biology applications, hFF is obtained as a by-product of 
ART (Bianchi et al, 2013).  In future research, the identification of good biomarkers in 
hFF may demand further studies to attempt detecting signs of the identified biomarkers in 
other body fluids such as blood or urine.  This may enable the application of the diagnostic 
biomarkers for women with natural, none stimulated ovulatory cycle.   
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 Concluding remarks: 
This study adds further novel hFF proteins to the repertoire and confirms some of the 
previously described hFF proteins. The compiled hFF protein data from the literature in 
this study is a resource for future reference of the currently available hFF protein data. 
Enhanced understanding of protein components of hFF is vital for further research into 
biomarkers for oocyte quality, understanding of the fertilisation environment and potential 
improvements in ART. 
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Chapter 3  
COMPARATIVE PROTEOMIC STUDY OF SPERM 
VERSUS SPERM AND HUMAN FOLLICULAR FLUID 
INTERACTIONS  
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3.0 Abstract:  
Sperm are transcriptionally and translationally inactive and they rely markedly on proteins 
acquisition/loss and post-translational modification to achieve functional competence. hFF 
has been shown to provide a favourable media for sperm longevity, capacitation, and 
acrosome reaction. Aim: to perform a comparative proteomic analysis and identify any 
hFF proteins which may bind to sperm and may be linked to sperm acquisition of 
fertilisation capability. Method: sperm cells were prepared by Percoll gradient 
centrifugation and sperm were either left to capacitate in standard ART media alone 
(control sperm samples) or capacitated in the media with hFF for 90-120 minutes to allow 
for capacitation and any protein binding to occur.  Both control sample and sperm + hFF 
preparations were processed using two approaches, total binding and membrane-associated 
protein approach. In both approaches, two cycles of washing were performed for both 
sample types  (to remove any unbound hFF fractions in sperm + hFF samples).  In the total 
binding approach, the pellet part for both samples (representing total binding fractions in 
sperm + hFF samples) were run on SDS-PAGE and analysed by MS.  In the membrane-
associated approach, control and sperm + hFF samples were further incubated in 2 M 
NaCL and Tris-base pH 10.6 for 40-60 minutes and centrifuged for 5 minutes. The 
supernatant part (representing the sperm + hFF membrane-associated proteins) was run on 
SDS-PAGE and analysed by MS. Results: comparative data analysis of control versus 
sperm + hFF samples from both approaches revealed 24 hFF proteins in the sperm + hFF 
samples. Functional analysis revealed that sperm-bound hFF proteins have lipid transport 
and antioxidant activities which may suggest their role in cholesterol efflux during 
capacitation and sperm protection against oxidative damage. Future studies are 
recommended to illustrate the roles of the sperm-bound hFF proteins in fertilisation.  
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3.1 Introduction:  
Sperm have been shown to only acquire motility and fertilising potential following their 
maturation in the epididymis (Cornwall, 2014) and capacitation in the FRT (Chang, 1951, 
Austin, 1951).  Following these distinctive maturational processes (chapter 1, sections 
1.1.3 and 1.4.1), testicular sperm, which are immotile and unable to fertilise oocytes 
acquire their fertilisation potential (Cornwall, 2009).  Remarkably, both processes of 
sperm maturation in the epididymis and capacitation in FRT occur despite the lack of de 
novo protein synthesis in sperm cells (Baker, 2016).  Sperm cells are transcriptionally and 
translationally inactive (Miller et al., 2010, Oliva and Castillo, 2011), however, their 
protein profile undergoes dynamic changes which are highly attributed to PTM and 
proteins loss/acquisition (Samanta et al, 2016).    
During the epididymal transit, cysteine-rich secretory protein1 (CRISP1) is one of the 
important proteins secreted by the epididymal epithelium (Cameo and Blaquier, 1976) and 
acquired by the sperm (Kohane et al., 1980, Cohen et al., 2000). CRISP1 has been 
suggested as a decapacitation factor when loosely associated with the sperm surface 
(Roberts et al., 2003, Cohen et al., 2000, Kohane et al., 1980) whereas the strongly bound 
CRISP1 has been linked to sperm-ZP binding and sperm-oocyte fusion (Ernesto et al., 
2015). 
In their journey toward the ampulla, sperm are exposed to several variable environments 
including FRT’s epithelial lining and different types of fluid and secretions (Zhu et al., 
1994, De Jonge, 2005, Suarez and Pacey, 2006, Lambert et al., 1985). However, the 
knowledge of molecular events facilitating sperm’s acquirement of fertilisation capability 
in FRT is still limited (Barratt et al., 2011). Several studies have indicated the contribution 
of proteins in the oviductal microenvironment in the modulation of sperm function 
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(Munuce et al., 2009, Zumoffen et al., 2015, Zumoffen et al., 2010).  Sperm incubated 
with human oviductal-tissue conditioned medium with high protein contents, mainly 
lactoferrin, were shown to inhibit sperm capacitation (Zumoffen et al, 2010, Zumoffen et 
al, 2015).  The authors suggested that this effect of oviductal proteins may broaden the 
capacitation window and thereby extend the lifespan of sperm in the oviduct (Zumoffen et 
al, 2015).  In ram, some oviductal proteins including heat shock protein 8 (HSPA8) and  
soluble apical plasma membrane proteins (sAPM) extracted from the oviductal epithelial 
cells  have been shown to enhance sperm survival for up to 48 hours (Lloyd et al., 2009). 
hFF is also considered as a rich source of steroid hormones mainly progesterone, proteins 
and other factors such as atrial natriuretic peptide (Revelli et al., 2009) important for sperm 
function and fertilisation capability (Emiliozzi et al., 1996, De Jonge, 2005).  hFF is 
produced during folliculogenesis by GCs of the developing ovarian follicle (Fortune, 
1994).  At ovulation, hFF is released along with the COC, hence hFF may travel along the 
oviduct and become available at the ampulla for the sperm to be exposed to on their way 
towards the COC (De Jonge, 2005, Hansen et al., 1991). This spread of hFF to the site of 
fertilisation and therefore its potential role in guiding sperm through chemotaxis (Tacconis 
et al., 2001) and or modulating fertilisation environment is of interest in understanding the 
effects of hFF on sperm functions.  hFF is also a potential culture media for preservation of 
sperm vitality and motility (Hamamah et al., 1995, Getpook and Wirotkarun, 2007). 
Follicular fluid has been shown to stimulate sperm capacitation (Yao et al., 2000), 
hyperactivation (Mbizvo et al., 1990, Kulin et al., 1994), sperm progressive motility 
(Falcone et al., 1991, Getpook and Wirotkarun, 2007, Hong et al., 1993, Revelli et al., 
2009), chemotaxis (Tacconis et al., 2001, Ralt et al., 1994) and acrosome reaction 
(Burrello et al., 2004) in several species.  
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Limited knowledge is available about the exact mechanism by which hFF enhances sperm 
function apart from the effects of progesterone (Jaiswal et al., 1999). Progesterone is one 
of the prominent components of both hFF and cumulus secretions (Laufer et al., 1984, 
Chian et al., 1999, De Jonge, 2005) and it has been shown to induce sperm chemotaxis 
(Villanueva-Diaz et al., 1995, Wang et al., 2001) and AR (Morales et al., 1992, Saaranen 
et al., 1993).   
Nonetheless, not only progesterone and other steroid hormones but also proteins from hFF 
have been shown to affect sperm function and fertilisation (Tesarik et al., 1990, Yao et al., 
2000).  For instance, the high abundance of albumin, lysophosphatidylcholine (LPC) and 
platelet activating factor in hFF has been suggested to contribute to hFF capacitating effect 
by enhancing sperm membrane cholesterol efflux  (Lepage et al., 1993).  In other studies, 
sperm capacitation induced by hFF was attributed to a lipid transfer mechanism (Ravnik et 
al., 1992, Muller and Ravnik, 1995) involving a lipid transfer protein (LTP1) also known 
as cholesteryl ester transfer protein which was purified from hFF (Ravnik et al., 1992). 
Glycosaminoglycans, which are proteoglycans formed of protein core and covalently 
bound repeated disaccharide units, have also shown to affect sperm motility and 
fertilisation capability (Hamamah et al, 1995).   
Some studies focused on four glycodelins, which are a group of glycoproteins that have a 
similar protein core but different glycosylation sites, and considered their effects on sperm 
(Yeung et al., 2006). Glycodelins have been shown to affect sperm function in different 
ways (figure 3-1) (Yeung et al., 2006). During early pregnancy, Glycodelin-A (GdA) is 
also suggested to protect the fetus against maternal immune response by the suppression of 
the cytotoxic activity of natural killer cells, which represent 70 % of the uterine leukocyte 
(Seppala et al., 2007). 
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Sperm receptors for glycodelin F (GdF) from hFF have been described as a low affinity 
receptor of fucosyltransferase-5 on sperm surface which binds both GdF and GdA (Chiu et 
al., 2003b, Chiu et al., 2007, Yeung et al., 2009).  Determination of other hFF proteins that 
bind to sperm similar to GdF may enhance our understanding of sperm regulation induced 
by hFF.  The identification of the hFF candidate proteins acquired by sperm may also 
enable the design of media to enhance sperm function and longevity.  
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Figure 3-1 Diagrammatic representation of the roles of glycodelins in reproduction (from 
Yeung et al, 2009, with permission). Glycodelin S (GdS) in seminal plasma works as a de-
capacitation factor which retains the ejaculated sperm in non-capacitated condition by 
inhibiting albumin-induced cholesterol efflux (Yeung et al., 2006; Uchida et al, 2013). 
Following semen deposition in the FRT, cervical mucus removes the GdS from the sperm 
surface and permits capacitation by enhancing cholesterol efflux (Yeung et al., 2006). 
GdA, found in endometrial fluid (Li et al, 1993) and GdF (from hFF) bind to sperm and 
GdF suppresses early onset AR induced by P4 (progesterone)  and inhibits sperm zona 
binding while GdC, from the cumulus cells, stimulates sperm-zona (ZP) binding (Chiu et 
al., 2003a, Chiu et al., 2007, Yeung et al., 2006, Yeung et al., 2009, Chiu et al., 2005, Chiu 
et al., 2003b).  
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3.1.1 Human sperm and hFF proteomics: 
Proteomics is defined as the systematic analysis of the whole proteins present in a cell, 
tissue or organism under specific conditions and at a particular time (Domon and 
Aebersold, 2006, Cox and Mann, 2007). The term proteome combines both words 
PROTEin and genOME and was introduced by Wilkins et al. (1996) as a new concept for 
analysis of the entire proteins expressed by a genome.  Proteins form major structural and 
functional components of the cells and their study may provide better understanding of 
molecular pathways (Wilkins et al, 1996). Human follicular fluid proteome has been 
studied extensively in the literature and was highlighted in chapter 2. Human sperm 
proteome has also gained great interest in recent years with thousands of sperm proteins 
being identified in several studies (Baker et al., 2007, Azpiazu et al., 2014, Castillo et al., 
2014, Amaral et al., 2014b).  The accessibility, easy purification and lack of transcriptional 
and translational activity of the human sperm cells, as mentioned earlier, ensure the high 
suitability of these cells for proteomic studies (Oliva et al., 2009, Amaral et al., 2014a).  
The compiled human sperm proteome from 30 proteomic studies produced a list of 6198 
unique proteins with highlights of possible metabolic pathways involved (Amaral et al, 
2014a).  Several approaches have been applied to study sperm proteomic such as the whole 
cell proteomic analysis (Baker et al., 2007, Wang et al., 2013, de Mateo et al., 2007) and 
the subcellular proteome analysis of sperm cell fractions.  For example, sperm head, tail 
(Amaral et al., 2013, Baker et al., 2013), nucleus (de Mateo et al., 2011) and fibrous sheath 
(Kim et al, 2007) have been analysed to improve throughput of sperm proteins 
identification (de Mateo et al, 2011; Amaral et al, 2014a).     
Prior to sperm proteomic analysis, an initial step of sperm samples purification from 
seminal plasm, leukocytes and round cells is important and is usually achieved using 
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swim-up or Percoll density gradient centrifugation (de Mateo et al., 2013, Amaral et al., 
2014a).  Following protein extraction, two different techniques are generally applied in 
human sperm proteomic analysis using mass spectrometry (de Mateo et al, 2013).  The 
first technique involves sperm protein separation using either one or two dimensional 
polyacrylamide gel electrophoresis (1D SDS-PAGE, 2D-PAGE) with subsequent in-gel 
proteins digestion and MS analysis using either LC-MS/MS or MALDI-MS of the 
generated peptides (Paiva, 2015, Amaral et al., 2014a, de Mateo et al., 2013). This 
approach has been shown to enhance the quality of the protein identification due to 
reduced complexity of the protein mixture as a result of the prior separation (Baker et al., 
2007, Amaral et al., 2013, Wang et al., 2013).  The high efficiency of the combined 
techniques of LC and MS along with enhanced throughput by prior protein separation and 
digestion resulted in thousands of human sperm proteins being identified in several studies 
using this approach (Baker et al., 2007, Baker et al, 2013, Amaral et al., 2013; Wang et al., 
2013).  In the second proteomic strategy, sperm proteins are directly digested into peptides 
with no prior separation and then the generated peptides are either separated by LC or 
isoelectric focusing (IEF) followed by MS analysis (de Mateo et al, 2013; Amaral et al, 
2014a). The peptide/protein identification for both proteomic techniques is then achieved 
using a software search of peptide/protein databases (Amaral et al, 2014a).  
Amaral et al (2014a) indicated that 2D-PAGE was the classic approach to separate human 
sperm proteins and resulted in the detection of numerous proteins (< 200) in several 
studies (Pixton et al., 2004, Chu et al., 2006, Martinez-Heredia et al., 2006).   Recently, 
studies that applied LC-MS/MS for peptide detection of digested proteins with prior 
separation using 1D SDS-PAGE have resulted in the identification of a higher throughput 
of up to 400-1000 proteins (Amaral et al, 2013, Wang et al, 2013, Amaral et al, 2014a).  
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Nonetheless, protein digestion into peptides prior to LC-MS/MS results in inability to 
identify possible PTM of the detected proteins, which is considered as a drawback of this 
technique (Amaral et al, 2014a). Figure 3-2 summarises the different flow options of 
sperm proteomic strategies.  
 
 
 
Figure 3-2  The sequential steps in different human sperm proteomic approaches starting 
with sperm purification using swim-up or Percoll gradient centrifugation to the final 
analysis of peptides using mass spectrometry (from Amaral et al, 2014a, with permission). 
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3.2 Objectives 
To conduct a comparative proteomic analysis of sperm capacitated in capacitation media 
alone versus sperm capacitated in the presence hFF to identify any putative hFF which 
may have bound to sperm. The analysis also aims to conduct functional classification of 
the putative hFF proteins and investigate their possible role in sperm regulation.  
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3.3 Methods: 
3.3.1 Materials:  
Table 3-1 
Product name  Company  Product code  
Acetonitrile Millipore, Watford, UK.  UN1648 
Ammonium bicarbonate Sigma, Dorset, UK 09830-1KG 
Bovine serum Albumin (BSA) Millipore, Watford, UK. 82-002-4 
Dithiothreitol (DTT) Melford Laboratories, 
Suffolk, UK 
MB1015 
Ethylene-diamine tetra-acetic acid 
(EDTA) 
Sigma, Dorset, UK E5134EDTA 
Formic acid Sigma, Dorset, UK  14265-50ML 
Iodoacetamide BioRad laboratory, 
Hertfordshire, UK  
1632109 
20 × MOPS SDS Running Buffer (3-(N-
Morpholino) propanesulfonic acid) 
Sigma, Dorset, UK. M1254 
NuPAGE Novex (10% Bis-Tris gel)  Invitrogen, Paisley, UK NP0302Box  
Percoll  Sigma, Dorset, UK. P1644 
Phpsphate Buffered Saline (PBS) Invitrogen, Paisley, UK  14040083  
Seeblue plus 2 pre-stained standard  Invitrogen, Paisley, UK LC5925 
Sodium chloride (NaCl)  Sigma, Dorset, UK. S9888 
Sodium dodecyl sulfate (SDS) Sigma, Dorset, UK L6026-250G 
supplemented Earle’s balanced Salt 
Solution (sEBSS)  
Geneflow, Fradley, UK 06-2010-03-1B 
Tris-(hydroxymethyl)aminomethane  Sigma, Dorset, UK 252859 
Trypsin (sequencing grade, modified, 
porcine)  
Promega, Southampton, 
UK 
V511A 
Urea Sigma, Dorset, UK U5378-5KG 
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3.3.2 Sperm preparation: 
Semen samples were obtained by masturbation from healthy research donors at 
Birmingham Women's Hospital (Human Fertilisation and Embryology Authority Centre 
0119; HRA NRES Ethical Approval for the Centre for Human Reproductive Science 
Reproductive Tissue Bank: 13/EM/0272; within the bank approval this project was 
reference: Application Project 5) following 2-5 days of sexual abstinence. Informed 
consent was obtained from all the donors and all procedures were performed in accordance 
to HFEA Code of Practice. Semen samples were allowed to liquefy for 30 minutes and 
then sperm cells were prepared by Percoll density gradient centrifugation.  100 % isotonic 
Percoll (285-300 mOsm/kg) solution was prepared from the original Percoll by the 
addition of 10 × M medium (1.37 M NaCl, 25 mM KCl, 200 mM N-(2-hydroxyethyl) 
piperazine-N’-(2-ethanesulfonic acid) (HEPES), 100 mM glucose). Two different Percoll 
fractions (80% and 40%) were made isotonic by the addition of 1 × M medium (137 mM 
NaCl, 2.5 mM KCl, 20 mM HEPES, 10 mM glucose) (Lefievre et al., 2007).  A density 
gradient of Percoll was prepared by under-layering 1 ml of 40 % Percoll with 1 ml 80 % 
Percoll and a top layer of 1 ml liquefied semen was added in a 15 ml Falcon tube and 
centrifuged for 20 minutes at 500 g at room temperature. The supernatant fluid was 
discarded and pellet part was washed with 5 ml of Phosphate Buffered Saline (PBS), 
centrifuged for 5 minutes at 500 g. Sperm concentration was determined by Neubauer 
haemocytometer and at least 400 cells were scored.  Semen samples for this study were 
obtained from three different donors. 
3.3.3 Follicular fluid collection: 
See section 2.3.2 for hFF sample collection. 
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3.4  Methodology: 
In this study, two approaches were used as follows:  
3.4.1 Sperm + hFF total protein binding approach: 
Following sperm preparation by Percoll gradient centrifugation, the total count of the 
sperm cells was adjusted to 1 × 10
6
 cells using sEBSS + 0.3% BSA.  Two different 
preparations were performed: control sperm samples in which sperm cells were capacitated 
in sEBSS + 0.3% BSA alone, total volume 50 μl and sperm + hFF samples in which sperm 
cells were incubated in the presence of hFF (30 % final hFF concentrations), total volume 
50 μl, (n= 3). 
The samples were incubated with the lids open for 90-120 minutes at 37°C, 6% CO2 to 
allow sperm capacitation and for any sperm and hFF protein binding to occur. The samples 
were then centrifuged at 500 g for 5 minutes at room temperature and the supernatant fluid 
was discarded to remove any excess hFF and only minimum volume of the pellet was left 
in each tube (around 20 μl). The pellets were washed twice using 500 μl PBS by 
centrifugation at 500 g for 5 minutes to remove any unbound excess hFF. The supernatant 
was discarded and minimum volume of the pellet was left in each tube (around 20 μl) to 
run on SDS-PAGE (section 3.4.3) and then in-gel protein digestion (section 3.4.4) was 
carried out on the protein bands.  Figure 3-3 summarises the methodology for the sperm + 
hFF total binding approach. 
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Figure 3-3 Summary of the methodology of the sperm + hFF total binding approach, 
sperm cells were prepared by Percoll gradient centrifugation (Percoll GC), two sets of 
samples prepared with and without hFF, both samples were incubated and washed prior to 
SDS-PAGE using only the pellet parts, SDS-PAGE/MS was then performed  
 
3.4.2 Sperm + hFF membrane-associated proteins approach: 
Similar to the total binding proteins, following sperm preparation by Percoll gradient 
centrifugation sperm cells total count was adjusted to 1 × 10
6
 cell using sEBSS media + 
0.3% BSA and sperm were either incubated in sEBSS containing 0.3% BSA alone as 
sperm control samples or in hFF (30% final concentration).  Samples were incubated with 
the lids open for 90-120 minutes at 37°C, 6% CO2 to capacitate and to allow time for any 
sperm and hFF protein binding. The samples were then centrifuged at 500 g for 5 minutes 
at 24°C, the supernatant fluid was discarded and only minimum volume of the pellet 
(around 20 μl) was left in each tube. Two cycles of washing in 500 μl PBS by 
centrifugation at 500 g for 5 minutes were performed for all samples. The supernatant fluid 
was discarded and minimum volume of the pellet was left in each tube (around 20 μl). To 
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achieve detection of the sperm + hFF membrane-associated protein fractions, different 
chemical conditions were first tested to select the appropriate method to carry on 
solubilisation of sperm membrane proteins along with any bound hFF.   
One of the following chemical preparations was used on one pair of samples (control 
sperm alone and sperm + hFF) as follows: 
 First preparations (EDTA): 5mM EDTA, 150mM NaCl , 20mM Tris-base pH7.5 
 Second preparations (high pH):150mM NaCl, 20mM Tris-base pH 10.6 
 Third preparations (high molarity salt) : 500mM NaCl, 20mM Tris-base pH7.5 
 Forth preparations (heat): 150mM NaCl, 20mMTris-base pH7.5 and kept at 65° C 
in the block heater.  
25 μl of one of these preparations was added to one pair of samples (both sperm control 
samples and sperm + hFF samples).  The samples were then left for 40-60 minutes in the 
incubator at 37°C, 6% CO2 except for the heat preparation which was kept at 65°C  in the 
block heater for 40-60 minutes.  Each tube was then centrifuged at 500 g for 5 minutes at 
room temperature and the supernatant fluid (which represent the sperm + hFF membrane-
associated proteins in sperm + hFF samples) from each tube was collected and run on 
SDS-PAGE and the protein bands were compared from the different preparation 
techniques. The high pH (second preparation) and the high molarity NaCl (third 
preparation) showed darker protein bands on the SDS-PAGE compared to the other 
preparations. Therefore, the next step was to carry out a salt concentration curve 
experiment to determine the appropriate NaCl molarity and pH to use for the detection of 
sperm + hFF membrane-associated proteins. In the NaCl concentration curve experiment, 
samples preparations followed the same protocol above until the stage where the different 
chemical preparations were used. In this experiment, three different molarities of NaCl 
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prepared with two different pHs (Tris-base pH 7.5 and pH 10.6) were used to determine 
the appropriate salt molarity and pH for the membrane-associated approach.  The NaCl 
molarities and pH used were as follow: 
 750 mM NaCl  Tris-base  pH 7.5 
 750 mM NaCl  Tris-base  pH 10.6 
 1M NaCl Tris-base pH 7.5 
 1M NaCl Tris-base pH 10.6  
 2M NaCl Tris-base pH 7.5 
 2M NaCl Tris-base pH 10.6 
25 μl of one of these preparations was added to one pair of samples (both sperm control 
samples and sperm + hFF samples).  The samples were then left for 40-60 minutes in the 
incubator at 37°C, 6% CO2.  Each tube was then centrifuged at 500 g for 5 minutes at 
room temperature and the supernatant fluid (which represent the sperm + hFF membrane-
associated proteins in sperm + hFF samples) from each tube was collected and run on 
SDS-PAGE and the protein bands were compared from the different preparation 
techniques.  From this experiment, the 2M NaCl in Tris-base pH10.6 preparation produced 
the darkest protein bands in the SDS-PAGE (figure 3-4) and thus this preparation was 
used in the sperm + hFF membrane-associated proteins experiment throughout the rest of 
the experiments (n=4).   
The supernatant fluids obtained in these experiments were run on SDS-PAGE and then in-
gel protein digestion was carried out on the protein bands. Figure 3-5 summarises the 
methodology for the membrane-associated proteins approach.  
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Figure 3-4  NaCl concentration curve for membrane-associated approach. NaCl molarity 
and Tris-base pH in these experiments were as follow: A- 750 mM NaCl/Tris-base pH 7.5, 
750 mM NaCl/Tris-base pH 10.6 and 1M NaCl/Tris-base  pH 7.5 (samples were prepared 
from the same ejaculate from one donor). B- 1 M NaCl/Tris-base pH 10.6, and C- 2 M 
NaCl/Tris-base pH 7.5, 2 M NaCl/Tris-base pH 10.6 (the two gels in B and C were 
prepared from two ejaculates from the same donor) .  
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Figure 3-5 Summary of the methodology of sperm + hFF membrane-associated proteins; 
sperm cells were prepared by Percoll gradient centrifugation (Percoll GC), two sets of 
samples prepared with and without hFF, both samples were incubated, washed and the 
pellet parts were further incubated in 2M NaCl prior to SDS-PAGE using only the 
supernatant parts, SDS-PAGE/MS was then performed. 
 
 
3.4.3 SDS -PAGE: 
The same SDS-PAGE protocol was used for both total binding and membrane-associated 
approaches. For details of SDS-PAGE methodology, see section 2.4.2.2. Figure 3-6 shows 
the SDS-PAGE for both approaches.  
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Figure 3-6  SDS-PAGE of samples in both approaches (A- Total binding approach and B- 
membrane-associated approach). Sperm and sperm + hFF samples were run along with a 
prestained standard in a precast 10% gel, gels were stained with Coomassie Brilliant blue.    
 
 
3.4.4 In-gel protein digestion: 
See section 2.4.2.3.  
3.4.5 Mass spectrometry analysis: 
This work was completed by Dr Ashley Martin and Dr Douglas Ward, University of 
Birmingham. An on-line, direct infusion into an ESI (ElectroSpray Ionisation) interface – 
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TOF (Time of Flight) mass spectrometry that has MS/MS capability was utilised in the 
data analysis. Fro more details of MS analysis, see section 2.4.4.  
3.4.6 Acrosome reaction assay 
3.4.6.1 Materials and methods 
Table 3-2 Materials 
Product name  Company  Product code  
Progesterone (4-pregnene-3,20-dione) Sigma, Dorset, UK.   P0130 
poly-D-Lysine Millipore, Watford, UK A-003-E 
Pisum sativum (pea) agglutinin FITC 
labelled (FITC-PSA) powder 
Sigma, Dorset, UK.  L0770  
sEBSS  Geneflow, Fradley, UK  06-2010-03-18  
Fluoromount  BDH Merck ,Poole,  Dorset, 
UK 
360982B 
Dimethyl sulfoxide (DMSO)  
 
 
Life Technology  (Thermo 
Fisher Scientific), Rockford, 
USA 
D12345 
Phosphate buffered saline (PBS)  Invitrogen, Paisley, UK  14040083  
Calcium Ionophore/ A23187  Sigma, Dorset, UK.  C5149  
Methanol  Fisher Scientific, 
Loughborough, UK.  
M/3950/17  
Bovine Serum Albumin (BSA)                   Millipore, Watford, UK  82-002-4  
Sodium citrate  Sigma, Dorset, UK.  S1804  
Fructose Sigma, Dorset, UK. F0127 
5 mL Falcon round-bottom 
polystyrene tube 
Becton Dickinson Labware, 
New Jersey, USA.  
 2054 
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3.4.6.2 Sperm preparation and capacitation: 
Semen samples were obtained in a similar procedure to section 3.3.2. Sperm cells were 
prepared by swim-up (Mortimer, 1994). Briefly, 1ml of sEBSS + 0.3 % BSA was under-
layered with 400 μl of liquefied semen in 5ml Falcon round-bottom tubes and left to 
incubate for 1 hour at an angle of 45° at 37° C, 6% CO2.  The top 700 μl containing motile 
sperm fraction was gently harvested using sterile transfer pipette and pooled into 15 ml 
Falcon tube.  Sperm concentration in the collected fraction was assessed by a Neubauer 
hemocytometer and the final concentration adjusted to 6 ×10
6 
sperm/ml using sEBSS + 
0.3% BSA.  The sperm samples were divided into aliquots of 100 μl and left to capacitate 
for 4-6 hours at 37°C, 6% CO2, (n = 6). 
Following sperm capacitation, sperm aliquots were stimulated either by addition of 
progesterone (final concentration of 13.5 µM), 10 µM ionomycin /A23187 as a positive 
control, hFF (30 % final concentration) and DMSO (1:1000) as a negative control. The 
different preparations were left to incubate for 1 hour then centrifuged at 300g for 
5minutes. The supernatants were discarded and sperm were re-suspended and incubated in 
500 μl of hypo-osmotic swelling medium (HOS) (0.74% sodium citrate, 1.35 % fructose in 
distilled water) for 45 minutes. The sperm preparations were then centrifuged at 300g for 5 
minutes and re-suspended in a minimum volume of the HOS medium (approximately 
50μl). The different sperm preparations were then smeared on duplicate slides (25 μl of 
each sperm preparation on each slide) pre-coated with 0.001% poly-D-lysine solution and 
left to air dry.  The slides were then immersed in 100 % methanol for 1 minute to 
permeabilize the cells and slides were dried on a hot plate. 100 μl of 50 µg/ml FITC-PSA 
in PBS was laid on each slide and left to incubate for 45 minutes in a moist chamber at 
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37°C.  The slides were then rinsed with PBS and left to air dry before they were mounted 
with fluoromount and left overnight in the dark to prevent fade.   
Sperm were visualised using a 100 × oil immersion lens and assessment of acrosomal 
status was performed using a fluorescence microscopy (Cross et al., 1988). Only viable 
sperm with curly tails were scored with 200 cells being scored per treatment (100 sperm 
per slide).  Sperm cells were scored according to the criteria described by Mendoza et al. 
(1992). 
 The Mean of acrosomal status for each treatment was obtained from the duplicates of each 
treatment scored.  AR percentage data was converted to an arcsine values before testing for 
statistical significance between treatment groups using paired T tests and statistical 
significance was set at P value < 0.05.  All calculations and statistical analyses were 
accomplished by the application of Microsoft Excel 2010 software.   
The percentages of AR induction for hFF and progesterone treatments were also 
normalised to both the positive control (10 μM ionmoycin) and spontaneous AR (negative 
control, DMSO) and expressed as percentage stimulation of AR according to the formula: 
 % Stimulation of AR = [
      treatment AR%    ̶    spontaneous AR%           
 Positive AR%     ̶    spontaneous AR%
] × 100  
 
3.5  Results  
3.5.1 Sperm + hFF total binding approach: 
In one of the experiments of the sperm + hFF total binding approach the MS analysis did 
not detect any peptides which may have resulted from contamination during samples 
preparation. The results of the two successful experiments were analysed according to the 
sample type (sperm + hFF or sperm control) as follow: 
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Sperm +hFF samples: Twenty-one hFF proteins were identified in sperm + hFF samples 
this approach, the details of the data analysis are summarised in figure 3-7.  The protein 
lists from sperm + hFF samples were compiled and loaded into UniProt knowledge base to 
obtain UniProt accession numbers. Proteins were then compared with the sperm protein 
data in a recent systematic review compiles sperm proteins from 30 sperm proteomic 
studies with 6198 sperm proteins (Amaral et al., 2014a) and also protein data from the 
sperm control samples in this study.  Following the comparison,  31proteins were not 
sperm proteins and they were compared with the hFF protein data (a table with all the hFF 
proteins described in the published studies up to date was produced in this study, see 
chapter 2). Twenty-one hFF proteins were identified in the sperm + hFF samples. Sperm 
do not previously possess these proteins as they were found neither in sperm control nor in 
Amaral et al (2014a) compiled sperm data.     
The total number of proteins identified in the sperm + hFF samples was 1060 proteins.  
1030 were sperm proteins, found in the sperm compiled protein data Amaral et al (2014a) 
and/or in the sperm control samples. Fourteen proteins out of the 1030 were novel sperm 
proteins, detected in the sperm control samples but not in Amaral et al (2014a) sperm data. 
There was another group of proteins which was considered as unknown source proteins 
that were only found in sperm + hFF samples but not in the sperm control samples.  These 
proteins were neither found in sperm compiled data (Amaral et al, 2014a) nor in hFF data. 
These proteins were detected for the first time in this study and therefore they may belong 
to either the novel sperm or the novel hFF proteins. Nine proteins belong to this category 
which may add to the sperm + hFF total binding if they are novel hFF proteins. Figures 3-
7 and 3-8 illustrate the data analysis for the sperm +hFF samples in the total binding 
approach.  
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Figure 3-7 Summary of the data analysis of the of sperm + hFF samples in the total 
binding approach. Protein data were compared with sperm data from Amaral et al, 2014a 
to recognise novel sperm proteins. Data were also compared with hFF compiled data from 
the literature to identify hFF acquired by sperm. 
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Figure 3-8  Venn diagram for the results of sperm + hFF samples in the total binding 
approach, 21 hFF proteins were identified in the sperm + hFF samples and 14 novel sperm 
proteins in this approach. 
 
 
Sperm control samples data analysis: The sperm control protein data were compiled 
from the two experiments performed and a total of 1303 proteins were identified. The 
compiled list of the sperm control proteins was loaded into UniProt knowledgebase to 
obtain the UniProt accession numbers. The list was compared with sperm protein data in 
Amaral et al (2014a) to distinguish any novel sperm proteins, which were detected for the 
first time in this study. Fifty-three proteins were not previously described in Amaral et al 
(2014a) and were considered as novel sperm proteins. Fourteen out of the 53 novel sperm 
proteins were detected in both sperm control and sperm +hFF samples in this approach.  
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Figures 3-9 and 3-10 show a summary of the data analysis and a Venn diagram of sperm 
control protein results.  
 
 
Figure 3-9  Summary of the data analysis of sperm control samples in the total binding 
approach.  Protein data were compared with sperm data from Amaral et al, 2014a to 
recognise novel sperm proteins.  
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Figure 3-10  Venn diagram of the results of sperm control protein data analysis in the total 
binding approach, 53 novel sperm proteins were identified in this approach  
 
 
3.5.2 Sperm + hFF membrane-associated proteins approach: 
Five hFF proteins were identified as sperm membrane-associated proteins. The details of 
the analysis are summarised below.  
Sperm + hFF samples data analysis: similar to the total binding approach data analysis, 
the protein data from the sperm + hFF membrane-associated approach were analysed to 
determine which hFF proteins were bound to the sperm. Proteins from the sperm + hFF 
samples were compiled and a total of 278 proteins identified. The protein data were loaded 
into UniProt knowledge base to determine the UniProt accession number for each protein.  
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The data were compared with sperm data (Amaral et al, 2014a) and sperm control samples 
in the membrane-associated approach. Two hundred and seventy proteins were sperm 
protein out of which eight were novel sperm proteins.  Eight proteins were not found in the 
sperm data and they were compared with the hFF protein data in the literature.  Five 
proteins were only found in hFF data and these proteins were considered as hFF protein 
acquired by the sperm following sperm incubation with hFF.  Three proteins were 
unknown source proteins, detected only in the sperm + hFF samples (either novel sperm or 
novel hFF proteins).  Figures 3-11 and 3-12 summarise the analysis and results of the 
sperm + hFF membrane-associated proteins approach. 
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Figure 3-11 Summary of the data analysis of sperm + hFF samples in the membrane-
associated approach. Protein data were compared with sperm data from Amaral et al, 
2014a to recognise novel sperm proteins. Data were also compared with hFF compiled 
data from the literature to identify hFF acquired by sperm. 
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Figure 3-12  Venn diagram of the results of the sperm +hFF membrane-associated 
approach. Five hFF proteins identified in the sperm + hFF samples, 8 novel sperm proteins 
and 3 unknown source proteins. 
 
 
Sperm control data analysis: protein data from the sperm control samples were compiled 
and compared with sperm data (Amaral, et al, 2014a) to distinguish any novel proteins 
which were detected for the first time in this study.  A total of 212 proteins were detected 
in the sperm control samples with 13 proteins not found in Amaral et al (2014a) sperm 
data (novel sperm proteins).  Seven out of the 13 novel sperm proteins were also found in 
the sperm + hFF samples. Figures 3-13 and 3-14 summarise the results of the membrane-
associated proteins approach.  
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Figure 3-13 Summary of the data analysis of sperm control samples in the membrane-
associated approach. Protein data were compared with sperm data from Amaral et al, 
2014a to recognise novel sperm proteins, 13 proteins were novel sperm proteins. 
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Figure 3-14 Venn diagram of the protein results of sperm control samples in the 
membrane-associated approach, 13 novel sperm proteins were identified. 
 
 
3.5.3 Compiled results from both approaches:  
Twenty-four hFF proteins (never previously detected in sperm) were detected in the sperm 
+ hFF samples from both approaches. Two out of the 24 hFF proteins (vitronectin and 
alpha-1-antichymotrypsin) were detcted in both the total binding and the membrane-
assoicated approaches. The total number of proteins identified in both approaches (total 
binding and membrane-associated) was 1530 of which 953 proteins (62%) were identified 
in two or more samples and/or independent experiments and 241 proteins were detected in 
both approaches.  Out of the 1530 proetins, 1428 were described in sperm compiled data 
(Amaral et al, 2014a) while 103 proteins were not found in Amaral et al (2014a) sperm 
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data. Out of the 103 proteins,  63 proteins were novel sperm proteins found in sperm 
control samples.   Eleven proteins from sperm + hFF samples were neither found in sperm 
control nor in hFF data from the literature and were considered as unknown source 
proteins (either novel sperm or novel hFF proteins). Some proteins were common between 
sperm and hFF data from the literature (not shown in the diagram).  Four proteins were 
keratin and excluded from the final protein compiled data list leaving 1526 proteins 
included.  Figures 3-15 and 3-16 illustrate these data.  
 
 
 
 
Figure 3-15 Summary of the data analysis of the compiled results from both approaches.  
The total number of proteins identified in this study was 1530 proteins, Keratin proteins 
(four) were excluded from the final list. 
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Figure 3-16  Data compiled from both approaches, total binding and membrane-associated 
(both sperm control and sperm + hFF samples). hFF compiled proteins data were obtained 
from chapter two. The total number of proteins identified in this study was 1530 proteins, 
11 proteins were unknown source proteins (either novel sperm or novel hFF) not shown in 
this Venn diagram, four other proteins were keratins and excluded from the final list.  
 
Novel sperm proteins:  
In addition to identification of hFF sperm-bound proteins, novel sperm proteins were 
identified in this study.  A total of 63 proteins from both approaches were detected in 
sperm control samples with some being detected also in sperm + hFF samples.  
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3.5.4  hFF proteins identified in sperm + hFF binding fraction: 
Twenty-four hFF were identified in the sperm + hFF samples in this study compiled from 
both approaches (table  3-3). The lsit of identified proteins (table 3-3) were searched for 
functional classification and localisation and any relevance to sperm fertilisation.
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Table 3-3 hFF proteins detected in sperm + hFF samples compiled from both approaches and their known function according to PANTHER  
Classification system  
UniProt 
accession 
number  
Protein name  Approach  Known 
function 
References in hFF proteomic studies 
P04004 Vitronectin  Total binding 
and 
Membrane-
associated  
Adhesion Hanrieder et al, 2008; Kushnir et al, 2012; Twigt et al, 2012; Ambekar et al, 2013; Bianchi et al, 2013; 
Zamah et al, 2015 
P01011 Alpha-1-
antichymotrypsi
n  
Total binding  
and 
Membrane-
associated  
serine 
protease 
inhibitor 
 Angelucci et al, 2006; Hanrieder et al, 2008;Hanrieder et al, 2009; Jarkovska et al, 2010;  Kushnir et al, 
2012; Twigt et al, 2012; Ambekar et al, 2013;  Zamah et al, 2015  
P01860 Ig gamma-3 
chain C region  
Total binding   Immune 
response 
Hanrieder et al, 2009; Twigt et al, 2012 
P19827 Inter-alpha-
trypsin inhibitor 
heavy chain H1  
Total binding   Immune 
response 
Hanrieder et al, 2008; Twigt et al, 2012; Ambekar et al, 2013; Zamah et al, 2015 
P02679 Fibrinogen 
gamma chain  
Total binding   Signalling Anahory et al, 2002; Angelucci et al, 2006; Kim et al, 2006; Hanrieder et al, 2008; Kushnir et al, 2012; 
Twigt et al, 2012; Ambekar et al, 2013;  Severino et al, 2013; Bianchi et al, 2013; Zamah et al, 2015; Wu 
et al, 2015 
P00738 Haptoglobin  Total binding   Antioxidant Spitzer et al, 1996; Anahory et al, 2002; ngelucci et al, 2006; Hanrieder et al, 2008; Schweigert et al,  
2006; Estes et al, 2009; Sim and Lee; 2008;  Kushnir et al, 2012; Twigt et al, 2012;Ambekar et al, 
2013;Bianchi et al, 2013;  Ambekar et al, 2014; Severino et al, 2013; Zamah aet al, 2015; Wu et al, 2015 
P01042 Kininogen-1  Total binding   Catalysis Hanrieder et al, 2008;  Hanrieder et al, 2009; Kushnir et al, 2012; Twigt et al, 2012; Ambekar et al, 2013; 
Bianchi et al, 2013; Severino et al, 2013;Ambekar et al, 2014;Hashemitabar et al, 2014; Zamah et al, 
2015 
P13671 Complement 
component C6  
Total binding   Immune 
response 
Twigt et al, 2012; Ambekar et al, 2013; Aseverino et al, 2013; Zamah et al, 2015 
P19823 Inter-alpha-
trypsin inhibitor 
heavy chain H2  
Total binding   Immune 
response 
Hanrieder et al, 2008;  Hanrieder et al, 2009; Kushnir et al, 2012; Twigt et al, 2012; Ambekar et al, 2013; 
;Ambekar et al, 2014; Zamah et al, 2015 
Q14624 Inter-alpha-
trypsin inhibitor 
Total binding   Immune 
response 
Hanrieder et al, 2008;  Hanrieder et al, 2009; Sim and Lee, 2008; Kushnir et al, 2012; Twigt et al, 2012; 
Ambekar et al, 2013; Bianchi et al, 2013; Severino et al, 2013;Ambekar et al, 2014; Zamah et al, 2015 
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heavy chain H4  
P01766 Ig heavy chain 
V-III region 
BRO  
Total binding   Immune 
response 
Hanrieder et al, 2008; Hanrieder et al, 2009; Estes et al, 2009;  Twigt et al, 2012; Zamah et al, 2015 
 
 
  
P04217 Alpha-1B-
glycoprotein  
Total binding   catalysis Hanrieder et al,2008; Hanrieder et al, 2009; Kushnir et al, 2012; Twigt et al, 2012; Bianchi et al, 2013; 
Ambekar et al, 2013;Ambekar et al,2014;  Zamah et al, 2015   
P01625 Ig kappa chain 
V-IV region 
Len  
Total binding   Immune 
response 
Twigt et al, 2012 
P01765 Ig heavy chain 
V-III region 
TIL  
Total binding   Immune 
response 
Hanrieder et al, 2008; Hanrieder et al, 2009 
O14791 Apolipoprotein 
L1  
Total binding   Lipid 
transport 
Twigt et al, 2012; Ambekar et al, 2013; Zamah et al, 2015 
O95445 Apolipoprotein 
M  
Total binding   Lipid 
transport 
Ambekar et al, 2013; Bianchi et al,2013;  Zamah et al, 2015 
P01597 Ig kappa chain 
V-I region DEE  
Total binding   Immune 
response 
Twigt et al, 2012 
P02671 Fibrinogen 
alpha chain  
Total binding   Signalling 
molecule 
Angelucci et al, 2006; Hanrieder et al, 2008; Hanrieder et al, 2009;  Estes et al, 2009; Kushnir et al, 2012; 
Twigt et al, 2012; Ambekar et al, 2013; Severino et al, 2013;   Zamah et al, 2015 
P02765 Alpha-2-HS-
glycoprotein  
Total binding   cysteine 
protease 
inhibitor 
Angelucci et al, 2006; Hanrieder et al, 2008; Hanrieder et al, 2009; ; Ambekar et al, 2013; Bianchi et al, 
2013;  Ambekar et al,2014;  Zamah et al, 2015 
P04433 Ig kappa chain 
V-III region 
VG (Fragment)  
Total binding   Immune 
response 
Hanrieder et al, 2009; Twigt et al, 2012 
P80748 Ig lambda chain 
V-III region 
LOI  
Total binding   Immune 
response 
Twigt et al, 2012 
P02749 Beta-2-
glycoprotein 1  
Membrane-
associated  
Binding Angelucci et al, 2006; Estes et al, 2009; Twigt et al, 2012; Bianchi et al, 2013; Ambekar et al, 2013; 
Ambekar et al, 2014; Zamah et al, 2015 
P06703 S100-A6  Membrane-
associated  
Calcium 
signalling 
 hFF data from hFF proteomic study (chapter 2) 
P05155 Plasma protease 
C1 inhibitor  
Membrane-
associated  
Protease 
inhibitor 
Hanrieder et al, 2008; Kushnir et al, 2012; Twigt et al, 2012; Ambekar et al, 2013;Zamah et al, 2015 
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Functional classification of the hFF proteins bound to sperm: 
The list of the 24 hFF proteins (table 3-3) identified in the sperm + hFF samples were 
analysed in terms of molecular function and biological processes, using PANTHER 
Classification System Version 10.0 (section 2.4.5) at http://www.pantherdb.org/ accessed 
in July 2015, to recognize their functions and their possible role in sperm modulation.  The 
molecular functions and protein class of the 24 hFF proteins are illustrated in figures 3-17 
and 3-18.   
 
 
Figure 3-17 Molecular functions of the hFF proteins bound to sperm using PANTHER 
classification system; binding and catalysis were among the the highest categories 
followed by the enzyme regulation and receptor activity 
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Binding and enzyme catalysis were among the highest protein categories along with 
enzyme regulation and receptor activity. Some proteins were mapped to more than one 
molecular function. For example, alpha-2-macroglobulin was mapped into the enzyme 
catalytic category and receptor activity. However, seven proteins had no PANTHER hit in 
the functional classification with no functions described. These proteins were 
immunoglobulins heavy chain proteins with different regions. Further details of the 
functional analysis of the hFF proteins bound to sperm are included in section 3.6. 
 
147 
 
 
Figure 3-18  Functional analysis for protein class of the hFF proteins acquired by sperm 
using PANTHER classification system. Enzyme modulators and signalling molecules were 
among the highest categories. 
  
 
 
3.5.5 Acrosome reaction results:  
Across this replicates (n = 6), 30% hFF induced statistically significant AR when 
compared to the negative control (DMSO) with p value < 0.0002.  AR triggered by 30 % 
hFF was not significantly different from 13.5 µM progesterone (p. value < 0.03), figure 3-
19.  
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AR was also evaluated using the AR stimulation formula (section 3.4.6.2) which enables 
the analysis of AR based on excluded spontaneous AR in the sperm population 
(represented by the negative control DMSO) and manifests maximum stimulation of AR 
levels observed in sperm exposed to the positive control ionomycin/calcium ionophore, 
(Correia, 2011), table 3-4. 
 
Table 3-4 % stimulation of acrosome reaction in the different treatments  
Treatments % of Stimulation of acrosome reaction 
 Exp1  Exp2  Exp3 Exp4 Exp5 Exp6 Mean  ± SEM 
Ionomycin  100 100 100 100 100 100 100 ± 0 
hFF 23 17.4 14.6 21.4 15.7 26.3 19.7 ± 1.9 
Progesterone  30 23.5 17 22 17.5 28 23 ± 2. 2 
DMSO 0 0 0 0 0 0 0  ± 0 
 
.  
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Figure 3-19  Acrosome reaction analysis data (n = 6) plotted as mean ± SEM. Sperm cells 
were treated with ionomycin (positive control), DMSO (negative control), progesterone 
and hFF.  * indicates a significant difference between control and treatments (* = P ≤ 0.05, 
** = P ≤0.01, *** = P ≤ 0.0001). 
 
 
3.6  hFF proteins identified in the sperm + hFF samples:  
3.6.1 Functional relevance: The hFF proteins detected in both the sperm + hFF total 
binding and membrane-associated approaches, which were possibly acquired by sperm 
following incubation, were searched in PubMed at http://www.ncbi.nlm.nih.gov/pubmed 
with the key words: sperm AND/OR fertilisation AND/OR reproduction, to construct 
possible links to sperm regulation mechanism.  Some of the hFF proteins were selected 
according to their relevance to sperm and reproduction in the searched literature and a 
summary for the identified hFF protein function is highlighted in this section.  
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Immunoglobulins: six out of the 24 hFF proteins detected in the sperm + hFF samples 
were immunoglobulins.  In a study investigating the effect of heavy and light chains of 
human IgG, the authors suggested that the purified preparation of IgG induced sperm 
acrosome reaction (Saragüeta et al., 1994).   This effect was only examined by anti-human 
lgG antibody in the study and was not supported by any further studies in the literature .  
Vitronectin is a glycoprotein with ability to interact with several molecules including 
glycosaminoglycans and proteoglycans enabling it to contribute to numerous biological 
functions such as cell adhesion and cell surface proteolysis (Gibson et al., 1999, Bronson 
et al., 2000, Thys et al., 2012). In human, low concentrations of vitronectin (< 100 nM) 
supplementation was suggested to enhance sperm-egg adherence, while at higher 
concentrations, vitronectin was suggested to reduce sperm-egg adhesion (Fusi et al., 1996).  
In cattle, addition of high concentrations (more than 500nM) of exogenous vitronectin to 
the IVF culture media has been shown to inhibit sperm-oocyte interaction and thus 
suggesting  that vitronectin could be a ligand in the bovine sperm-oocyte recognition 
process  (Thys et al., 2012, Tanghe et al., 2004). Whether vitronectin from hFF which has 
bound the sperm following sperm + hFF incubation in this study possesses similar effects 
to the exogenously added vitronectin in terms of enhancing sperm-egg adhesion and 
interaction described in the above indicated studies is interesting for further research. The 
presence of vitronectin as an intrinsic sperm protein has been claimed in some studies 
which applied monoclonal anti-vitronectin antibody on semen sample from one donor 
(Bronson et al., 2000).  The same research group has suggested enhanced expression of 
vitronectin on sperm surface following capacitation and vitronectin release following 
acrosome reaction (Fusi et al., 1996, Fusi et al., 1992, Fusi et al., 1994).  Another study has 
described vitronectin to be localised to the equatorial area of the sperm head (Jeremias and 
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Witkin, 1996) and to have correlation with sperm’ ability to acrosome react (Fusi et al., 
1992). Nevertheless, none of the recent studies analysing sperm proteins via mass 
spectrometry have detected vitronectin in sperm cells (vitronectin was searched in a 
systematic review of compiled 6198 sperm proteins from 30 human sperm proteomic 
studies (Amaral et al., 2014a). In the current study, vitronectin was only detected in two 
independent experiments in sperm + hFF samples and not in any sperm control data from 
the two approaches applied. 
 Vitronection described on sperm surface following capacitation and acrosome reaction 
(Fusi et al., 1996) might have been acquired from exogenous sources and become bound to 
sperm during the incubation period. Additionally, the Velcro effect of vitronectin on 
sperm-oocyte adhesion (Fusi et al, 1996) was only observed when vitronectin was detected 
on the sperm surface following capacitation. The role of hFF vitronectin in sperm 
functions may require further research by the application of techniques such as 
recombinant proteins to identify the exact role of this protein in sperm functions.   
Kininogen-1 is the precursor protein for both high and low molecular weights kininogens  
and is part of the kallikrein-kinin system which has been suggested to be involved in 
human sperm motility regulation (Schill, 1975). Kininogens and the other three 
components of the kallikrein-kinin system namely  kallikreins, kinins and kininases have 
been detected in the human male seminal secretions and have been shown to enhance 
sperm metabolism and motility (Schill and Miska, 1992).  However, kininogen-1 has not 
been described in the compiled sperm proteome by Amaral et al (2014a). The mechanism 
by which the components of the kallikrein- kinin system affect the sperm is not clearly 
understood, however, some studies advocated the presence of certain sperm membrane 
bradykinin subtype B receptors for the kinins’ effects on sperm (Schill and Miska, 1992).  
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Furthermore, enhancement of sperm penetration to cervical mucus was shown following 
sperm incubation in media with of kininogen, kallikrein and acrosin and also suggested the 
likelihood of some traces of kininogen anchored to the sperm surface allowing release of 
kinin (Schill et al., 1979).  In these studies, porcine pancreatic kallikerins were used to 
investigate their effects on cervical mucus penetration.  In the current study, kininogen-1 
from hFF was found in sperm + hFF sampes and may have similar effects to the 
pancreatic-derived kininogen, however, further research is necessary to confirm this 
suggestion. 
S100 A6 is a member of the S100 protein family which are involved in calcium signalling 
and phosphorylation (Schafer and Heizmann, 1996, Donato, 2001) and in regulation of cell 
motility,  growth, and survival (Gross et al., 2013). S100 A6 is a calcium binding protein 
with the main function in calcium signalling by the interaction with other proteins (Nedjadi 
et al., 2009).  S100 A6 is also involved indirectly in the reorganization of the actin 
cytoskeleton and in cell motility (Nedjadi et al., 2009). Until now, the exact physiological 
function of S100A6 is unknown (Leśniak et al., 2005), however,  it has been suggested that 
S100A6 may contribute to cellular motility (Gross et al., 2013), cytoskeleton 
rearrangement (Breen and Tang, 2003), cell proliferation and exocytosis (Timmons et al., 
1993).  The link between S100A6 and cell motility was shown mainly in cancer cells such 
as pancreatic cancer and osteosarcoma through S100A6 interaction with Annexin A2 
(Nedjadi et al., 2009). Depleted levels of S100 A6 show loss of cell migration and invasion 
of pancreatic cancer cells (Nedjadi et al., 2009). However, the specific regulation 
mechanism by which S100A6 affects cell motility is still elusive (Gross et al., 2013).  No 
further articles exploring the effect of S100A6 on cellular motility in none cancer cells 
such as sperm were found in the literature. Although the invasive nature of malignant cells 
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and their migration are distinct from motility in sperm cells and its ability to penetrae the 
egg; the role of the bound S100A6 on sperm surface requires further study.   
Plasma protease C1 inhibitor: also known as C1 esterase inhibitor and SERPING1 with 
UniProt accession number P05155 (IC1_HUMAN) and its short name is C1-Inh which 
will be used in this study.  C1-Inh is a protease inhibitor which participates in several 
physiological functions such as complement cascade, fibrinolysis and coagulation (Davis, 
1988) and it belongs to the SERPIN superfamily.  As indicated earlier, C1-Inh was not 
among the 6198 proteins listed in Amaral, et al (2014a) compiled sperm data and was not 
detected in sperm control samples and only detected in sperm + hFF  in this study and in 
hFF protein data . However, the identification of a C1- Inh-Like molecule on the sperm 
surface mainly the head and midpiece regions was claimed in a study using polyclonal 
antibody (Jiang et al., 1997).  The authors assumed that C1- Inh-like was synthesised in the 
testis or within the sperm itself and it became attached to the sperm surface (Jiang et al., 
1997).  Prevention of sperm lysis in the presence of C1- Inh-Like on the sperm surface was 
suggested to be part of the complement regulation mechanism played by this protein (Jiang 
et al., 1997).  Since sperm and extra-embryonic membranes are allogenic to the maternal 
cells, the involvement of complement system regulation in fertilisation is believed to play 
significant role for successful fertilisation and prevention of complement-mediated damage 
to the sperm and embryonic tissues (Vanderpuye et al., 1992). This observation was 
illustrated in the case of infertile patients with C1-Inh-Like deficiency in semen (Jiang et 
al., 1996) who have sperm antibodies which bind C1 complement component and results 
in complement-mediated destruction of sperm (Jiang et al., 1997). C1-Inh-Like on the 
sperm surface was also suggested to play a role in regulation of sperm motility and that 
antibodies against this protein inhibit motile sperm (Jiang et al., 1997).  
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Nonetheless, neither C1- Inh nor its C1- Inh-Like homologue has been identified in the 
sperm in any of the 30 sperm proteomic studies included in Amaral et al, 2014a sperm 
proteome. This could open the door for speculations on the role of this protein which is 
present in hFF and may bind to the sperm surface following their incubation with hFF as 
investigated in this study.  hFF displays complement activity (D'Cruz et al., 1990) and the 
presence of  C1- Inh in both hFF and in the sperm + hFF samples may signify its role in 
the protection of sperm against sperm damage caused by complement cascade activation.  
Such speculations require further research to elucidate possible roles of C1- Inh in sperm 
fertilisation.  
3.6.2 Future work:  
Although the current knowledge of the function of the acquired hFF proteins may not 
indicate any direct effects on sperm regulation and fertilising capability; further research 
into their roles is essential.  Techniques, such as recombinant proteins or combinations of 
purified forms of these specific hFF proteins acquired by sperm, and studying their effect 
on sperm parameters may increase our understanding of their role in sperm fertilisation.  
Investigation of the effects of specific antibodies to the acquired hFF proteins (for 
example, monoclonal anti-vitronectin antibodies (Bronson et al., 2000)) on sperm 
regulation may enable better understanding of the role of the acquired hFF proteins in 
capacitation and AR. Subcellular fractionation of the sperm samples following their 
incubation with hFF may be an alternative approach to enable localisation of the site of 
hFF proteins binding e.g. on the head or tail regions. Validation of the detected hFF in 
sperm + hFF samples by western blot may also enable further confirmation of the identity 
of the acquired hFF proteins. The application of these techniques, however, was out of the 
scope of this study.  
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3.7 hFF and sperm acrosome reaction data:  
In the current study, among six replicates, 30% hFF induced AR in approximately 20% 
subpopulation of sperm following capacitation of 4-6 hours. The ability of hFF to induce 
AR in a subpopulation of sperm has been documented in several studies (Tesarik, 1985, 
Calvo et al., 1989, Yao et al., 2000).  The rate of AR in response to hFF has been shown as 
dose-dependent (Burrello et al., 2004).  For example, the rate of AR in response to 25% -
50% concentrations of hFF varied from 11% to up to 59% of sperm (Siegel et al., 1990, 
Tesarik, 1985, Yao et al., 2000).  This variation in the rate of AR among these studies may 
have resulted from differences in the experimental design such as the duration of 
incubation with the treatments, sperm pre-incubation for capacitation and the difference in 
the hFF dose applied (Yao et al, 2000).   
In the current study, capacitated sperm were incubated in hFF for 1 hour. The duration 
after which hFF induces AR varied widely in the literature ranging from 15 minutes to up 
to 24 hours of extended exposure in some studies (Pilikian and Mimouni, 1988, Stock and 
Fraser, 1989, Yao et al., 2000). While Yudin et al. (1988) stated that hFF stimulated AR in 
40% of the sperm population within 180 seconds, Gearon et al. (1994) claimed that a 
minimum of 6 hours is required to induce sperm acrosomal exocytosis in response to hFF.  
Most other studies agree on one hour duration of incubation in order for hFF to induce AR 
(Tesarik, 1985; Calvo et al, 1989; Siegel, 1990; De Jonge et al, 1993; Yao et al, 2000).   
3.8  Discussion: 
To our knowledge, this is the first study to conduct a comparative proteomic analysis of 
sperm capacitated in capacitation media alone versus sperm capacitated in the capacitation 
media in the presence of  hFF. Protein identification was achieved using MS analysis.  
Twenty-four  hFF proteins were detected in sperm + hFF samples following two proteomic 
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approaches and these hFF proteins may have been acquired by the sperm following sperm 
incubation with hFF.   
In the total binding approach, 1488 proteins were detected and they were mostly soluble 
sperm proteins with only 81 (approximately 5%) sperm membrane proteins when 
compared to sperm membrane proteins from Gu et al (2011) and 22 hFF proteins were 
detected.  Membrane proteins are the site where sperm interaction with their surrounding 
environments in both the male and female reproductive tracts  is believed to take place 
(Naaby-Hansen et al., 1997).  To have better access to the sperm membrane proteins along 
with any bound hFF proteins and to investigate sperm surface protein remodelling 
following exposure to hFF, the membrane-associated approach was designed.  The first set 
of experiments in the membrane-associated approach was performed to determine which 
chemical conditions are appropriate to disrupt sperm membrane and enable separation of 
any membrane-associated hFF proteins using chemical elution. Elution is a process in 
which some substances are extracted from another using washing with chemical solvents. 
2M NaCl/Tris-base pH 10.6 preparation was selected for the membrane-associated 
approach following SDS-PAGE salt concentration curve.  Preparations containing high salt 
concentrations has been shown to disrupt electrostatic interactions  between the integral 
and peripheral membrane proteins resulting in the release of the peripheral fraction of 
membrane proteins (Gadella, 2009).  However, out of the total 328 proteins detected in the 
membrane-associated approach from both sperm control and sperm + hFF samples, 52 
(approximately 15%) were sperm membrane proteins when compared to sperm membrane 
proteins from Gu et al (2011) and five hFF proteins were detected.     
The challenge of detecting sperm membrane proteins along with any bound hFF proteins 
may be attributed to the nature of the membrane proteins in general.  It is well documented 
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that membrane protein solubilisation is a major challenge in proteomic studies with no 
well established approach to achieve their purification from intracellular protein 
contamination (Kalipatnapu and Chattopadhyay, 2005, Jamshad et al., 2011). In 
proteomics, it is a well-recognised difficulty to solubilise and extract all proteins from 
cells, particularly highly hydrophobic proteins using standard techniques (Brewis and 
Gadella, 2010). Despite the significance of sperm membrane proteomic study in 
understanding the initial stages of fertilisation, the best choice of techniques for 
solubilisations of sperm membrane proteins is still lacking (reviewed in Brewis and 
Gadella (2010) and Nowicka-Bauer and Kurpisz (2013). Several techniques have been 
applied in sperm membrane proteomic studies such as nitrogen cavitation, ultra-sonication 
and biotinylation (Gadella, 2009, Brewis and Gadella, 2010). However, low purity of the 
detected sperm membrane proteins with more intracellular proteins being detected are still 
problematic in these techniques (Brewis and Gadella, 2010).  
Discussion of the study’s strengths,  limitations and methodological choices,: 
While 62 % of the proteins detected in this study were detected more than once, 38% 
sperm proteins were only detected once in one experiment and/or approach. This may have 
resulted from physiological reasons such as the generally observed heterogeneity in sperm 
samples (Holt and Van Look, 2004) with intra (between ejaculates from the same sperm 
donor) and inter-variabilities (between ejaculates from different donors) being observed in 
sperm proteomic studies (Amaral et al, 2014a).  Additionally, sperm capacitation has been 
shown to only occur in a subpopulation of sperm and does not occur simultaneously in all 
sperm cells and may not occur in some sperm and this may affect the protein profile 
among the same population of sperm (Amaral et al, 2014a).  Since only a subpopulation of 
sperm may undergo capacitataion at a given time (Amaral et al, 2014a) it may be 
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reasonable to expect only this subpopulation to acquire some hFF proteins during the 
sperm surface membrane remodelling in the current study.   
Low abundance of certain hFF is another possible explanation for missing detection of 
potential hFF proteins bound to sperm.  As highlighted in chapter 2, low abundance 
follicle-specific hFF proteins are generally of high relevance to the functional aspects of 
hFF proteins in reproduction (Jarkovska et al, 2010). Whether the detection of the 
identified hFF proteins in the sperm + hFF samples was due to their binding to the sperm 
or their abundance in hFF requires further research. Low number of replicates in this study 
is another limitation. Six experiments (two in the total binding and four in the membrane-
associated approaches) were performed in this work.  Future studies may apply larger 
number of semen samples in the study of sperm + hFF interactions to achieve better 
representation of biological variation.   
Discussion of the methodological choice: 
Sperm purification, in this study, was performed using Percoll density gradient 
centrifugation which has been shown to effectively eliminate seminal plasma and none 
sperm cells such as leukocytes (Gandini et al., 1999, Wang et al., 2013).  Out of the 30 
sperm proteomic studies compiled by Amaral et al (2014a), 21 studies have utilised 
density gradient centrifugation for sperm purification (see table 3-5 for studies’ 
references).  It has also been shown that Percoll density gradient centrifugation produced 
superior reproducibility with less variation between gels prepared from same semen donors 
on different occasions compared to swim-up technique (Pixton et al, 2004). This is 
suggested to possibly result from elimination of seminal plasma sperm-adhered proteins by 
density gradient centrifugation that are not removed by swim-up (Pixton et al, 2004).   
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 In the current study, sperm + hFF were incubated for 90-120 minutes to allow for sperm 
capacitation and any hFF binding to take place.  It has been suggested that sperm cells may 
have a rapid response, within one hour, to the hFF exposure since this exposure occurs in 
the oviduct shortly prior to fertilisation (Yao et al, 2000).  Yao et al (2000) has manifested 
that sperm capacitation following incubation with hFF occurs within one hour as evaluated 
by CTC stain for cells undergoing AR as an indicator of capacitation. 
Previous work in our group has examined the effects of human cumulus cells and hFF on 
sperm modulation and their relationship to pregnancy outcomes (Frettsome, 2012). 
Preliminary data from our group has shown that sperm incubated with hFF manifested 
darker protein bands on 10% SDS gel compared to sperm control samples (with no hFF) 
which may indicate that sperm acquire some of the hFF proteins. 
Protein separation in this study was achieved using 1D-SDS-PAGE which is considered 
superior to 2D-PAGE in terms of number of protein identification and also its 
compatibility with the use of charged detergents. The use of 2D-PAGE in sperm 
membrane proteomic is not highly recommended because of the limited compatibility of 
this technique with the use of charged detergents to solubilise membrane proteins  (Brewis 
and Gadella, 2010).  Additionally, large and highly charged proteins are difficult to resolve 
in 2D-PAGE (Rabilloud, 2009).  In a comparative study of capacitated versus ejaculated 
sperm using 2D-PAGE, Secciani et al. (2009) identified 58 sperm proteins of which only 
one was a membrane protein.  
hFF proteins and sperm modulation: Sperm cells are transcriptionally and 
translationally inactive and they may rely on other sources of factors and proteins to 
achieve functional competence (Miller et al., 2010, Oliva and Castillo, 2011).  In this 
study, sperm are  shown to acquire hFF proteins which sperm never have and the putative 
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hFF proteins may induce modulation of sperm function.   Although most of the published 
studies support the concept of hFF steroid hormones, specifically progesterone, to be 
responsible for the observed effects of hFF on sperm function (Morales et al., 1992, Fabbri 
et al., 1998). Nonetheless, there is a growing body of evidence to indicate the significance 
of proteins in hFF to participate in the induction of sperm functions (Hamdi et al., 2010). 
Apolipoproteins and high-density lipoproteins (HDL) in hFF have been suggested to play a 
role in sperm hyperactivation (Hamdi et al, 2010).  Some of the other suggested 
mechanisms by which hFF may modulate sperm and induce capacitation include lipid 
transfer and enhancement of cholesterol efflux which may increase sperm cell membrane 
fluidity (Ravnik et al., 1992, Muller and Ravnik, 1995, Lepage et al., 1993, Hamamah et 
al., 1995). Follicular and oviductal fluids are rich in albumin and lipoproteins which have 
been shown to induce cholesterol efflux important for sperm capacitation (Ehrenwald et 
al., 1990, Visconti et al., 1999).  In the current study, two of the hFF proteins 
(apolipoprotein L1 and complement component C6) which were found in the sperm + hFF 
samples belong to the transport activity which is defined in the PANTHER classification 
system as the ability of the protein to facilitate the directed movement of lipids into, out of 
or within a cell, or between cells.   Lipid transport activity of proteins have been shown to 
play a role in facilitating sperm capacitation by enhancing cholesterol efflux (Hamdi et al, 
2010).  The role of these two hFF proteins may require further research to establish their 
effects on sperm modulation for capacitation.  Additionally, the antioxidant properties of 
hFF has been described in the literature (Huang et al., 2014) and in this study one of the 
hFF sperm-bound proteins was haptoglobin which is known for its antioxidant 
characteristics (Jelena et al., 2013).  
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In the current study, comparison of protein profiles from sperm incubated in capacitating 
media alone (sperm control samples) and sperm incubated in the capacitation media along 
with hFF (sperm + hFF samples) was performed.  This comparative proteomic analysis 
may reveal the global protein modification of sperm proteins following capacitation in the 
presence of hFF.   It has been suggested that comparative proteomics analysis, in which 
sperm protein profiles from two sets of samples are compared, may enable the 
identification of sperm proteins with functional relevance (Aitken and Baker, 2008).  Such 
comparative proteomic studies have been applied to compare sperm protein profiles from 
capacitated versus ejaculated sperm (Secciani et al, 2009) or fertile donors against infertile 
patients (Rajeev and Reddy, 2004, Pixton et al., 2004).  The study of changes in sperm 
protein profile in response to exposure to body’s milieus has also been recommended 
(Gadella, 2009).  In the current study, the aim of the comparative proteomic analysis of 
sperm cells was to study sperm protein profile following exposure to hFF proteins and to 
identify any hFF in the sperm +hFF samples. Twenty-four hFF proteins were detected in 
the sperm + hFF samples following the concomitant incubation which suggest that, sperm 
may have uniquely acquired these proteins. The relevance of the putative hFF proteins to 
sperm fertilisation potential requires further investigation as illustrated in section 3.6.  
Some proteins were common proteins found in both sperm data and in hFF data in the 
literature and were detected in sperm + hFF samples in this study. The origin of these 
proteins in this study was not ascertained and they were not considered in the binding 
fraction of hFF.   However, the potential of sperm cells to replace or add proteins they 
already have with some from the hFF proteins that common to both, require further 
research. During their transiet in the epididymis, sperm acquire some proteins which are 
similar to the testicular proteins which sperm already possess (Cooper  and Young, 2006). 
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Similarly, we may suggest, from this study, that sperm may acquire hFF proteins which 
sperm already have.  
Concluding remarks: 
In summary, this study is the first to our knowledge to present comparative proteomic 
profile of sperm incubated in capacitating media alone versus sperm incubated in 
capacitation media with hFF.  Identification of candidate hFF proteins may enhance our 
understanding of their role in sperm fertilisation. Supplementation of IVF media with the 
candidate hFF proteins will also be a promising approach prior to IVF to enhance sperm 
function and fertilisation.  Alternatively, the knowledge of candidate hFF proteins which 
influence sperm fertilisation may enable the development of diagnostic tools of male 
infertility or design of male contraceptive.    
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Table 3-5 Methods of sperm purification for proteomic analysis in the literature, data 
taken from Amaral et al, 2014a, total number of studies 29  
 
Technique of 
sperm cells 
purification 
Number of 
studies utilised 
the technique 
References 
Density gradient 
centrifugation 
(Percoll or Pure 
Sperm) 
19 Ficarro  et al, 2003, Pixon et al, 2004, Martínez-Heredia  et 
al., 2006, Lefievre et al, 2007,  de Mateo et al, 2007,  Li et 
al, 2007,  Baker et al, 2007, Zhao et al, 2007, Martinez-
Heredia  et al, 2008, Chan  et al, 2009, Liao  et al, 2009; 
Frapsauce  et al, 2009, Siva et al, 2010,  Nixon  et al, 2011; 
Redgrove  et al, 2011, Wang et al. 2013, Amaral et al,  
2013, Baker et al, 2013, Vigodner  et al, 2013  
Swim-up  3 Gu et al, 2011, Xu   et al, 2012, Secciani et al, 2009 
Both Percoll 
fractionation 
and/or swim-up 
2 Naaby-Hansen  et al, 2010,  Naaby-Hansen and 
Herr, 2010 
Washing and/or 
isolation of sperm 
subcellular 
compartments  
5 Johnston et al, 2005, de Mateo et al, 2011, Kim  et al , 
2007,  Parte et al, 2012  
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Chapter 4  
SPERM METABOLOMICS 
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4.0 Abstract 
Metabolomics enables the identification of low molecular weight exogenous and 
endogenous molecules involved in metabolism such as amino acids and peptides contained 
within a biological sample. Sperm metabolomics may provide understanding of sperm 
energy metabolism, biomarkers of infertility and insight into possible signalling 
mechanisms induced by metabolites released by sperm into the female reproductive tract 
(FRT).  However, current knowledge of the human sperm metabolome is still very limited. 
The current study is the first to our knowledge to conduct a comparative metabolomic 
analysis of released sperm metabolites following one hour of swim-up and 6 hours of 
capacitation.  Method: sperm cells were prepared by swim-up and adjusted to 6 × 10
6
 
sperm/ml. Three sample sets were prepared. Media alone controls which had not been 
exposed to sperm; TP1 in which sperm had 1 hour of swim-up and TP7 samples, where 
sperm has a further 6 hours capacitation time. All samples were centrifuged and the 
supernatant filtered through 0.22µm sterile filter before being frozen for subsequent 
metabolomics analysis. Reults: ninety-four statistically significant metabolites (p < 0.05) 
were detected in two sets of data (n=18) (the p-value was not adjusted for multiple 
calculations). The fold change of the metabolites concentrations (TP1 metabolite 
concentration/TP7 metabolite concentration) are reported. Fatty acids and oxidised fatty 
acids had statistically different concentrations between TP1 and TP7 samples. The results 
of this study indicate that sperm consume and release metabolites from/into the 
capacitation media. Further research for fertility diagnostics and into the effects of these 
metabolites on FRT signalling is warranted. 
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4.1  Introduction: 
The omics fields, namely, genomics, transcriptomics, proteomics, and metabolomics are 
now the main techniques to study complex biological samples (Courant et al., 2013).  
Metabolomics is one of the comprehensive approaches, which enables the study of 
metabolites (low molecular weight exogenous and endogenous molecules involved in 
metabolism) such as amino acids and peptides in a biological sample (Courant et al., 2013, 
Nicholson et al., 2002).  Discovery of diseases’ biomarkers, understanding the biological 
pathways, drug development and investigation of disease pathology are some of the 
substantial applications of metabolomics (Zhang et al., 2012).  The significance of 
metabolomics emerges from the fact that metabolites are the main building blocks 
involved in the regulation of the metabolic processes in human body which also provide 
valuable insights into the human metabolic phenotype (Dunn et al., 2011).    
Metabolomics is a promising novel approach in scientific research, but the field is still in 
its infancy in terms of the available human metabolome databases compared to the human 
genome (Patti et al., 2012, Zhang et al., 2012). Hence, not all the currently identified 
metabolites are recorded in the available metabolomics databases which results in 
incomplete understanding of cellular metabolism (Baker, 2011, Kind et al., 2009).  
Currently, the human metabolome (defined as the complete quantitative identification of 
metabolites in a biological system) (Oliver et al., 1998) is estimated to have more than 
40,000 metabolites (Wishart et al., 2013) with around seventy human-specific metabolic 
pathways involved (Ma et al., 2007). The high complexity of the human metabolome with 
massive diversity of metabolites including amino acids, peptides and nucleotides creates 
another challenge in metabolomics studies (Zhang et al., 2012).  Nevertheless, 
considerable progress has been achieved in the metabolomics studies by the application of 
167 
 
advanced techniques that enabled better access to the human metabolome (Dunn et al., 
2015).  Several advanced techniques such as nuclear magnetic resonance (NMR) 
spectroscopy, gas chromatography–mass spectrometry (GC–MS) and ultra-performance 
liquid chromatography–mass spectrometry (UPLC–MS) have been applied in 
metabolomics with the latter two (GC–MS and UPLC–MS) being superior in accessing the 
whole metabolome  (Dunn et al., 2015, Kell and Goodacre, 2014).  This is attributed to the 
sample preparation in which the chromatographic separation of the thousands of human 
metabolites precedes the mass spectrometry analysis and increases the metabolome 
coverage of these techniques (Kell and Goodacre, 2014, Thiele et al., 2013, Dunn et al., 
2015).      
In metabolomics research, two approaches are currently applied which are targeted and 
untargeted metabolomics workflows with more recently a semi-targeted approach being 
recognised as an intermediate technique (Dunn et al., 2011). The untargeted approach is a 
comprehensive metabolic profiling of a whole range of metabolites in a biological sample 
which provides a wide range of metabolomics data important in generating hypothesis and 
expanding knowledge in certain aspects in the metabolic network (Dunn et al, 2011).  By 
contrast, the targeted metabolomics approach starts with a specific hypothesis and aims to 
answer particular questions in which certain metabolites linked to specific pathways are 
quantified in the samples (Dudley et al., 2010).   In the current study, an untargeted 
approach was utilised to accomplish a global overview of sperm metabolites during 
capacitation.        
It is noteworthy that the metabolomics software applied in metabolite detection only 
provides p-value and fold change (FC) associated with changes in the concentrations of 
certain metabolites between classes of samples (Patti et al., 2012). To proceed further with 
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metabolite identification, the metabolite databases are searched using the accurate mass of 
the metabolite(s) of interest (Patti et al., 2012).  Nonetheless, further confirmation of the 
metabolite identity is required as the database match only indicates a putative metabolite 
and comparison of the metabolites of interest’s retention times and MS/MS data with that 
of a model compound may confirm the identity of the metabolite of interest (Patti et al, 
2012).    
In many cases a search may not return any matches due to the incomplete and evolving 
nature of current metabolite databases and therefore, complete identification of the entire 
metabolite profile in a sample is still challenging (Patti et al, 2012).  Similar to other 
evolving technologies, metabolomics faces some challenges such as the incomplete 
identification of both the active metabolic pathways and the chemical structure of many of 
the detected metabolites (Deepinder et al., 2007, Hollywood et al., 2006).  Additionally, 
the multivariate and complex nature of metabolomics data is another difficulty that 
necessitates special validations of the generated data prior to their upload into the 
databases (Deepinder et al., 2007).  Both genetic and environmental factors are involved in 
the regulation of metabolism and any differences in these components among studied 
individuals may result in huge perturbations in the metabolomics data acquired  (Johnson 
and Gonzalez, 2012).  For example, differences in the individuals’ diet, life style, stress 
patterns and gender have to be considered when designing metabolomics studies (Johnson 
and Gonzalez, 2012).   
4.1.1 Metabolomics in reproductive biology: 
Metabolomics studies have already made significant contributions in reproductive biology 
such as identification of serum metabolites linked to ovarian malignancy where leading to 
the discovery of six serum metabolites considered as potential biomarkers for early 
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diagnosis of the disease (Chen et al., 2011).   The application of metabolomic techniques 
in semen profiling has the advantage of being a non-invasive and potentially cost effective 
strategy for semen quality assessment (Deepinder et al., 2007).  Recently, some studies 
have identified certain metabolites such as superoxide anion (Iuliis et al., 2006) which is 
linked to defective sperm function and alanine, glycerophosphocholine, citrate, tyrosine 
and phenylalanine from seminal fluid as potential biomarkers for male infertility (Gupta et 
al., 2011b) amongst others (Courant et al, 2013).  For a review of male infertility 
biomarkers in metabolomics see Lee and Foo (2014) and Bieniek et al., (2016).  
Several other promising applications of metabolomics in reproductive biology may include 
testing of endometrial receptivity and fetal monitoring by analysis of samples from the 
endometrium and amniotic fluid respectively (Deepinder et al., 2007, Chu, 2016).  One of 
the metabolomics studies on testicular tissue biopsies also indicated significant differences 
in the tissue concentration of the metabolites phosphocholine and taurine between testis 
with normal spermatogenesis (NS) and those with Sertoli-cell only syndrome (SCO) 
(Aaronson et al., 2010).  This study suggested the potential of using this definable 
distinctive metabolic signature to differentiate between testis with NS and SCO and to 
diagnose non- obstructive azoospermia in a non-invasive way (Aaronson et al., 2010).      
Previous work in our group has shown that sperm trigger calcium-signalling in oviductal 
tissue and that whatever induces this signal is a diffusible messenger released by sperm 
during capacitation (Connolly, 2012).   The application of metabolomic and proteomic 
studies to investigate human sperm-FRT interactions has not been much considered in 
published research to date. The molecular basis of sperm-oviductal communication(s) are 
still poorly characterised in human (Huang et al., 2015) compared to other mammals in 
which a carbohydrate moiety on the surface of the oviduct has been characterised and 
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shown to bind a molecule on the sperm plasma membrane overlying the acrosome (Suarez, 
2001, Reeve et al., 2003).   
4.1.2 Sperm metabolomics:  
Knowledge of the sperm metabolome is still limited as only a few studies in this relatively 
new field have applied metabolomic techniques to study sperm (Egea et al., 2014).  
Compared to more than thirty studies which have considered the human sperm proteome 
and have identified over 6000 proteins (Amaral et al, 2014a); sperm metabolomics is still 
in its infancy. Only one previous study has investigated the human sperm metabolome 
from sperm extract and identified 69 metabolites (Paiva et al, 2015).  Metabolomic 
techniques were applied to determine sperm DNA damage caused by oxidative stress 
(Sanchez et al., 2012) and to compare oxidative DNA damage in semen and blood samples 
from fertile and infertile subjects (Guz et al., 2013).   Metabolomic analyses of human 
seminal plasma from infertile patients receiving traditional Indian herbal medicines 
revealed twenty-three different metabolites (Gupta et al., 2011a, Gupta et al., 2013). 
Metabolomic studies of sperm occurred in rhesus monkey (Lin et al., 2009, Hung et al., 
2009), boar (Marin et al., 2003) and goat (Patel et al., 1999) with only twenty metabolites 
being detected in total (Paiva et al., 2015).  
Sperm cells have a high energy requirement to fuel their motility and function (Amaral et 
al., 2013).  Following over 60 years of research into sperm energy metabolism since Mann 
(1946) identified that fructose rather than glucose is the carbohydrate substrate in seminal 
plasma, the mechanism of energy production for sperm motility has still not been fully 
characterised (Storey, 2008, Amaral et al., 2013). Two principal metabolic pathways are 
described: glycolysis which mainly occurs in the principal piece and oxidative 
phosphorylation in mitochondria (Storey et al, 2008, Amaral et al, 2013).    However, the 
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principal energy sources of sperm motility under in vivo conditions in the FRT where 
sperm have been shown to survive for up to 120 hours (Gould et al., 1984) are yet to be 
elucidated (Amara et al, 2013).    
Sperm energy metabolism:  
Energy metabolism is a vital feature for sperm motility and signalling pathways (Miki, 
2007, Goodson et al., 2012) which involves energy production and formation of essential 
substances for cell survival (Amaral et al, 2014a). Both glycolysis and oxidative 
phosphorylation are involved in ATP production by the sperm cells (Visconti, 2012).  It 
has been shown that sperm may require different metabolic substrates and metabolic 
pathways during their different modification processes in the FRT (Miki, 2007). For 
example, capacitation has been shown to involve mainly glycolysis for ATP production in 
the presence of pyruvate (Hereng et al., 2011) while glucose and mannose are required for 
sperm hyperactivation and tyrosine phosphorylation in mouse (Goodson et al, 2012).  In 
the absence of any metabolic substrates, the motility of sperm cells have been shown to 
decline as the ATP levels rapidly decrease and the cells are incapable to undergo 
hyperactivation (Goodson et al, 2012; Visconti, 2012).  However, human sperm have been 
shown to survive in a culture medium of PBS for prolonged period of more than one week 
without any external energy substrates (Amaral et al., 2011) which may suggest the ability 
of sperm to utilise endogenous energy substrates for their energy requirement (Amaral et 
al, 2013).   
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4.2 Objectives: 
To use an untargeted metabolomics approach to examine metabolites released and/or 
consumed by sperm following immediate swim-up preparation (TP1 samples) and 
following 6-hour incubation in capacitation media (TP7 samples) (to mimic the in vivo 
FRT physiology). A comparative metabolomics analysis of capacitation media alone, used 
as a control,  compared to both TP1 and TP7 samples was conducted.      
 
 
4.3  Methods 
4.3.1 Materials: 
Table 4-1 
Product name  Company  Product code  
Bovine Serum Albumin (BSA)  Millipore, Watford, UK.  82-002-4  
Disposable sterile filter unit, 
membrane pore size 0.22µm 
Millipore, Watford, UK.  SLGP033RS 
Supplemented Earle’s Balanced Salt 
Solution (sEBSS)  
Geneflow, Fradley, UK  06-2010-03-1B 
10 ml sterile syringes  Becton Dickinson Labware, New 
Jersey, USA. 
 302188 
5ml  Falcon round bottom tubes  Becton Dickinson, Labware, New 
Jersey, USA. 
352054 
15 ml Falcon tubes Becton Dickinson Labware, New 
Jersey, USA. 
 352095 
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Table 4-2 Components of suplemented Earls Balanced Salt Solution (sEBSS) 
Components Molecular weight Concentrations    
g/L                              mM 
Sodium phosphate 
(NaH2PO4·2H2O)  
156.01 0.158 1.01 
Potassium chloride 
(KCl)  
74.55 0.4 5.37 
Magnesium sulphate 
(MgSO4·7H2O)  
246.48 0.2 0.81 
Dextrose 
(C6H12O6)  
180.16 1 5.55 
Sodium pyruvate 
(C3H3NaO3)  
110.05 0.3 2.73 
dl-lactic acid 
(C3H6O3)  
112.06 4.68 41.76 
Calcium chloride 
(CaCl2·2H2O)  
147.02 0.264 1.80 
Sodium bicarbonate 
(NaHCO3)  
84.01 2.2 26.19 
Sodium chloride 
(NaCl)  
58.44 6.8 116.36 
 
sEBSS : 285-295 mOsm,  pH 7.15-7.45, produced by Geneflow, Fradely, UK.  0.3% BSA 
was added before use for final capacitating formulation (sEBSS + 0.3 % BSA). 
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4.3.2 Sperm preparations: 
All semen samples were obtained in accordance with HFEA Code of Practice in this 
project (see section 3.3.2 for semen collection procedure).  Semen samples were allowed 
to liquefy for approximately 30 minutes and were prepared by swim-up (Mortimer, 1994). 
Briefly, 1ml of sEBSS + 0.3 % BSA was under-layered with 400 μl of liquefied semen in 
5ml Falcon  round-bottom tubes and left to incubate for 1 hour at an angle of 45° at 37 °C, 
6% CO2.  The top 700 μl containing motile sperm fraction was gently harvested using 
sterile transfer pipette and pooled into 15 ml polystyrene Falcon tube. Sperm concentration 
in the collected fraction was assessed by a Neubauer hemocytometer and the final 
concentration adjusted to 6 × 10
6
 sperm/ml using sEBSS + 0.3% BSA.  Three different 
sets of samples were then prepared as follows: media alone controls (sEBSS + 0.3% BSA) 
which had not been exposed to sperm; TP1 in which sperm had 1 hour of swim-up and 
TP7 samples,  where sperm has a further 6 hours capacitation time at 37 °C, 6% CO2. All 
samples were centrifuged for 5 minutes at 500g and the supernatants filtered through 0.22 
µm pore size sterile filter to remove any sperm before being frozen for subsequent 
metabolomics analysis.  Figure 4.1 summarises the methodology of samples preparations. 
Nine different sperm donors were used in the samples preparations (n = 18). For the 
purpose of metabolomics data analysis, the samples from the first 13 experiments (n = 13) 
were sent for metabolomics analysis as a first set of data. The second set of data (n = 5) 
were sent for metabolomics analysis a few months later. The results from both data sets 
were compiled and analysed as shown in the results section. The chemical contents of the 
capacitation media (sEBSS + 0.3 % BSA) are included in table 4-2 in the material section 
4.2.1. 
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Figure 4-1 Summary of the methodology of sperm sample preparations for metabolomics 
analysis. Three sets of samples were prepared: Control media (no sperm), TP1: 1 hour 
swim-up and TP7: 6 hours capacitation following 1 hour swim-up   
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4.3.3 Metabolic profiling of samples:  
The metabolomics analysis was performed by Dr Warwick Dunn in Phenome Centre 
Birmingham at the University of Birmingham using untargeted metabolomics approach. 
Metabolomics analysis was performed using ultra performance liquid chromatography-
mass spectrometry (UPLC-MS) followed by statistical analysis to identify statistically 
significant metabolites and fold changes of the detected metabolites and to compare the 
three sets of samples in terms of metabolic profiles.  
Ultra-Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS): 
Samples were thawed on ice for approximately 60 minutes and de-proteinised by addition 
of 600μl of methanol (pre-chilled to -20°C for 24h; HPLC grade, Sigma-Aldrich 
Chromasolv) to 200μl of cell media followed by vortexing (15 seconds), centrifugation 
(15-minutes, 13500 xg, 3°C) and drying of 600μl of the supernatant (Thermo Scientific 
Savant SpeedVac Concentrator SPD111V). A single pooled quality control (QC) sample 
was prepared by combining 120μl aliquots of each biological sample followed by vortex 
mixing for one minute. 200μl aliquots were prepared in an identical process as described 
above. All samples were analysed applying Ultra Performance Liquid Chromatography 
(Ultimate3000RS; Thermo Scientific, Hemel Hempstead, UK) interfaced to an 
electrospray mass spectrometry (Q Exactive Focus, Thermo Scientific, Hemel Hempstead, 
UK). Samples were reconstituted in 100μl 80/20 methanol/water and analysed with QC 
samples analysed ten times at the start of the batch (for system equilibration and MS/MS 
data acquisition), followed by injection after every 5th sample and finally two QC samples 
were analysed at the end of the analytical batch. Samples were randomised across a single 
analytical batch for analysis. The mass spectrometer was tuned and calibrated applying 
standard procedures and solutions as defined by Thermo Scientific. UPLC separations 
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were performed applying a Hypersil Gold C18 reversed phase column (100 x 2.1 mm, 1.9 
mm) at a flow rate of 400 mL.min-1, temperature of 40°C and with two solvents: solvent 
A (HPLC grade water +0.1% formic acid) and solvent B (HPLC grade methanol +0.1% 
formic acid).  A gradient elution was performed as follows: hold 100% A 0–1.5 min, 100% 
A–100% B 1.5–6 min curve 3, hold 100% B 6–12 min, 100% B–100% A 12–13 min curve 
3, hold 100% A 13–15 min. Injection volume was 5µL. UPLC eluent was introduced 
directly into the electrospray mass spectrometer with source conditions as follows: spray 
voltage -4.0 kV (ESI-) and +4.5 kV (ESI+), sheath gas 30 arbitrary units, aux gas 15 
arbitrary units, capillary voltage 35 V, tube lens voltage -100 V (ESI-) and +90 V (ESI+), 
capillary temperature 280°C, ESI heater temperature 300°C. Data were acquired in ion 
mode switching in the m/z range 100–1000 at a mass resolution of 35 000 (FWHM 
defined at m/z 200), with a scan speed of 0.4 s and an AGC setting of 1 x 106.  
Data pre-processing:  
Data were processed applying XCMS as described previously (Dunn et al., 2008). All 
metabolites reporting a relative standard deviation (RSD) > 20% and which were detected 
in <70% of QC samples from injection nine onwards were removed. Metabolites were 
annotated applying PUTMEDID_LCMS (Brown et al., 2011). All metabolites were 
annotated according to level 2 (putatively annotated metabolites) as defined by the 
Metabolomics Standards Initiative (Sumner et al., 2007). Statistically significant 
metabolites were grouped into classes related to chemical structure or metabolic function 
similarity. 
Univariate and multivariate analysis:   
Processed data was analysed using paired Mann-Whitney test for statistical significance.  
Application of a critical p-value of <0.05 without the application of FDR correction was 
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performed. The p-value was not adjusted for multiple calculations in these data as the 
number of samples was low in each class and corrections do not work well with small 
numbers of samples (Dr Dunn, personal communication). Calculation of the fold changes 
was performed using the equation: median peak area at TP1 hour /median peak area at 
TP7. 
4.4 Results: 
The preliminary results of the current study have revealed differences in the metabolomics 
level between capacitated (TP7 samples) and sperm immediately prepared following 
swim-up  (TP1 samples) across the 18 replicates.  A total of 203 metabolites have been 
detected in the sperm incubation media from two sets of experiments (1st set n = 13, 2nd 
set n = 5).  There were certain classes of metabolites which were statistically significant 
(p-values of ≤ 0.05) and showed the same relative change (upregulated or downregulated) 
throughout the study samples namely, fatty acids, oxidised fatty acids and peptides. 
Multiply charged metabolites (most likely peptides/proteins) also showed the same 
statistically significant changes in both sets of data, however, the exact identity of these 
metabolites is yet to be identified.  Amino acid metabolism, glycerophospholipids, 
arginine and proline metabolism, sterol and steroid metabolism and sulphur metabolism 
were among the other classes of metabolites identified in this study. Arginine and proline 
metabolism and amino acid metabolism show a major change in the level only in one set 
of data (second set of experiments, n = 5). 
For the purpose of data analysis, four classes of samples were analysed; quality samples 
(QC) applied for quality control; media or control sample (sEBSS + 0.3 %BSA); TP1 is 
the 1 hour samples following swim-up and TP7 is the 7-hour samples (6-hour capacitation 
following swim-up). The concentration of the metabolites in the TP1 and TP7 samples 
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were compared using paired Mann-Whitney test with statistical significance at a p.value ≤ 
0.05 (appendix 5).  For all the metabolites which manifested a statistically significant 
differences between TP1 and TP7 samples in the 2
nd
 set of data, a boxplot analysis for all 
the sample classes analysed (QC, media, TP1 and TP7) was performed. The boxplot 
analysis demonstrated whether the identified metabolites have higher median 
concentration in the TP1 samples (immediately following swim-up) or in the TP7 samples 
(following 6 hours of capacitation) or in the original media (control samples with no 
sperm).  From the boxplot analysis, 46 (16 known identity and 30 multiply charged most 
likely peptide/proteins) metabolites showed higher median concentration in the TP1 
samples compared to both the control media and TP7 samples.  41 Metabolites (38 known 
identity and 3 multiply charged most likely peptide/proteins) had higher median 
concentrations in the TP7 samples compared to both the control media and TP1 samples.  
Seven metabolites showed higher median concentration in the media (control, no sperm) 
compared to TP1 and TP7. Details of the metabolites identity and the boxplot figures are 
shown  in table 4-3 and figures 4-2, 4-3, 4-4, 4-5, 4-6, 4-7, 4-8 4-9, 4-10, 4-11, 4-12 and 
4-13.  These results may indicate that sperm release or secrete certain metabolites while 
consuming others.  This is manifested by the higher concentration of certain metabolites 
following the 7-hours incubation period of sperm (TP7) which may indicate that sperm 
have released these metabolites into the media. Forty-one metabolites demonstrated higher 
median concentration in the TP7 samples with a p.value ≤ 0.05.  In contrast, some 
metabolites were found in lower concentrations in the TP7 samples compared to the TP1 
samples which may indicate that these metabolites have been consumed by the sperm.  
Forty-six metabolites with a p.value ≤ 0.05 belong to this category.  Another set of 
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metabolites were highest in the control media with no sperm which may suggest they have 
been consumed by sperm in the swim-up (TP1) samples and in the TP7 samples. 
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Table 4-3 Details of number of metabolites and their classes in each sample type 
Sample type Number of metabolites  Metabolite class 
 
 
 
TP1 
 
31 Possible protein and peptide  
6 Fatty acids and oxidised fatty acids  
4 Peptides  
2 Glycerophospholipids  
1 hormones 
1 Vitamin D metabolism  
1 others 
Total  46  
 
 
 
 
 
TP7 
 
 
 
 
9 Fatty acids and oxidised fatty acids  
7 Mixed class  
5 Other class  
4 Amino acid metabolism  
3 Glycerophospholipids  
3 Arginine and proline metabolism 
3 Possible protein and peptides  
2 Sterol and steroid metabolism  
2 Carbohydrate  
1 Sulphur metabolism  
1 Peptides  
1 Acyl carnitines 
Total 41  
 
 
Media  
2 Sulphur metabolism 
2 Others 
1 Sterol and steroid metabolism  
1 Peptides  
1 Mixed class  
Total  7  
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Figure 4-2 Metabolites with the median concentration highest in the TP1 samples (one hour swim-up) compared to the TP7 samples (7 h-hour 
capacitation) and media (control).    
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Figure 4-3 Metabolites with the median concentration is highest in the  TP1 samples (one hour swim-up) compared to the TP7 samples (7 h 
hour capacitation) and media (control) 
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Figure 4-4  Metabolites with the median concentration is highest in the TP1 samples (one hour swim-up) compared to the TP7 samples (7 h-
hour capacitation) and media (control) 
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Figure 4-5 Metabolites with the median concentration is highest in the TP1 (one hour swim-up) compared to the TP7 samples (7 h-hour 
capacitation) and media (control) 
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Figure 4-6 Metabolites with the median concentration is highest in the TP1 samples (one hour swim-up) compared to the TP7 samples (7 h-
hour capacitation) and media (control) 
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Figure 4-7 Metabolites with the median concentration is highest in the TP7 (7-hour capacitation) samples compared to the TP1 (one hour 
swim-up) samples and control media 
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Figure 4-8 Metabolites with the median concentration is highest in the TP7 (7-hour capacitation) samples compared to the TP1 (one-hour 
swim-up) samples and control media 
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Figure 4-9 Metabolites with the median concentration is highest in the TP7 (7-hour capacitation) samples compared to the TP1 (one-hour 
swim-up) samples and control media 
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Figure 4-10 Metabolites with the median concentration is highest in the TP7 (7-hour capacitation) samples compared to the TP1 (one-hour 
swim-up) samples and control media 
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Figure 4-11 Metabolites with the median concentration is highest in the TP7 (7-hour capacitation) samples compared to the TP1 (one-hour 
swim-up) samples and control media 
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Figure 4-12 Metabolites with the median concentration is highest in the TP7 (7-hour capacitation) samples compared to the TP1 (one-hour 
swim-up) samples and control media 
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Figure 4-13 Metabolites with the median concentration is highest in the TP7 (7-hour capacitation) samples compared to the TP1 (one-hour 
swim-up) samples and control media 
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4.5 Discussion: 
To the best of our knowledge, this is the first human sperm metabolomics study conducted 
to investigate the metabolite changes during sperm capacitation. While more than 30 
studies have considered the human sperm proteome and have identified thousands of 
sperm proteins as mentioned earlier (Amaral et al, 2014a), only one previous study has 
investigated the human sperm metabolome (Paiva et al, 2015).    
Variation in the metabolites detected in both data sets:  
In the current study, both data sample sets were prepared and analysed in an identical 
methodology and the only reason to separate them was that the 1
st
 data set was prepared in 
January 2016 while the 2
nd
  was in July 2016.  However, none of the metabolites was 
detected in both sets of data. This could be attributed to the high intra- and inter-individual 
variabilities, which have been generally observed in previous metabolomics studies of 
human samples (Courant et al, 2013).  Additionally, physiological reasons such as the 
generally observed heterogeneity in semen samples with inter- and intra-variability being 
well documented (Holt and Van Look, 2004; Secciani et al, 2009) may be the reason for 
the differences in metabolites detected in the two data sets. The fact that no results were 
duplicated across the sets would seem to imply that a wide range of pathways and 
therefore metabolites are available within a sperm, only further work would reveal whether 
certain ones occur in specific individuals or phenotypes. Further replicates would 
presumably provide a more comprehensive and coherent dataset.  
Human metabolomes are highly diverse compared to the genome and proteome due to the 
effects of the environmental factors such as diet which highly contribute to the 
metabolome and make the characterisation of the human metabolomes challenging 
(Wishart et al, 2013). It may be that this has also influenced our data, though this would 
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imply diet having a long-term effect on sperm cell metabolism after their removal from the 
body fluids.   
The comparison of the metabolites detected in the current study with those detected in 
Paiva et al (2015) did not also show any similar metabolites. This could be attributed to the 
difference in the sample type (human sperm extract in Paiva et al, (2015) study of 
endogenous sperm metabolites versus exogenous metabolites in human sperm incubation 
media in the current study).  The differences in the techniques applied (NMR and GC-MS 
versus UPLC-MS) in both studies may also be another reason for the dissimilarity of the 
metabolites detected.   
Eighteen replicates (5 and 13 replicates in the 1
st
 and 2
nd
 data sets) were analysed in the 
current study with 203 metabolites were detected. This could be due to the considerably 
smaller number of metabolites when compared to the number of proteins in the cells 
(Kouskoumvekaki and Panagiotou, 2011; Wishart et al., 2013). One previous study on 
metabolomics of human sperm extract revealed 69 sperm metabolites out of 15 sperm 
samples (n =9) with only four metabolites detected by both techniques (proton nuclear 
magnetic resonance (
1
H-NMR) spectroscopy and gas chromatography coupled to mass 
spectrometry (GC-MS) applied in the study (Paiva et al, 2015).   
 
Discussion of the methodological choice: 
The choice of using untargeted metabolomics approach in this study aims to obtain a 
global view of the metabolites released/consumed in sperm capacitation media at the two 
time points since this is the first study, to our knowledge, to investigate human sperm 
metabolomics.  Mass spectrometry  has been shown to have higher sensitivity than NMR 
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spectroscopy with sub-nanomolar concentrations of metabolites for the MS compared to 
sub-millimolar concentrations detected by NMR spectroscopy  (McRae et al., 2012). 
The study design in terms of capacitation media utilised and the incubation time of 6 hours 
were selected to best mimic physiological conditions in the FRT.  In this study, sperm cells 
were prepared by swim-up to enable selection of the best motile fraction of sperm, 
representative of those that may accomplish their journey in the FRT. The metabolites 
detected in higher concentration in the TP1 samples, therefore, may represent the 
metabolites released by sperm during active motility and homeostatic energy metabolism, 
the lack of their detection later may imply that they can also be consumed by sperm at 
other stages of their metabolic cycle.  Metabolites detected in higher concentration in the 
TP7 samples may additionally represent those released by sperm following capacitation 
and cell death.  Metabolites which had highest concentration in the control media may 
represent substrates that have been consumed by sperm following swim-up and 6 hour 
capacitation. Future research may help confirm the identity of metabolites detected in the 
three cases.  
The background chemical noise was not a problem for the detection of metabolites or the 
annotation of metabolites. This is untargeted metabolomics where the analysis never 
provides a name to all detected metabolites and have a global view of the contents 
analysed.  Some of the expected metabolites such as ATP were not detected in this study.  
ATP is an intracellular metabolite and is not detected in extracellular samples as cells do 
not secrete ATP. As we were studying the sperm capacitation media, ATP was not 
detected.  
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Relevance of the detected sperm metabolites to future applications:  
In understanding sperm energy metabolism: Research into sperm metabolomics is 
significant in unravelling the uncertainty surrounding sperm energy metabolism and 
understanding the vital biological process sperm undergo to achieve fertilisation (Paiva et 
al, 2015).  The study of the human sperm metabolome under in vitro conditions may also 
enable characterisation of the metabolic substrates consumed or released by sperm for 
better understanding of sperm energy metabolism. This study is the first, to our 
knowledge, to conduct a comparative metabolomics study of human sperm metabolites 
detected in sperm capacitation media following 1h swim-up versus 6 hours capacitation. 
Knowledge of the human sperm metabolome is still limited as only a few studies in this 
relatively new field have applied  metabolomics techniques to study human sperm (Egea et 
al., 2014).  The identified human sperm metabolites in this study may have relevance to 
future studies investigating human sperm energy metabolism during capacitation and 
identification of capacitation biomarkers. In the current study, 203 human sperm 
metabolites were detected in the capacitation media following 1-hour swim-up and 6-hours 
capacitation. The relevance of these detected metabolites to sperm metabolism is still 
elusive. In the current study, fatty acids and oxidised fatty acids were among the 
metabolites which show statistically significant fold changes (up and down regulations) in 
the concentrations between TP1 and TP7 samples. The role of the identified fatty acids and 
oxidised fatty acids in sperm energy metabolism for energy production during motility and 
capacitation, therefore, deserve further research.  Fatty acid oxidation of endogenous 
substrates is a form of metabolic pathway which has been suggested to operate in human 
sperm in the lack of exogenous energy substrates (Amaral et al, 2013).  Fatty acid 
198 
 
oxidation is involved in the modulation and transfer of fatty acids and acyl groups into 
mitochondria for beta-oxidation (Paiva et al, 2015). Lipid metabolism has been suggested 
as an important mechanism for sperm energy production (Amaral et al, 2014a; Amaral et 
al, 2014b).  Incubation of human sperm with etomoxir, an inhibitor of fatty acid oxidation, 
resulted in a dramatic decline in sperm motility which indicated the significance of fatty 
acid oxidation for human sperm energy production (Amaral et a, 2013). Some studies 
reported a correlation between lower levels of certain sperm metabolites, mainly L-
carnitine, in semen and male infertility (Matalliotakis et al., 2000; Li et al., 2007). Future 
studies may identify the significance of other sperm metabolites to male reproductive 
health.  
 In the female reproductive tract signalling: a significant application of sperm 
metabolomics is to study sperm signalling in the FRT. The importance of sperm-oviduct 
interaction cannot be undermined as numerous studies have shown the beneficial effects 
on sperm following co-incubation with oviductal epithelial cells such as enhanced motility 
(Yao et al., 2000, Yeung et al., 1994) and prolonged viability (Morales et al., 1996).   
Key for my findings is that human sperm have recently been shown to induce calcium 
signalling in uterine and oviductal cells, but importantly this response could also be 
induced by culture media conditioned by their presence - indicating a possible role for 
sperm metabolites in this signalling (Connolly, 2012).  It is quite possible that the signals 
observed in Connolly (2012) would cause sperm-induced changes in endometrial 
proteome.  In turn these would go on to influence implantation or future child health as per 
the observations in murine species in response to seminal plasma (Robertson, 2014, 
Schjenken and Robertson, 2015). A next stage for this research would be to examine 
identified metabolites for their signalling effects in the female tract cells as utilised by 
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Connolly (2012). If a metabolite(s) was identified which caused similar tract signalling a 
randomised clinical trial of infusion of the sperm metabolite(s) to the uterus and evaluation 
of implantation rates and pregnancy success rates may enable better understanding of the 
role of sperm metabolites in human reproduction and open up an exciting new therapy. 
This would have particular significance as the Robertson’s data may suggest it would 
improve the health of children being born not just a treatment success rate (Robertson et al, 
2015).   
In the study of implantation and changes in the oviduct secretory proteomic profile: 
The metabolites detected in the sperm capacitation media in this study may have 
significant relevance to future studies into  implantation and changes in the oviduct 
secretory proteome. The newly recognised potential for sperm to influence the female tract 
in implantation and ongoing child health, stems from mouse evidence reviewed in 
Schjenken and Robertson (2015). Removal of the seminal vesicle resulted in decreased 
implantation rate and poor embryo development in mice (Robertson, 2014, Robertson et 
al., 1996). Obesity, abnormal metabolic parameters and decreased glucose tolerance were 
also manifested in the male mice offspring in this study which highlighted the implications 
of FRT exposure to seminal fluid on the offspring health (Robertson et al., 2006b). In  
humans, seminal plasma does not reach the uterine cavity so if the murine-type signalling 
was to occur in humans it would actually be based upon a sperm-induced signal caused by 
released metabolites. 
Sperm have also been shown to induce changes in the oviduct secretory proteomic profile 
in some species such as pigs (Georgiou et al., 2005) and to enhance prostaglandin 
secretion in bovine oviduct (Kodithuwakku et al., 2007).  The significance of the 
activation of specific sperm signalling cascade within the oviduct, which results in 
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modulation of its gene expression and protein secretions, has also been linked to prolonged 
fertilisation span and sperm survival (Murray and Smith, 1997, Yeste et al., 2014, Kolle, 
2015).  Sperm ability to activate a particular transduction pathway following their binding 
to oviductal epithelial cells has been suggested to cause changes in certain heat shock 
proteins gene expression in pigs (Yeste et al., 2014). The changes in these specific heat 
shock protein (namely clusterin CLU, heat shock proteins: HSP90AA1, HSPA5, and 
HSPA8) have been proposed to play role in modulation of sperm viability within the 
oviduct (Lloyd et al., 2009, Elliott et al., 2009, Yeste et al., 2014). Another study by  
Georgiou et al. (2007) demonstrated that sperm may induce alteration of expression of up 
to twenty proteins in the FRT, mainly the oviduct, including fibrinogen and complement 
C3.    
 
Limitations of the study:  
As discussed earlier, some limitations were inevitable in terms of limited number of 
replicates and variation and heterogeneity in semen samples. Additionally, sperm samples 
were prepared by swim up to obtain the best motile fraction of sperm which may achieve 
fertilisation in vivo.  The assessment of efficiency of sperm purification from contaminants 
such as leukocytes and epithelial cells was not performed. Paiva et al, (2015) 
recommended checking the prepared sperm samples with phase contrast microscopy to 
ensure complete purity of the analysed samples prior to metabolomics analysis, none were 
observed when cell counts were performed in this study, but that does not preclude the 
presence of contaminants at a low level. 
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Additionally, assessment of the percentage of live and dead sperm could be relevant to 
sperm apoptosis, to consider whether the detected metabolites in the TP7 samples are 
partly because of cell death.  In the current study, sperm metabolomics of capacitated 
versus uncapacitated human sperm has shown statistically significant pattern of 
metabolites which may also be a novel approach for population capacitation assessment. 
However, the TP1 samples in this study (considered as uncapacitated sperm) were timed 
after one hour of swim-up during which some sperm cells may have already undergone 
protein phosphorylation (Secciani et al, 2009).  Further studies are certainly required to 
identify more human sperm metabolites and to relate the sperm metabolomics data to 
sperm functionality and fertilisation competence. 
 
Metabolomics versus proteomics sperm studies: 
Compared to more than thirty studies which have considered the human sperm proteome 
and have identified over 6000 proteins (Amaral et al, 2014a) as highlighted earlier; sperm 
metabolomics is still in its infancy. Comparison of the proteomic profile of capacitated 
versus ejaculated sperm and fertile versus infertile subjects have revealed different 
protemic feature between the two compared sperm populations (Rajeev and Reddy, 2004; 
Pixton et al, 2004; Secciani et al, 2009).  Similarly, comparative metabolomics studies of 
different sperm populations, for example from fertile versus infertile subjects, in future 
studies may provide insights of the underlying pathologies in patients with unexplained 
infertility. Another interesting application of sperm metabolomics is to link to sperm 
proteomic data by exploring the relevance of certain metabolic pathways such as lipid 
metabolism to the proteins with metabolic function (Amara et al, 2014a, Paiva et al, 2015).   
The fact that sperm metabolomics are generally performed in in vitro setting may highlight 
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the challenge in accurately identifying the contribution of the different metabolic pathways 
in sperm metabolism in the FRT (Amaral, et al, 2014a). Combining sperm proteomic data 
with sperm metabolomics data may enable better understanding of in vivo sperm 
metabolomics pathway by the identification of sperm proteins/enzymes which are actively 
involved in these pathways (Amaral et al, 2014a).  
Concluding remarks: In summary, this study presents, for the first time, a comparative 
metabolomics study of human sperm metabolites detected in sperm capacitation media 
following 1h swim-up versus 6 hours capacitation. Fatty acids and oxidised fatty acids 
were among the statistically significant metabolic class detected in this study.  The 
detected sperm metabolites are of relevance for understanding sperm energy metabolism 
during capacitation and for future study of signalling in FRT.   
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Chapter 5  
SPERM MICRO-PARTICLE IMAGE VELOCIMETRY  
(Sperm µPIV) 
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5.0 Abstract 
To achieve fertilisation, sperm have to navigate the complex architecture of the FRT by 
actively propelling through the different viscous milieus they face during this journey.    
Motility is, therefore, one of the most significant aspects of sperm functional competence 
for natural fertilisation and is a target for enhancing animal breeding. The fluid dynamics 
of sperm motility is a subject of evolving significance for understanding the sperm journey 
toward the oocyte.  Biological and molecular aspects of progressive sperm motility have 
gained much attention compared to the mechanical aspects. The effects of the motile 
sperm on the surrounding fluid in terms of fluid mixing which could be relevant to 
biological mechanisms such as chemotaxis has not been previously considered.  A micro-
particle image velocimetry (μPIV) using polystyrene beads as tracing micro-particles in 10 
μm chambers have been applied in this study to investigate fluid velocity and vorticity 
around motile sperm in both low and high viscosity media. Data analysis was achieved 
using computing programming language MATLAB and its applications.  Fluid velocity 
around motile sperm was estimated in the range of 25-45 µm/s in low viscosity media 
(LVM) and 20-35 µm/s in high viscosity media (HVM). The preliminary results of this 
study indicated that minimum fluid disturbance is observed around the motile sperm with 
localised fluid vorticity averaged as a trail for sperm motility path.  The negligible fluid 
mixing exerted by the motile sperm may be relevant to sperm chemotaxis with minimum 
disruption to chemical gradients created in the vicinity of the egg.  This work may provide 
an initial platform for future studies aiming to explore sperm- fluid interaction in terms of 
fluid mixing in in vitro setting and for chemotactic studies to investigate sperm motility 
from fluid mixing perspectives.         
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5.1 Introduction: 
Fertilisation requires sperm cells to traverse the FRT and to arrive at and penetrate the 
oocyte vestments (Suarez and Ho, 2003, Suarez et al., 1991b).  The FRT represents a 
challenging environment to the sperm to swim through. The complex geometry of the FRT 
from the narrow cervical crypts to the confined tortuous UTJ and oviduct represent 
mechanical challenges to the sperm (Katz et al, 1989, Suarez and Pacey, 2006). The high 
viscosity of the cervical, uterine and oviductal fluids as well as the narrow opposed 
surfaces in these passages may also hinder sperm migration (Katz et al., 1989).  Not 
surprisingly, only a tiny fraction of sperm out of the hundreds of millions deposited into 
the vagina may accomplish their journey and arrive at the ampulla (Williams et al., 1993, 
Scott et al., 2000).    
Progressive motility has been shown as an essential functional element of ejaculated sperm 
to navigate the FRT and achieve fertilisation (Mortimer and Mortimer, 2013, Mortimer, 
1997). The prediction of functional competence of the sperm during semen analysis is also 
suggested to be more reliant on sperm progressive motility than on sperm concentration in 
a semen sample (Macleod and Gold, 1951, Mortimer and Mortimer, 2013).   Progressive 
motility has been shown as an interactive process between both sperm cells and the 
surrounding environment with physical and chemical characteristics of the FRT playing 
major roles in this process (Katz et al, 1989).   The biophysical activities of the FRT 
including uterine peristaltic movements, ciliary beating and fluid currents within the tract 
may contribute to the sperm transport (Kunz et al., 1996, Katz et al., 1989).   It has also 
been suggested that the fluid flow and ciliary beating within the oviduct may enable 
reorientation of sperm trapped in the cul de-sacs of the oviductal epithelium and contribute 
to maintain luminal patency of the oviduct (Katz et al, 1989). Alternatively, sperm 
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deposition in the FRT may enhance uterine peristalsis via seminal fluid’s contents of 
oxytocin and prostaglandins (Katila, 2001, Watson et al., 1999, Harper, 1988).   
The unique ultrastructural characteristics of the sperm flagellum with dynein, the motor 
molecules in the axoneme, being the main inducer of the sliding movement are vital for 
sperm motility (Lindemann et al., 1992). Sperm motility is shown to be driven by a 
combination of factors including the forces created by the passive flagellar structures and 
the sliding movements initiated by dynein molecules (Gaffney et al, 2011). The 
mechanisms activating the coordinated activity of the dynein arms are still elusive; 
however, it has been shown that these arms act by ATP-ase enzyme converting chemical 
energy into mechanical one (Lindemann, 2009). The sperm flagellum waveform 
(curvature) is suggested to result from a balance between internal sliding forces generated 
by dynein microtubules, the elastic rigidity of the flagellum and the viscous fluid’s 
response to the moving flagellum (Teran et al., 2010, Smith et al., 2009b, Brokaw, 1966). 
The sperm flagellar bending has been shown to confine to the distal flagellum in HVM in 
both human and bull sperm (Katz et al., 1989, Ishijima et al., 1986, Rikmenspoel, 1984). 
Several studies have considered characterisation of molecular aspects of sperm motility 
(Yanagimachi, 1994a, Carlson et al., 2007, Pereira et al., 2015, Luconi et al., 2005).  
Nonetheless, mechanical aspects of sperm motility have gained less attention in the 
literature. Studies investigating the impact of the motile  human sperm on the fluid 
surrounding them in terms of mixing and disturbance are also scarce.  Additionally, Smith 
et al (2009b) and Eamer et al. (2015) indicated that most of the sperm motility studies have 
applied low viscosity media which is in contrast to the in vivo conditions where sperm 
encounter high viscosity FRT fluids such as cervical mucus (Suarez and Pacey, 2006).  
The first study to consider modelling sperm motility in a viscoelastic fluid was in 1998 by 
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Fulford  et al.  Recently, advances in high speed live-cell imaging and computational 
analysis have provided great opportunities to study sperm motility in the view of fluid 
dynamics (Gaffney et al, 2011).  Multidisciplinary studies are in the heart of sperm 
motility research with collaborations between mathematicians and biologists have resulted 
in pioneering studies (Gaffney et al, 2011, Smith et al, 2009b). The application of high 
speed imaging technology and fluid mechanics in studies of sperm motility may enhance 
the understanding flagellar propulsive movements by allowing access to better through-put 
image capture for sperm flagellar wave characterisation (Smith et al, 2009b; Gaffney et al, 
2011).  Both theory and experimentation in such studies play major roles in understanding 
sperm swimming behaviour (Fulford et al, 1998, Gillies et al, 2009, Friedrich  et al, 2010, 
Gaffney et al, 2011).   
Some studies have investigated the changes in the sperm swimming patterns and beat 
frequency in response to alterations in fluid viscosity and encountering boundaries (Smith 
et al., 2009a, Smith et al., 2009b).  The application of high viscosity media (HVM) in in 
vitro studies of sperm motility and guidance is crucial to enable understanding of the 
sperm migration behaviour in the FRT where high viscosity fluids and chemotaxis may 
play role in sperm fertilisation capability (Smith et al, 2009b).  Furthermore, the 
mechanism of sperm interaction with boundaries has potential implications in 
understanding certain aspects of sperm journey in the FRT (Gaffney et al, 2011, Smith et 
al, 2009a) since the close proximity between the opposing epithelial surfaces and the 
motile sperm (Katz et al, 1989).  Sperm have the tendency to swim near surfaces 
(Woolley, 2003, Rothschild, 1963) but the impact of surrounding boundaries on sperm 
flagellar beat pattern is still elusive (Smith et al, 2009a).  Katz et al (1989) indicated that 
when the distance between the sperm and the surrounding boundaries is less than the 
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sperm’s length, the fluid movement caused by the flagellar beating is constrained by the 
boundary (Woolley, 2003, Katz et al., 1989, Katz et al., 1975). The increased energy 
resulted from the boundary constrain causes the sperm flagellum to thrust harder to 
accomplish similar local fluid motion obtained without this constrain (Katz et al, 1989, 
Katz et al, 1975).   Additionally, the boundary effect results in increased passive resistance 
to the sperm head subsequent to the increased hydrodynamic drag on the head and thus 
suggested to counter any possible increase in flagellar thrust (Katz et al, 1989).  
Nevertheless, the mechanism by which increased viscosity may enhance the efficiency of a 
three- dimensional swimmer like sperm is still uncharacterised (Katz et al, 1989; Teran et 
al, 2009).  The tendency of swimming flagellated objects in close vicinty to beat in 
synchrony was observed more than 60 years ago (Taylor, 1951).  However, the relevance 
of this observation to human sperm transport and fertilisation has not been explored 
extensively (Smith et al, 2009a).  Flagellar synchronisation has been observed in bull 
sperm (Woolley et al, 2009), micro-organism such as between the two flagellae of the 
Chlamydomonas (Polin et al., 2009) and some types of bacteria (Hsu and Dillon, 2009).  
The synchronisation of the two flagellae of Chlamydomonas has been suggested to be 
crucial for chemotaxis (Berg and Brown, 1972, Polin et al., 2009).  Understanding of 
sperm-fluid dynamics and its applications may provide answers to such unresolved 
questions in reproductive biology (Gaffney et al, 2011).  The application of sperm-fluid 
dynamic studies has also been implicated in the design of sperm-sorting micro-devices for 
the selection of competent sperm based on sperm motility (Seo et al., 2007, Shao et al., 
2007, Gaffney et al., 2011) and also in advancing the currently available CASA machines 
(Computer Assisted Semen Analysis) (Smith et al, 2009a). For a comprehensive review of 
sperm –fluid dynamic see Gaffney et al (2011).  
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5.1.1 Micro-resolution particle image velocimetry (μPIV): 
 In this study, a technique of micro-resolution particle image velocimetry (μPIV) was 
applied to investigate both fluid velocity and fluid vorticity created by the motile sperm in 
low and HVM in a micro-chamber.  μPIV is a technique used in microfluidic studies for 
measurements of fluid motion in a spatially determined way with the length scales in the 
range of 10 
-4 
- 10
-7 m (100 nm to 100 μm) (Wereley and Meinhart, 2010).   
The flow tracing micro-particles added to the fluid enable the fluid motion to be observed 
and traced as the successively captured images of the moving particles are compared 
(Wereley and Meinhart, 2010). In μPIV, each pair of the flow-tracing particles’ images is 
captured sequentially with specific time interval denoted as Δt.  The image pairs are 
divided into interrogation areas (figure 5-1) which are cross correlated to identify the local 
displacement of the tracing particles Δx.   
 
 
Figure 5-1 Selection of interrogation regions for PIV analysis; two interrogation areas are 
selected and cross correlation coefficient is calculated to determine vector displacement 
per image analysed.  
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The fluid velocity (u) is then calculated by the equation u = Δx / Δt.   Thus, the tracing 
micro-particles local motion is used to infer the velocity of the fluid of interest within the 
microchannel used in the experiment (Wereley and Meinhart, 2010).   
µPIV, or in some articles, µPTV (µParticle Tracking Velocimetry) has several applications 
such as study of blood flow velocity in the microcirculation (Ravnic et al., 2006), 
measurement of intra-aneurysmal flow in cerebrovascular aneurysm (Liou et al., 2004) and 
evaluation of aqueous flow in the eye following laser iriditomy (Yamamoto et al., 2006). 
For data analysis, MATLAB (MATrix LABoratory, MATLAB R2015b, Mathworks, 
Natick, Massachusetts) a powerful data analysis and visualisation tool which enables 
image processing and interpretation (Thielicke and Stamhuis, 2014) was used in this study.  
PIVlab-GUI (Particle Image Velocimetry lab_ Graphical User Interface) which is software 
applies some of the built-in MATLAB functions (Thielicke and Stamhuis, 2014) was 
applied to provide quantitative imaging of fluid flow and fluid velocity magnitude around 
sperm .    
Sperm are considered neutrally buoyant (have an average density equivalent to the 
surrounding fluid allowing them to neither sink nor rise) with gravity being the only force 
affecting the flow and this force becomes negligible on microscopic scales (Montenegro-
Johnson, 2013).  The Reynold number for motile sperm is also very low, approximately 
10
-3
, and therefore inertia (the tendency to remain unchanged) is considered negligible 
(Gaffney et al, 2011) and the small length scales described for the μPIV become 
applicable.  Reynolds number is the ratio between inertial forces and viscosity (Or et al., 
2011).  At low Reynold numbers, the fluid flow is usually laminar and viscosity forces 
dominate compared to high Reynold numbers where the flow is turbulent and inertial 
forces dominate (Videler, 1993).  
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The environment within the FRT is described to encompass complex non-Newtonian 
fluids (Fauci and Dillon, 2006) which signify that the properties of the fluid flow cannot be 
described by a constant viscosity value since the fluid viscosity alters in response to shear 
forces applied to them (Winet et al., 1984). 
In this study, fluid motion was evaluated in the form of fluid vorticity, which is a 
microscopic measure of local rotation at any point in the fluid while circulation is the 
macroscopic measure of fluid rotation (Liu et al., 2015).  Vorticity quantifies rotational 
motion of the fluid.   The study of fluid vorticity may provide insights to the influence of 
sperm on fluid mixing and pattern and extent of this mixing and its relevance to 
chemotaxis. Study of fluid velocity around sperm in the view of fluid vorticity is a new 
perspective for sperm motility studies and also for chemotaxis. 
Both fluid flow and viscosity are suggested to play a role in sperm swimming pattern 
within the FRT and ability of sperm to explore larger surface area of the oviduct (Kantsler 
et al., 2014).  An upstream spiralling motion has been described for both human and bull 
sperm and has been suggested to enhance the likelihood of sperm encountering the oocyte 
(Kantsler et al., 2014).  Several other guidance mechanisms such as chemotaxis, 
thermotaxis and rheotaxis have been suggested in the FRT to guide sperm to encounter the 
oocyte (chapter1, section 1.5.4).  While in in vitro assays of chemotaxis the linear gradient 
of the chemotactic attractant can be maintained, it has been suggested that in in vivo 
conditions the maintenance of such gradient could be challenging where the oviduct is 
exposed to muscular contractions and ciliary beating (Fauci and Dillon, 2006). Limited 
knowledge is available regarding mechanical mixing induced by motile human sperm of 
their surrounding fluid environment which could be interesting for chemotaxis studies.    
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5.2 Objectives: 
The aims of this study were to investigate the fluid velocity and vorticity in the vicinity of 
the motile sperm in both low (LVM) and high viscosity media (HVM) to evaluate the 
range of fluid perturbation caused by the motile sperm.   
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5.3 Methods: 
5.3.1 Material  
Table 5-1 
Product name  Company  Product code  
Bovine serum albumin (BSA) Millipore, Watford, UK. 82-002-4 
CellVision Counting Chamber 10μm 
manual counting chamber 
Mitrone Healthcare Ltd 
(CellVision) , Dublin, UK  
CV1010- 4cv 
Cristaseal Hawksley, Sussex, UK 01503-00 
5ml  Falcon round bottom tubes  Becton Dickinson, UK 352054 
Methylcellulose 4000 Sigma, Dorset, UK M0512 
Poly D lysine solution  Sigma, Dorset, UK.  P8920  
Polystyrene beads (PS beads) 0.50 µm 
mean diameter , 10% solids 
Bangs laboratory, Stratech 
Scientific limited, Suffolk, 
UK 
PS03N 
Percoll Sigma, Dorset, UK. P1644 
supplemented Earle’s balanced Salt 
Solution (sEBSS) without phenol red, 
containing energy substrates 5 mM 
glucose, 2.5 mM Na pyruvate and 19 
mM Na lactate 
Geneflow, Fradley, UK 06-2010-03-1B 
TWEEN-20  Sigma, Dorset, UK.  P1379  
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5.3.2 Methodology:  
The tracer micro-particles used in this study were the polystyrene beads and they will be 
referred to as PS beads throughout the study.  The study was conducted in LVM and HVM 
as follow: 
5.3.2.1 Free motile sperm (single and ≤ 2-10 sperm in the field of view) in low 
viscosity media (LVM): 
a- PS Beads preparation in LVM 
The LVM was prepared using supplemented Earle’s Balanced Salt Solution (sEBSS) + 
0.3% BSA and the coating of the PS beads was achieved by simple adsorption.  The PS 
beads were prepared in the LVM according to the following protocol: 
The PS beads were coated with BSA a day before the experiment as follow: 50μl PS beads 
was mixed with 950μl sEBSS and centrifuged at 10,000g for 2 minutes and the supernatant 
fluid was discarded and this step was repeated three times.  The pellet was then re-
suspended in 950μl of the coating solution (sEBSS + 5% BSA + 0.02% Tween).  The 
preparation was vortexed and left in a cold room at 6°C on a shaker overnight to facilitate 
the mixing and coating process which reduce beads sticking to each other and to the 
surface of chamber walls. On the day of the experiment, the preparation of the coated 
beads was centrifuged at 10,000g for 2 minutes, the supernatant was discarded and the 
pellet was re-suspended in 950μl of the washing solution (sEBSS + 0.02% Tween). The 
washing step was performed three times by centrifugation at 10,000g for 2 minutes and 
discarding the supernatant and re-suspending in the washing solution each time.  The 
washing steps before and after PS beads coating aimed to reduce the toxicity of the PS 
beads on sperm. Tween-20 as a surfactant also reduces the beads hydrophobicity. Finally, 
the PS beads were re-suspended in the final suspension solution (sEBSS + 0.3 % BSA). 
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All the preparation solutions (coating, washing and final suspensions) were prepared a day 
before the experiment. The PS beads solution was vortexed between washes as the PS 
beads tend to form a pellet which is trapped and do not mix with the added washing 
solutions. Figure 5-2 shows an image of sperm in LVM.   
The LVM was prepared using sEBSS which has a viscosity similar to water at 20 ̊ C of 
approximately 10 
-3 
Pa.s (Smith et al, 2009b).  Following the addition of the PS beads, the 
viscosity of the LVM was calculated using Einstein’s formula as follows:  
ηˆ ≈ η (1 + 2.5 φ)  
Where (ηˆ)  is the viscosity of the LVM containing PS beads, (η )is the viscosity of the 
sEBSS prior to the addition of the PS beads (10 
-3 Pa.s) and φ is the volume fraction of the 
PS beads in the preparation (The final concentration of the PS beads in the preparation was 
0.005% (v/v) since the original Ps beads preparation contains 10 % solids). 
ηˆ ≈ η (1 + 2.5 φ) =   
ηˆ ≈ 10 -3 ×  (1 + 2.5 × 0.005) ≈ 1.0125 × 10 -3  Pa.s (final viscosity of the LVM containing 
PS beads).  
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Figure 5-2 Image of sperm cells ≤ 2-10  in low viscosity media (LVM), PS beads’ 
diameter is 0.5µm) viewed in a 10 micron chamber under 40 × magnification lens.  
 
 
b-  Sperm preparation:  
All semen samples were obtained in accordance with HFEA Code of Practice in this 
project (see section 3.3.2 for semen collection procedure). The semen samples were left to 
liquefy for 30 minutes and the sperm cells were prepared by swim-up in sEBSS + 0.3 % 
BSA (section 3.4.7.2). Sperm concentration was adjusted by dilution in sEBSS + 0.3% 
BSA to obtain only ≤ 2-10 sperm cells per field of view.  The addition of BSA to the PS 
beads coating preparation and sperm solution may prevent the adherence of the PS beads 
and sperm cells to the chamber walls (Weibel et al., 2005). 
All the semen samples used in this study (both in LVM and HVM) were delivered to the 
laboratory within one hour of ejaculation.  Imaging and data analysis were performed on 
sperm from 15 donors. CASA machine (Hamilton-Thorne IVOS Version 10.9, Beverly) in 
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Birmingham women’s Hospital was used to evaluate the primary base-line for the sperm 
samples motility prior to subsequent experimentations.  
c- Chamber preparation: 
The capacity of each loading zone in the 10 μm chamber (figure 5-3) is only 2 µl.          
 1 μl of the prepared LVM (containing PS beads) was injected into one of the chamber’s 
loading zones immediately following PS beads preparation. 2-5 μl of sperm preparation 
was loaded at the open end of the chamber’s loading zone which has the beads loaded in.  
The sperm were left to swim into the chamber’s loading zone thereafter aided by capillary 
action and the excess solution was wiped off and the chamber loading zone was sealed 
with cristaseal.   
 
 
 
Figure 5-3  10 μm vertical depth chamber used in this study; A, B, C, D are the loading 
zones with loading capacity of 1-2 µl.  
 
d- Imaging 
Sperm cells were imaged using an inverted Olympus (Nikon TE200) microscope with 
positive phase contrast lens (40×) connected to a high-speed video camera (FASTCAM 
SA3, Photron), pixel size 17 µm. The imaging data was streamed directly to a Dell PC 
workstation. The microscope stage was kept at 37 °C by a LINKAM C0102 stage heater.   
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The recording of the movies was performed at a frame rate of 500fps (frame per second).  
The field of view was adjusted either to the full 1024×1024 pixel resolution and then the 
images were cropped using image J software or a region of interest were selected during 
the PIV data analysis.   In some movies, the resolution was adjusted to only include region 
of interest (ROI) for imaging sperm and to have longer time recording. Imaging and data 
analysis were performed on sperm from at least 15 donors; data presented in the results 
section were taken from eight representative sperm donors. 
5.3.2.2 Free motile sperm (≤ 2-5 sperm in the field of view) in high viscosity media 
(HVM): 
a- PS beads preparation in HVM  
The HVM was prepared by dissolving methylcellulose (MC) powder in sEBSS + 0.3% 
BSA to obtain 1% MC which has a viscosity of approximately 0.14 Pa.s which comparable 
to midcycle mucus (Smith et al, 2009b). Following the addition of the PS beads, the 
viscosity of the HVM (1% MC + PS beads) was calculated using Einstein’s formula as 
follows:  
ηˆ ≈ η (1 + 2.5 φ)  
Where (ηˆ)  is the viscosity of the HVM containing PS beads, (η ) is the viscosity of the 1 
% MC prior to the addition of the PS beads (0.14 Pa.s) and φ is the volume fraction of the 
PS beads in the preparation (The final concentration of the PS beads was 0.005% (v/v)). 
ηˆ ≈ η (1 + 2.5 φ) =   
ηˆ ≈  0.14  ×  (1 + 2.5 × 0.005) ≈    0.14175 Pa.s (final viscosity of the HVM + PS beads).  
The HVM was prepared in two different ways to overcome the problem of beads 
clustering following the addition of the methylcellulose powder to the sEBSS media and 
Ps beads.  In the first method, the PS beads were prepared and coated (according to the PS 
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beads preparation protocol in section (a) in 5.3.2.1 for LVM preparation).  On the day 
before the experiment, 0.01 g of MC powder was added to 1ml of the final solution of 
sEBSS + 0.3 % BSA containing suspended PS beads, mixed vigorously and left on a roller 
overnight in the cold room to mix homogenously.  However, this preparation resulted in 
the PS beads forming clumps after the addition of the MC powder (figure 5-4).  
 
 
Figure 5-4  Clumps formation following the addition of the methylcellulose powder to the 
PS beads preparation to obtain high viscosity media of 1 % methylcellulose + PS beads, 
this preparation was not utilised in the study. 
 
 
 
To overcome this problem, the PS beads were prepared in 2% MC and then adjusted to 1 
% MC as follows:  0.2g MC powder was dissolved in 10 ml of sEBSS + 0.3 % BSA and 
left  overnight in the cold room at 6 ̊ C to mix on a roller.  The PS beads were prepared 
according to the protocol (section (a) in 5.3.2.1) and left overnight to coat. On the next 
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day, equal volumes of PS beads solution and the 2% MC preparation were mixed to 
achieve the desired 1% MC viscosity + PS beads.  The new preparation was left on a roller 
overnight in the cold room to ensure homogenous 1 % MC with PS beads (figure 5-5). 
The prepared HVM (PS beads in 1% MC) were viewed under 100 × magnification to 
visualise whether the PS beads are moving within the preparation.  The HVM was also 
viewed on a slide with coverslip to confirm the beads were moving along with the fluid 
flow. Some degree of PS beads cluster formation was unavoidable; however, the second 
preparation technique reduced the PS clusters in the MC media and was used throughout 
the rest of this study in the HVM experiments. 
 
 
Figure 5-5 Improved HVM preparations with minimum clumps formation following the 
addition of PS beads solution to the  2% MC (methylcellulose) to achieve final 
concentration of 1% MC containing PS beads  
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b-  Sperm preparation:  
Sperm cells were prepared by swim-up into 1% MC prepared in sEBSS + 0.3% BSA + PS 
beads preparation (as above).  Several aliquots of 300 μl of liquefied semen was under-
layered beneath 700 μl of HVM (1% methylcellulose + PS beads) in 5 ml round bottom 
Falcon tubes and were incubated at 37°C and 6% CO2 for one hour. The motile fraction of 
the sperm were collected from the top 400 μl of the medium and transferred to a new tube.    
c- Chamber preparation: 
2μl of sperm prepared by swim up in HVM was injected into the loading zone of the 
chamber and any residue was left for sperm to swim into the loading zone of the chamber 
aided by capillary action. To avoid drying of the media containing sperm, the chamber 
preparation were left in a moist box in the incubator at 37 ̊ C and 6% CO2 and the number 
of sperm swimming into the chamber was checked after 5-10 minutes of loading.  The 
open end of the chamber’s loading zone was sealed by cristaseal after any excess fluid was 
wiped dry.  
d-  Imaging  
Similar to imaging technique in LVM, (section 5.3.2.1,  part d).  Imaging and data analysis 
was performed on sperm from 4 donors; data presented in the results section were taken 
from two representative donors. 
5.3.3 PIV data analysis: 
Representative movies were selected from LVM (8 movies) and HVM (4 movies) and 
were converted into image sequence using movie to image sequence code in MTALB and 
images were cropped or rotated using Image J software.  The sequenced images were 
loaded into PIVlab_GUI for analysis of fluid velocity and vorticity around motile sperm.  
Figure 5-6 illustrates the steps followed for the PIV data analysis.  
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Figure 5-6  PIV analysis workflow for fluid velocity and vorticity analysis. Recorded 
sperm movies were sequenced into images and the quality of the retrieved images was 
enhanced using pre and post-processing tools available in MATLAB built-in function.  
 
 
 
As shown in figure 5-6, each analysis step involves selection of data smoothing tools.  For 
example, in the pre-processing step three filters can be enabled to smooth the loaded 
images (figure 5-7 and 5-8). CLAHE (Contrast limited adaptive histogram equalisation) 
improves the readability of the image data by equalisation of light intensities on the 
different regions of the image (Thielicke and Stamhuis, 2014). The intensity high-pass 
filter allows the removal of background noise caused by inhomogeneous illumination of 
the images by eliminating any low frequency information (Shavit et al, 2007; Thielicke 
and Stamhuis, 2014).  While intensity capping filter prevents the high brightness in some 
areas of the image to cause bias in the analysis by selecting an upper limit of the greyscale 
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intensity which is applied as a threshold to adjust the image brightness (Shavit et al, 2007; 
Thielicke and Stamhuis, 2014).  These pre-processing tools were used to enhance the 
image quality and were applied to all the frames in each movie analysed in this study. 
 
 
 
 
Figure 5-7  Sperm in LVM, original image before and after pre-processing filters enabled. 
CLAHE (Contrast limited adaptive histogram equalisation) enables equalisation of light 
intensities on the different regions of the image. The intensity high-pass filter allows the 
removal of background noise while the intensity capping filter enables selection of  a 
threshold to adjust the image brightness.  
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Figure 5-8  Sperm in HVM (high viscosity media), original image before and after pre-
processing filters enabled (the function of the filters are illustrated in figure 5-7 in LVM)  
 
 
The PIV setting also enables selection of region of interest (ROI) from the full field of 
view (figure 5-9). The selection of ROI allows the analysis of one area (for example 
around single sperm ) within the field of view.  
 The calibration filters allow selection of a reference distance and real time. For calibration 
of real time and real distance in this study, 0.002 second and 0.000425mm (0.425µm) were 
used respectively. These measurements were based on the frame rate (500fps, 1frame takes 
0.002second) and the pixel size for the camera and lens magnification (17 microns (pixel 
size) / 40 × magnification = 0.425µm). The calibration step enables the velocity magnitude 
to be evaluated in m/second instead of pixel/ frame prior to the calibration. The analysis 
setting was saved and was used consistently among all the movies analysed in this study.  
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Figure 5-9  A- Selection of region of interest (ROI) from the full field of view in the 
original movie and B-  the analysis of the velocity magnitude based on the selected ROI. 
Sperm position is indicated on the velocity plot by illustration taken from the matching 
frame in the original movie. 
 
 
The command Fast Fourier Transform (FFT) enables cross correlation of the interrogation 
areas of each image pair to select the most probable particle movement in the analysed 
interrogation areas (Thielicke and Stamhuis, 2014).  For further details on FFT please refer 
to Thielicke and Stamhuis (2014).    
 In this study, FFT was used with 3 passes using an interrogation area of 64 × 64 pixels in  
pass1,  32 × 32 pixels in pass 2 and 16 × 16 pixels in the pass 3 (each pass with 50 % 
overlap between the neighbouring interrogation areas),  figure 5-10.  
 
A B 
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Figure 5-10  Fast Fourier Transform (FFT) with three passes and interrogation areas 
selected, pass 1 at 64 × 64 pixels, pass 2 at 32× 32 pixels and pass 3 at 16× 16 pixels (each 
pass with 50 % overlap between the neighbouring interrogation areas). The image was 
taken from sperm in HVM movie 2. 
 
The post processing filters aim to validate the data by the selection of velocity limits from 
the scatter plot which excludes any outliers from the analysis.  The interpolating missing 
data command enables replacement of missing vectors (the outliers which were removed 
in the validation step) by taking the nearest value to include in the data analysis and 
applying this to all the frames (Thielicke and Stamhuis, 2014).  
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Figure 5-11 An example of a scatter plot to select velocity limit and exclude any outliers 
which may affect the average value in the data analysis (velocity magnitude is shown in 
pixel/frame, prior to calibration).  
 
Following fluid velocity analysis, fluid vorticity was calculated using MATLAB built-in 
function.  For averaging the fluid vorticity around the motile sperm, a MATALAB code, 
created by Dr Hermes Gadelha, was used to estimate the average fluid vorticity along the 
sperm motility path across the image frames in each movie.  The colourmap in the 
software can be adjusted to enhance the final view of the averaged fluid vorticity aroun the 
motile sperm (figure 5-15 and 5-16, section 5.4). 
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5.4 Results: 
The results of this study were divided according to the viscosity of the media used in the 
experiments, either low (LVM) or high viscosity media (HVM) as follows:   
5.4.1 Results in LVM: 
5.4.1.1 Fluid velocity around motile sperm:  
Fourteen movies in LVM from ten donors were analysed and fluid velocity magnitude 
around motile sperm was evaluated in each movie. The data presented here are taken from 
eight representative samples. The fluid velocity around motile sperm in LVM was 
evaluated in the range of 25-45 µm/s across the repliacates. The colour codes in MATLAB 
software indicate the range of fluid velocity in the field of view and by comparing the 
original movie with the velocity magnitude analysis the area adjacent to the motile sperm 
can be determined (figure 5-12 and 5-13).  The fluid velocity in areas distant from sperm 
in these movies manifested lower range of ≤ 5 µm/s. To further confirm this observation, 
control areas where no sperm is present in the field of view were analysed to determine the 
fluid velocity in the absence of sperm.  The fluid velocity in the control area was in the 
reange of 0.5-4 µm/s (figure 5-14).    
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Figure 5-12  Fluid velocity around motile sperm coded in yellow colour shows a 
maximum velocity magnitude 4.5 × 10
-5 
m/s (45 µm/s). Minimum velocity was 5× 10
-6 
m/s 
(5 µm/s) in areas distant from the motile sperm coded in blue colour. The range of fluid 
velocity near a motile sperm in this movie was 30-45 µm/s. Sperm position is indicated on 
the velocity plot by illustration taken from the matching frames in the original movies. 
Data taken from LV8: low viscosity 8th movie with ≤ 2-10 motile sperm in the field of 
view. 
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Figure 5-13 Fluid velocity magnitude around single motile sperm in LVM at different 
frame points. Sperm position is indicated on the velocity plot by illustration taken from the 
matching frames in the original movie. Fluid velocity magnitude near motile sperm 
(yellow coded areas) in this movie ranged from 2.5 × 10 
-5 
m/s – 4 × 10 -5 m/s (25-40µm/s)  
. 
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Figure 5-14 Control area with no sperm in the field of view in LVM, the maximum 
velocity magnitude coded in yellow was 4 × 10 
-6 
m/s (4 µm/s) and the minimum was 0.5 
10 
-6 
m/s (0.5 µm/s)   
 
 
5.4.1.2 Fluid vorticity around motile sperm : 
By averaging the fluid vorticity over the frame range in the analysed movies, a trail was 
demonstrated (figure 5-16 and 5-17).  Using vorticity codes in MATLAB (created for this 
work by Dr Hermes Gadelha), a trail was visualised along the sperm swimming path in the 
LVM which decays rapidly in time once the sperm has moved past.  In movies where the 
whole field of view was imaged and analysed with single sperm in the field of view, the 
vorticity trail was only observed in areas where sperm have passed (along the sperm 
swimming path, figure 5-19) while areas with no sperm have no trail (trail LV1, figure 5-
16).   In movies with single sperm in the field of view and where a region of interest (ROI) 
232 
 
was selected, the trail was also observed to confine to the sperm path (trail LV2, figure 5-
16).   
Interestingly, in movies with only two sperm in the field of view, two trails were observed 
(trails LV3 and LV4, figure 5-15 and 5-16).  In movies with ≤ 2-10 sperm in the field of 
view, several trails can be observed (trails LV5 and LV6, figure 5-17).   To further 
confirm this observation (time-averaged fluid vorticity around motile sperm produce a 
trail), control area with no sperm was analysed to identify the average fluid vorticity in the 
absence of sperm. The time-averaged fluid vorticity in the selected control area did not 
show any trails (figure 5-18). 
In one of the movies (LV7), a single motile sperm in the field of the view was adhered to 
the slide and the average fluid vorticity around this sperm was confined to the vicinity of 
the sperm and the plotted trail was circumscribed area around the adhered sperm (trail 
LV7, figure 5-17).  In another movie where ≤ 2-10 sperm were in the field of view with 
one sperm adhered to the slide, the averaged fluid vorticity around the freely motile sperm 
showed trails while the averaged fluid vorticity around the adhered sperm showed 
circumscribed area similar to the one observed in the LV7 movie (trail LV8, figure 5-17). 
The MATLAB codes for fluid vorticity calculation are included in appendix 6.  The colour 
code represents the averaged vorticity for the movie sequence. To clearly visualise the 
formed trails in each data analysis, the colourmap bar was adjusted accordingly and 
therefore the colour scales change from one data set to another as seen in figures 5-15 and 
5-16. 
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Figure 5-15  The time-averaged fluid vorticity near motile sperm manifested as sperm 
trails along the sperm swimming paths. Trail LV1 is for a single sperm analysed in a full 
field of view, trail LV2 is for a single sperm analysed in a ROI, trails LV3 and LV4 for 
two sperm analysed in ROI and trails LV5 and LV6 are for ≤ 2-10 sperm in the full field of 
view, colour codes represent fluid vorticity around motile sperm measured in inverse 
seconds S
-1 
. 
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Figure 5-16 The same time-averaged fluid vorticity near motile sperm in figure 5-15 to 
show how adjusting the colormap bar in each data set will enhance the visualisation of  the 
averaged vorticity trails analysed.  
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Figure 5-17 Time-averaged fluid vorticity for a single sperm adhered to the surface of the 
chamber’s wall.  LV7: averaged vorticity trail manifested as a circumscribed area around 
the adhered sperm in LVM with single sperm in the field of view. LV8: averaged fluid 
vorticity around ≤ 2-10 sperm in the field of view with one sperm adhered to the 
chamber’s inner wall. The adhered sperm showed a circumscribed area for the averaged 
fluid vorticity similar to the one observed in LV7 while the freely motile sperm showed 
trails.  
 
 
 
Figure 5-18  Averaged fluid vorticity for control area with no sperm in the field of view in 
LVM, , no trail was manifested.    
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Figure 5-19  Sperm-motility path of a single sperm  A- Image 1, the first image in the 
original movie with sperm position highlighted in red, B- Image 1727, the last image in the 
image sequence with sperm position highlighted in red. C- The averaged fluid vorticity 
analysis over the whole frame range of image sequence; a fluid vorticity trail can be 
visualised along the sperm motility path (images were taken from movie LV1 in LVM).  
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Calculation of Brownian error : 
In the current study the effect of the Brownian error was substantially minimised by  the 
application of the cross correlation analysis of multiple  interrogation areas in the image 
pairs to identify the local displacement of the PS beads as shown in section 5.3.3.  
However, the realtive error caused by Browinian motion is a recommended consideration 
in studies using microparticle tracer particles to trace velocity of  >10 µm/s (Santiago et 
al., 1998).  Brownian error (εB) results from Brownian motion, a random thermal noise 
observed for the PS beads as they vibrate randomly (Santiago et al., 1998) even in the 
absence of any motile sperm (observed in the control areas with no sperm).   
To calculate εB  in the data the following equation  from Santiago et al (1998) and 
Wereley and Meinhart (2010) was used :  
𝜀𝑩 =
𝟏
𝐮
√
𝟐𝐃
∆𝐭
 
Where u is the local fluid velocity (calculated in this study 25-45µm/s); ∆𝐭 is the time 
interval (calibrated at 0.002 second) and D is the diffusivity of the PS beads given by the 
Stokes-Einstein equation: 
 
where kB is Boltzmann's constant (1.38 ×10
-23
 J/k)                                                               
T is the absolute fluid temperature (37 + 273 = 310 Kelvin (all experiments in the study 
were conducted on a stage heater at 37 ̊ C), π = 3.14 
 μ is the viscosity of the fluid (the viscosity of the LVM with PS was calculated as 1.0125 
× 10 
-3 
Pa.s) and dp is the diameter of the PS beads which is 0.5 × 10
-6 
m (0.5µm).   The 
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calculated Brownian error by the above equation for a maximum fluid velocity of 45µm/s 
in LVM was  = 2.1 % which is the relative error due to Browinian motion.  
 
Calculation of the Peclet number and diffusion coefficient for chemoattractants:  
The relevanace of the study of fluid vorticity and velocity around motile sperm may be 
significant for understanding sperm chemotaxis in vivo and for studies of chemical 
gradient assays in vitro.  To evaluate the relative importance of the sperm-driven fluid flow 
and diffusion in the current study, the Peclet number (a dimensionless ratio to illustrate 
relative significance of convection to diffusion (Huysmans and Dassargues, 2005) was 
calculated for some physiological ligands.    
Peclet number =  velocity × length scale/diffusion coefficient 
The diffusion coefficient for  progesterone is 6.88 × 10
-6  
cm
2
/s  (Seki et al., 2003) and the 
diffusion coefficient for bourgeonal (a sperm chemoattractant (Spehr et al, 2003) is 5.7 × 
10
-6  
cm
2
/s (Correia , 2011) (both in aqueous solution).  The lengthscale assumed in the 
model is the length of the oviduct (approximately 10 cm) and fluid velocity of 45 µm/s in 
LVM: 
Peclet number for progesterone = 45 × 10
-4  
cm/s × 10 cm /6.88 × 10
-6  
cm
2
/s  =  6.54 × 10
3  
 
Peclet number for bourgeonal =  45 × 10
-4  
cm/s  × 10 cm /5.7 × 10
-6  
cm
2
/s = 7.89 × 10
3  
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5.4.2 Results in HVM 
Fluid velocity magnitude near motile sperm in HVM was evaluated in the range of 20-35 
µm/s (yellow coded areas around motile sperm), figures 5-19 and 5-20.   
 
 
 
 
Figure 5-20 Fluid velocity magnitude around motile sperm coded in yellow colour shows 
a maximum velocity magnitude of 2.5 × 10
-5 
m/s (25 µm/s). Minimum velocity magnitude 
was < 5 × 10
-6 
m/s (5 µm/s) in areas distant from sperm, coded in blue colour. The range 
of fluid velocity near a motile sperm in this movie was 15-25 µm/s.  Sperm position is 
indicated on the velocity plot by illustration taken from the matching frames in the original 
movies. Data taken from HV4 movie with ≤ 2-10 sperm in the field of view. 
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Figure 5-21 Sperm velocity magnitude in HVM in the range of 20-30 µm/s in this movie. 
Sperm position is indicated on the velocity plot by illustration taken from the matching 
frames in the original movies, data  taken from movie HV2, ROI. 
 
 
Similar to the LVM, the range of the fluid velocity magnitude in HVM  was highest near 
the motile sperm and minimum in areas with no sperm (≤ 5 µm/s).  
The analysis of averaged fluid vorticity in HVM also demonstrated a trail created for the 
sperm swimming path in the fluid (figure 5-21).  The Browninan error was estimated for 
HVM (using the same equations in section 4.5.1 and changing fluid viscosity µ to 0.14175 
Pa.s, the estimated Brownian error was  = 21.8 %.  
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Figure 5-22 Averaged-fluid vorticity around motile sperm analysed in HVM;  trails HV1, 
HV3 and HV4 analysed with ≤ 2-10 sperm in the field of view while HV2 was analysed 
with a single sperm in the field of view  
 
 
Similar to averaged vorticity in LVM, single sperm produced one localised trail of 
vorticity (trail HV2, figure 5-22) and sperm of ≤ 2-10 showed multiple vorticity trails 
(trails HV1, HV3 and HV4, figure 5-22).  To clearly visualise the formed trails in each 
data analysis, the colourmap bar was adjusted accordingly and the colour bar scales change 
from one data set to another as seen in figure 5-22.  
Peclet number for sperm chemoattractant is also relevant in HVM, however, the diffusion 
coefficients of progesterone and burgeonal was only available in aqueous solution and not 
viscous ones.   
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5.5 Discussion:  
This study is the first to our knowledge to examine human sperm motility from this 
perspective of fluid vorticity and mixing using PS beads as tracing micro-particles.   The 
current study investigated fluid velocity and vorticity around motile sperm imaged in a 10 
μm chamber in low and HVM.  This study’s preliminary results indicated that sperm cells 
move with minimal mixing of their fluid surrounding and.  The observed fluid motion or 
‘mixing’ around the motile sperm was localised spatially to the vicinity of the sperm body 
and when averaged across the sperm path a trail was observed.  
 Both free single sperm and a small population of sperm (≤ 2-10 in the field of view) were 
imaged and fluid vorticity around their trajectory was investigated.  Studies of single-cell 
biomechanics has been shown as a valuable approach for exploring the cell’s response to 
modulation in the surrounding environment (Kohles et al., 2007, Nève et al., 2008).   
Although the results of the study are preliminary, this work may serve as a platform for 
future studies employing high frame rate imaging to explore how sperm affect the fluid 
environment around them in vitro.    The first observation in this study was that, sperm do 
not cause major disturbance in the fluid environment around their swimming trajectory. 
The fluid mixing is also observed to be restricted to the sperm immediate vicinity as 
illustrated by the “trail” of fluid vorticity.  The averaged vorticity trails formed by the 
motile sperm observed in the current study may imply the locality of the fluid mixing 
exerted by the motile sperm.  These observations could be significant for reproductive 
phenomena such as chemotaxis, as sperm moving with minimum mixing may maintain 
any established chemical gradients.  In some marine species, it has been observed that the 
fertilisation success is largely linked to the relationship between chemical signals and fluid 
flow, which regulates the sperm-egg encounter rate (Zimmer and Riffell, 2011).              
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The significance of the identified fluid “trail” formed by the human sperm in the current 
study may link to maintenance of minimum disruption to established chemotactic gradients 
traversed by sperm. Further inferences may require additional studies.    
No previous studies have explored fluid mixing caused by human sperm. PIV studies of 
fluid mixing have been applied in some marine species to explore biogenic mixing, a 
phenomenon described for motile macroscopic organisms to enhance nutrients and other 
materials transport in the environment, for example in oceans (Kurtuldu et al., 2011, Katija 
and Dabiri, 2009).  On microscopic level, local mixing has been described for flagellated 
microorganisms such as chlamydomonas for optimum nutrient uptake and transport (Tam 
and Hosoi, 2011, Short et al., 2006).  
The limited understanding of the mechanical impact of motile human sperm on the fluid 
milieus within the FRT and scarcity of sperm models looking at the potential roles of this 
mechanism were the main motivations for this study.   Fluid mixing or stirring could be 
relevant for chemotactic response which has been observed for human sperm (Spehr et al., 
2003, Eisenbach and Giojalas, 2006). Sperm chemotaxis in the vicinity of the COC has 
been suggested as an important guide mechanism to direct sperm to encounter the oocyte 
(Cohen-Dayag et al, 1995, Fabro et al., 2002; Eisenbach, 2004).  The local sperm mixing 
action on the fluid environment observed in this study with no large scale disturbance 
could be significant for sperm swimming through, for example hFF or progesterone 
hormone, on their way to the oocyte.    
The calculation of the Peclet number of both progesterone and burgeonal showed both 
sperm chemoattractant have high Peclet numbers ( > 1-2) which suggests that mixing at a 
distance of 10cm in LVM is negligible. However, since chemotaxis is shown to be relevant 
in the vicinity of the COC (Eisenbach, 2004, Eisenbach and Giojalas, 2006), the 
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calculation requires estimated distance from the COC when sperm chemotaxis is operating 
which is not available in the literature and the diffusion coefficient of both chemoattractant 
should be in viscosity comparable to oviductal fluid. 
The study of fluid mixing may also be relevant to investigate the influence of motile  
sperm on each other in terms of navigating their way through the same fluid gradients.  
The minimum mixing of the fluid environment by the vanguard sperm (the sperm in the 
frontline population), may maintain any chemical gradient for the following sperm to swim 
through in their journey toward the fertilisation site.  For example, progesterone, which has 
been shown as an important chemoattractant factor for sperm (Serrano et al., 2001, Teves 
et al, 2006) may exist in a gradient concentration in the fluid environment in the oviduct 
(released from COC and present in hFF (Uñates et al., 2014).  This negligible mixing of 
the environment observed by the low vorticity and confined trails evaluated in this study 
may indicate that there is minimum perturbation of the fluid during sperm journey which 
commences with large numbers of sperm and may end with only few near the fertilisation 
site (Williams et al, 1993).  The averaged fluid vorticity over the image sequenced movies 
demonstrated a trail which may indicate the localised effect of motile sperm on the 
surrounding fluid which also disappears near instantaneously once the sperm has moved 
on.   
The study of sperm motility from the point of view of fluid vorticity may be vital for 
research into chemotaxis and other aspects of fluid flow and rheotaxis.  In vivo, sperm 
motility is modulated by several factors such as boundary constraints, the viscoelastic 
properties of the FRT secretions and their flow and the epithelial lining of the tract (Katz et 
al., 1989). Therefore, fluid mechanics is a relevant aspect to study sperm motility 
behaviour and this approach has been applied in several studies in reproductive biology 
245 
 
(Smith et al, 2009a, Gaffney et al, 2011, Hyun et al, 2012, Miki and Clapham, 2013, 
Eamer et al, 2015). Such studies require interdisciplinary teamwork and application of 
techniques from both reproductive biology and mathematics. The high complexity of the 
techniques applied and the requirement of mathematical data processing in such studies are 
sometimes challenging.    
In addition to investigating fluid vorticity, velocity magnitude around human sperm was 
also considered in both LVM and HVM in this study.  Fluid velocity around motile sperm 
was evaluated to be 25- 45 µm/s in LVM and 20-35 µm/s in HVM.  The lower average 
values in the HVM could be attributed to the reduced PS bead motion with the fluid flow 
after certain periods  particularly in the HVM as illustrated below. 
The solid boundary created by the 10 μm chamber surfaces are also known to constrain the 
fluid motion generated by the sperm swimming near the chamber surfaces (Barratt et al., 
2011).  This boundary effect is complicated with several aspects including the tendency of 
sperm cells to swim near surfaces (Smith et al., 2009a) and also to the restrained flagellum 
active thrust due to constrained sperm head movement caused by increased passive 
resistance (Zhu et al., 1994, De Jonge, 2005).  
Methylcellulose, which is an inert, non-toxic synthetic viscoelastic fluid medium, was used 
in this study to mimic the high viscosity fluid encountered by the sperm in the FRT. 1% 
methylcellulose preparation has been shown as a good analogue to peri-ovulatory cervical 
mucus ((Smith et al., 2009b, Ivic et al., 2002).  However, the procedure of mixing the PS 
beads with the methylcellulose for HVM preparation was problematic as the PS beads tend 
to stick to each other and form clumps which did not follow the fluid flow faithfully in 
some settings. The hydrophobic characteristic of the polystyrene beads causes non-specific 
binding due to hydrophobic interactions or the charge-based interactions (Kim et al., 
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2004).  The PS beads were moving along with the fluid flow, however, some degree of 
beads clumping was unavoidable, but was minimised (as shown in the methodology 
section 5.3.2.2, part a). Coating the PS beads with BSA was based on simple adsorption 
which prevents non-specific binding and enables minimising the beads sticking to each 
other and prevents adherence of the beads to the surfaces of the chamber (Weibel et al., 
2005). The successive washing steps of the PS beads also aimed to reduce any toxicity for 
the sperm cells.The lack of evident movement of the PS beads in the HVM  under the 40 ×  
lens could be anticipated due to the increased viscosity which causes the thermal 
movement to be damped.  However, under higher magnification, the PS beads were 
confirmed to be moving with the fluid flow.   
Discussion of the methodological choice, strengths and limitations of the study: 
In this study, both low and high viscosity media were utilised to study fluid velocity and 
vorticity around motile sperm. The study of sperm motility in HVM is highly relevant to in 
vivo sperm modulations and natural conception (Smith et al, 2009b).  In fluid dynamic 
studies of sperm, the use of HVM setting is recommended (Smith et al., 2009b, Zimmer 
and Riffell, 2011) since sperm in the FRT encounter highly viscous fluid environments 
(Katz et al, 1989; Suarez and Pacey, 2006). The viscosity of human FRT fluids is 
estimated in the range of 1.7 Pa.s (1700 centipoise) and above (Hyun et al., 2012, Tam et 
al., 1980). Nonetheless, study of sperm motility in LVM is also vital to understand sperm 
motility modulations in vitro and probably in FF at ovulation (Smith et al, 2009b). 
 
The size of the used PS beads in this study was 0.5 µm which is both sufficiently small to 
follow the flow and yet can be visualised under microscope. It has been suggested that the 
smaller the beads compared to the scale of the flow the better the beads follow the fluid 
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flow in a reliable manner (Sharp and Adrian, 2005).  On the other hand, the beads have to 
be sufficiently large to be visualised and imaged under microscope and also reduce errors 
caused by Brownian motion (Wereley and Meinhart, 2010).  It has been suggested that 
Brownian error is a significant consideration for particles with 50 to 500 nm diameter with 
velocity flow of approximately 1 × 10
-3 
m/s (Wereley and Meinhart, 2010).  In the current 
study the Brownian error was calculated as 2.1%, however, as discussed earlier, this figure 
was not considered in the data analysis based on the validation steps taken during data 
analysis using FFT correlation. 
One of the limitations of the study is the tendency of the number of moving PS beads to 
decrease with time even in the LVM, therefore, immediate imaging was aimed after each 
chamber preparation in both types of media as well as using a new chamber with PS beads 
preparation vortexed immediately before loading the chamber. The addition of the PS 
beads to the media also increased the viscosity of both LVM and HVM as seen in the 
calculations of media viscosity following Ps beads addition in the methodology section 
which also reduced the beads movement.   
In addition to the reduced movements of the PS beads after some time of the chamber 
preparation, the background noise caused by the Brownian motion of the PS beads was 
another consideration during data analysis. The impact of the Brownian motion was 
minimised by both obtaining the average of numerous particles in each interrogation area 
and averaging of multiple calculations of the velocity magnitude (Thielicke and Stamhuis, 
2014).   Three passes using an interrogation area of 64 × 64 pixels in  pass 1,  32 × 32 
pixels in pass 2 and 16 × 16 pixels in the pass 3 (each pass with 50% overlap between the 
neighbouring interrogation areas) were applied, (see figures 5-1 and 5-10).  Additionally, 
the velocity magnitude was plotted as an average over the whole frame range in each 
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movie and the fluid velocity magnitude presented was an average over eight movies in 
LVM and 4 movies in HVM.  In PIV analysis, the correlation analysis is important since 
identification of the exact particle displacement for the many thousands of PS beads 
between frames is impossible (Thielicke and Stamhuis, 2014).  In this study, correlation 
was performed using Fast-Fourier Transform (FFT) algorithms.  
During the analysis process, several filters were used to smooth and validate the data at 
every step of the analysis using the software (as shown in the figures 5-6, 5-7, 5-8, 5-9, 5-
10 and 5-11).  The data smoothing filters were used to minimise the background noise 
caused by Brwonian motion and to ensure data validation. These filters enabled the 
acquisition of applicable results for the  fluid velocity and fluid vorticity near the motile 
sperm in the PIV analysis.  The advantage of using fluid vorticity along with the velocity 
analysis is that fluid vorticity is not affected by the time and distance calibration from one 
movie to another as vorticity expresses local rotation of the fluid. In future studies, the 
µPIV technique may be further validated on larger scales in other studies to use on models 
for calculations of fluid vorticity around sperm.   
In addition to viscosity, the velocity of the sperm has been shown to be highly temperature 
dependent (Esfandiari et al., 2002, Appell and Evans, 1977, Milligan et al., 1978).  In this 
study, the stage heater was maintained at 37°C throughout the experiments included in the 
data analysis to ensure optimum physiological conditions for sperm motility.  Nonetheless, 
some studies have suggested a decrease in the viscosity of the methylcelluose  media when 
temperature is increased (Hyun et al., 2012).  In this study, MC was prepared at room 
temperature with estimated viscosity 0.14 Pa.s at 20°C.  
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The flagellar beat frequency in human sperm has been linked to the viscosity of the media 
surrounding the swimming sperm and has been estimated as 10-20 Hz (Smith et al. 
2009b).  Fluid viscosity has also been suggested to cause pivotal effects on sperm motility 
and flagellar waveform (Hyun et al, 2012, Smith et al, 2009b, Eamer et al, 2015).  A study 
investigating the effects of high viscosity media on sperm motility’s energetics suggested 
that fluid viscosity influences the mechanical aspects of sperm motility and not the 
molecular pathways involved in its energetics (Hyun et al., 2012).  Increased viscosity is 
associated with increased frictional forces and suggested to decrease sperm curvilinear 
velocity (Hyun et al, 2012) and decrease flagellar wave amplitude (Eamer et al, 2015), 
however, in this study, these parameters have not been examined.  Other studies looking at 
the effect of viscoelastic fluids on two dimensional sheet swimmers indicated that the 
response of the viscous fluid may enhance the velocity of the swimmer in a mechanism not 
fully understood (Montenegro-Johnson et al., 2013, Teran et al., 2010). 
While sperm are shown in this study to cause spatially confined mixing or stirring of the 
fluid around them, the mechanical influence of the fluid has also been suggested in other 
studies to guide steering of sperm on large-scale distances (Miki and Clapham, 2013).   
Therfore, while sperm are stirring the fluid, the fluid is steering the sperm to guide them in 
their journey toward the oocyte.  This study’s preliminary results indicated that sperm cells 
move with minimal mixing of their fluid surrounding which was spatially localised to the 
vicinity of the sperm body. 
   
Future research and recommendations 
In the current study, fluid vorticity around freely motile sperm with progressive motility 
were investigated.  In prospective studies, it is worth considering fluid vorticity around 
250 
 
sperm with hyperactivation, which manifest vigorous asymmetric flagellar beating (Suarez 
and Ho, 2003).  Comparison of the fluid mixing patterns caused by both types of motility 
(progressive and hyperactivated) may enable elucidation of the different roles of both type 
of motility in fertilisation (for example in chemotaxis). A study modelling tethered sperm 
has investigated the role of hyperactivated motility in sperm escape from the oviduct 
epithelial surfaces (Curtis et al., 2012). The study revealed that hyperactivated sperm may 
exert stronger force which enables sperm to be released from the oviductal epithelium 
(Curtis et al., 2012).   
 Modelling of tethered sperm in HVM may represent similar setting to sperm bound to the 
oviductal epithelium reservoir which has been described for mammalian sperm (Suarez et 
al., 1991a, Reeve et al., 2005). The formation of the functional sperm reservoir is 
suggested to be facilitated by the high viscosity of the oviductal fluid which counteracts 
the progressive sperm motility and assists sperm attachment and adhesion to the epithelial 
lining of the oviduct (Hunter, 2008).  Nonetheless, modelling of sperm may require the 
consideration of numerous factors involved in sperm motility modulation including fluid 
flow created by ciliated epithelia, boundaries effect, muscular contractions along with 
rheotaxis and non-Newtonian fluids (Winet et al., 1984).  It is, therefore, challenging to 
model sperm in vitro and apply the results to in vivo sperm behaviour.  Studies of sperm 
fluid dynamics may eventually enable the design of microfluidic device for sperm 
selection for IVF according to sperm velocity (Eamer et al, 2015).    
Another aspect which has not been studied extensively is the hydrodynamic interaction of 
a population of human sperm in terms of synchronisation (Woolley et al., 2009) and 
altruism (Pizzari and Foster, 2008).  In wood mice sperm, the apical hook on the head has 
been shown to become hooked to the neighbouring sperm flagellum or apical hook in the 
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fertilisation media forming clusters of hundreds of sperm (Moore et al, 2002, Fauci and 
Dillon, 2006, Pizzari and Foster, 2008). This phenomenon is described as “sperm trains”, 
which is suggested to enhance the wood mice sperm velocity (Moore  et al, 2002, Pizzari 
and Foster, 2008).  Although human sperm lack hooks, the possibility of other mechanisms 
of cooperation is still possible and requires further research. Future studies considering 
human sperm synchronisation may investigate fluid vorticity created by synchronised 
sperm and their effect on sperm chemotaxis.  
This study presented a new perspective of mechanical aspects of human sperm motility 
and indicated the importance of multidisciplinary research in understanding sperm 
fertilisation. 
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253 
 
General discussion  
The sperm journey through the female reproductive tract (FRT) is not merely a passive 
passage, but is an interactive process in which sperm cells interact with the FRT’s 
epithelial lining and secretions (Yeung et al., 2009, Suarez, 2016). The research presented 
has investigated certain aspects of sperm-FRT interactions including at both the molecular 
and physical/mechanical levels, figure 6-1.   
Sperm modulation by the environmental milieu of the FRT during capacitation, motility 
and oocyte interaction are differing aspects of molecular sperm-FRT interaction.  Sperm 
cells may also interact in the reverse direction with the FRT by releasing certain 
substances or metabolites that may elicit chemical signalling relevant to fertilisation 
(Connolly, 2012) or later events.  The FRT of a number of non-primate mammals has been 
shown to respond to the presence of sperm by the release of complex combination of 
proteins and hormones, which play roles in sperm regulation and preparation for 
fertilisation (Suarez, 2016).   Finally, physical modulation of the sperm’s migration may 
occur for numerous reasons including: orientation along the complex geometry of the 
FRT; sperm  response to the fluid flow induced by the ciliary beat; and changes in the 
viscoelastic secretions in which sperm migrate through the tract (Suarez, 2016).   
Characterisation of hFF proteome was the first stage of this research.  hFF is a highly 
complex body fluid surrounding the oocyte, through which a fertilising sperm will pass 
and which proceeds ahead of the ovulated oocyte through the female tract. 
A combination of proteomic approaches were applied in order to tackle the challenge of 
the high dynamic range of hFF proteins and to achieve better detection of low abundance 
proteins.  This study applied solid phase extraction, high abundance proteins depletion and 
filtration/concentration of the depleted hFF coupled with high performance liquid 
254 
 
chromatography/mass spectrometry for thorough proteomic analysis. A total of 479 
proteins were identified compiled from both crude and depleted hFF samples with 103 
novel hFF proteins added to the repertoire.  Most recent hFF proteomic studies have 
applied a combination of proteomic techniques (Hanrieder et al., 2008; Hanrieder et al., 
2009; Jarkovska et al, 2010; Bianchi et al, 2013, Ambekar et al., 2014; Zamah et al., 2015) 
to achieve better hFF proteins identification.  The results of this study in terms of number 
of identified proteins is similar to other recent hFF studies which identified a range of 240 
to up to 770 proteins in the hFF with at least one third novel proteins identified (see table 
2.1, chapter 2 for further details).  This may highlight the high variety of hFF proteins and 
the significance of the application of a combination of proteomic techniques to study hFF 
proteins (Twigt et al, 2012). 
Some of the novel hFF proteins identified in this study are members of protein families 
with the other members being identified in previous hFF proteomic studies. For example,   
annexin A1 from the annexins family was identified for the first time in this study while 
annexins A2, A4, A5, A6 and A10 have been previously detected in hFF (Zamah, et al, 
2015; Angelucci et al, 2006; Ambekar et al, 2014).  This observation may indicate the 
significance of compiling hFF protein data from several hFF studies and to work toward 
the complete hFF proteome for better understanding of the functions of these hFF proteins 
in reproduction (Zamah, et al, 2015). Therefore, along with the protein data identified in 
this study, hFF proteins from 24 published studies were also compiled. The compiled hFF 
proteome from the literature resulted in 1586 hFF proteins presented in a table with their 
UniProt accession numbers and references of the studies detected them.  This hFF protein 
table provides a resource for future research into folliculogenesis, discovery of biomarkers 
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for oocyte quality, study of fertilisation environment and potential improvements in IVF 
media used in assisted reproductive techniques. 
The study of the hFF proteome is not only relevant for biomarkers of oocyte quality but 
also to sperm as sperm is exposed to hFF in the ampulla just prior to fertilisation.  The 
relevance of this exposure is seen in different aspects of sperm functions (as summarised 
in chapter 1, section1.5) 
Brewis and Gadella (2010), suggested that prior proteomic study of the fluid milieus sperm 
encounter in male and female reproductive tracts may be beneficial in evaluating their 
influence on sperm surface proteins since proteins and other factors from these milieus 
may induce alteration of sperm surface protein composition and organisation (Brewis and 
Gadella, 2010).  In the current work this strategy has been followed, hFF proteomics being 
characterised prior to examination of sperm-hFF proteomic interaction. 
A comparative proteomic study of sperm incubated in capacitation media alone and sperm 
incubated in capacitation media along with hFF was conducted to investigate whether 
sperm may acquire hFF proteins.  Sperm are transcriptionally and translationally inactive 
and therefore may rely on other sources of proteins to achieve maturation and fertilisation 
(Miller et al., 2010, Oliva and Castillo, 2011) or to survive for long periods of time. In this 
study, sperm were incubated with and without hFF in capacitation media and two 
analytical approaches were applied.  The total binding protein approach allowed the 
analysis of the total sperm + hFF protein sample preparation with high number of soluble 
sperm proteins being identified and therefore sperm + hFF membrane-associated approach 
was designed aiming to identify sperm loosely-associated surface membrane proteins 
along with newly bound hFF proteins.  
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During the comparative protein data analysis, the compiled hFF proteome table (generated 
from 24 hFF proteomic studies in the literature and hFF data in this work) was used to 
compare protein data from the sperm + hFF samples to identify any hFF protein in the data 
set.  Twenty-four hFF proteins, never previously identified in sperm, were found in the 
sperm + hFF samples. The results of this study, therefore, suggest that sperm may acquire 
proteins from hFF and their putative effects warrant further study into their role in sperm 
functions.  The identified hFF proteins in the sperm + hFF samples may also be relevant 
for future studies interested in purifying relevant hFF proteins to prepare media either for 
IVF or increasing the longevity of sperm.  The possible roles of the putative hFF proteins 
identified in this study on sperm may involve complement regulation mechanism to protect 
sperm against damage caused by the immune response in the FRT, protection of sperm 
from oxidative damage by the antioxidant properties of some of these hFF proteins and 
enhancement of cholesterol efflux and sperm membrane fluidity important for 
capacitation.  In addition to the detection of the hFF proteins in the sperm + hFF proteomic 
study, 63 novel sperm proteins were also identified in this study that add new proteins to 
the characterised human sperm proteome.   
The next objective of this work was to conduct a comparative metabolomics study to 
investigate the human sperm metabolites released during sperm capacitation of 6 hours and 
those present prior to sperm capacitation (1h swim-up). An untargeted metabolomics 
technique using UPLC-MS analysis was applied to characterise, for the first time, the 
human sperm metabolites in two preparations. The choice of using untargeted 
metabolomics approach was to obtain a global view of the metabolites released/consumed 
in sperm capacitation media since this is the first study, to our knowledge, to investigate 
human sperm metabolomics.  The capacitation media utilised and the incubation time of 6 
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hours were selected to best mimic physiological conditions in the FRT.  Two hundred and 
three metabolites were detected in this study with fatty acids, oxidised fatty acids and 
peptides being among the main groups of metabolites identified. Sperm releasing certain 
metabolites while consuming others during in vitro capacitation may be relevant to sperm 
capacitation in the FRT. Although the results of the current sperm metabolomics study are 
preliminary, it shows validity and promise for its use in further research exploring sperm 
metabolism. The detected sperm metabolites are also relevant to research into sperm 
signalling in the FRT.  Previous work in our group has shown that sperm trigger calcium-
signalling in oviductal tissue and that whatever induces this signal is a diffusible 
messenger released by sperm during capacitation (Connolly, 2012).  The current work has 
identified some of the metabolites, which are produced by the sperm into their surrounding 
media during capacitation, a key next stage would be to examine the effect of these 
metabolites upon the female tract at relevant concentrations to discover whether any 
signals are induced. The significance of sperm signalling observed in Connolly (2012) to 
changes in the endometrial proteome and preparation for implantation may require further 
research.  In murine species, it has been shown that signalling induced by seminal plasma 
may influence implantation and future child health (Robertson, 2014, Schjenken and 
Robertson, 2015).  
The next aspect that was investigated in this work was fluid velocity and vorticity around 
human sperm in both LVM and HVM.  The physical aspects of human sperm motility are 
relatively overlooked with most studies focusing on the molecular and biochemical 
characterisation of sperm motility (Smith et al, 2009b).  Sperm migration in the FRT may 
introduce mixing of the fluid in the tract, which may have relevance in terms of studying 
chemotaxis and other aspects of chemical and mechanical sperm-FRT interactions.  The 
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currently available knowledge of whether sperm cause any perturbation or mixing of the 
fluids they swim through is almost unknown and was the main motivation for this study.  
This work was the first to our knowledge to investigate the effects of human sperm 
motility from the perspective of fluid velocity and vorticity in LVM and HVM. In 
collaboration with mathematicians, the application of µPIV using MATLAB and 
PIVlab_GUI programes enabled the study of fluid velocity and vorticity around motile 
sperm.  In this study, sperm were shown to cause minimum perturbation to the fluid 
surrounding them while migrating in a confined space represented by a 10-micron 
chamber.  A trail was demonstrated, for the first time in this study, by averaging the fluid 
vorticity around the motile sperm along their migration path using MATLAB codes 
developed for this work.  The sperm trails may signify the locality of the sperm mixing 
effect on the fluid surrounding them. This observation may be relevant to sperm 
chemotaxis and to sperm’s ability to only cause minimum mixing of any established 
chemotactic gradient in vivo in the vicinity of the COC. Fluid velocity around motile 
sperm was also investigated and the average fluid velocity was 25-45 µm/s in the LVM 
and 20-35 µm/s in the HVM.  
In conclusion, the study of sperm and FRT interactions needs to involve both physical and 
molecular aspects to illustrate the different impacts of these factors on sperm fertilisation 
capability (as also suggested by Suarez, 2016).  
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Figure 6-1 Some of the different aspects of sperm and FRT interactions. 1- hFF is released 
along with the COC at ovulation  2- hFF proteomic analysis was conducted in this work 
and identified 479 proteins  3- sperm + hFF proteomic interactions with hFF proteins 
acquired by sperm and their relevance to sperm modulation 4- Sperm metabolomics and 
the relevance of sperm metabolites to FRT signalling  5- Sperm µPIV and its relevance to 
chemotaxis   
 
Future work: 
Several studies have considered hFF proteins, however, the ideal hFF proteomic profile 
which may enable prediction of best oocyte quality and IVF outcome is yet to be 
characterised (Benkhalifa et al., 2015). The high dynamic protein range and the presence 
of HAPs which may hinder the detection of follicle-specific proteins in hFF may limit 
protein biomarkers detection (Bianchi et al, 2013).  Additionally, another challenge in the 
study of hFF proteomic is to progress from lists of detected proteins to a more advanced 
understanding of molecular function (Twigt et al, 2012).   Future studies exploring hFF 
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proteomics may take advantage of the growing field of metabolomics and combine hFF 
proteo-metabolomics analysis.   
Recently, coupled proteomic and metabolomics analysis of human sperm extract revealed 
interesting relationship between the proteomic profile of sperm and their metabolites in 
normozoospermic and asthenozoospermic samples (Paiva et al, 2015).  A similar approach 
could be applied in hFF analysis, hFF metabolomics profiling as has already been 
suggested as a promising future approach in clinical practice for the evaluation of oocyte 
developmental potential prior to IVF (McRae et al., 2012, Xia et al., 2014). Coupled with 
advanced proteomic techniques, hFF metabolomics analysis may enable the detection of 
the best oocyte quality for IVF (McRae et al, 2012).   
The majority of hFF studies support the concept that steroid hormones in hFF, mainly 
progesterone, are responsible for the observed effects of hFF on sperm function (Morales 
et al., 1992, Fabbri et al., 1998).  This work has revealed that some hFF proteins may bind 
to sperm following incubation and therefore we suggest that these proteins may have 
relevance to the different aspects of sperm functions including acquisition of fertilisation 
competence and longer sperm survival. Future work investigating the effects of, for 
example, purified hFF proteins in the presence versus in the absence of progesterone on 
sperm functions may reveal new insights of the role of hFF proteins in sperm fertilisation.  
The role of hFF protein in sperm fertilisation may also be relevant to the discovery of new 
targets for male contraception. In this study, sperm incubated with hFF was investigated in 
the view of whole sperm proteome and membrane-associated proteome.  Future studies 
may apply subcellular proteomics to study sperm and hFF interactions on the level of, for 
example, the sperm acrosome, head and flagellum. While such studies may be technically 
challenging and time-consuming (Brewis and Gadella, 2010; Amaral et al, 2014a), they 
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may enable localisation of any binding sites of hFF to sperm and provide more insights of 
the functional roles of the bound hFF proteins in sperm fertilisation capability.  The 
subcellular proteomic approach may also enable the identification of low abundance hFF 
proteins which bound to sperm and may not be detected in whole sperm proteomic 
analysis. A further advantage of subcellular sperm proteomic is the reduced sample 
complexity and   better detection of low abundance sperm proteins (de Mateo et al., 2011; 
Amaral et al., 2013).     
In this work, comparison of sperm metabolites from normozoospermic samples following 
1h swim-up and 6h capacitation was conducted. Future studies may consider differences 
between human sperm metabolome in fertile and infertile subjects which may enable the 
discovery of certain male infertility biomarkers. Currently, only one study has applied 
comparative analysis of sperm metabolomics in normozoospermic and asthenozoospermic 
samples with initial results indicating an overall lower concentration of the identified 
metabolites in the asthenozoospermic samples (Paiva et al, 2015). 
Study of the effect of different environmental factors such as smoking, diet and physical 
exercise on the pattern of human sperm metabolomics may also provide insights into the 
effects of the different environmental factors on male fertility.   
The examination of the signalling effect of the sperm metabolites identified in this work on 
the female tract cells would be the next stage of this research. As described by Connolly 
(2012), a signalling response was elicited in an oviductal tissue extract following its co-
incubation with sperm. If a metabolite(s) was identified which caused similar tract 
signalling, a randomised clinical trial of infusion of the sperm metabolite(s) to the uterus 
and evaluation of implantation rates and pregnancy success rates may enable better 
understanding of the role of sperm metabolites in human reproduction and open up an 
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exciting new therapy. This would have particular significance as the Robertson’s group 
data(Robertson, 2007, Robertson et al., 2006a, Schjenken and Robertson, 2015) may 
suggest it would improve the health of children being born not just a treatment success 
rate.   
The mechanical aspects of sperm motility in terms of perturbing chemical gradients such 
as hFF, progesterone or other relevant fluid in the FRT has gained little attention in the 
literature.   Future studies exploring the fluid vorticity and the effects of motile sperm on 
an established gradient of, for example, hFF or progesterone are therefore recommended.  
Sperm stirring and the role of sperm population in causing mechanical changes in the FRT 
fluid and the impact of such type of hydrodynamic interaction on fertilisation rates have 
not been explored in human sperm. Future studies applying µPIV to explore the 
relationship between fluid flow, sperm chemotaxis and rate of fertilisation may be relevant 
to in vivo conception. The rate of fertilisation success in some marine species has been 
highly linked to sperm-oocyte encounter regulated by fluid flow and chemotaxis (Zimmer 
and Riffell, 2011).  In humans, sperm chemotaxis to hFF has been correlated to oocyte 
fertilise-ability (Ralt et al, 1999). Nonetheless, the roles of fluid flow and sperm 
mechanical motility on sperm- oocyte encounter and fertilisation rates have not been 
thoroughly investigated.  
Development of virtual sperm models which respond to the signalling and variation of the 
FRT’s ambivalent microenvironments in comparable way to the in vivo sperm is the 
ultimate goal of multidisciplinary research in reproduction and mathematics (Gaffney et al, 
2011).   In this work, a 10-micron glass chamber was used to investigate sperm velocity 
and fluid vorticity.  For future studies, it may worth applying micro-channels with elastic 
walls, which may mimic the microenvironment in the FRT to better model sperm in in 
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vitro studies.  An elastic silicon-based polydimethylsiloxane has been used recently to 
create micro-channels to study sperm swimming behaviour near surfaces (Denissenko et 
al., 2012). The elasticity of such chambers may provide better resemblance to the in vivo 
epithelial surface in the FRT (Suarez, 2016).  Another microfluidic model has been 
developed to simulate the fluid flow and the micro-crypts of the FRT to study the effects 
of the FRT biophysical characteristics, mainly fluid flow and microgrooves on sperm 
migration (Tung et al., 2014, Tung et al., 2015). The advancement in understanding of 
sperm fluid dynamics may enable the design of sperm-sorting micro-devices for the 
selection of competent sperm based on sperm motility (Seo et al., 2007, Shao et al., 2007, 
Gaffney et al., 2011). 
To the best of our knowledge, this work is the first to conduct a comparative proteomic 
analysis of human sperm versus sperm-hFF interaction and to perform a metabolomics 
analysis of human sperm’s capacitation media at two time points. As knowledge of sperm 
regulation in the female tract advances, possible new approaches for male infertility 
diagnosis based on sperm metabolic profile and/or the pattern of sperm proteomic 
interactions with the FRT secretions may be developed.  Development of sperm media 
enriched with hFF proteins relevant to sperm survival and regulation may also enhance 
sperm fertilisation capability. Prior exposure of FRT to certain sperm metabolites may be a 
new approach to enhance implantation and pregnancy outcome.  The novel perspective of 
mechanical aspects of sperm motility by studying fluid velocity and vorticity around 
motile sperm may add also a new approach to the study of sperm motility and chemotaxis. 
The improved understanding mechanical aspects of sperm motility may also enable the 
design of microfluidic devices for sperm selection based on motility.   
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Appendix 1:   
 Buffers and recipes:       
 SDS sample buffer (5 ×): Bromophenol blue (0.25%), DTT (dithiothreitol; 0.5 M), 
Glycerol (50%), SDS (sodium dodecyl sulphate; 10%), Tris-Cl (0.25 M, pH 6.8). 
 20× MOPS buffer (3-(N-morpholino) propanesulfonic acid) for running the gel 
(50mM MOPS, 50mM Tris base, 1mM EDTA, 400ml of distilled water.  25 ml of 
20 × MOPS in distilled water up to a total volume 500 ml to obtain  1 × MOPS 
buffer  
 Coomassie Brilliant Blue stain: 1 g of Coomassie Brilliant Blue (Bio-Rad) in 1 liter 
of the following solution: 50% Methanol, 10%  Glacial acetic acid, 40% H2O  
 Phosphate Buffered Saline (PBS) :137 mM NaCl, 2.7  mM KCl, 10  mM Na2HPO4, 
2 mM KH2PO4. 
 10 × M medium (1.37 M NaCl, 25 mMKCl, 200 mM N-(2-hydroxyethyl) 
piperazine-N’-(2-ethanesulfonic acid) (HEPES), 100 mM glucose)  
 HPLC solvent A: 1ml of trifluoroacetic acid (TFA) in 1L of distilled water,  mixed 
thoroughly in a glass cylinder and then kept in the HPLC reservoir bottle. 
 Buffers provided with the IgY12 SCs are : 1 × Dilution buffer: 1 × Tris Buffered 
Saline: 10 mM Tris-HCl, pH 7.4, 150 mM sodium chloride), 1× stripping buffer 
(0.1 M Glycine-HCl, pH 2.5) and  1× neutralization buffer (0.1 M Tris-HCl, pH 
8.0)
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Appendix2:  (chapter 2) 
List of hFF proteins identified in the hFF proteomic study:  
Protein  Peptides Score  Protein  Peptide Score  Protein  Peptides Score  Protein  Peptides Score  Protein  Peptides Score  
P01024 113 6895.6  P01023 18 917.4  P0CG05  10 709.6  P08238 5 205.9  Q96IY4 5 160.2 
P02768 106 6892.4  P05155 18 1163.2  P07360 9 649.4 P01764 6 254.8 P16070 5 270.7  
P98160 73 4176.2  P01876 18 1102.3  P12111 9 458.3  P22105 6 256.5  P04207 5 163.3  
P0C0L5 64 4032.7 P03952 18 1030.6  P0C0L4 9 510.5  P43251 6 367.6  P80362 5 279.5  
P02787 62 4532.1  P01011 17 1088.6  P05452 9 495.8  P47972 6 300.5  P04206 5 477.6  
P01009 45 2976.5) P02675 17 956.9  P05154 9 474.9  P05543 6 467.2  P18065 4 178.2  
P08603 43 2301.3  P01859 17 969.4  P68032 9 364.5  P00742 6 232.0  O95445 4 173.0  
P00734 37 2420.3  P01860 17 987.9  P11047 8 558.7  P08263 6 236.1  P13645 4 131.1  
P06727 34 1764.4  P10909 16 1023.8  P02750 8 360.8  P15309 6 271.1  P08195 4 167.0  
P02774 34 1963.2  P02760 16 1107.1  P01834 8 1006.1  Q16610 6 243.4  P63104 4 144.2  
Q14624 32 1936.2  P01861 16 920.0  P04196 8 451.8  P01622 6 330.8  P19320 4 157.3  
P01042 30 2054.9  P05156 15 888.5  P29622 8 337.8) Q03591 5 229.5  P08779 4 138.1  
P02790 29 1607.6  P01019 15 842.4  P07225 8 320.5  P35527 5 216.5  P32119 4 140.8  
P02647 28 1655.6  P13671 15 749.1  Q9NZP8 7 307.1  P07737 5 276.8  P30101 4 225.0  
P01008 28 1811.5  P02748 14 756.1  P04075 7 280.3  P36980 5 179.7  P01871 4 267.0  
P02751 28 1713.5  P02765 14 1204.8  P02649 7 352.5  P27169 5 248.1  P01619 4 286.6  
P19823 27 1713.5  P05090 14 627.8  P04004 7 434.9  P09871 5 354.7  P01765 4 267.0  
P00747 26 1479.6  P36955 14 802.6  P05546 7 381.3  P01620 5 427.4  P01766 4 311.0  
P19827 25 1728.5  P07357 13 833.5  P04278 7 327.4) P80748 5 210.5  P06310 4 189.0  
P06681 24 1172.4  P00738 13 762.8  P01768 7 282.4  P01597 5 346.4  P19652 4 128.6 
P06396 24 1296.9  P01877 13 801.0  P04003 7 316.6  P01625 5 417.6  P01880 4 125.4  
P43652 23 1099.8  P07358 13 750.6  P55268 7 238.5  Q04756 5 221.2) P01594 4 257.3  
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Protein  Peptides Score  Protein  Peptide Score  Protein  Peptides Score  Protein  Peptides Score  Protein  Peptides Score  
P00751 22 1258.9  P02749 12 831.8  P62937 7 322.2  O75882 5 294.2  P01610 4 198.5  
P04114 22 1108.9  P00748 12 587.3  P07093 7 352.6  P33151 5 221.0  P01762 4 228.4  
P00450 21 1372.0  P08697 12 662.2  P00736 7 337.2  Q96KN2 5 302.6  P01767 4 202.7  
P01857 21 1346.8  P51884 12 580.6  P11142 7 296.4  Q96PD5 5 344.5  P01781 4 254.9  
Q06033 21 1296.0  P02679 11 549.8  P06733 7 364.4  P04275 5 156.2  P04406 4 148.4  
P01031 20 901.3  P60709 11 476.9  P22792 7 440.1  P13796 5 149.4  P15169 4 171.0  
P02671 20 901.5  P02766 10 740.2  P18135 7 338.8  P23142 5 316.8  P17936 4 173.5  
P00739 20 1110.2  P02753 10 626.2  P02652 6 218.2 P80108 5 252.8  P26927 4 172.8  
P10643 19 1062.2  P35858 10 537.2  Q9UGM5 6 319.9  Q14520 5 232.3  P07996 4 250.3  
P04217 19 1252.2  P13611 10 469.0  P04264 6 283.2  P07900 5 221.6  P06858 4 161.9  
Q9UK55 4 210.2 P81605 3 130.3  P07355 3 224.9  P09382 2 78.4  P55290 2 49.0  
P03951 4 264.4  P01034 3 244.4  P12277 3 131.0  P13667 2 135.0  P25311 2 79.7  
P00740 4 169.7  P02746 3 155.2  Q6UVK1 3 192.9  P16144 2 141.8  P02747 2 78.6  
P15311 4 119.7 Q15113 3 83.3  P07237 3 169.4  P26439 2 61.5  Q9BXR6 2 53.9  
Q12805 4 183.0  P27918 3 78.9  P13598 3 122.5  P30520 2 139.6  P39059 2 79.4  
P14625 4 213.9  Q15166 3 139.4  P13639 3 122.8  P35221 2 46.9  P59665 2 97.3 ( 
O60664 4 172.5  P02533 3 71.2  P14314 3 108.6  P37837 2 98.6  P14174 2 80.1  
P07602 4 220.4  O43866 3 173.8  P30041 3 93.6  P43490 2 149.6  Q9Y5Y7 2 107.8  
P14618 4 273.3  O75874 3 109.5  P35241 3 86.0  P48741 2 77.3  P02655 2 124.8  
P19338 4 224.0  P80188 3 117.6  P37802 3 115.2  P49321 2 47.9  O00533 2 75.8  
P22314 4 308.0  P22692 3 152.5  Q02818 3 91.7  P55060 2 90.2  P08123 2 64.3  
P55072 4 171.3  P35908 3 216.4  P04259 3 131.6  P61221 2 78.7  P13591 2 53.0  
Q16658 4 219.5  P08253 3 99.6  P35579 3 172.8  P63241 2 96.6  P13647 2 115.2 
P04430 4 171.5  P10599 3 121.0  P01596 3 227.0  P67936 2 66.4  P16035 2 73.9  
P34932 4 142.4  P48668 3 113.8  P01599 3 227.0 Q02952 2 62.3  P26022 2 80.8  
Q15366 4 116.3  Q99584 3 129.5  P01604 3 138.9  Q14103 2 83.0  P41222 2 75.4  
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Protein  Peptides Score  Protein  Peptide Score  Protein  Peptides Score  Protein  Peptides Score  Protein  Peptides Score  
Q99715 4 179.5  Q04695 3 71.3  P01609 3 259.0  Q14574 2 70.3  P48740 2 46.2  
P01593 4 292.2  P31151 3 158.2  P06316 3 125.9  Q15084 2 103.2  Q15262 2 109.0  
O00391 3 165.8  P60174 3 157.7  P31948 3 144.1  Q15149 2 70.4  Q76LX8 2 88.5  
P25391 3 142.0  P09211 3 105.1  P01608 3 179.1  Q92598 2 74.4  Q8NBP7 2 100.8  
Q06830 3 126.3  P35542 3 89.2  P01613 3 191.9  Q92973 2 57.8  P08476 2 48.5  
Q14126 3 150.4  Q08380 3 161.0  P01614 3 230.9  Q9NQ38 2 71.9  P49908 2 49.0  
Q6EMK4 3 115.6  P01617 3 169.7  P01701 3 69.2  Q9Y653 2 99.6  Q13103 2 76.2  
P04180 3 166.7  O75636 3 87.1  P01714 3 185.8  P01623 2 150.3  P00338 2 72.8  
P20742 3 158.6  P08185 3 193.6  Q9NPH3 2 70.4  P23083 2 108.1  P00441 2 106.8  
O14791 3 95.6  P01598 3 251.5  P04434 2 77.8  P83593 2 64.2  P00915 2 63.9  
P02786 3 162.2  P01602 3 220.3  Q96NH3 2 58.9  P01601 2 84.1  Q6UXB8 2 96.5  
P00746 3 92.9  P01779 3 203.2  P04083 2 114.2  P01611 2 133.5  Q9HCB6 2 53.3  
P00558 3 117.9  P98066 3 150.6  P05455 2 66.6  P01763 2 105.0  P00918 2 99.2  
P05067 3 167.9  P55058 3 157.0  P09104 2 109.7  P13489 2 89.6) P31025 2 144.2  
P02788 2 63.6  P09172 2 64.1  P00488 2 105.9  P18206 2 89.1  Q13630 1 46.4  
P04433 2 95.8  P12259 2 117.7  P23284 2 122.6  P22626 2 119.7  Q14257 1 40.8  
P02763 2 79.8  Q99435 2 62.2  Q8IWY4 2 140.0  P36952 1 92.4  Q15392 1 67.7  
P02656 2 134.1  Q13822 2 75.9  P68871 2 113.8  P39023 1 60.5  Q15404 1 77.3  
P01700 2 106.5  O43707 2 49.8  P30153 2 112.0 ( P39687 1 87.1  Q15750 1 63.7  
P01773 2 65.0  P05997 2 73.7  P52565 2 145.4  P49006 1 61.4  Q16401 1 47.6  
P01769 2 86.2  P08758 2 110.4  P54578 2 106.1  P49411 1 72.9 ( Q16787 1 69.9  
P05160 2 93.3  P12814 2 81.2  P83110 2 68.0  P49588 1 70.4  Q86UP2 1 65.4  
P11021 2 83.1  P16112 2 67.8  Q02809 2 114.4  P49756 1 72.4  Q8WY91 1 55.8  
P35443 2 69.1  P19022 2 130.4  Q5SZK8 2 57.0  P50502 1 68.8  Q8WZA0 1 48.2  
P49747 2 120.4  P23528 2 87.4  Q9BTY2 2 130.8  P17706 1 55.8  Q9BY32 1 65.2  
Q99969 2 59.7  P52209 2 58.1  Q9Y4L1 2 54.3  P17987 1 88.9  Q9H0U4 1 72.4  
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Protein  Peptides Score  Protein  Peptide Score  Protein  Peptides Score  Protein  Peptides Score  Protein  Peptides Score  
P08571 2 116.4  Q9Y5C1 2 101.7  P04070 2 60.4 Q9H8L6 1 106.4  Q9H0X4 1 50.4  
P09455 2 68.7  P01033 2 150.7  P07942 2 86.9  P15814 1 87.2  Q9H4M9 1 72.0  
P01591 2 115.2  P01344 2 57.3  P09238 2 64.6  Q9NZT1 1 36.5  Q9NUQ9 1 78.2  
Q7Z7G0 1 65.4  P07108 1 41.7  O00232 1 83.8  P52907 1 49.9  Q9NY33 1 44.4  
P19883 1 52.3  P08519 1 47.4  O00267 1 44.4  P58546 1 58.9  Q9NYQ8 1 44.0  
O00339 1 50.6  P10451 1 64.6  O00469 1 45.5  P61970 1 65.4  Q9UMS4 1 47.3  
P05019 1 52.9  P12004 1 53.1  O14950 1 79.3  Q09328 1 78.8  Q9UQE7 1 52.9  
P35237 1 105.9  P14209 1 45.1  O75937 1 49.5  Q13561 1 57.3  Q9HAV7 1 55.2  
Q01995 1 51.5  P16422 1 117.6  O76003 1 45.1  Q14195 1 53.6  P01699 1 30.9  
Q13421 1 44.4  P02461 1 61.4  O76096 1 41.6  P80723 1 63.5  P01777 1 79.5  
Q13838 1 43.3  P07339 1 64.4  O95716 1 57.6  O75144 1 52.1) P27482 1 53.1  
Q16543 1 71.8  Q9BWP8 1 79.7  P02730 1 47.7  Q12841 1 60.6 Q9UGM3 1 29.4) 
Q99733 1 90.5  P02462 1 79.1  P02776 1 41.3  P02775 1 40.8  P04208 1 88.0  
Q99985 1 45.7  P0CG47  1 57.8  P04746 1 51.0  P07307 1 44.5  P01825 1 61.4  
Q9H173 1 62.7  P0DJI8 1 60.8  P05787 1 61.0  P18669 1 76.4  Q15582 1 71.6  
O43790 1 74.3  P01717 1 79.3  P14151 1 56.3  P25787 1 68.4  P22352 1 61.3  
P21741 1 67.5  O94985 1 43.7  P05111 1 81.7  P29401 1 50.0  P18428 1 99.6  
Q8IVF4 1 66.0  O95479 1 55.0  P02654 1 43.8  P30044 1 44.9  P06276 1 63.8  
P01742 1 47.8  P40925 1 67.1  P01621 1 79.2  P30530 1 44.8  P27348 1 98.0  
P01833 1 82.6  Q13790 1 47.3  P05109 1 38.5  P08670 1 68.8  P69905 1 41.1  
A5YKK6 1 56.2  Q9Y490 1 64.2  P61981 1 43.7  P09622 1 47.4  P07195 1 52.2  
O00170 1 45.4  P06702 1 28.7  P61626 1 79.1  P43121 1 56.9     
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Appenidix 3 (chapter 2) 
 The inclusion criteria for hFF protein data for the hFF proteins table  
Authors Criteria for protein, peptide identifications 
Ambekar et al, 
2013 
False discovery rate (FDR) was calculated using peptide validator node of the Proteome Discoverer where, FDR is calculated based on 
decoy database search. Peptide spectral matches which qualified for 1% FDR were considered for drawing protein inference from the 
peptide data 
Ambekar et al, 
2104 
Precursor and fragment mass tolerance were set to 20 ppm and 0.1 Da, respectively. Peptide identifications were filtered with 1% false 
discovery rate threshold at the peptide level. Differentially abundant proteins were identified with 1.5-fold change as the cut off value. 
Anahory et al, 
2002 
The maximum number of missed cleavage sites was set to 1. Peptide coverage of the full-length protein exceeded 15% confirming the 
protein to be RBP.  The RBP spot identified by MALDI-MS was also confirmed by co-migration of RBP purified on IEF followed by 
SDSPAGE (data not shown). 
Angelucci et al, 
2006 
Protein identification was confirmed by peptide mass finger printing analysis. Score is −10 Log(P), where P is the probability that the 
observed match is a random event, it is based on NCBInr database using the MASCOT searching program as MALDI-TOF data.  
Significance evaluated with Mann-Whitney test, P<0.0001. A spot was considered as such only if it was detected in three out of five 
replicates for all patients and defined “common spot” (i.e., always present and in the same position on all 25 follicular fluid gels). 
Relative spot volumes were determined by modelling the optical density in individual spot segments using a two-dimensional Gaussian 
analysis. Spot identification was carried out by gel comparison with the human plasma 2-DE reference map available on-line 
Bianchi et al, 2013 Protein identification was carried out by peptide mass fingerprinting and by peptide sequencing on an Ultraflex III MALDI-TOF/TOF 
mass spectrometer equipped with a 200 Hz smartbeam™ I laser. Tandem MS was also performed on a nanoscale LC-ESI/MS-MS 
system using a Micro-HPLC Pump Phoenix 40 (Thermo Finnigan, San Jose, CA) and a LCQ DECA IT mass spectrometer (Thermo). 
Estes et al, 2009 The presence of spots A and B was confirmed in five out of the eight additional pairs in the similar pattern identified in the original 
two pairs (spots present in a total of seven out of ten pairs). Subsequently, because of the large number of gels analyzed (16 samples), 
PDQuest program was used to maximize comparison of the additional gels. The purpose of the PDQuest analysis program is to 
identify differences that may not otherwise be noted. An independent evaluation of the raw spot density data of the five spots identified 
by PDQuest and the two spots identified visually (data extracted manually from PDQuest by using the 3  3 mm average area density of 
each spot in the subsequent 16 2D PAGE images) confirmed the significant differences between the success and failure groups 
(P<.05).Quantitative Validation by ELISA: The total antithrombin (AT) level in follicular fluid was quantified by using direct ELISA 
with the purified polycolonal antibody against antithrombin. 
Hanrieder et al, 
2008 
Proteins were found and identified by integrated mascot database batch search of all MS/MS in UniProt KB. All matches are identified 
significantly. Identified proteins are considered as a positive match on at least a 99% significance level (p<0.01) corresponding to a 
significance threshold in score of 28. At least one matching peptide for each identified protein must fulfil significance criteria 
Hanrieder et al, 
2009 
The significance threshold was set to a minimum of 95% (p≤0.05). The reproducibility of protein and peptide identification was 
evaluated by analysis of three consecutive CE-MALDI runs of one sIEF fraction. 
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Hashemitabar et 
al, 2014 
Only those spots that were present on all three replicate gels were quantified and enrolled for statistical analysis. The spots with 
significant differences in expression levels (p < 0.05) between the two groups were considered up- or down-regulated. 
Jarckovska et al, 
2010 
For PMF database searching, peak lists in XML data format were created using flex Analysis 3.0 program with SNAP peak detection 
algorithm. No smoothing was applied and maximal number of assigned peaks was set to 50. After peak labelling, all known 
contaminant signals were removed. No restrictions on protein molecular weight and pI value were applied. Proteins with MOWSE 
score over the threshold 56 calculated for the used settings were considered as identified. If the score was lower or only slightly higher 
than the threshold value, the identity of protein candidate was confirmed by MS/MS analysis. 
Kim et al, 2006 for declaring a protein hit, protein score > 13, peptide score > 10, and SPI (%) >70 were applied throughout the data analysis 
procedures. All the proteins identified based on at least two peptides assignment 
Kushnir et al, 
2012 
Criteria used for acceptance of peptide assignments for proteins identified based on single peptide were: (a) score for the peptides 
match greater than 10; (b) error in mass accuracy of the parent ion within 20 ppm (for over 80% of the peptides error was within 10 
ppm); (c) good alignment of predicted vs observed ion series; (d) number of unmatched ions in mass spectra less than 50% of the 
expected number of ions; (e) forward score greater than the reverse score; (f) well-defined chromatographic peaks at the retention time 
where the mass spectrum was acquired. 
L Turco et al, 
2013 
considering at least two unique proteotypic peptides 
Lee et al, 2005 Using ExPASy PeptIdent with an error tolerance of 100 ppm, information on the peptide mass fingerprinting data was searched against 
databases of relevant species. 
Liu et al, 2007 To validate the search results, Western blot analysis on apolipoprotein A-I and Collagen type IV was performed. In these cases, the 
expression changes of the selected proteins further confirmed the direct analysis of tryptic digests by MALDI-TOF MS (Data were 
normalized by using the external standard signals (B) (means±SD, n=10). * value significantly differs from the control (P<0.05), ** 
value significantly differs from the control (P<0.01). 
Lo Turco et al, 
2010 
Only proteins in attendance scores and confidence higher than 50% and 99%, respectively, were considered in order to accept these 
database searches, and when the same protein was identified for different MS/MS fragment ions, those presenting the highest score 
were considered for comparisons and data presentation 
Regiani et al, 2015 Each pool in this study was analyzed in quadruplicate and only proteins present in at least two replicates were included in the study. 
The minimal fragment ion matches per protein was 7 and the minimal peptide matches per protein was 1. 
Schweigert et al, 
2006 
To surely identify proteins, an immunoassay was applied. The different antibodies (haptoglobin, prealbumin and transferrin were 
coupled on the chip surface. Mass resolution (defined as m/Δm) is routinely in the range of 300–400, and mass accuracy was within 
0.1%. Peaks with amplitudes at least five times greater than the average background noise level were considered. 
Severino et al, 
2013 
Protein and peptide scores were set up to maintain the false positive peptide ratio below 5% 
Sim and Lee, 2008 We searched for identical known protein sequences from NCBInr and EST databases using the MASCOT search program 
(www.matrixscience.com) and BLAST in order to identify the proteins. 
Spitzer et al, 1996: Amino acid sequences were compared with the PIR protein sequence database (Program Manual for the Wisconsin Package, Version 
8, September 1994, Genetics Computer Group, 575 Science Drive, Madison, Wisconsin 53711, USA). Position numbers were assigned 
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to correspond with the position of amino acid residues in the protein as given in the database. 
Twigt et al, 2012 Scaffold (version Scaffold_2_06_02, Proteome Software,Portland, OR) was used to validate MS/MS based peptide and protein 
identifications. Peptide identifications were accepted if they could be established at greater than 95.0% probability as specified by the 
Peptide Prophet algorithm. Protein identifications were accepted if they could be established at greater than 99.0% probability and 
contained at least one identified peptides (resulting in a 0.1% protein false discovery rate). Protein probabilities were assigned by the 
Protein Prophet algorithm. 
Wu et al, 2015 Proteins matching more than four peptides and with a MSCOT score >64 were considered significant (P < 0.05). Proteins with a 
minimal 1.5-fold change between groups and P < 0.05 were considered significantly differentially expressed. 
Zamah et al, 2015   Proteins detected with 5% local FDR were reported. To determine significant changes in protein abundances log-transformed iTRAQ 
ratios were analyzed using Student’s t-test and the threshold for differential abundance was p < 0.05 
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Appendix 4 (chapter 3)  
List of the proteins identified in the sperm + hFF proteomic interactions 
Protein  Peptides Score Protein Peptide score Protein Peptide Score Protein Peptide Score 
Q5JQC9 80 4318.1 P04259 22 1441.4 Q8N1F7 16 657.8 P04075 16 867.3 
O75969 51 2573.2 P11142 22 1087 Q9Y4L1 16 548.8 P13639 16 506 
P07900 47 2297.8 P14625 21 833.2 P40926 16 948.4 P21266 16 849 
P54652 44 2236.7 P26640 21 764.7 P40939 16 689.4 Q5THR3 16 531 
P02788 44 2170.5 P60174 21 1116.2 Q13618 16 646.1 Q6BCY4 16 652.1 
Q5BJF6 42 1922.1 O14556 20 880.1 P10323 15 589.7 O75952 11 429.8 
Q5VU65 41 1643.4 O75694 20 830 P13647 15 560 O95757 11 490.9 
Q96JB1 40 1379.2 P33121 20 741 P36969 15 573.6 P01857 11 739.3 
Q01813 37 1681 P49327 20 649.3 P49368 15 519.5 P04843 11 387.5 
Q9UFH2 37 1218.6 P55072 20 831.8 P60709 15 744.2 P06733 11 395 
P08238 32 1436.2 Q02383 20 840.1 P68363 15 677.7 P07237 11 342.9 
P11021 29 1388.2 Q9BVA1 20 942.5 Q16698 15 752.1 P46459 11 416.4 
P04264 28 1449.6 P07437 19 976.8 Q8NCR6 15 612.5 P55786 11 442.9 
P07864 27 1213.9 P08779 19 762.4 Q9Y277 15 927.9 P10809 11 454.3 
P14618 27 1130.9 P35527 19 921.9 O60309 14 521.7 Q8WUD1 11 432.1 
P13645 26 1247.7 P49221 19 848.4 P30101 14 546.1 Q9BZX4 11 607.6 
Q9BZW7 26 1107.6 Q13748 19 910.8 P61019 14 724.6 Q9NY65 11 502.8 
A6NMS7 25 1119.8 Q99798 19 721.8 Q13509 14 719.6 Q96RQ9 11 373.5 
P35908 25 1173.5 P02538 18 728.5 Q6NUT2 14 488.3 Q9UKU0 11 353.4 
P02768 24 1059 P25705 18 756.6 Q8WXX
0 
14 530.2 Q14568 11 555.1 
P07205 24 999.4 P48668 18 724.7 Q8TC71 13 440.8 Q14990 11 597.1 
P34931 24 1276.2 Q04695 18 1052.2 Q96A08 13 798.2 P17987 12 425.8 
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Protein  Peptides Score Protein Peptide score Protein Peptide Score Protein Peptide Score 
Q00610 24 1002.2 Q8NEB7 18 894.4 Q99832 13 423.8 P36873 12 459 
Q14997 24 840.8 Q8TEM1 18 651.5 Q9BXF9 13 479 P45880 12 637.9 
P04279 23 990.1 Q92621 18 555.4 Q9BYZ2 13 511.5 P62805 12 731 
P48741 23 1142.2 P02533 17 643.5 Q9HAT0 13 680.3 P63261 12 513.8 
P19367 23 930.5 Q14203 17 583.4 P04350 13 792.2 Q96QE4 12 560.9 
P29144 23 761.4 Q71U36 17 791.6 P04406 13 588.3 Q13733 13 493.5 
P68371 23 1158.3 Q86VP6 17 679.7 P08237 13 472.4 Q13939 13 635.5 
Q9H0B3 23 790.2 Q96PU9 17 615.1 P25786 13 514.7 P05141 12 473.2 
P47897 13 460.7 P12235 11 470.5 P84243 9 335.2 P53396 9 331.4 
P50991 13 541 P35579 11 425.5 Q13162 9 349.9 P02743 9 368.9 
Q9BS86 12 609.8 O00410 10 384.9 Q15008 9 271.8 P05109 9 414.8 
Q9BUN1 12 742.7 O75976 10 334.1 Q16531 9 276.7 P0C0S8 9 546.3 
Q9H0C2 12 490.1 P00918 10 438.6 Q4G0X9 9 331.1 P12277 9 403.1 
Q9NTJ4 12 439.4 P02787 10 337 Q6J272 9 304 P12821 9 299 
Q9NXE4 12 411.8 P06576 10 570.5 Q92820 9 372.3 P22695 9 335.6 
Q9Y6C9 12 490.3 P15309 10 356.1 P13073 9 288.8 P25788 9 338.4 
P07814 12 395.7 P24752 10 457.4 P17066 9 423.3 Q9UJT2 9 290.5 
P15104 12 486.5 P29218 10 393.8 O43847 8 299.8 P31040 9 284 
P17174 12 420.8 Q5SRE5 10 345 P00558 8 305.9 P22492 9 315 
Q8TC56 11 357.2 Q6UWU2 10 395.7 P00747 8 228.3 A8MYP8 8 277.7 
P10909 11 517.1 Q7L266 10 592 Q8TBY8 8 264.6 O14645 8 254 
P00338 9 416.3 Q99623 8 323.5 Q8IVF4 8 204.5 Q53H82 9 352.9 
Q5JST6 9 297.3 Q9NSE4 8 247.9 Q9HBV2 8 448.9 P08758 8 318.9 
Q5JX69 9 320.9 P62140 8 288.1 Q9BTM1 8 493.2 P13646 8 374.1 
Q9UIA9 9 309.6 P68366 8 455 Q9BVM2 8 263.8 P13667 8 275.2 
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Q96KX2 9 306.7 Q14697 8 242.7 Q99613 8 220.6 P13861 8 275.5 
Q9H1X1 9 351.9 Q3LXA3 8 304.3 P50990 8 382.8 P27348 8 291.9 
P25789 9 430.7 Q5VTE0 8 342.6 P38646 9 358.8 P28074 8 289.8 
P26641 9 416 Q6ZR08 8 253.1 P35232 8 318.9 P30041 8 296.1 
Q00325 8 387 Q5JVL4 7 266.8 Q9HDC9 8 265.2 P30044 8 296.9 
Q02978 8 349.6 Q8NBX0 7 270.4 P57105 8 276.8 P36542 8 311.2 
Q04837 8 364.8 Q15046 7 210.3 P60900 8 361.8 P61106 8 262.9 
Q8TEX9 8 256.1 P48643 8 224.1 P41250 8 224.3 Q13576 7 237.5 
Q93009 8 253 Q9C0G6 8 278.3 P47756 8 282.2 Q7Z745 7 244.4 
Q96BH3 8 295.5 Q9Y230 8 283.4 O00743 7 202.9 P61006 7 219.1 
P12273 7 279.2 P01860 7 268 O75390 7 257.6 P62258 7 295 
P15144 7 259.9 P01861 7 456.6 O75746 7 246.9 P63104 7 337.3 
P15586 7 239 P06899 7 359.5 P01024 7 209.9 P68104 7 337.7 
P22061 7 257 P07195 7 275.5 Q93077 7 309.5 Q16891 7 220.3 
P22314 7 190.6 P07954 7 274.6 Q96KK5 7 325.5 Q1ZYL8 7 244.6 
P43155 7 256.6 P10515 7 268.7 Q96P26 7 233.4 Q562R1 7 249.7 
P49748 7 288.4 P11177 7 311 Q7Z3B4 7 293.2 P68400 6 213.5 
P54136 7 246.8 Q96RL7 7 221.2 P78406 6 170 Q8IXA5 6 283.1 
Q6UW49 7 324.5 Q99447 7 287 P98160 6 196 Q8IYK2 6 180.7 
Q75WM6 7 290.1 Q99880 7 375.8 Q00796 6 266.1 Q8N427 6 172.1 
Q5T9G4 7 207.8 P21912 6 216.2 O14818 6 204.7 Q02218 6 217.3 
Q9UBX3 7 265 P22748 6 206.7 O43242 6 211.8 Q06210 6 245.8 
Q9UI46 7 222.4 P25685 6 223.1 O43772 6 183 Q12931 6 279.3 
Q9UJS0 7 274.9 P28066 6 229.2 O75874 6 158.1 Q13200 6 206.7 
Q9UL16 7 228.9 P28331 6 241.5 O96011 6 183.2 Q14974 6 222.7 
Q9NTM9 7 256 P31937 6 231.5 P06702 6 239.4 Q58FF6 6 246.8 
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Q7Z4H3 7 237.5 P31948 6 192.1 P06727 6 329.2 Q6NXT2 6 213.7 
P68871 6 188.6 P34932 6 209.2 P06744 6 284.7 Q6X784 6 222.3 
Q86VQ3 6 220 P53621 6 163.7 P07737 6 315.7 Q15631 5 221.5 
Q9Y262 6 182.1 P54577 6 149.8 P08727 6 278.6 Q15907 5 140.1 
P60842 6 219.6 P55060 6 169.8 P0C5Z0 6 350.5 Q5CZC0 5 139.6 
P61247 6 189.8 P55084 6 197.6 P13796 6 283.2 Q5JX71 5 187.1 
Q92523 6 187.2 P25787 5 283.9 O94905 5 152.1 Q96GK7 5 160.3 
Q92526 6 214.3 P13798 6 194.5 Q5T4S7 5 151.4 Q96PF2 5 143.1 
Q92598 6 264.4 P16152 6 253.1 Q6P2I3 5 184.1 Q96QH8 5 316.2 
Q96JQ2 6 216.3 Q9NS25 6 409.6 Q6URK8 5 157.3 Q99536 5 160 
Q96M32 6 203.4 Q9NSD9 6 176 Q6ZN84 5 164.6 Q9BS26 5 167.4 
Q96M98 6 190.3 Q9NQT6 6 286 Q6ZQR2 5 185.1 Q9BXA6 5 195.7 
Q96NG3 6 249.1  P62987 6 304.1 Q86X76 5 184 Q96DC9 5 232 
Q96QV6 6 286.3 A0AVT1 6 198.7 Q8IUE6 5 227.9 Q96FW1 5 132 
Q9C099 5 156.9 P20618 5 179.7 Q8IZ16 5 217.4 Q8TAA3 5 214.2 
Q9H0K4 5 161.8 P20674 5 198.4 Q9P0L0 5 189.9 Q8TCU4 5 206.7 
Q9H4B8 5 218.6 P21796 5 240.4 Q9P225 5 131.1 Q8TDQ7 5 156.5 
Q9H4Y5 5 168.7 P23526 5 142.1 Q9UFE4 5 134.2 Q8WW24 5 200.2 
Q9NY33 5 257.8 P23634 5 190.4 Q9UIF3 5 139.3 Q8WZ59 5 201.5 
P26373 5 234.4 P25325 5 237.7 Q9Y371 5 168.8 Q01469 4 182.3 
P28838 5 147.1 O95861 5 182.4 Q9Y5B8 5 180.2 Q07020 4 137.5 
P30086 5 238.5 P00568 5 196.5 P99999 5 201.2 Q0VFZ6 4 136.6 
P37837 5 218.8 P01876 5 163.7 Q00059 5 188.9 Q14410 4 109.9 
P38117 5 124.5 P02751 5 128.3 Q12907 5 177.1 P18669 5 173.8 
P40925 5 186.2 P04004 5 167.1 Q13011 5 209.4 P19827 5 178.2 
P42126 5 168.6 P05388 5 137 Q15257 5 126.6 P22612 4 93.2 
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P46926 5 176.4 P08574 5 179.1 Q15506 5 310.4 P23284 4 102 
P55145 5 196.4 P0C7P4 5 167.2 P63244 4 172.3 Q9P0J0 4 148.5 
P60660 5 178.6 P11310 5 133.8 P67812 4 127.8 Q9P2R7 4 123.6 
P61313 5 169.2 P11766 5 169.7 Q9BTE6 4 132.6 Q9UFN0 4 131.4 
P61604 5 199.3 P12429 5 229.8 Q9BTW9 4 104.1 Q9UJ70 4 135.6 
P61981 5 202.7 P14314 5 227.8 Q9C002 4 116.9 Q9UM54 4 119.7 
P62158 5 233.4 P15374 5 163.3 Q9GZS0 4 173.6 Q9UNN5 4 150.7 
P62241 5 144 P15531 5 186.5 Q15435 4 123.2 Q9Y265 4 157.6 
P62249 5 177.9 P16219 5 120 Q15785 4 113.2 Q9Y4P3 4 125.4 
P78371 5 171.3 P16403 5 155.3 Q15836 4 141.6 Q9Y570 4 186.6 
P23368 4 127.5 P62269 5 199.9 Q16836 4 130.2 Q9Y6A4 4 136.9 
P23396 4 148.6 A2RUT3 4 208.3 Q4G0P3 4 94.4 P62888 4 168.1 
P26436 4 142.3 A6NDG6 4 158.9 Q53EV4 4 142.9 P62906 4 95 
P27487 4 132 O00231 4 117 Q5T2S8 4 125.3 P62701 4 117 
P29401 4 125.2 O00468 4 142.4 Q6UW1
5 
4 169.6 Q9H0J4 4 148 
P29803 4 151.6 O15173 4 99.2 Q6UX06 4 184.7 Q9HB07 4 188.2 
P30040 4 124.7 O75602 4 94.4 Q6ZU69 4 107 Q9HC21 4 208 
P30046 4 148.6 O75947 4 128.2 Q6ZUB1 4 122.4 Q9NQ86 4 146.1 
P33176 4 140.1 P00450 4 169.2 Q8IYT1 4 179.5 Q9NUJ1 4 212.4 
P35268 4 154.9 P00492 4 221.4 Q8N158 4 141 Q9NY87 4 263.2 
P35580 4 116.6 P00738 4 124.2 Q8N1V2 4 140 Q9NYU2 4 166 
P36404 4 142.7 P01834 4 326.5 Q8N4E7 4 151.3 Q8WZ42 4 126.5 
P39656 4 163.1 P01859 4 180.5 Q8N6M
8 
4 174.1 Q92928 4 145.7 
P40227 4 115.5 P02679 4 128.5 Q8NA47 4 143.4 Q96HS1 4 140.3 
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P42765 4 119.5 P04792 4 166.5 Q8NFW
8 
4 122.5 Q96JN2 4 129.1 
P43490 4 121.5 P05023 4 118.4 P62826 4 169.2 Q96KX0 4 170.8 
P46379 4 107.7 P0C0L5 4 139.1 P18754 4 124.8 Q96MR6 4 126.1 
P49821 4 91.7 P0C0S5 4 170.6 P19012 4 136.4 Q99426 4 153.2 
P49913 4 193.6 P10644 4 128.3 Q8WWU
5 
4 130.5 Q99497 4 135.1 
P50502 4 134 P10768 4 139.8 Q8WXX
5 
4 169.2 Q99714 4 121.6 
P51665 4 131.5 P11169 4 208.6 P56556 4 94.8 P59910 4 162.5 
P51854 4 154.4 P12236 4 147.5 Q8TB22 4 122.5 Q99878 4 223 
P52292 4 117.3 P13489 4 120.1 Q8TC29 4 142.3 P19013 4 128.4 
P53007 4 141.1 P13637 4 162.6 Q8TC94 4 145 P20338 4 126.8 
P54727 4 141.4 P13804 4 103.4 P02675 3 89.7 P27797 3 91.9 
Q8TD57 4 127 P14550 4 127.5 P02763 3 102.9 P28070 3 85.8 
P17612 4 116.3 A4FU69 3 81.5 P04083 3 113.7 P29508 3 80.9 
P18124 4 152.3 A5D8V7 3 113.1 P05155 3 160 P29692 3 183.9 
Q8TDY3 4 180.2 O00232 3 63.8 P05164 3 128.2 P30042 3 85.9 
P62330 3 120.5 O00291 3 125.6 P05783 3 106.8 P30084 3 88.5 
P62333 3 134.4 O00299 3 107.8 P06396 3 96.3 P32119 3 98.1 
P62854 3 112.4 O00519 3 93.9 P06865 3 108.9 P32189 3 118.7 
P63167 3 124.8 O14744 3 77.4 P07288 3 117.3 P35998 3 67.7 
Q02878 3 82.9 O15230 3 88.3 P07339 3 98.6 P38567 3 87.1 
Q06830 3 118.6 O43175 3 79.2 P08134 3 118.2 P38606 3 79.9 
Q13508 3 77.2 O43236 3 108.4 P08603 3 73.8 P40616 3 104.9 
Q13617 3 77.7 O43488 3 106.9 P08865 3 89.8 P41252 3 73.4 
Q13642 3 167.3 O43592 3 81.1 P09622 3 141.7 P42785 3 85.4 
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Q14139 3 92.8 O43617 3 76.8 P0C0L4 3 82.2 P43304 3 104.7 
Q14409 3 127.9 O43822 3 152.1 P0CG04, 
P0CG05, 
P0CG06 
3 180.3 P43487 3 97.9 
Q15005 3 82.8 O60733 3 74.6 P10253 3 90.4 P46781 3 93 
Q15370 3 145.6 P60673 3 113.1 P10412 3 74.1 P47895 3 88.9 
O75340 3 71.6 P61018 3 92.8 P11047 3 93.9 P47929 3 168.7 
O75477 3 125.6 P61160 3 94.2 P12814 3 82.1 P48047 3 118.6 
O75521 3 75.9 P61163 3 130.6 P14555 3 115.8 P49189 3 82.4 
O75531 3 111.4 P61204 3 69.5 P14649 3 148.4 P49589 3 115.5 
O75569 3 99.6 P62195 3 85.2 P14854 3 125.6 P49755 3 88.5 
O75882 3 98.4 P62244 3 147.7 P14927 3 78.6 P50213 3 124.6 
O95202 3 109.2 P62263 3 91.2 P15259 3 101.2 P50914 3 114.1 
O95292 3 138.8 Q8N0W7 3 154.2 P15529 3 89.4 P51148 3 105.5 
O95336 3 88.2 Q8N335 3 80.4 P18077 3 115 P51157 3 93.5 
P00387 3 95.1 Q8N4L4 3 84.9 P20155 3 92.9 P52209 3 86.8 
P00505 3 131.8 Q8N5Q1 3 97.4 P23528 3 82.6 Q9BQA1 3 92.7 
P01009 3 216.5 Q8NA82 3 86.8 P24539 3 86.6 Q9Y282 3 99.9 
P01023 3 81.9 Q8NDM7 3 165.1 Q9UKF2 3 146.7 Q9Y615 3 84 
P02647 3 182.2 Q8NEP4 3 116.6 Q9UKR5 3 104.8 Q9NR28 3 108.8 
P02649 3 77.6 Q8NFH5 3 120.4 Q9UKU7 3 122.1 Q9NSB4 3 121.2 
P24666 3 110.4 Q8TC12 3 132.6 Q9UNZ2 3 126 Q9NVJ2 3 98.1 
P25398 3 118.9 Q8TC44 3 97 Q96FJ2 3 141.3 Q9H0R4 3 114.1 
P26440 3 83 Q8TDZ2 3 127.5 Q96HR9 3 73.8 Q9H1K1 3 91.7 
P26639 3 75.4 Q9BT09 3 92.8 Q96M34 3 84.4 Q8IYX7 3 87.5 
P27169 3 82.8 Q9BT78 3 107.6 Q96M63 3 112.3 Q8IZP2 3 134.1 
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P53597 3 121.9 Q9BTX1 3 110.2 Q96SB4 3 76.6 Q9BX68 3 222.4 
P54709 3 118.3 Q9BU02 3 85.2 Q9H503 3 136.6 P05387 2 102.3 
P54920 3 94.8 Q9BWH2 3 81.8 Q9HAE3 3 108.8 P06753 2 93.1 
P56385 3 106.6 Q16775 3 77.2 Q99567 3 76.6 P07108 2 63.4 
P59665 3 105.9 Q16854 3 93.9 Q99766 3 107.2 P07355 2 55.7 
P60228 3 82 Q53FA7 3 110.6 Q9BYD9 3 112.9 P08133 2 101 
Q5JRX3 3 71.8 Q5BN46 3 107.2 Q9H0I3 3 102.1 P08174 2 46.1 
Q5T749 3 85.9 Q8WUM4 3 106 Q9UGP8 3 91.6 P08670 2 92.5 
Q5TA50 3 77.1 Q8WWB3 3 73.6 Q9UHG3 3 76.6 P09211 2 84.4 
Q5TZJ5 3 72 Q8WYR4 3 69.5 Q8IWZ5 3 118.9 P09382 2 57.7 
Q5VYK3 3 86.4 Q92930 3 92.4 Q99436 3 122.7 P09669 2 61.3 
Q63HN1 3 77.4 Q969U7 3 87 O75190 3 146.9 P0C874 2 56.8 
Q68CQ1 3 115.6 Q96A26 3 80.5 Q9P2D7 2 66.5 P10606 2 61 
Q6IA69 3 145 Q96C74 3 111 Q9UBQ7 2 48.3 P11216 2 55.9 
Q6JEL2 3 93.4 Q9NZ45 3 77.4 Q9UBS4 2 99.5 P11279 2 55.3 
Q6P4A8 3 129.2 Q9UBF2 3 113.1 O95168 2 49.5 P11908 2 73.3 
Q71UI9 3 117.8 Q9UBX1 3 87.8 O95573 2 86.5 P13671 2 50.8 
Q7Z4W1 3 76.6 A4D1T9 2 74.7 O95825 2 52.4 P13716 2 66.3 
Q7Z794 3 122.4 A6NCJ1 2 62.4 O95831 2 61.2 P14174 2 71.3 
O15296 2 62 A6NFA0 2 46.9 O95881 2 67.7 P14406 2 54.3 
O15372 2 47.7 A6NFE3 2 68.4 O95994 2 43.3 P15121 2 96.6 
O15393 2 52.6 A6NJV1 2 62.3 O96000 2 48.2 P15289 2 55.1 
O43298 2 86.8 A6NKQ3 2 74.7 O96008 2 77.6 P15311 2 52.8 
O43324 2 59.5 Q96PK2 2 42.5 P00390 2 49.6 P15735 2 92.2 
O43678 2 47.8 B1ANS9 2 50.5 P00403 2 68.1 P15924 2 50.5 
O43684 2 53.2 O00159 2 71.3 P00441 2 99.3 P16401 2 62.6 
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O43708 2 70.3 O00487 2 70.3 P01011 2 108.5 P36578 2 46.2 
O43813 2 78 O14520 2 110.7 P01040 2 106 P36776 2 115.7 
O43920 2 52.2 O14618 2 55 P01042 2 68.5 P38405 2 53.8 
O60809 2 53.1 O14746 2 65.4 P01623 2 190.8 P39019 2 69.2 
O75367 2 53.6 O14829 2 65.5 P01766 2 68.2 P40429 2 50.4 
Q9UHL4 2 54.6 O14910 2 58 P02753 2 136.7 P40763 2 54.4 
Q9UHP6 2 62.7 O14950 2 69.7 P02774 2 57.8 P41218 2 86.8 
Q9UHR6 2 68.7 O14980 2 53.8 P04179 2 43.8 P41222 2 81.9 
Q9UII2 2 51.7 O15068 2 43 P04217 2 65.6 P42766 2 63 
Q9ULC5 2 81.9 P25311 2 111.7 P04554 2 73.8 P43034 2 53.6 
Q9UM00 2 53.8 P26885 2 67.2 P31930 2 98 P43358 2 48.9 
Q9UM07 2 49.2 P27105 2 130.7 P31939 2 53.9 P43897 2 53.3 
Q9UNM6 2 50.7 P27635 2 55.6 P31946 2 58.9 P98095 2 83 
Q9UNX3 2 58.4 P27824 2 79.4 P31947 2 73.5 Q00169 2 55.4 
Q9UPN7 2 49.7 P28072 2 123.7 P32969 2 60.8 Q01518 2 62.2 
Q9UQ80 2 78.5 P30038 2 60.2 P34896 2 66.5 Q02127 2 54.7 
Q9Y234  2 74.7 P30048 2 52.9 P34913 2 54.3 Q04760 2 55.9 
Q9Y266 2 62.8 P30153 2 57 P35237 2 61.2 Q05469 2 58.5 
Q9Y2B4 2 60.6 P31025 2 146.1 P35658 2 52.2 Q06323 2 58.7 
Q9Y303 2 61.8 P31150 2 70.3 P35813 2 65.5 Q15366 2 54 
Q9Y376 2 55.1 P50402 2 60.1 P36405 2 75.7 Q15369 2 46.6 
Q9Y3A5 2 61.8 P51149 2 52.8 P56134 2 109.5 Q16181 2 67.8 
Q9Y3B3 2 113.4 P52272 2 43.1 P56180 2 46.1 Q16222 2 57 
Q9Y4W6 2 80.8 P52565 2 59.6 P56192 2 50.7 Q16401 2 48 
O75396 2 51.7 P52566 2 49 P56730 2 51.8 Q16563 2 101.1 
O75438 2 56.1 P52907 2 47.1 P56851 2 53.4 Q16566 2 56.6 
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O75951 2 75.9 P53602 2 49.6 P57678 2 64.1 Q16718 2 54.6 
O76003 2 52.6 P53680 2 78.4 P58340 2 77.5 Q8IV63 2 67.3 
O94788 2 68.1 P54107 2 90.9 P59282 2 122.1 Q8IWZ6 2 55.1 
O94808 2 82.3 P55884 2 64.1 P60510 2 62 Q8IXS2 2 58.2 
P16435 2 73.8 Q08722 2 53.5 P60866 2 66.8 Q8IXY8 2 63.7 
P16562 2 92.9 Q13057 2 67.4 P61009 2 85.8 Q8IY82 2 45.9 
P17050 2 77.9 Q13404 2 107.2 Q14156 2 63.7 Q8IYP2 2 48.5 
P18085 2 67.4 Q13561 2 46.2 Q14165 2 104 Q8IYX1 2 52.1 
P19652 2 93.8 Q13564 2 54.9 Q14204 2 43.4 Q96L21 2 48.9 
P19784 2 45.4 Q13765 2 95.3 Q14507 2 44.8 Q96LM6 2 48.4 
P19823 2 68.4 Q14019 2 46.7 Q14624 2 47.3 Q96M29 2 51.4 
P20142 2 65.6 Q14093 2 42.1 Q15102 2 70.7 Q96MA6 2 46.3 
P20810 2 56.5 Q14152 2 58.3 Q15181 2 62.9 Q96S97 2 52.7 
P22732 2 66.9 Q5W111 2 76.4 Q15363 2 54.6 Q99417 2 67.5 
P23786 2 91.3 Q5XKE5 2 53.5 Q7Z5L4 2 54.1 Q99460 2 68 
P24534 2 81.8 Q66GS9 2 43.6 Q7Z6W1 2 56.2 Q99523 2 66.7 
P61353 2 61.1 Q68DN1 2 69.3 Q86SX6 2 53.7 Q99598 2 48.8 
P61962 2 77.9 Q6DD88 2 53.6 Q86WT1 2 42 Q99963 2 62.3 
P62191 2 106.3 Q6IAN0 2 60.2 Q86Y39 2 44.1 Q9BRA2 2 50.7 
P62280 2 56.3 Q6ICG8 2 71.8 Q8N6Q1 2 57.6 Q9BRY0 2 72.9 
P62312 2 85.5 Q6NXR0 2 61.9 Q8N7U6 2 64 Q9NR31 2 75.4 
P62424 2 66.4 Q6P1M0 2 61.3 Q8N865 2 60 Q9NZC3 2 58.5 
P62491 2 56.8 Q6P656 2 55.8 Q8N9V2 2 70.7 Q9Y581 2 75.1 
P62714 2 95.9 Q6TDU7 2 73.1 Q8WW2
2 
2 60.4 Q9Y5Z4 2 48.5 
P62829 2 47.9 Q8TBQ9 2 57.9 Q969H8 2 47.8 P45954 2 73.4 
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P62753 2 119.5 Q6UWP2 2 66 Q8WXQ
8 
2 53 Q9Y697 2 55.1 
P62851 2 81.6 Q8TC36 2 73.9 Q969V4 2 63.2 P45974 2 122.9 
P62917 2 78.8 Q8TC99 2 67.5 Q96D96 2 64.8 P46776 2 86.3 
P62937 2 62.4 Q8TCS8 2 81.8 Q96E40 2 70.6 P46777 2 79.8 
P63173 2 55.3 Q8TDM5 2 130.1 Q96GG9 2 57.8 P47985 2 52.7 
P63208 2 61.4 Q8WUK0 2 95.4 Q96HA9 2 66.9 P48729 2 78.4 
P67870 2 63.1 Q8WUW1 2 69.2 Q96IU4 2 90.1 P49411 2 86.6 
P78362 2 54.5 Q8WVP5 2 93.2 Q96IX5 2 76.2 P49588 2 48.7 
P78395 2 49.5 Q9NRW1 2 54.3 Q96L03 2 47.9 P49591 2 75.7 
P83731 2 76.5 Q9NSB2 2 53.8 Q9NRG9 2 80.4 P49720 2 88.1 
P84098 2 60.4 Q9NTJ5 2 59.3 Q9NRN7 2 63 P49721 2 75 
Q6UWQ5 2 61.2 Q9NU02 2 45 Q9H845 2 120.7 P49773 2 58.6 
Q6UXV1 2 76.8 Q9NVH1 2 65.9 P07478 1 36 Q5FVE4 2 44.6 
Q6UXV4, 
Q9BUR5 
2 67.8 Q8IYX3 2 98.9 P07738 1 26.2 Q5GAN3 2 78.1 
Q6V702 2 70.1 Q8IZ96 2 60.1 P07741 1 34.9 Q5JU67 2 56.6 
Q6ZU64 2 59.2 Q8IZS6 2 55.7 P07910 1 44.8 Q5RI15 2 77.1 
Q6ZUB0 2 80.2 Q8N0U8 2 47.4 P08559 1 39 Q5SRN2 2 63.5 
Q6ZVS7 2 58.6 Q8N3X6 2 63.6 P09417 1 25.7 Q5SVJ3 2 52.8 
Q7L2H7 2 69.7 Q8N6G2 2 60.4 P09496 1 40.4 Q5T655 2 62.2 
Q7Z4W2 2 60.9 Q9BU61 2 81.4 P09936 1 49.8 Q5T871 2 43.2 
Q8NCW5 2 57.7 Q9BVK6 2 61.4 P0C7M6 1 56 Q5TCS8 2 63.3 
Q8NE09 2 79.9 Q9BWD1 2 47.8 P62979  1 55.7 Q2M243 2 45.2 
Q8NE22 2 85 Q2TAA8 2 51 P10599 1 69.5 Q9BXW7 2 118.8 
Q8NE62 2 50.6 Q3ZCQ8 2 67 P12830 1 29.3 Q9C093 2 56.2 
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Protein  Peptides Score Protein Peptide score Protein Peptide Score Protein Peptide Score 
Q8NEG0 2 63.5 Q495T6 2 47.5 P13987 1 35 Q9GZZ8 2 83.9 
Q8NEH6 2 85.9 Q499Z3 2 77.4 P14621 1 32 Q9H061 2 76 
Q8NFH3 2 74.4 Q53FT3 2 54.8 A1A4V9 1 31.4 Q9BWS9 2 43 
Q8NHS0 2 104.2 Q53QW1 2 50 A1A519 1 27.9 O60664 1 54.1 
Q8NHU2 2 52.1 Q5D862 2 78.5 A4QMS7 1 49 O60763 1 43 
Q9HAQ2 2 52.9 Q9H095 2 69.2 A6NFR6 1 29.5 O60884 1 35.2 
Q9HC35 2 59.1 Q9H299 2 80.6 A7E2U8 1 48.5 O60888 1 44.8 
Q9NPJ3 2 82.9 Q9H2U2 2 86.3 A8MV24 1 42.7 O75223 1 26.5 
Q9NQ48 2 64.3 Q9H361 2 61.8 A8MYZ5 1 28.4 O75251 1 26.2 
Q9NQP4 2 57.6 O14782 1 33.1 B3GLJ2 1 63.7 O75306 1 29.6 
P14735 1 48.6 P17980 1 36.9 P81605 1 38.8 Q02413 1 25 
P14868 1 24.9 P18440 1 27 P83881 1 24.9 Q02543 1 30.4 
P15291 1 28.1 P20151 1 31.2 Q00577 1 38.6 Q07021 1 51.5 
P15880 1 27.4 P21399 1 30.3 Q00765 1 52 Q07955 1 39 
P16444 1 28.5 P22033 1 34 Q00839 1 34.2 Q12798 1 33 
P16949 1 37.4 P78368 1 25.1 Q13144 1 43.9 Q12904 1 28.9 
P17152 1 31.2 P80748 1 33.9 Q13155 1 52 Q13107 1 37.1 
O96015 1 26.8 O14787 1 33.4 O00154 1 45.8 O75323 1 26.2 
P00846 1 33.6 O14791 1 51 O00161 1 28.3 O75348 1 45.1 
P01008 1 40 O14880 1 52 O00170 1 26 O75369 1 26 
P01033 1 25.7 O14949 1 28.9 O00303 1 51.4 O75380 1 38.9 
P01597 1 51.1 O15054 1 37.5 O00330 1 44.5 O75425 1 42.9 
P01616 1 35.2 O15084 1 38.8 O00483 1 37.9 O75487 1 31.7 
P01619 1 46.3 O15371 1 55.4 O14494 1 31.2 O75489 1 38.7 
P01625 1 32.4 O15511 1 49.7 O14521 1 32.6 O75503 1 25 
P01709 1 34 O43247 1 35.8 O14523 1 30.6 O75608 1 31.9 
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Protein  Peptides Score Protein Peptide score Protein Peptide Score Protein Peptide Score 
P01764 1 42.4 O43396 1 50.8 O14561 1 25.4 O75676 1 32.3 
P01765 1 42.4 O43414 1 26 O14579 1 27.4 O75928 1 27.1 
P01777 1 71.8 O43676 1 37.4 O14684 1 28 O75935 1 28.9 
P02511 1 54.1 O43716 1 25.4 O14737 1 47 O75964 1 34.7 
P02671 1 45.7 O43759 1 27.6 O95445 1 34.6 O94979 1 44.1 
P02749 1 53.7 O43765 1 26.2 O95456 1 52.1 O95816 1 44.3 
Q92506 1 34.8 Q96IY4 1 35.2 Q5T681 1 36.7 Q13630 1 46.5 
Q92530 1 48.5 Q96LK8 1 44.1 Q5TZF3 1 43.1 Q9Y285 1 34.6 
Q92542 1 32.7 Q96M91 1 35.5 Q5VTH2 1 30.6 Q9UHV9 1 29.7 
Q92597 1 48.2 Q9NY47 1 25.4 Q5VTT2 1 33.3 Q13347 1 27.4 
Q92696 1 25.7 Q9NZL4 1 32.9 Q5VVP1 1 36 P33316 1 38.1 
Q93100 1 36.2 Q9P1Z9 1 33.9 Q5VZ72 1 33.8 P46821 1 26.7 
Q969L2 1 26.8 Q9P2J5 1 29.6 Q5W041 1 43.1 O95865 1 31.9 
Q96A05 1 33.4 Q9P2M1 1 56.9 Q9UI09 1 27.5 O95870 1 26.3 
Q96AB3 1 38 Q9P2X0 1 30.9 Q9UIC8 1 30.3 O95989 1 32 
Q96CN7 1 45.2 Q9UBN7 1 26 Q9UJ68 1 44.2 O95995 1 31.8 
Q96CT7 1 35.1 Q9UDW1 1 34 Q9UJW0 1 36.9 P62266 1 30.1 
Q96DB2 1 37.5 Q9UGM3 1 82.6 Q9UKF5 1 25.6 P62277 1 42.3 
Q96DB5 1 36.4 Q9UGV2 1 26.2 Q9UMX
2 
1 54.5 P62306 1 37.7 
Q96EY8 1 49.8 O43805 1 47 O95473 1 55.5 P62310 1 40.8 
Q96FC7 1 26.9 O43808 1 29.6 O95749 1 28.4 P62316 1 32.9 
Q96FZ7 1 68.1 O43924 1 59.4 P56381 1 31.9 P62341 1 32.7 
Q96IV0 1 29.6 O60220 1 41.6 P56537 1 26.1 P62495 1 41.5 
P02765 1 31 O60271 1 26.1 P56597 1 51.1 P62750 1 44.6 
P02766 1 26.8 O95159 1 27.6 P57088 1 52.7 P62837 1 32.8 
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Protein  Peptides Score Protein Peptide score Protein Peptide Score Protein Peptide Score 
P02790 1 48.7 O95169 1 41.3 P58546 1 39.9 P62857 1 72.9 
P04066 1 41.6 O95373 1 25.5 P60981 1 33.4 P62910 1 34.9 
P04196 1 38.8 O95433 1 28.6 P61026 1 31.8 P62913 1 44.2 
P04433 1 39.3 P51659 1 24.8 P61088 1 41.9 P62942 1 47.6 
P05496 1 31 P51692 1 55.8 P61289 1 36.7 P63172 1 28.2 
P06703 1 27.6 P52198 1 58.2 P61626 1 58.6 P68402 1 48.2 
P07203 1 35.6 P52788 1 28.4 P61769 1 29.8 P78318 1 32.2 
P07311 1 31.3 P52948 1 40 P61803 1 46 Q8N7F7 1 41.1 
P48163 1 28.4 P53367 1 27.2 P61923 1 49.3 Q8N9A8 1 48.4 
P48449 1 27.4 P53618 1 34.4 P61966 1 34.9 Q8NA61 1 41.6 
P48454 1 32.3 P54578 1 67.6 P61970 1 31.7 Q8NCM2 1 43.5 
P48507 1 26.6 P54819 1 28.5 P62081 1 26.3 Q8NCS7 1 29.1 
P48556 1 34.5 P55036 1 69.4 Q8IW45 1 29 Q8ND76 1 48.6 
P48637 1 25.2 P55064 1 27.1 Q8IWG1 1 30.3 Q8NDH3 1 26.2 
P49223 1 34.4 P55809 1 55.2 Q8IY31 1 45.5 Q8NG35 1 28.9 
P49585 1 33.8 Q6UY27 1 28.6 Q8IYF3 1 56 Q8NHX4 1 37 
P49840 1 62.8 Q6YN16 1 32.3 Q8IYM1 1 30 Q8TAP6 1 26.9 
P49841 1 25.2 Q6ZNM6 1 42.3 Q8N104 1 54.2 Q8TAQ9 1 28.9 
P50395 1 34.9 Q6ZQQ2 1 25 Q8N1D5 1 29 Q8TBP0 1 28.4 
P51571 1 44.6 Q6ZST8 1 28.2 Q8N443 1 32.3 Q8TCD5 1 27.2 
Q5XX13 1 43.8 Q6ZVC0 1 39.3 Q8N5M
9 
1 29.2 Q8TF05 1 41.2 
Q68G75 1 35.4 Q76KD6 1 26.1 Q8N688 1 30.4 Q8TF09 1 70.5 
Q6DKK2 1 33.9 Q7RTN6 1 26.7 Q8N6K0 1 36.7 Q8TF72 1 28.5 
Q6EEV6 1 73.2 Q7Z3U7 1 24.9 Q8N6Q3 1 31.3 Q8WUD6 1 35.1 
Q6GMV3 1 37.3 Q7Z4T9 1 27.1 Q8N7B9 1 29.9 Q8WW14 1 39.2 
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Protein  Peptides Score Protein Peptide score Protein Peptide Score Protein Peptide Score 
Q6IPR1 1 24.9 Q7Z7G8 1 26.1 Q9BUP3 1 36.6 Q8WW32 1 35.6 
Q6NVY1 1 26.8 Q7Z7H3 1 33.2 Q9BVL2 1 33.1 Q8WXA2 1 52.1 
Q6NXE6 1 33.9 Q7Z7H5 1 35.6 Q9BVM
4 
1 59.7 Q9HD34 1 41.8 
Q6P047 1 26.6 Q86U86 1 34.6 Q9BW8
3 
1 27.2 Q9NPE6 1 34.4 
Q6P1Q0 1 25.1 Q86WA6 1 32.2 Q9BWX
1 
1 26.2 Q9NQ60 1 38.2 
Q6P9G0 1 30 Q86Y82 1 37.8 Q9BY14 1 42.4 Q9NQ88 1 41.3 
Q6PEW0 1 38.8 Q86YW0 1 28.8 Q9H0T7 1 34.1 Q9NQC3 1 28.4 
Q6PEY2 1 35.6 Q99733 1 28.5 Q9H0W
9 
1 29.6 Q9NQE9 1 36.2 
Q6PF18 1 39.6 Q99932 1 42.7 Q9H1E5 1 37.5 Q9NQW7 1 25.8 
Q6PI48 1 41.8 Q99988 1 25.4 Q9H3G5 1 34.2 Q9NRG7 1 70.3 
Q6SA08 1 28.6 Q9BPX5 1 31.6 Q9H4A4 1 38.4 Q9NS69 1 33.4 
Q6UW68 1 29.6 Q9BRX2 1 50.9 Q9H4K1 1 35.5 Q9NUQ2 1 26.2 
Q96MT7 1 34.6 Q9BSF0 1 25.9 Q9H579 1 27.5 Q16595 1 39.9 
Q96RM1 1 33.8 Q9GZT8 1 30.6 Q9H7C9 1 33.3 Q16851 1 26.4 
Q96RT7 1 40.2 Q9H069 1 27.7 Q9H9E3 1 52.2 Q16864 1 58.1 
Q96RY7 1 25.9 Q9H0D6 1 29.3 Q9HC38 1 71.6 Q17RC7 1 29.4 
Q96S96 1 49.5 Q9H0E2 1 28.7 Q9HC84 1 44.9 Q3B820 1 61.1 
Q99643 1 33.2 Q9H0I9 1 35.2 Q9HCN8 1 30 Q3KQZ1 1 27.7 
Q9BT73 1 25.3 Q9Y2Z0 1 37.5 Q13724 1 32.2 Q4G0N4 1 27.4 
Q9BUD6 1 31.3 Q9Y315 1 37 Q13838 1 26.1 Q5HYI8 1 32.3 
Q9BZ72 1 25 Q9Y512 1 32 Q14257 1 38.5 Q5JWF8 1 25.6 
Q9BYC2 1 39.3 Q9Y333 1 42.6 Q14166 1 32.1 Q5J5C9 1 29.2 
Q9BZH6 1 39.3 Q9NVV0 1 43.3 Q14435 1 32.8 Q5SQS8 1 26.9 
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Protein  Peptides Score Protein Peptide score Protein Peptide Score Protein Peptide Score 
Q9BZV1 1 42.1 Q9NWV4 1 27.2 Q149M9 1 25.6 Q5T0N1 1 28.9 
Q9C0B2 1 34.7 Q9UHY7 1 32.9 Q15084 1 70.1 Q5T1B0 1 32.4 
Q9Y547 1 42.4 P22234 1 25.9 Q15185 1 29.3 Q5T5A4 1 27.4 
Q9Y586 1 28.4 P23381 1 40.7 Q15365 1 36.8 P35052 1 27.2 
Q9Y5Y2 1 29.9 P24821 1 28.4 Q15388 1 31.7 Q9UNK0 1 35.7 
Q9Y6I9 1 30 P26447 1 33.1 Q15645 1 31.4 P43686 1 38.1 
Q9Y6M0 1 30.4 P30049 1 59.6 Q15742 1 27.5 P45877 1 26.2 
P35080 1 28.8 P30050 1 32.6 Q16186 1 31.3 P46782 1 54.9 
P35270 1 73.2 P30085 1 28.6 Q16568 1 40 P31153 1 39.2 
P35606 1 32.5 P30740 1 35.9 P46977 1 46.5 P31949 1 37.8 
P35754 1 34.6 P31151 1 43.8 P47914 1 35.1 P37198 1 31.4 
P36957 1 54.3 P40121 1 47       
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Appendix 5 (chapter 4)  
List of the metabolites identified in the sperm metabolomics study:  
1- Metabolites higher in the TP1 samples  
IDX p.value FDR mz rt Metabolites Metabolite Class ION 
MODE 
588 0.021584 0.9759 183.0646185 255.077586 Methylpentanoic acid;Caproic acid Fatty acids and oxidised 
fatty acids 
negative 
1035 0.035158 0.99901 265.1194304 114.885498 Phenylalanyl-Threonine Peptides negative 
1048 0.027021 0.99865 234.8004888 135.053322 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
Positive  
1187 0.001384
3 
0.51021 245.6462623 257.383779 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
positive 
1457 0.030621 0.99865 267.1330763 115.19577 Phenylalanyl-Threonine Peptides positive 
1469 0.029119 0.99865 268.1366039 114.523758 Phenylalanyl-Threonine Peptides positive 
1682 0.00703 0.99901 338.1356017 162.22971 Glutaminyl-Phenylalanine;Phenylalanyl-Gamma-glutamate Peptides negative 
1691 0.007920
9 
0.99901 339.1387588 162.54696 Glutaminyl-Phenylalanine;Phenylalanyl-Gamma-glutamate Peptides negative 
1721 0.008636
8 
0.99865 291.1343325 63.913953 Thyronine Hormones positive 
1728 0.037948 0.93227 289.2066532 104.588253 Arginyl-Isoleucine;Arginyl-Leucine Peptides positive 
2088 0.004140
5 
0.87782 321.9179841 263.844756 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
positive 
2304 0.022531 0.93227 358.3741645 63.71853 Multiply Charged ion - possible proteins and peptides Possibly proteins or 
peptides 
positive 
2445 0.024818 0.99865 351.6980238 133.96035 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
positive 
2480 0.004620
4 
0.88272 354.6834161 270.943686 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
positive 
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IDX p.value FDR mz rt Metabolites Metabolite Class ION 
MODE 
2484 0.005529 0.93227 386.3797216 225.127602 3-Deoxyvitamin D3 Vitamin D metabolism positive 
2516 0.015997 0.99865 357.8359618 182.646258 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
positive 
2537 0.010531 0.93227 395.1956368 237.543084 10,11-dihydro-12-oxo-LTB4";11-deoxy-PGE2;11-HpETE;"11,12-
DiHETE";"11H-14,15-EETA";11HPETE;12HPETE;12Leukotriene 
B4;"14,15-DiHETE";"14,15-Dihydroxy-8(17),13(16)-labdadien-19-
oic acid";"14,15-HxA3 ";"14,15-HxB3 ";15-epi-PGA1;"15H-11,12-
EETA";15HPETE;"17,18-DiHETE";5-HPETE;"5,12-DiHETE";"5,15-
DiHETE";5Hydroperoxyeicosatetraenoic acid;6-trans-12-epi-
Leukotriene B4;6-trans-Leukotriene B4;"6,7-dihydro-5-oxo-12-
epi-LTB4";8-iso-PGA1;"8,15-DiHETE";"8,9-DiHETE";8HPETE;9-
HpETE;HpETE;Leukotriene B4;Prostaglandin A1;Prostaglandin B1 
Fatty acids and oxidised 
fatty acids 
positive 
2575 0.016202 0.99865 363.5077124 97.088226 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
positive 
2752 0.008672
4 
0.99901 478.2256405 290.591064 10,11-Dihydrohydroxy-leukotriene E4 Fatty acids and oxidised 
fatty acids 
negative 
2814 0.000233
37 
0.23407 384.6878227 286.063743 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
positive 
2893 0.029376 0.93227 447.716048 64.117023 Multiply Charged ion - possible proteins and peptides Possibly proteins or 
peptides 
positive 
2923 8.51E-05 0.23407 395.1933549 281.223576 methyl-hexadecenoic acid;Heptadecenoic acid Fatty acids and oxidised 
fatty acids 
positive 
3059 0.023352 0.99865 409.5531826 273.804912 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
positive 
3081 0.015335 0.93227 482.7239441 224.530227 Multiply Charged ion - possible proteins and peptides Possibly proteins or 
peptides 
positive 
3165 0.046435 0.99865 419.2239033 329.877678 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
positive  
3211 0.044981 0.99865 424.1909035 66.400026 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
positive 
3225 0.034585 0.9759 590.273408 237.65019 PS[18:1];;PS[20:4] Glycerophospholipids Negative  
3325 0.023855 0.99865 436.1976457 62.781819 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
positive 
3337 0.042989 0.99865 437.7129274 90.449511 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
positive 
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IDX p.value FDR mz rt Metabolites Metabolite Class ION 
MODE 
3356 0.035481 0.9759 712.2213762 140.085261 Isoliquiritigenin 4-O-(5'''-O-p-coumaroyl)-apiofuranosyl-(1'''->2''')-
glucoside;Licorice glycoside B;Licorice glycoside D1;Licorice glycoside D2 
Other class Negative 
3402 0.049125 0.99865 443.554656 267.34929 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
Positive  
3450 0.007658
7 
0.99865 448.4564397 257.254476 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
Positive  
3463 0.04037 0.99901 713.3204854 272.530044 PA[28:2] Glycerophospholipids Negative  
3510 0.001864
3 
0.55761 456.2422176 286.002705 20-Hydroxy-leukotriene E4;20-hydroxy-LTE4;Lipoxin E4 Fatty acids and oxidised 
fatty acids 
Positive 
3540 0.030947 0.99865 460.2389423 283.194828 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
Positive  
3599 0.030629 0.99865 467.2400769 275.054916 1(3)-glyceryl-PGF2alpha;2-glyceryl-PGF2alpha;;"4,5-
epoxyHDHA";;14-F2-dihomo-IsoP;15-methylPGF2alpha methyl 
ester;"16,16-dimethyl-PGE1";"16,16-dimethyl-PGF2beta";17-F2-
dihomo-IsoP;"1a,1b-dihomo-PGE1";"1a,1b-dihomo-
PGF2alpha";20-ethyl PGF2alpha;7-F2-dihomo-IsoP 
Fatty acids and oxidised 
fatty acids 
Positive  
3603 0.001089
1 
0.51021 467.5706048 273.406038 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
Positive  
3612 0.030094 0.99865 468.8948025 272.435157 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
Positive  
3712 0.033981 0.99865 480.2403847 290.608452 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
Positive  
3732 0.012331 0.99865 482.720317 172.808772 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
Positive  
3733 0.011481 0.99865 482.7204151 115.928622 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
Positive  
3754 0.010539 0.93227 643.6290981 225.460407 Multiply Charged ion - possible proteins and peptides Possibly proteins or 
peptides 
positive  
3902 0.024119 0.93227 688.7547238 250.125924 Multiply Charged ion - possible proteins and peptides Possibly proteins or 
peptides 
positive  
4574 0.003470
5 
0.81904 592.7948106 277.852761 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
Positive  
4726 0.001681
3 
0.55761 613.8240498 274.291953 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
Positive  
4971 0.017709 0.99865 643.2905047 115.2348 Multiply Charged ion - possible peptide or protein Possible protein and Positive  
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peptide 
4980 0.0378 0.99865 644.0980283 286.062792 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
Positive  
5378 0.018065 0.99865 702.8383263 272.282946 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
Positive  
 
 
2- Metabolites higher in the TP7 samples  
IDX p.value FDR mz rt Metabolites Metabolite Class ION 
MODE 
9 0.036447 0.9759 102.0561245 84.281442 Aminobutanoic acid;Aminoisobutanoic acid;Dimethylglycine Other class negative 
52 0.033867 0.93227 107.0492223 141.868272 Benzaldehyde Fatty acids and oxidised 
fatty acids 
positive 
71 0.043134 0.9759 116.0718273 56.486883 5-Aminopentanoic acid;Betaine;Norvaline Amino acid metabolism negative 
109 0.026818 0.9759 125.0246933 237.375054 1,2,3-Trihydroxybenzene;"1,3,5-Trihydroxybenzene";4-Hydroxy-2H-pyran-
3-carboxaldehyde;Methyl 2-furoate 
Mixed class negative 
122 0.01562 0.9759 128.0354654 52.7772594 1-Pyrroline-4-hydroxy-2-carboxylate;N-Acryloylglycine;Pyroglutamic 
acid;Pyrrolidonecarboxylic acid;Furoic acid 
Arginine and proline 
metabolism 
negative 
220 0.031304 0.93227 128.0706205 214.923684 (▒)-4-Methylene-2-pyrrolidinecarboxylic acid;"2,3,4,5-
Tetrahydropiperidine-2-carboxylate";D-1-Piperideine-2-carboxylic 
acid;;"1,3-Benzenediol";"2,4-Hexadienedial";Muconic 
dialdehyde;Pyrocatechol 
Mixed class positive 
263 0.030506 0.93227 132.0541475 141.604116 1-(2-Furanylmethyl)-1H-pyrrole Other class positive 
301 0.04311 0.93227 138.0527504 51.807444 Proline Arginine and proline 
metabolism 
positive 
383 0.031405 0.93227 147.1129879 44.4615126 Lysine Amino acid metabolism positive 
465 0.034795 0.93227 156.0770912 46.4663982 Nicotinamide N-oxide;Urocanic acid Mixed class positive 
645 0.024376 0.93227 175.1188903 47.3949654 Arginine Arginine and proline 
metabolism 
positive 
751 0.012425 0.93227 188.0683809 141.817647 3-Pyridinebutanoic acid;Norsalsolinol Mixed class positive 
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IDX p.value FDR mz rt Metabolites Metabolite Class ION 
MODE 
752 0.025975 0.93227 188.0709048 241.02711 Tryptophan Amino acid metabolism positive 
827 0.026436 0.93227 195.115485 62.931615 Decenol Fatty acids and oxidised 
fatty acids 
positive 
974 0.015242 0.93227 212.1047932 68.125701 2-Propylpiperidine Other class positive 
1108 0.046479 0.9759 236.083055 270.957468 2,3,4,5,6,7-Hexahydro-6,7-dimethylcyclopent[b]azepin-8(1H)-one;"3,4-
Dimethyl-2-(1-pyrrolidinyl)-2-cyclopenten-1-one";"trans-4,5-Dimethyl-2-
(1-pyrrolidinyl)-2-cyclopenten-1-one 
Other class negative 
1165 0.01096 0.9759 241.118974 258.181632 Dodecenoic acid;Methyl-undecenoate Fatty acids and oxidised 
fatty acids 
negative 
1190 0.004006
9 
0.99901 281.2486169 577.774284 Octadecenoic acid;methyl-heptadecenoic acid Fatty acids and oxidised 
fatty acids 
negative 
1269 0.034021 0.9759 251.0797958 259.758522 Deoxyinosine;Dethiobiotin Mixed class negative 
1276 0.011314 0.9759 252.0859138 247.56129 Isovalerylglutamic acid;Suberylglycine Amino acid metabolism negative 
1315 0.009048
2 
0.99901 295.2276752 496.389285 Oxo-octadecenoic acid;Hydroxy-octadecadienoic acid;12-OxoOME;"12,13-
EpOME";"12,13-EpOME(9)";6-HODE;9-HODE;"9,10-
EpOME(12)";Epoxyoctadecenoic acid 
Fatty acids and oxidised 
fatty acids 
negative 
1333 0.040588 0.99901 297.2432106 507.39738 10-HOME(8);Oxooctadecanoic acid;11-HOME(9);12-HOME;13-HpOME;17-
HOME;19-HOME;5-HOME(2);;8-HOME(9);9-HOME;9-HOME(12) 
Fatty acids and oxidised 
fatty acids 
negative 
1339 0.039973 0.99901 298.2465666 507.385632 10-HOME(8);Oxooctadecanoic acid;11-HOME(9);12-HOME;13-HpOME;17-
HOME;19-HOME;5-HOME(2);;8-HOME(9);9-HOME;9-HOME(12) 
Fatty acids and oxidised 
fatty acids 
negative 
1345 0.024823 0.93227 250.0388463 142.672257 Norepinephrine sulfate Sterol and steroid 
metabolism 
positive 
1571 0.033151 0.9759 283.9293679 113.475189 Cysteine-S-sulfate Sulphur metabolism negative 
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IDX p.value FDR mz rt Metabolites Metabolite Class ION 
MODE 
1898 0.024197 0.9759 317.0211759 82.773975 gamma-Glutamyl-S-methylcysteine sulfoxide;Cysteinyl-Hydroxyproline Peptides negative 
1906 0.045118 0.99901 365.2306628 506.671614 10-HOME(8);Oxooctadecanoic acid;11-HOME(9);12-HOME;13-HpOME;17-
HOME;19-HOME;5-HOME(2);;8-HOME(9);9-HOME;9-HOME(12) 
Fatty acids and oxidised 
fatty acids 
negative 
2027 0.000684
43 
0.41887 381.1720615 576.789336 9-Octadecenal Fatty acids and oxidised 
fatty acids 
negative 
2037 0.006904
5 
0.99901 382.1755899 576.762948 9-Octadecenal Fatty acids and oxidised 
fatty acids 
negative 
2247 0.03945 0.9759 358.1262286 76.049436 Hydroxyhexanoycarnitine Acyl carnitines negative 
2380 0.041963 0.9759 377.2294313 301.21443 13,14-Dihydro PGE1;"13,14-Dihydro PGF2a";"13,14-dihydro-15-keto-
PGF1alpha";"13,14-dihydro-PGF2alpha";PGF1beta;Prostaglandin F1a 
Fatty acids and oxidised 
fatty acids 
negative 
2621 0.017857 0.9759 416.1792654 69.228369 Coutaric acid Other class negative 
2673 0.009106
9 
0.9759 425.1721083 272.675535 11-Dehydro-thromboxane B2;11-dehydro-TXB2;19-Hydroxy-PGE2;"20-
COOH-10,11-dihydro-LTB4";20-dihydroxyleukotriene B4;20-hydroxy-
PGD2;20-Hydroxy-PGE2;"5,12-diHPETE";"5,15-diHPETE";5(6)-Epoxy 
Prostaglandin E1;6-Ketoprostaglandin E1;"6,15-Diketo,13,14-dihydro-
PGF1a";"8,15-diHPETE";D17, 6-keto PGF1a";diHPETE;hydroperoxy-
PGD2;hydroperoxy-PGE2;Prostaglandin G2;16,17-epoxy-DHA";"16,DHA-
epoxide 
Fatty acids and oxidised 
fatty acids 
negative 
2757 0.033887 0.9759 442.166732 645.41436 Chitobiose Carbohydrates negative 
3096 0.023398 0.9759 527.211275 186.498876 16,17-Dihydro-16a,17-dihydroxygibberellin A4 17-glucoside;;"3)-2-
(acetylamino)-1,5-anhydro-2-deoxy-D-arabino-Hex-1-enitol";"4)-2-
(acetylamino)-1,5-anhydro-2-deoxy-D-arabino-Hex-1-enitol 
Mixed class negative 
3144 0.01282 0.9759 545.222018 82.201905 3)-2-(acetylamino)-2-deoxy-D-Galactose Carbohydrates negative 
3436 0.014969 0.93227 557.2904566 238.479102 Cholesterol sulfate;;"26,27-Dihomo-1alpha-hydroxy-24-epivitamin 
D2";"26,27-Dihomo-1alpha-hydroxyvitamin D2";28-Hydroxy-14-
taraxeren-3-one;32-oxolanosterol;3beta-3-Hydroxy-18-lupen-21-
one;3beta-Hydroxy-22(30)-hopen-29-al;"4,4-Dimethyl-14a-formyl-5a-
cholesta-8,24-dien-3b-ol 
Sterol and steroid 
metabolism 
positive 
3578 0.048024 0.93227 594.3073006 245.573466 PC(P-19:1/0:0) Glycerophospholipids positive 
3617 0.044844 0.93227 609.312446 248.819763 PG[22:2] Glycerophospholipids positive 
3999 0.045369 0.93227 725.3757941 260.206179 PG[30:4];PA[32:4] Glycerophospholipids positive 
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IDX p.value FDR mz rt Metabolites Metabolite Class ION 
MODE 
4313 0.034015 0.99865 561.8434171 275.787015 Multiply Charged ion - possible peptide or protein Possible protein and 
peptide 
positive 
6088 0.012633 0.99865 807.4122655 282.513804 1alpha,3beta,Trihydroxyergosta-5,-dien-26-oic acid 3-O-b-D-glucoside 26-
O-b-D-glucosyl ester";;PA[39:7];Octaprenyl diphosphate;PG[29:0] 
Mixed class positive 
4048 0.040556 0.93227 749.7087436 258.129228 Multiply Charged ion - possible proteins and peptides Possibly proteins or 
peptides 
positive 
2979 0.02015 0.93227 464.2461608 237.615198 Multiply Charged ion - possible proteins and peptides Possibly proteins or 
peptides 
positive 
 
3- Metabolites higher in the control media  
IDX p.value FDR mz rt Metabolites Metabolite Class ION MODE 
489 0.042884 0.99865 177.0641043 385.675848 2-Ethylpyrazine Other class positive 
832 0.0084477 0.93227 196.1196554 732.23673 Dibutyl disulfide Sulphur metabolism positive 
1012 0.024578 0.99865 231.0344358 154.954944 Dimethyluracil;Imidazolepropionic acid;Methylimidazoleacetic acid Mixed class positive 
1095 0.049493 0.9759 234.9805272 53.8880178 3,3'-Thiobispropanoic acid Sulphur metabolism negative 
1327 0.049503 0.99901 297.0973778 316.389606 2-Phenylethanol glucuronide;;Asparaginyl-Lysine;Lysyl-Asparagine Peptides negative 
2384 0.04777 0.99865 346.2359678 552.538209 12-Methoxy-8,11,13-abietatrien-20,11-olide;"9,11alpha-epoxypregn-4-
ene-3,20-dione 
Sterol and steroid metabolism positive 
2506 0.011861 0.99865 356.9082142 808.62708 3,3-Dibromo-2-n-hexylacrylic acid Other class positive 
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Appendix 6 (chapter 5)  
MTALAB codes for vorticity analysis :  
 
for j=1:456 
    clear u v vort x y 
    load(sprintf('PIVlab_%04d.mat',j)); 
  
    u1(:,:,j) = u; 
    v1(:,:,j) = v; 
     w(:,:,j) = vort; 
     V(:,:,j) = sqrt(u.^2 + v.^2); 
    x1(:,:,j) = x; 
    y1(:,:,j) = y; 
     
end 
  
%% 
figure; 
for j=1:456 
  
  pcolor(x1(:,:,j),y1(:,:,j),w(:,:,j)); shading interp 
 % pcolor(x1(:,:,j),y1(:,:,j),V(:,:,j)); shading interp 
hold on; 
quiver(x1(:,:,j),y1(:,:,j),u1(:,:,j),v1(:,:,j),'b') 
hold off 
axis equal tight 
colormap jet 
title(sprintf('%04d',j)) 
colorbar 
  
%set(gca, 'CLim', [Vmin, 20*10^-6]); 
set(gca, 'CLim', [-80, 80]); 
    F(j) = getframe; 
end 
  
%% 
  
for j=1:456 
     
  Vmean(j) = mean(mean(V(:,:,j))); 
  Vstd(j) = std(std(V(:,:,j))); 
   
  wmean(j) = mean(mean(abs(w(:,:,j)))); 
  wstd(j) = std(std(w(:,:,j))); 
   
end 
  
%% 
figure; 
subplot(1,2,1);plot(Vmean) 
subplot(1,2,2);plot(Vstd) 
  
figure 
subplot(1,2,1);plot(wmean) 
297 
 
subplot(1,2,2);plot(wstd) 
  
figure; 
plotyy(1:456,Vmean,1: 456,wmean) 
  
%% Fourier Transform 
figure; 
Fs = 100;                    % Sampling frequency 
T = 1/Fs;                     % Sampling period 
L = 456;                     % Length of signal 
t = (0:L-1)*T;                % Time vector 
  
f = Fs*(0:(L/2))/L; 
Y = fft(Vmean); 
P2 = abs(Y/L); 
P1 = P2(1:L/2+1); 
P1(2:end-1) = 2*P1(2:end-1); 
  
plot(f,P1) 
title('Single-Sided Amplitude Spectrum of S(t)') 
xlabel('f (Hz)') 
ylabel('|P1(f)|') 
  
%% 
wsum=0; 
Vsum=0; 
for j=1:456 
  
  wsum = wsum + abs(w(:,:,j)); 
  Vsum = Vsum + V(:,:,j); 
end 
%% 
figure 
 pcolor(x1(:,:,j),y1(:,:,j),wsum); shading interp 
  
axis equal tight 
colormap jet 
  
colorbar 
  
set(gca, 'CLim', [0, 2000]);
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